FN Thomson Reuters Web of Science™ VR 1.0 PT J AU DAVIS, H BAUM, C GRAHAM, DJ AF DAVIS, H BAUM, C GRAHAM, DJ TI INDEXES OF DRUG MISUSE FOR PRESCRIPTION DRUGS SO INTERNATIONAL JOURNAL OF THE ADDICTIONS LA English DT Article DE DRUG AND NARCOTIC CONTROL; SUBSTANCE ABUSE; SUBSTANCE DEPENDENCE; PRESCRIPTIONS, DRUG ID ABUSE WARNING NETWORK; CLINICAL-PRACTICE; DEPENDENCE; DAWN AB Few studies of prescription-drug misuse have taken into account the numbers of prescriptions dispensed for specific drugs. Using data from the Drug Abuse Warning Network (DAWN) and the National Prescription Audit, we calculated indices of drug misuse for specific prescription drugs that are used mainly in outpatient settings and are either benzodiazepines, barbiturates, other sedative-hypnotics, analgesics, or CNS stimulants. In 1983-1985 the drugs associated with the highest numbers of DAWN medical examiner-reported drug-misuse deaths were codeine, diazepam, propoxyphene, phenobarbital, and secobarbital. However, the drugs with the highest indices of DAWN medical examiner-reported drug-misuse deaths/100,000 dispensed prescriptions were methamphetamine, methaqualone, amobarbital, secobarbital, and glutethimide. An index of fatality risk, calculated as 100 x DAWN medical examiner-reported drug-misuse deaths/DAWN emergency room-reported drug-misuse episodes, suggested that the risk of death from a glutethimide-associated drug-misuse episode had increased 92% from 1975-1979 to 1983-1983 and in 1983-1985 was the highest for the drugs studied. These indices might assist public health authorities attempting to design effective strategies to efficiently address the problem of prescription-drug misuse. C1 US FDA,OFF EPIDEMIOL & BIOSTAT,ROCKVILLE,MD 20857. US FDA,DIV EPIDEMIOL SURVEILLANCE,ROCKVILLE,MD 20857. US FDA,CTR DRUG EVALUAT & RES,EPIDEMIOL BRANCH,ROCKVILLE,MD 20857. RP DAVIS, H (reprint author), NATL CTR HLTH STAT,DIV HLTH EXAMINAT STAT,6525 BELCREST RD,HYATTSVILLE,MD 20782, USA. NR 11 TC 9 Z9 9 U1 0 U2 1 PU MARCEL DEKKER INC PI NEW YORK PA 270 MADISON AVE, NEW YORK, NY 10016 SN 0020-773X J9 INT J ADDICT JI Int. J. Addict. PY 1991 VL 26 IS 7 BP 777 EP 795 PG 19 WC Substance Abuse; Psychiatry SC Substance Abuse; Psychiatry GA GF435 UT WOS:A1991GF43500005 PM 1960000 ER PT B AU PITTMAN, M AF PITTMAN, M BE SATO, Y SATO, H TIRU, M BROWN, F TI HISTORY OF THE DEVELOPMENT OF PERTUSSIS-VACCINE SO INTERNATIONAL SYMPOSIUM ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES SE DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION LA English DT Proceedings Paper CT INTERNATIONAL SYMP ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES CY SEP 14-15, 1990 CL TEIJIN INST EDUC & TRAINING, SHIZUOKA, JAPAN SP NIH, INT ASSOC BIOL STANDARDIZAT, AMVAX, BANYU PHARM, BIKEN, CHIBA SERUM INST, DENKA, KAKETSUKEN, KITASATO INST, LEDERLE PRAXIS BIOL HO TEIJIN INST EDUC & TRAINING RP PITTMAN, M (reprint author), US FDA,CTR BIOL EVALUAT & RES,HFB-210,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 0 TC 14 Z9 14 U1 0 U2 1 PU KARGER PI BASEL PA BASEL BN 3-8055-5457-5 J9 DEV BIOLOGICALS JI Dev. Biols PY 1991 VL 73 BP 13 EP 29 PG 17 WC Immunology; Medicine, Research & Experimental; Pathology SC Immunology; Research & Experimental Medicine; Pathology GA BU66A UT WOS:A1991BU66A00003 PM 1778306 ER PT B AU STIBITZ, S YANG, MS AF STIBITZ, S YANG, MS BE SATO, Y SATO, H TIRU, M BROWN, F TI GENETIC AND IMMUNOLOGICAL STUDIES ON POLYPEPTIDES ENCODED BY THE VIR LOCUS OF BORDETELLA-PERTUSSIS SO INTERNATIONAL SYMPOSIUM ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES SE DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION LA English DT Proceedings Paper CT INTERNATIONAL SYMP ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES CY SEP 14-15, 1990 CL TEIJIN INST EDUC & TRAINING, SHIZUOKA, JAPAN SP NIH, INT ASSOC BIOL STANDARDIZAT, AMVAX, BANYU PHARM, BIKEN, CHIBA SERUM INST, DENKA, KAKETSUKEN, KITASATO INST, LEDERLE PRAXIS BIOL HO TEIJIN INST EDUC & TRAINING RP STIBITZ, S (reprint author), US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20014, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU KARGER PI BASEL PA BASEL BN 3-8055-5457-5 J9 DEV BIOLOGICALS JI Dev. Biols PY 1991 VL 73 BP 87 EP 91 PG 5 WC Immunology; Medicine, Research & Experimental; Pathology SC Immunology; Research & Experimental Medicine; Pathology GA BU66A UT WOS:A1991BU66A00011 PM 1778338 ER PT B AU KENIMER, JG PROBST, PG KARPAS, AB BURNS, DL KASLOW, HR AF KENIMER, JG PROBST, PG KARPAS, AB BURNS, DL KASLOW, HR BE SATO, Y SATO, H TIRU, M BROWN, F TI MONOCLONAL-ANTIBODIES AGAINST THE ENZYMATIC SUBUNIT OF BOTH PERTUSSIS AND CHOLERA TOXINS SO INTERNATIONAL SYMPOSIUM ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES SE DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION LA English DT Proceedings Paper CT INTERNATIONAL SYMP ON PERTUSSIS : EVALUATION AND RESEARCH ON ACELLULAR PERTUSSIS VACCINES CY SEP 14-15, 1990 CL TEIJIN INST EDUC & TRAINING, SHIZUOKA, JAPAN SP NIH, INT ASSOC BIOL STANDARDIZAT, AMVAX, BANYU PHARM, BIKEN, CHIBA SERUM INST, DENKA, KAKETSUKEN, KITASATO INST, LEDERLE PRAXIS BIOL HO TEIJIN INST EDUC & TRAINING RP KENIMER, JG (reprint author), US FDA,CTR BIOL EVALUAT & RES,CELLULAR PHYSIOL LAB,BETHESDA,MD 20892, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU KARGER PI BASEL PA BASEL BN 3-8055-5457-5 J9 DEV BIOLOGICALS JI Dev. Biols PY 1991 VL 73 BP 133 EP 141 PG 9 WC Immunology; Medicine, Research & Experimental; Pathology SC Immunology; Research & Experimental Medicine; Pathology GA BU66A UT WOS:A1991BU66A00015 PM 1778307 ER PT B AU MARCUSSEKURA, CJ AF MARCUSSEKURA, CJ GP INT ASSOC BIOL STANDARDIZAT TI VALIDATION OF REMOVAL OF HUMAN RETROVIRUSES SO INTERNATIONAL SYMPOSIUM ON VIROLOGICAL ASPECTS OF THE SAFETY OF BIOLOGICAL PRODUCTS SE DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION LA English DT Proceedings Paper CT INTERNATIONAL SYMP ON VIROLOGICAL ASPECTS OF THE SAFETY OF BIOLOGICAL PRODUCTS CY NOV 08-09, 1990 CL ZOOL SOC LONDON, LONDON, ENGLAND SP ARES SERONO SYMP HO ZOOL SOC LONDON RP MARCUSSEKURA, CJ (reprint author), US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20014, USA. NR 0 TC 1 Z9 1 U1 0 U2 1 PU KARGER PI BASEL PA BASEL BN 3-8055-5467-2 J9 DEV BIOLOGICALS JI Dev. Biols PY 1991 VL 75 BP 133 EP 143 PG 11 WC Biology; Medicine, Research & Experimental; Virology SC Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine; Virology GA BU82W UT WOS:A1991BU82W00016 PM 1794615 ER PT J AU BENINGER, PR COOPER, EC AF BENINGER, PR COOPER, EC TI POSTEXPOSURE CHEMOPROPHYLAXIS - APPROVAL CRITERIA FOR CLINICAL-TRIALS SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY LA English DT Article AB Five scenarios are proposed that investigators and clinicians might consider in the evaluation of an investigational drug for postexposure chemoprophylaxis. They are (a) safety as the only standard required for an indication for postexposure chemoprophylaxis; (b) efficacy of the drug for treatment of HIV-infected patients as a sufficient criterion for an indication for postexposure chemoprophylaxis; (c) a classic placebo-controlled trial as the basis for evaluation of postexposure chemoprophylaxis; (d) a clinical trial design that evaluates outcome in relation to varying times from exposure to initiation of treatment; and (e) combination therapy. Federal regulations are sufficiently flexible to allow demonstration of safety and efficacy of an investigational drug for this indication. The necessary element is that both safety and efficacy be demonstrated in an objective and reliable manner. C1 US FDA,DIV ANTIVIRAL DRUG PROD,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU LIPPINCOTT-RAVEN PUBL PI PHILADELPHIA PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 SN 1077-9450 J9 J ACQ IMMUN DEF SYND JI J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. PY 1991 VL 4 IS 5 BP 513 EP 515 PG 3 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA FG785 UT WOS:A1991FG78500009 PM 2016688 ER PT J AU HENDRY, RM PARKS, DE MELLO, DLAC QUINNAN, GV CASTRO, BG AF HENDRY, RM PARKS, DE MELLO, DLAC QUINNAN, GV CASTRO, BG TI LACK OF EVIDENCE FOR HIV-2 INFECTION AMONG AT-RISK INDIVIDUALS IN BRAZIL SO JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY LA English DT Article DE HIV-1; HIV-2; BRAZIL; CROSS-REACTIVITY ID IMMUNODEFICIENCY VIRUS HIV; T-LYMPHOTROPIC RETROVIRUS; CROSS-REACTIVITY; WESTERN BLOT; AIDS; TYPE-2; ANTIBODIES; AMERICAS; PATIENT; SERA AB Recent reports have indicated the possibility that HIV-2 has been introduced into groups at risk for AIDS in Brazil. We studied sera collected in 1987 and 1988 from 1,821 at-risk individuals from diverse regions in Brazil. Of the 1,821 sera, 367 (20%) were confirmed as being positive for HIV-1 antibodies by enzyme-linked immunosorbent assay (ELISA), immunofluorescence (IF), and Western blot. An additional 33 (2%) sera displayed some reactivity to HIV-2-infected cells by IF. All 33 sera were subsequently tested in HIV-1 and HIV-2 Western blots as well as an ELISA using HIV-1- or HIV-2-specific peptides. All sera were confirmed as positive for HIV-1 and negative for HIV-2 antibodies in both assays. We conclude that caution should be used in the interpretation of serologic cross-reactivity between HIV-1 and HIV-2 and that there is no evidence that HIV-2 has entered groups at risk for HIV infection in Brazil. C1 US FDA,CTR BIOL EVALUAT & RES,DIV VIROL,RETROVIRUS RES LAB,BETHESDA,MD 20014. JOHNSON & JOHNSON BIOTECHNOL CTR,LA JOLLA,CA. FUNDACAO OSWALDO CRUZ,WHO,COLLABORATING CTR AIDS,SALVADOR,BA,BRAZIL. NR 33 TC 7 Z9 7 U1 0 U2 1 PU LIPPINCOTT-RAVEN PUBL PI PHILADELPHIA PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 SN 1077-9450 J9 J ACQ IMMUN DEF SYND JI J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. PY 1991 VL 4 IS 6 BP 623 EP 627 PG 5 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA FM102 UT WOS:A1991FM10200011 PM 2023103 ER PT J AU HOLCOMB, M THOMPSON, HC AF HOLCOMB, M THOMPSON, HC TI ANALYSIS OF AFLATOXIN-(B1, AFLATOXIN-B2, AFLATOXIN-G1, AND AFLATOXIN-G2) IN RODENT FEED BY HPLC USING POSTCOLUMN DERIVATIZATION AND FLUORESCENCE DETECTION SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY LA English DT Article ID POST-COLUMN DERIVATIZATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; SAMPLE CLEANUP; FOODS AB Aflatoxins are cancer-causing toxins that are produced by the molds Aspergillus flavus and Aspergillus parasiticus when the ideal environmental conditions such as temperature and humidity are met. An existing method was modified for application to the analysis of aflatoxins in vitamin-fortified rodent feeds. The aflatoxins were extracted from the feeds with 70% methanol/water followed by cleanup on an affinity column. The aflatoxins were eluted from the affinity column with methanol and quantitated via HPLC using postcolumn derivatization with iodine followed by fluorescence detection. The minimum detectable limit was 0.25 ppb for B1, B2, and G1 and 0.12 ppb for G2. Recoveries for B1 and G1 averaged 85% over a concentration range of 0.5-50 ppb. Recoveries for B2 averaged 77% over the same range, while recoveries for G2 averaged 58% over a concentration range of 0.25-25 ppb. The method was also successfully used for analysis of aflatoxins in animal cage bedding material. RP HOLCOMB, M (reprint author), US FDA,NATL CTR TOXICOL RES,DIV CHEM,OFF RES SERV,JEFFERSON,AR 72079, USA. NR 13 TC 17 Z9 17 U1 2 U2 9 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0021-8561 J9 J AGR FOOD CHEM JI J. Agric. Food Chem. PD JAN PY 1991 VL 39 IS 1 BP 137 EP 140 DI 10.1021/jf00001a026 PG 4 WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology SC Agriculture; Chemistry; Food Science & Technology GA ET705 UT WOS:A1991ET70500027 ER PT J AU GROSSMAN, LW KNIGHT, WB AF GROSSMAN, LW KNIGHT, WB TI RESOLUTION TESTING OF INTRAOCULAR LENSES SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY LA English DT Article DE ACCEPTANCE TESTING; INTRAOCULAR LENS; POLY(METHYL METHACRYLATE); RESOLUTION; STANDARD AB A basic goal associated with the manufacture of intraocular lenses (IOLs) is that they not be vision limiting. Manufacturers must therefore test IOL resolution against some minimum requirement. Currently, American National Standards Institute voluntary standard Z80.7-1984 addresses IOL optical requirements. One criterion of this standard is a minimum resolving power of 100 line-pairs-permillimeter. This report presents some results of lens testing that suggest this standard is inadequate because it may not control the performance of a large enough fraction of the optic aperture. RP GROSSMAN, LW (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,OFF SCI & TECHNOL,1901 CHAPMAN AVE,ROCKVILLE,MD 20857, USA. NR 0 TC 6 Z9 6 U1 0 U2 0 PU AMER SOC CATARACT REFRACTIVE SURGERY PI FAIRFAX PA 4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 SN 0886-3350 J9 J CATARACT REFR SURG JI J. Cataract. Refract. Surg. PD JAN PY 1991 VL 17 IS 1 BP 84 EP 90 PG 7 WC Ophthalmology; Surgery SC Ophthalmology; Surgery GA ET458 UT WOS:A1991ET45800013 PM 2005564 ER PT J AU HERRERA, CR LYNCH, C AF HERRERA, CR LYNCH, C TI BALDNESS AND CORONARY-DISEASE - RESPONSE SO JOURNAL OF CLINICAL EPIDEMIOLOGY LA English DT Letter C1 US FDA,CTR BIOL EVALUAT & RES,WASHINGTON,DC 20204. RP HERRERA, CR (reprint author), UNIV TEXAS,SCH MED,HLTH SCI CTR,DIV GEN MED,HOUSTON,TX 77030, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0895-4356 J9 J CLIN EPIDEMIOL JI J. Clin. Epidemiol. PY 1991 VL 44 IS 8 BP 865 EP 865 DI 10.1016/0895-4356(91)90143-W PG 1 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA GL682 UT WOS:A1991GL68200023 ER PT J AU LOVETT, J FRANCIS, DW PEELER, JT TWEDT, RM AF LOVETT, J FRANCIS, DW PEELER, JT TWEDT, RM TI QUANTITATIVE COMPARISON OF 2 ENRICHMENT METHODS FOR ISOLATING LISTERIA-MONOCYTOGENES FROM SEAFOODS SO JOURNAL OF FOOD PROTECTION LA English DT Article ID PERINATAL LISTERIOSIS; EPIDEMIC LISTERIOSIS; RAW-MILK; OUTBREAK; INFECTION; TRANSMISSION; PRODUCTS; POULTRY; CHICKEN; CHEESE AB Two enrichment methods that had been used as standard procedures by the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) were quantitatively compared for their ability to isolate Listeria monocytogenes from seafoods. Cultures of a clinical sample and a seafood isolate were inoculated into raw and cooked shrimp; cultures heated at 57.8-degrees-C for 5 min were added to surimi, cooked crabmeat, and cooked shrimp. With the FDA procedure, which used enrichment intervals of 24 h, 48 h, and 7 d, KOH culture treatment and enrichment for 24 h provided no advantage for Listeria recovery. The FDA procedure isolated heated L. monocytogenes from seafoods at a lower level than the USDA method; however, the two methods isolated unheated cells equally well. The greater selectivity of the USDA procedure may offer an advantage for isolating nonheat-stressed Listeria when the aerobic plate count of the product is high. C1 US FDA,DIV MICROBIOL,WASHINGTON,DC 20204. US FDA,DIV MICROBIOL,CINCINNATI,OH 45226. NR 39 TC 12 Z9 12 U1 2 U2 2 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JAN PY 1991 VL 54 IS 1 BP 7 EP 11 PG 5 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA ET061 UT WOS:A1991ET06100002 ER PT J AU BRADSHAW, JG PEELER, JT TWEDT, RM AF BRADSHAW, JG PEELER, JT TWEDT, RM TI THERMAL-RESISTANCE OF LISTERIA SPP IN MILK SO JOURNAL OF FOOD PROTECTION LA English DT Article ID HEAT-RESISTANCE; RAW-MILK; DAIRY-PRODUCTS; BOVINE-MILK; MONOCYTOGENES CELLS; SOFT CHEESES; INACTIVATION; SURVIVAL; OUTBREAK; BEHAVIOR AB The thermal resistance of one strain each of Listeria ivanovii, L. seeligeri, and L. welshimeri and three L. monocytogenes strains was determined in raw and sterile milk. Listeria spp. suspended in milk at concentrations of 1 x 10(5) cells/ml were heated at temperatures ranging from 52.2 to 71.1-degrees-C for various contact times. The heat resistance of L. monocytogenes appeared somewhat greater than that of the other Listeria spp. in both milks, but the difference was not statistically significant (alpha = 0.05). High-temperature, short-time processing is adequate for pasteurization of raw milk. C1 US FDA,DIV MICROBIOL,WASHINGTON,DC 20204. US FDA,DIV MICROBIOL,CINCINNATI,OH 45226. NR 40 TC 28 Z9 28 U1 1 U2 3 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JAN PY 1991 VL 54 IS 1 BP 12 EP & PG 0 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA ET061 UT WOS:A1991ET06100003 ER PT J AU ALLEN, G BRUCE, VR ANDREWS, WH SATCHELL, FB STEPHENSON, P AF ALLEN, G BRUCE, VR ANDREWS, WH SATCHELL, FB STEPHENSON, P TI RECOVERY OF SALMONELLA FROM FROZEN SHRIMP - EVALUATION OF SHORT-TERM SELECTIVE ENRICHMENT, SELECTIVE MEDIA, POSTENRICHMENT, AND A RAPID IMMUNODIFFUSION METHOD SO JOURNAL OF FOOD PROTECTION LA English DT Article ID ENZYME-IMMUNOASSAY; MEAT-PRODUCTS; GREEN BROTH; FOODS; TEMPERATURE; FEEDS AB Frozen shrimp was used as a high-moisture food matrix to evaluate the effect of the following conditions and media on the recovery of Salmonella: comparative efficiency of 6 and 24 h selective enrichment incubation periods; efficiency of Rappa-port-Vassiliadis (RV) medium relative to selenite cystine (SC) and tetrathionate (TT) selective enrichment broths; need for postenrichment; and reliability of the immunodiffusion method (Salmonella 1-2 TEST) as a rapid screening procedure. From a total of 244 Salmonella-positive samples, recoveries at 6 h for selective enrichments SC, TT, RV(1) receiving 1 ml of inoculum, and RV(2) receiving 0.1 ml of inoculum, were 147, 149, 200, and 169, respectively; at 24 h, recoveries were 148, 142, 193, and 205, respectively. As a selective enrichment, RV medium was generally more productive than either SC or TT broths. Postenrichment reduced method sensitivity. Test kit reactions were read independently by three analysts to evaluate the immunodiffusion method. Examination of 200 shrimp samples by standard cultural and 1-2 TEST methods detected 52.5-57% and 56.5-60.5% positive samples, respectively. RP ALLEN, G (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 27 TC 11 Z9 11 U1 0 U2 1 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JAN PY 1991 VL 54 IS 1 BP 22 EP 27 PG 6 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA ET061 UT WOS:A1991ET06100006 ER PT J AU SINGLETON, ER HAMDY, MK MCCAY, SG ZAPATKA, FA AF SINGLETON, ER HAMDY, MK MCCAY, SG ZAPATKA, FA TI DETECTION OF FIMBRIAE (CFA/I) ON ENTEROTOXIGENIC ESCHERICHIA-COLI USING ANTIBODIES SO JOURNAL OF FOOD SAFETY LA English DT Article ID DNA COLONY HYBRIDIZATION; STABLE ENTERO-TOXIN; FACTOR ANTIGEN-I; VIRULENCE FACTORS; PLASMIDS; STRAINS; SEROTYPES; DIARRHEA; ADHESINS; PROBES AB Fimbriae (CFA/I) were isolated after detachment from an enterotoxigenic Escherichia coli (ETEC) strain H10407, purified by successive isoelectric point precipitation at pH 3.5, and injected into rabbits. The antisera containing the polyclonal antibodies against the fimbrial proteins (antigens) were then used to detect the presence of CFA/I on other E. coli cultures using an indirect ELISA system. The ELISA procedures for the CFA/I assay was as sensitive as the DNA hybridization for detecting the ETEC strains. Two bands (major and minor) were present when the isolated fimbrial proteins were subjected to SDS-PAGE. The major band had a molecular mass of 40.3 and the minor 36.4 kDa. Electron microscopy of the fimbriae appeared as thin thread rods with variable length (5-15-mu-m). C1 UNIV GEORGIA,DEPT FOOD SCI,ATHENS,GA 30602. US FDA,ATLANTA,GA 30309. NR 29 TC 1 Z9 1 U1 0 U2 0 PU FOOD NUTRITION PRESS INC PI TRUMBULL PA 6527 MAIN ST, P O BOX 374, TRUMBULL, CT 06611 SN 0149-6085 J9 J FOOD SAFETY JI J. Food Saf. PY 1991 VL 11 IS 3 BP 215 EP 225 PG 11 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA FW152 UT WOS:A1991FW15200008 ER PT J AU DALLAS, HL TRAN, TT POINDEXTER, CE HITCHINS, AD ROMANELL, LJ AF DALLAS, HL TRAN, TT POINDEXTER, CE HITCHINS, AD ROMANELL, LJ TI COMPETITION OF FOOD BACTERIA WITH LISTERIA-MONOCYTOGENES DURING ENRICHMENT CULTURE SO JOURNAL OF FOOD SAFETY LA English DT Article AB Thirty-two foodborne bacterial isolates were tested as potential competitors of Listeria monocytogenes strain LM82 during enrichment because of their resistance to the selective agents in Listeria enrichment and isolation media. Competitive ability of each isolate was classified as weak, moderate, or strong by determining the ratio at which it masked identification of LM82 at an inoculation concentration of 10 colony forming units (CFU)/10 mL of Listeria enrichment broth. Of the competitive isolates identified, six were Enterococcus spp., two were Staphylococcus spp., and one was a Corynebacterium sp. Although several strains of Enterococcus faecium were examined, not all were competitive. Of six other bacterial strains associated with food fermentations and tested for competitiveness with LM82, one, a Gram-positive tetrad, was competitive. This study showed that although food microfloral strains that are able to survive in enrichment and isolation environments are fairly common, they do not necessarily compete with Listeria. Not all strains in a competitive species are necessarily competitive. C1 US FDA,DIV MICROBIOL,HFF-234,200 C ST SW,WASHINGTON,DC 20204. DIST COLUMBIA GEN HOSP,WASHINGTON,DC 20203. NR 16 TC 22 Z9 22 U1 0 U2 0 PU FOOD NUTRITION PRESS INC PI TRUMBULL PA 6527 MAIN ST, P O BOX 374, TRUMBULL, CT 06611 SN 0149-6085 J9 J FOOD SAFETY JI J. Food Saf. PY 1991 VL 11 IS 4 BP 293 EP 301 DI 10.1111/j.1745-4565.1991.tb00060.x PG 9 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA GC657 UT WOS:A1991GC65700006 ER PT J AU HOLLINGWORTH, TA KAYSNER, CA COLBURN, KG SULLIVAN, JJ ABEYTA, C WALKER, KD TORKELSON, JD THROM, HR WEKELL, MM AF HOLLINGWORTH, TA KAYSNER, CA COLBURN, KG SULLIVAN, JJ ABEYTA, C WALKER, KD TORKELSON, JD THROM, HR WEKELL, MM TI CHEMICAL AND MICROBIOLOGICAL ANALYSIS OF VACUUM-PACKED, PASTEURIZED FLAKED IMITATION CRABMEAT SO JOURNAL OF FOOD SCIENCE LA English DT Article ID CLOSTRIDIUM-PERFRINGENS; IRON MILK; ENUMERATION; HISTAMINE; STORAGE AB Various procedures were used to attempt to correlate spoilage of imitation crabmeat with sensory analysis after storage at 4-degrees-C, 10-degrees-C and 22-degrees-C. Total volatile acids, total volatile bases, cadaverine, putrescine, histamine, aerobic plate count, and proteolytic count correlated well with product spoilage at 22-degrees-C. Even though 22-degrees-C is considered abusive, the only pathogenic organism isolated was Bacillus cereus. In contrast, at 4-degrees-C and 10-degrees-C, neither the chemical nor microbial indicators were adequate to assess quality of the product. Thus sensory analysis, despite is limitations, remained the only method currently available to assess product acceptability after prolonged storage at reduced temperatures. C1 US FDA,SEATTLE DISTR LAB,BOTHELL,WA 98041. RP HOLLINGWORTH, TA (reprint author), US FDA,SEAFOOD PROD RES CTR,BOTHELL,WA 98041, USA. NR 19 TC 19 Z9 22 U1 0 U2 3 PU INST FOOD TECHNOLOGISTS PI CHICAGO PA SUITE 300 221 N LASALLE ST, CHICAGO, IL 60601-1291 SN 0022-1147 J9 J FOOD SCI JI J. Food Sci. PD JAN-FEB PY 1991 VL 56 IS 1 BP 164 EP 167 DI 10.1111/j.1365-2621.1991.tb08002.x PG 4 WC Food Science & Technology SC Food Science & Technology GA EX949 UT WOS:A1991EX94900047 ER PT J AU FEINSTONE, SM AF FEINSTONE, SM TI THE VIROLOGY OF HEPATITIS-C SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY LA English DT Article; Proceedings Paper CT SATELLITE MEETING OF THE INTERNATIONAL ASSOC FOR THE STUDY OF THE LIVER : TREATMENT OF VIRAL HEPATITIS CY SEP 03-05, 1990 CL GOLD COAST, AUSTRALIA SP SCHERING PLOUGH ID VIRUS GENOME; NON-A C1 NIH,FOOD & DRUG ADM,CTR BIOL EVALUAT & RES,DIV VIROL,BETHESDA,MD 20892. NR 5 TC 2 Z9 2 U1 0 U2 0 PU BLACKWELL SCIENCE PI CARLTON PA 54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA SN 0815-9319 J9 J GASTROEN HEPATOL JI J. Gastroenterol. Hepatol. PY 1991 VL 6 SU 1 BP 26 EP 28 DI 10.1111/j.1440-1746.1991.tb01163.x PG 3 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA GQ304 UT WOS:A1991GQ30400008 PM 1661191 ER PT J AU HARVATH, L ROBBINS, JD RUSSELL, AA SEAMON, KB AF HARVATH, L ROBBINS, JD RUSSELL, AA SEAMON, KB TI CAMP AND HUMAN NEUTROPHIL CHEMOTAXIS - ELEVATION OF CAMP DIFFERENTIALLY AFFECTS CHEMOTACTIC RESPONSIVENESS SO JOURNAL OF IMMUNOLOGY LA English DT Article ID HUMAN POLYMORPHONUCLEAR LEUKOCYTES; BETA-ADRENERGIC MODULATION; LYSOSOMAL ENZYME RELEASE; PROTEIN-KINASE INHIBITOR; CYCLIC-AMP LEVELS; CALCIUM MOBILIZATION; RABBIT NEUTROPHILS; PERTUSSIS TOXIN; CHOLERA-TOXIN; INTRACELLULAR CONCENTRATION AB Neutrophils (PMN) treated with cAMP elevating agents were evaluated for their chemotactic responsiveness to FMLP and leukotriene B4 (LTB4). PGE1 and isoproterenol, increased PMN cyclic AMP production and inhibited chemotaxis to both FMLP and LTB4. In contrast, forskolin, which activates adenylate cyclase directly, inhibited chemotaxis to FMLP but not to LTB4. The phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX), was required for inhibition of PMN chemotaxis to FMLP by forskolin, PGE1, and isoproterenol. Isoproterenol and PGE1 inhibited PMN chemotaxis to LTB4 in the absence of IBMX and chemotaxis was further inhibited in the presence of IBMX. PMN cAMP levels were stimulated 2- to 3-fold with isoproterenol, 6- to 10-fold with PGE1, and 5- to 7-fold with forskolin over basal levels in the presence of IBMX. These observations demonstrate that total cellular cAMP concentration is not correlated with inhibition of PMN chemotaxis to all stimuli; forskolin, which increased cyclic AMP 5- to 7-fold over basal levels, did not inhibit chemotaxis to LTB4, whereas isoproterenol, which increased cyclic AMP only 2- to 3-fold over basal levels, inhibited chemotaxis to LTB4. PMN cAMP extrusion was determined under basal conditions and in the presence of PGE1, isoproterenol, and forskolin. PMN extruded cAMP under all conditions examined. C1 US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,BETHESDA,MD 20892. RP HARVATH, L (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,HFB 480,BLDG 29,RM 331,8800 ROCKVILLE PK,BETHESDA,MD 20892, USA. NR 67 TC 104 Z9 104 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD JAN 1 PY 1991 VL 146 IS 1 BP 224 EP 232 PG 9 WC Immunology SC Immunology GA EQ340 UT WOS:A1991EQ34000037 PM 1701793 ER PT J AU KELLEY, I CERNIGLIA, CE AF KELLEY, I CERNIGLIA, CE TI THE METABOLISM OF FLUORANTHENE BY A SPECIES OF MYCOBACTERIUM SO JOURNAL OF INDUSTRIAL MICROBIOLOGY LA English DT Article DE BIOREMEDIATION; FLUORANTHENE; MICROBIAL DEGRADATION; POLYCYCLIC AROMATIC HYDROCARBON ID POLYCYCLIC AROMATIC-HYDROCARBONS; FUNGAL OXIDATION; MUTAGENIC METABOLITES; BENZOPYRENE; DEGRADATION; IDENTIFICATION; BACTERIUM; SEDIMENT; INVITRO; SOOT AB A Mycobacterium sp., which was previously isolated from oil-contaminated estuarine sediments, mineralized the polycyclic aromatic hydrocarbon fluoranthene. When supplemented with an alternative carbon source, the organism was able to mineralize up to 78% of the added [3-C-14]fluoranthene to C-14O2 after 5 days of incubation, with relatively little accumulation of intermediate metabolites. The distribution of the C-14 label was monitored throughout the mineralization process. The Mycobacterium degraded in excess of 95% fluoranthene within a 24 hour period following an initial 6-12 h lag phase. At that point approximately 53% of the radioactivity was located in the ethyl acetate extractable fraction, 31.8% in CO2, and 14.7% in the aqueous phase. Incubation of the Mycobacterium sp. with soil and river water, in the presence of fluoranthene, enhanced mineralization of fluoranthene by 92.7% over the indigenous biota. These results, in conjunction with previously reported studies, suggest the potential application of this Mycobacterium sp. for the bioremediation of polycyclic aromatic hydrocarbon contaminated wastes in the environment. C1 US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 31 TC 37 Z9 39 U1 3 U2 4 PU STOCKTON PRESS PI BASINGSTOKE PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS SN 0169-4146 J9 J IND MICROBIOL JI J. Indust. Microbiol. PD JAN PY 1991 VL 7 IS 1 BP 19 EP 26 DI 10.1007/BF01575598 PG 8 WC Biotechnology & Applied Microbiology SC Biotechnology & Applied Microbiology GA EV564 UT WOS:A1991EV56400004 ER PT J AU ARCINIEGA, JL HEWLETT, EL JOHNSON, FD DEFOREST, A WASSILAK, SGF ONORATO, IM MANCLARK, CR BURNS, DL AF ARCINIEGA, JL HEWLETT, EL JOHNSON, FD DEFOREST, A WASSILAK, SGF ONORATO, IM MANCLARK, CR BURNS, DL TI HUMAN SEROLOGIC RESPONSE TO ENVELOPE-ASSOCIATED PROTEINS AND ADENYLATE-CYCLASE TOXIN OF BORDETELLA-PERTUSSIS SO JOURNAL OF INFECTIOUS DISEASES LA English DT Article ID SERUM ANTIBODY-RESPONSES; ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES; VIRULENCE FACTORS; COMMON ANTIGEN; BACTERIAL; VACCINATION; INFECTION; HEMOLYSIN; CLONING AB The human serologic response to several envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis was examined using immunoblot techniques. Antigens recognized by sera from individuals with culture-confirmed pertussis and by sera from infants immunized with three doses of conventional whole-cell pertussis vaccine included a 63,000-Da protein that was shown to be antigenically related to a mycobacterial heat-shock protein. A 29,000-Da protein reacted with sera from convalescent individuals, whereas a 91,000-Da protein reacted with sera from vaccinated individuals. Antibodies to adenylate cyclase toxin were common in sera from individuals diagnosed with pertussis. B. pertussis lipooligosaccharide was also recognized by antibodies in some of these sera. These data suggest that some of these antigens may play a role in immunity to pertussis. C1 UNIV VIRGINIA,MED CTR,SCH MED,CHARLOTTESVILLE,VA 22901. TEMPLE UNIV,HLTH SCI CTR,SCH MED,PHILADELPHIA,PA 19140. CTR DIS CONTROL,ATLANTA,GA 30333. RP ARCINIEGA, JL (reprint author), US FDA,CTR BIOL EVAL & RES,8800 ROCKVILLE PIKE,BETHESDA,MD 20205, USA. FU NIAID NIH HHS [R01-AI18000]; PHS HHS [200-83-613] NR 29 TC 34 Z9 34 U1 1 U2 1 PU UNIV CHICAGO PRESS PI CHICAGO PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637 SN 0022-1899 J9 J INFECT DIS JI J. Infect. Dis. PD JAN PY 1991 VL 163 IS 1 BP 135 EP 142 PG 8 WC Immunology; Infectious Diseases; Microbiology SC Immunology; Infectious Diseases; Microbiology GA EP678 UT WOS:A1991EP67800023 PM 1984460 ER PT J AU SCHENCK, FJ BARKER, SA LONG, AR AF SCHENCK, FJ BARKER, SA LONG, AR TI MATRIX SOLID-PHASE DISPERSION (MSPD) ISOLATION AND LIQUID-CHROMATOGRAPHIC DETERMINATION OF CLORSULON IN MILK SO JOURNAL OF LIQUID CHROMATOGRAPHY LA English DT Article AB A method for the isolation and liquid chromatographic determination of the anti-parasitic drug clorsulon in milk is presented. Milk samples (0.5 g) were blended with 2 grams of C-18 (octadecylsilyl-derivatized silica column packing material). A column was made from the C-18/milk matrix and first washed with hexane. The clorsulon was then eluted from this column with ethyl ether. The ether eluate was cleaned up by Florisil solid phase extraction, and clorsulon was subsequently determined by liquid chromatography with UV detection. The overall recovery of clorsulon from milk spiked at 50-200 ppm was 93.0 % with a coefficient of variation of 5.6 %. The MSPD method and a solid phase extraction method used by the FDA gave comparable values for milk containing incurred clorsulon residues. C1 LOUISIANA STATE UNIV,SCH VET MED,DEPT VET PHYSIOL PHARMACOL & TOXICOL,BATON ROUGE,LA 70803. US FDA,ANIM DRUG RES CTR,DENVER,CO 80225. RP SCHENCK, FJ (reprint author), US FDA,900 MADISON AVE,BALTIMORE,MD 21201, USA. NR 8 TC 7 Z9 8 U1 0 U2 1 PU MARCEL DEKKER INC PI NEW YORK PA 270 MADISON AVE, NEW YORK, NY 10016 SN 0148-3919 J9 J LIQ CHROMATOGR JI J. Liq. Chromatogr. PY 1991 VL 14 IS 15 BP 2827 EP 2834 DI 10.1080/01483919108049360 PG 8 WC Biochemical Research Methods; Chemistry, Analytical SC Biochemistry & Molecular Biology; Chemistry GA GK478 UT WOS:A1991GK47800001 ER PT J AU ASZALOS, A GRIMLEY, PM BALINT, E CHADHA, KC AMBRUS, JL AF ASZALOS, A GRIMLEY, PM BALINT, E CHADHA, KC AMBRUS, JL TI ON THE MECHANISM OF ACTION OF INTERFERONS - INTERACTION WITH NONSTEROIDAL ANTIINFLAMMATORY AGENTS, PENTOXIFYLLINE (TRENTAL) AND CGMP INDUCERS SO JOURNAL OF MEDICINE LA English DT Article DE AIDS; BURKITTS LYMPHOMA; CYCLIC GMP; DAUDI CELLS ELECTRON SPIN RESONANCE; INDOMETHACIN; INTERFERON; MECLOMEN; MEMBRANE POTENTIAL; PENTOXIFYLLINE; SODIUM AZIDE; TRENTAL AB In earlier studies, we showed that when interferon alpha (IFN-alpha) binds to cell receptors, it alters membrane potentials. In IFN-sensitive Daudi cells derived from Burkitt's lymphoma patients, IFNs produce dose-dependent hyperpolarization, decreased plasma membrane viscosity, modulation of the microfilament system, and altered synthesis of cAMP, cGMP and prostaglandins. No such changes were seen in IFN-alpha-resistant Daudi cells. In this study, we found that indomethacin, pentoxifylline, or the cGMP inducer sodium azide (NaN3) had no significant effect on the IFN-alpha induced membrane potential changes, or on membrane viscosity changes as measured by flow cytometry and electron spin resonance spectrometry. In tissue culture, indomethacin did not alter the antiproliferative effect of IFN-alpha on Daudi cells. Indomethacin may influence IFN synthesis, but not it's antiproliferative actions. Relatively high doses of pentoxifylline slightly inhibited proliferation of Daudi cells and synergized with IFN-alpha. Measurement of early biophysical changes induced by IFNs may represent a new screening method to rapidly explore certain types of IFN-alpha potentiating agents. C1 US FDA,DIV RES & TEST,WASHINGTON,DC 20204. NR 0 TC 6 Z9 6 U1 0 U2 0 PU P J D PUBLICATIONS LTD PI WESTBURY PA PO BOX 966, WESTBURY, NY 11590 SN 0025-7850 J9 J MED JI J. Med. PY 1991 VL 22 IS 4-5 BP 255 EP 271 PG 17 WC Medicine, Research & Experimental SC Research & Experimental Medicine GA HE269 UT WOS:A1991HE26900004 PM 1664849 ER PT J AU WHITE, JD AF WHITE, JD TI PRE-APPROVAL INSPECTIONS INVESTIGATIONS SO JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY LA English DT Editorial Material RP WHITE, JD (reprint author), US FDA,OFF SMALL BUSINESS SCI & TRADE AFFAIRS,OFF COMMISSIONER,HFC-50,ROCKVILLE,MD 20857, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU PARENTERAL DRUG ASSOC, INC PI BETHESDA PA 7500 OLD GEORGETOWN RD, STE, 620, BETHESDA, MD 20814 SN 0279-7976 J9 J PARENT SCI TECHN PD JAN-FEB PY 1991 VL 45 IS 1 BP 56 EP 63 PG 8 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EV327 UT WOS:A1991EV32700010 ER PT J AU GROSS, TP HAYES, SW AF GROSS, TP HAYES, SW TI HAEMOPHILUS CONJUGATE VACCINE AND GUILLAIN-BARRE-SYNDROME SO JOURNAL OF PEDIATRICS LA English DT Letter RP GROSS, TP (reprint author), US FDA, CTR DRUG EVALUAT & RES, DIV EPIDEMIOL & SURVEILLANCE, ROCKVILLE, MD 20857 USA. NR 1 TC 6 Z9 6 U1 0 U2 0 PU MOSBY-ELSEVIER PI NEW YORK PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA SN 0022-3476 EI 1097-6833 J9 J PEDIATR-US JI J. Pediatr. PD JAN PY 1991 VL 118 IS 1 BP 161 EP 161 DI 10.1016/S0022-3476(05)81876-1 PG 1 WC Pediatrics SC Pediatrics GA EU222 UT WOS:A1991EU22200037 PM 1986087 ER PT J AU MEDLOCK, KL FORRESTER, TM SHEEHAN, DM AF MEDLOCK, KL FORRESTER, TM SHEEHAN, DM TI SHORT-TERM EFFECTS OF PHYSIOLOGICAL AND PHARMACOLOGICAL DOSES OF ESTRADIOL ON ESTROGEN-RECEPTOR AND UTERINE GROWTH SO JOURNAL OF RECEPTOR RESEARCH LA English DT Article ID BREAST-CANCER-CELLS; ANTI-ESTROGENS; REPLENISHMENT; MECHANISMS; RESPONSES AB Estradiol (E2) regulation of estrogen receptor (ER) concentrations has been shown to be both time- and dose-dependent. E2 concentrations of 0.5 mg/ml or greater contained in Silastic capsules suppressed uterine ER concentrations after one day's exposure. In this study, we looked at the effects of physiological (1.0 and 10.0-mu-g subcutaneous injections) and pharmacological (5.0 mg/ml implants) doses of E2 on ER concentrations at times less than 24 hours. The implanted rats had maximum E2 plasma levels of approximately 2000 pg/ml for at least six hours which fell to around 800 pg/ml by 12 hours where they remained up to 24 hours. The physiological doses resulted in plasma levels at one hour of 2000 pg/ml (10-mu-g dose) and 250 pg/ml (1-mu-g dose) both of which fell to less than 60 pg/ml by six hours. All treatments caused maximal ER suppression by six hours; however, the implants caused a greater reduction in ER levels than either of the physiological doses. The reduction of ER levels was due primarily to a decrease in the "cytosolic" receptor. Despite the decrease in ER, all doses caused a significant and equivalent increase in uterine weight at six hours, however, only the implanted animals maintained the maximal uterine weight gain through 24 hours. This maintenance of uterine weight appears to be correlated with a small but significant increase in the nuclear ER level over this same time period. Thus, while E2 can cause a short-term suppression of its receptor concentration with no effect on short-term uterine weight gain, uterine growth is positively correlated with the level of nuclear ER. C1 UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM,LITTLE ROCK,AR 72205. RP MEDLOCK, KL (reprint author), US FDA,NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079, USA. NR 15 TC 29 Z9 30 U1 0 U2 4 PU MARCEL DEKKER INC PI NEW YORK PA 270 MADISON AVE, NEW YORK, NY 10016 SN 0197-5110 J9 J RECEPTOR RES JI J. Recept. Res. PY 1991 VL 11 IS 5 BP 743 EP 756 DI 10.3109/10799899109064677 PG 14 WC Cell Biology SC Cell Biology GA FY097 UT WOS:A1991FY09700003 PM 1920275 ER PT J AU LAYLOFF, TP AF LAYLOFF, TP TI THE FUTURE OF AOAC - A PROGNOSTICATION SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Editorial Material RP LAYLOFF, TP (reprint author), US FDA,DIV DRUG ANAL,1114 MARKET,RM 1002,ST LOUIS,MO 63101, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 20 EP 21 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600003 ER PT J AU TRUCKSESS, MW STACK, ME NESHEIM, S PAGE, SW ALBERT, RH HANSEN, TJ DONAHUE, KF AF TRUCKSESS, MW STACK, ME NESHEIM, S PAGE, SW ALBERT, RH HANSEN, TJ DONAHUE, KF TI IMMUNOAFFINITY COLUMN COUPLED WITH SOLUTION FLUOROMETRY OR LIQUID-CHROMATOGRAPHY POSTCOLUMN DERIVATIZATION FOR DETERMINATION OF AFLATOXINS IN CORN, PEANUTS, AND PEANUT BUTTER - COLLABORATIVE STUDY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article ID AFFINITY-CHROMATOGRAPHY; PRODUCTS; ASSAY AB An AOAC/IUPAC (International Union of Pure and Applied Chemistry) collaborative study was conducted to evaluate the effectiveness of an immunoaffinity column for the determination of aflatoxin. The test portion is extracted with methanol-water (7 + 3), filtered, diluted to < 30% methanol with water, and applied to the affinity column. The column is washed with water and the concentrated aflatoxins are eluted with methanol. Total aflatoxins are determined by solution fluorometry with bromine (SFB), and individual toxins are determined by reverse-phase liquid chromatography with postcolumn derivatization with iodine (PCD). Corn naturally contaminated with aflatoxins, and peanuts, peanut butter, and corn containing added aflatoxins (B1:B2:G1:G2 = 7:1:3:1) were sent to 24 collaborators in the United States, France, Canada, and the Republic of South Africa. Twelve collaborators used the SFB method, 9 used the PCD method, and 3 used both SFB and PCD methods. Twenty collaborators completed the study (10 used the SFB method, 7 used the PCD method, and 3 used both SFB and PCD methods). Test portions were spiked at 10, 20, and 30 ng/g. For SFB analyses, recoveries of total aflatoxins were 123, 105, and 107%, respectively; the relative standard deviation for repeatability (RSD(r)) ranged from 11.75 to 16.57%, and the relative standard deviation for reproducibility (RSD(R)) ranged from 10.97 to 33.09%. For PCD analyses, recoveries were 81, 81, and 83%, respectively; the RSD(r) ranged from 5.20 to 17.22%, and the RSD(R) ranged from 4.68 to 50.77%. The RSD(r) for aflatoxins B1 and G1 for spiked test portions ranged from 5.45 to 23.55%, and the RSD(R) ranged from 4.21 to 57.28%. The RSD(r) and RSD(R) for aflatoxins B2 and G2 were higher because of small amounts added. Analyses by both SFB and PCD methods showed acceptable within-laboratory and between-laboratories precision. The method has been adopted official first action by AOAC as an AOAC-IUPAC method. C1 VICAM,SOMERVILLE,MA 02145. RP TRUCKSESS, MW (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 13 TC 110 Z9 118 U1 2 U2 9 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 81 EP 88 PG 8 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600014 PM 2026580 ER PT J AU SMITH, E AF SMITH, E TI DRUGS .2. SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP SMITH, E (reprint author), US FDA,CTR DRUG EVALUAT & RES,WASHINGTON,DC 20204, USA. NR 6 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 111 EP 111 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600023 ER PT J AU ALEXANDER, TG AF ALEXANDER, TG TI DRUGS .5. SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP ALEXANDER, TG (reprint author), US FDA,CTR DRUG EVALUAT & RES,WASHINGTON,DC 20204, USA. NR 3 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 112 EP 113 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600026 ER PT J AU FINKELSON, MJ AF FINKELSON, MJ TI DRUGS .3. SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP FINKELSON, MJ (reprint author), US FDA,WINCHESTER ENGN & ANALYT CTR,109 HOLTON ST,WINCHESTER,MA 01890, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 112 EP 112 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600024 ER PT J AU NG, LL AF NG, LL TI DRUGS .4. SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP NG, LL (reprint author), US FDA,ROCKVILLE,MD 20857, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 112 EP 112 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600025 ER PT J AU BARNES, CJ AF BARNES, CJ TI DRUG RESIDUES IN ANIMAL-TISSUES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP BARNES, CJ (reprint author), US FDA,DIV VET MED RES,BELTSVILLE,MD 20705, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 113 EP 113 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600028 ER PT J AU CICHOWICZ, SM AF CICHOWICZ, SM TI FORENSIC SCIENCES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP CICHOWICZ, SM (reprint author), US FDA,200 C ST SW,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 113 EP 114 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600029 ER PT J AU FAZIO, T AF FAZIO, T TI FOOD-ADDITIVES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP FAZIO, T (reprint author), US FDA,OFF PHYS SCI,WASHINGTON,DC 20204, USA. NR 4 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 115 EP 118 PG 4 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600031 ER PT J AU FIRESTONE, D AF FIRESTONE, D TI OILS AND FATS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note ID PERFORMANCE RP FIRESTONE, D (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 22 TC 1 Z9 1 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 128 EP 131 PG 4 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600034 ER PT J AU PAGE, SW AF PAGE, SW TI PLANT TOXINS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article ID MUSHROOM AGARICUS-BISPORUS; PARA-HYDRAZINOBENZOIC ACID; CULTIVATED MUSHROOM; PYRROLIZIDINE ALKALOIDS; ERYTHRINA-ERIOTRIOCHA; TUMOR-INDUCTION; RAT-LIVER; MICE; AGARITINE; FLAVONOIDS RP US FDA, DIV CONTAMINANTS CHEM, WASHINGTON, DC 20204 USA. NR 109 TC 0 Z9 0 U1 0 U2 0 PU AOAC INT PI GAITHERSBURG PA 481 N FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 USA SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 131 EP 136 PG 6 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600035 ER PT J AU WEKELL, MM AF WEKELL, MM TI SEAFOOD PRODUCTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP WEKELL, MM (reprint author), US FDA,22201 23RD DR SE,POB 3012,BOTHELL,WA 98041, USA. NR 4 TC 1 Z9 1 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 136 EP 137 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600036 ER PT J AU WEKELL, MM AF WEKELL, MM TI SEAFOOD TOXINS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note ID PERFORMANCE LIQUID-CHROMATOGRAPHY; DIATOM NITZSCHIA-PUNGENS; PRINCE-EDWARD-ISLAND; DOMOIC ACID; MONOCLONAL-ANTIBODIES; MARINE NEUROTOXIN; AMINO-ACID; SHELLFISH; TETRODOTOXIN; SPECTRUM RP WEKELL, MM (reprint author), US FDA,22201 23RD DR SE,POB 3012,BOTHELL,WA 98041, USA. NR 45 TC 3 Z9 3 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 137 EP 141 PG 5 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600037 ER PT J AU BOLAND, FE AF BOLAND, FE TI FRUITS AND FRUIT PRODUCTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP BOLAND, FE (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 143 EP 145 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600041 ER PT J AU PROSKY, L AF PROSKY, L TI DIETARY FIBER SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP PROSKY, L (reprint author), US FDA,DIV NUTR,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 143 EP 143 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600040 ER PT J AU KRINITZ, B AF KRINITZ, B TI PRESERVATIVES AND ARTIFICIAL SWEETENERS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP KRINITZ, B (reprint author), US FDA,850 3RD AVE,BROOKLYN,NY 11232, USA. NR 1 TC 0 Z9 0 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 145 EP 145 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600043 ER PT J AU NEWTON, JM AF NEWTON, JM TI NONALCOHOLIC BEVERAGES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP NEWTON, JM (reprint author), US FDA,50 UN PLAZA,SAN FRANCISCO,CA 94102, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 145 EP 145 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600042 ER PT J AU MULVANEY, TR AF MULVANEY, TR TI PROCESSED VEGETABLE PRODUCTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP MULVANEY, TR (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 146 EP 146 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600044 ER PT J AU DEUTSCH, MJ AF DEUTSCH, MJ TI VITAMINS AND OTHER NUTRIENTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP DEUTSCH, MJ (reprint author), US FDA,DIV NUTR,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 147 EP 148 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600046 ER PT J AU CAPAR, SG AF CAPAR, SG TI METALS AND OTHER ELEMENTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP CAPAR, SG (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 149 EP 150 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600047 ER PT J AU SAWYER, LD AF SAWYER, LD TI MULTIRESIDUE METHODS (INTERLABORATORY STUDIES) SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP SAWYER, LD (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 150 EP 152 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600048 ER PT J AU MCMAHON, BM AF MCMAHON, BM TI ORGANOHALOGEN PESTICIDES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP MCMAHON, BM (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 152 EP 153 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600049 ER PT J AU BANDLER, R AF BANDLER, R TI ANALYTICAL MYCOLOGY AND MICROSCOPY OF FOODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP BANDLER, R (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 156 EP 156 PG 1 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600052 ER PT J AU BOESE, JL AF BOESE, JL TI EXTRANEOUS MATERIALS IN FOODS AND DRUGS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP BOESE, JL (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 156 EP 157 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600053 ER PT J AU HITCHINS, AD AF HITCHINS, AD TI COSMETIC MICROBIOLOGY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP HITCHINS, AD (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 6 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 157 EP 158 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600054 ER PT J AU ANDREWS, WH AF ANDREWS, WH TI FOOD MICROBIOLOGY (NONDAIRY) SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note ID SALMONELLA RP ANDREWS, WH (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 3 TC 7 Z9 7 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 158 EP 162 PG 5 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600056 ER PT J AU MONTGOMERY, RM ANTHONY, G BACKER, R CLARK, CC DOYLE, TD HOPES, TM MANNING, K ORANGERS, J SHEININ, EB WRIGHT, WW PRESSER, M AF MONTGOMERY, RM ANTHONY, G BACKER, R CLARK, CC DOYLE, TD HOPES, TM MANNING, K ORANGERS, J SHEININ, EB WRIGHT, WW PRESSER, M TI COMMITTEE ON DRUGS AND RELATED TOPICS - RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note C1 WARNER LAMBERT PARKE DAVIS,PARKE DAVIS DIV,MORRIS PLAINS,NJ 07950. US PHARMACOPEIAL CONVENT INC,ROCKVILLE,MD 20852. UNIV NEW MEXICO,OFF MED INVESTIGATOR,ALBUQUERQUE,NM 87131. US DRUG ENFORCEMENT ADM,SE REG LAB,MIAMI,FL 33166. US FDA,WASHINGTON,DC 20204. US FDA,NEW YORK REG LAB,BROOKLYN,NY 11232. UPJOHN CO,KALAMAZOO,MI 49001. US FDA,ROCKVILLE,MD 20857. RP MONTGOMERY, RM (reprint author), UNILEVER RES US INC,45 RIVER RD,EDGEWATER,NJ 07020, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 178 EP 180 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600067 ER PT J AU BOWERS, RH GEORGE, E BERKOWITZ, DB ENGEBRETSEN, DR BROOKER, JR POHLAND, AE LAWRENCE, JF ELLIS, RL PARK, DL NEWELL, R AF BOWERS, RH GEORGE, E BERKOWITZ, DB ENGEBRETSEN, DR BROOKER, JR POHLAND, AE LAWRENCE, JF ELLIS, RL PARK, DL NEWELL, R TI COMMITTEE ON FOODS .1. RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note C1 STATE DEPT AGR & MARKETS,ALBANY,NY 12235. LAND OLAKES INC,MINNEAPOLIS,MN 55440. NATL MARINE FISHERIES SERV,DIV SEAFOOD QUAL INSPECT,SILVER SPRING,MD 20910. US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204. HLTH & WELF CANADA,HLTH PROTECT BRANCH,BANTING RES CTR,OTTAWA K1A 0L2,ONTARIO,CANADA. US FOOD SAFETY & INSPECT SERV,WASHINGTON,DC 20250. UNIV ARIZONA,DEPT NUTR & FOOD SCI,TUCSON,AZ 85721. US FDA,DIV MATH,WASHINGTON,DC 20204. RP BOWERS, RH (reprint author), GEN MILLS INC,JAMES FORD BELL TECH CTR,9000 PLYMOUTH AVE N,MINNEAPOLIS,MN 55427, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 181 EP 183 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600068 ER PT J AU MARTIN, RA WOOD, R PEAKE, AA BULHACK, P BRUCCIANI, J BARK, DJ DEVRIES, J PHILLIPS, JG AF MARTIN, RA WOOD, R PEAKE, AA BULHACK, P BRUCCIANI, J BARK, DJ DEVRIES, J PHILLIPS, JG TI COMMITTEE ON FOODS .2. RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note C1 MAFF,FOOD SCI LAB,LONDON SW1P 3RD,ENGLAND. AGR CANADA,CALGARY T2G 0X5,ALBERTA,CANADA. WOODSON TENENT LABS,MEMPHIS,TN 38103. US FDA,DIV COLORS & COSMET,WASHINGTON,DC 20204. US FDA,ATLANTA,GA 30309. GEN MILLS INC,MINNEAPOLIS,MN 55427. USDA,EASTERN REG RES CTR,PHILADELPHIA,PA 19118. RP MARTIN, RA (reprint author), HERSHEY FOODS CORP,HERSHEY TECH CTR,1025 REESE AVE,POB 805,HERSHEY,PA 17033, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 184 EP 186 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600069 ER PT J AU CORNELIUSSEN, PE BOYER, KW CHIN, HB COOK, RF FONG, WG RIPLEY, BD SCHMITT, R MCCULLY, KA ALBERT, RH AF CORNELIUSSEN, PE BOYER, KW CHIN, HB COOK, RF FONG, WG RIPLEY, BD SCHMITT, R MCCULLY, KA ALBERT, RH TI COMMITTEE ON RESIDUES - RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note ID GAS C1 SO TESTING & RES LABS INC,WILSON,NC 27893. NATL FOOD PROCESSORS ASSOC,DUBLIN,CA 94568. FMC CORP,AGR CHEM GRP,PRINCETON,NJ 08543. FLORIDA STATE DEPT AGR,DIV CHEM,TALLAHASSEE,FL 32399. UNIV GUELPH,ONTARIO MINIST AGR & FOOD,PROV PESTICIDE RESIDUE TESTING LAB,GUELPH N1G 2W1,ONTARIO,CANADA. US EPA,OFF PESTICIDE PROGRAMS,WASHINGTON,DC 20460. HLTH & WELF CANADA,FIELD OPERAT DIRECTORATE,OTTAWA K1A 0L2,ONTARIO,CANADA. US FDA,DIV MATH,WASHINGTON,DC 20204. RP CORNELIUSSEN, PE (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 13 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 187 EP 190 PG 4 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600070 ER PT J AU MASTROROCCO, DA BOESE, J FLOWERS, RS SHARPE, A SCOTT, VN KAUTTER, D LANCETTE, G MCCLURE, FD AF MASTROROCCO, DA BOESE, J FLOWERS, RS SHARPE, A SCOTT, VN KAUTTER, D LANCETTE, G MCCLURE, FD TI COMMITTEE ON MICROBIOLOGY AND EXTRANEOUS MATERIALS - RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note C1 SILLIKER LABS INC,CHICAGO HTS,IL 60411. NATL FOOD PROCESSORS ASSOC,WASHINGTON,DC 20005. US FDA,DIV MICROBIOL,WASHINGTON,DC 20204. US FDA,DIV MATH,WASHINGTON,DC 20204. HLTH & WELF CANADA,HLTH PROTECT BRANCH,BUR MICROBIAL HAZARDS,OTTAWA K1A 0L2,ONTARIO,CANADA. US FDA,ATLANTA,GA 30309. RP MASTROROCCO, DA (reprint author), HERSHEY CHOCOLATE USA,POB 1028,STUARTS DRAFT,VA 24477, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 190 EP 192 PG 3 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600071 ER PT J AU CASPER, H REIMANN, LM NOEL, RJ KATZ, SE PARHAM, TM RHODIG, LL GEISLER, C LATIMER, GW BRASELTON, E COLVIN, BM MOWREY, DM AF CASPER, H REIMANN, LM NOEL, RJ KATZ, SE PARHAM, TM RHODIG, LL GEISLER, C LATIMER, GW BRASELTON, E COLVIN, BM MOWREY, DM TI COMMITTEE ON FEEDS, FERTILIZERS, AND RELATED MATERIALS - RECOMMENDATIONS FOR OFFICIAL METHODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note C1 WOODSON TENENT LABS,MEMPHIS,TN 38103. TRIAZONE CORP,GEISMAR,LA 70734. SMITH KLINE ANIM HLTH PROD,OMAHA,NE 68127. OFF TEXAS STATE CHEMIST,COLLEGE STN,TX 77841. RUTGERS STATE UNIV,DEPT BIOCHEM & MICROBIOL,NEW BRUNSWICK,NJ 08903. PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907. US FDA,DENVER FED CTR,DENVER,CO 80225. MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824. UNIV GEORGIA,COLL VET MED,TIFTON,GA 31794. ELI LILLY INT CORP,LILLY RES LAB,GREENFIELD,IN 46140. RP CASPER, H (reprint author), N DAKOTA STATE UNIV,VET DIAGNOST LAB,FARGO,ND 58105, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JAN-FEB PY 1991 VL 74 IS 1 BP 192 EP 193 PG 2 WC Chemistry, Analytical SC Chemistry GA EV856 UT WOS:A1991EV85600072 ER PT J AU DEARDORFF, TL JONES, RE KAYES, SG AF DEARDORFF, TL JONES, RE KAYES, SG TI ADHERENCE OF EOSINOPHILS TO THE EPICUTICLE OF INFECTIVE JUVENILES OF ANISAKIS-SIMPLEX (NEMATODA, ANISAKIDAE) SO JOURNAL OF THE HELMINTHOLOGICAL SOCIETY OF WASHINGTON LA English DT Note DE PARASITIC NEMATODE; ANISAKIS-SIMPLEX; TOXOCARA-CANIS; CBA/J MICE; EOSINOPHIL ADHERENCE; EPICUTICLE; JUVENILE-EOSINOPHIL INTERACTIONS; ANTIBODY ID BREINLIA-MACROPI MICROFILARIAE; SCHISTOSOMA-MANSONI INVITRO; TOXOCARA-CANIS; CYTO-TOXICITY; MEDIATED DESTRUCTION; RAT EOSINOPHILS; ANTIBODY; COMPLEMENT; LARVAE; RESPONSES AB We previously have observed that eosinophils were prominent in chronic granulomas around third-stage juveniles of Anisakis simplex surgically implanted in laboratory mice and destruction of the juveniles within the host tissues was initiated by day 14 postinfection (PI). Based on histology, the mechanism underlying destruction of these juveniles appeared to involve the interaction of eosinophils on the helminth's cuticle. To test this hypothesis, eosinophils were harvested by bronchoalveolar lavage from CBA/J mice previously infected with a closely related ascaridoid and added to cultures of juvenile worms in the presence or absence of sera from A. simplex-immune mice. Adherence of eosinophils occurred only in the presence of A. simplex-immune serum taken 14 or 21 days PI from mice infected with 10 worms. Transmission electron microscopy revealed active degranulation of eosinophils onto the epicuticle of the parasite. Destruction of the cuticular surface of the juveniles by eosinophils was not evident after 24 hr of in vitro culture. Apparently, eosinophils lack the ability to kill the juveniles. Damage to the cuticle, however, was observed in areas associated with macrophage adherence. C1 UNIV SO ALABAMA,COLL MED,DEPT STRUCT & CELLULAR BIOL,MOBILE,AL 36688. US FDA,FISHERY RES BRANCH,DAUPHIN ISL,AL 36528. NR 21 TC 7 Z9 7 U1 1 U2 4 PU HELMINTHOLOGICAL SOC WASHINGTON PI LAWRENCE PA C/O ALLEN PRESS INC, 1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 SN 1049-233X J9 J HELMINTHOL SOC W JI J. Helminthol. Soc. Wash. PD JAN PY 1991 VL 58 IS 1 BP 131 EP 137 PG 7 WC Parasitology; Zoology SC Parasitology; Zoology GA EZ670 UT WOS:A1991EZ67000023 ER PT J AU BOYER, IJ KOKOSKI, CJ BOLGER, PM AF BOYER, IJ KOKOSKI, CJ BOLGER, PM TI ROLE OF FDA IN ESTABLISHING TOLERABLE LEVELS FOR DIOXIN AND PCBS IN AQUATIC ORGANISMS SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH LA English DT Article ID INDUCTION; LIVER AB When fishery products shipped in interstate commerce contain an environmental contaminant that presents a potential threat to public health, the Food and Drug Administration (FDA) undertakes appropriate regulatory steps to minimize exposure. These efforts range from seizure of the affected product to formal rule-making to establish a limit. The basic provision of the Food, Drug, and Cosmetic (FD&C) Act by which the agency deals with environmental contaminants in the food supply is section 402(a)(1), which deals with poisonous and deleterious substances. Poisonous and deleterious components are deemed to be "added," even if they are natural constituents of food, if any amount is present through the artifice of man. Furthermore, when the level of a naturally occurring toxin is increased in the food through handling and/or processing, the sum of all of the contaminant is deemed to be "added." Unavoidable environmental contaminants may be controlled and/or regulated under this section by the "may render injurious" standard, whereby the agency must demonstrate that there is a significant possibility that exposure to the contaminant could be injurious to human health. "Action levels" are administrative guidelines or instructions to the agency field units that define the extent of contamination at which the agency may regard food as adulterated. Except for polychlorinated biphenyls, for which there is a tolerance established by regulation, FDA has controlled contaminants in aquatic organisms by using action levels. Under section 406 of the FD&C act, the agency can also establish tolerances for unavoidably added poisonous or deleterious substances. This section allows the agency to consider the extent to which a contaminant is unavoidable in food while it limits exposure to the extent necessary to protect the public health. Section 406 requires that the tolerance be established by assessing several factors, including risk. One of these is the capability of processing technology to prevent, reduce, or otherwise control the level of the contaminant. Another factor is the necessity to avoid the needless removal of large amounts of valuable food from the market. Finally, the available analytical and sampling methods must be capable of measuring the contaminant so as to ensure the enforceability of the tolerance. Although the FDA has no statutory authority over intrastate fishing considerations, such as noncommercial fishing, it does provide advice to local or state authorities. It is the best scientific opinion the agency can give, but it is not enforceable per se. Advice is provided when requested by local and state officials where no guideline or tolerance is available, and is meant to deal with local and/or regional public health concerns. One of the more well-known advisories is the one on dioxin that was issued at the request of the governors of the Great Lakes States in 1979. C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL REVIEW & EVALUAT,WASHINGTON,DC 20204. NR 21 TC 19 Z9 19 U1 0 U2 6 PU TAYLOR & FRANCIS PI BRISTOL PA 1900 FROST ROAD, SUITE 101, BRISTOL, PA 19007-1598 SN 0098-4108 J9 J TOXICOL ENV HEALTH JI J. Toxicol. Environ. Health PY 1991 VL 33 IS 1 BP 93 EP 101 PG 9 WC Environmental Sciences; Public, Environmental & Occupational Health; Toxicology SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology GA FN033 UT WOS:A1991FN03300008 PM 1903454 ER PT J AU WOLFF, GL GAYLOR, DW BLACKWELL, BN MOORE, GE AF WOLFF, GL GAYLOR, DW BLACKWELL, BN MOORE, GE TI BLADDER AND LIVER TUMORIGENESIS INDUCED BY 2-ACETYLAMINOFLUORENE IN DIFFERENT-F1 MOUSE HYBRIDS - VARIATION WITHIN GENOTYPES AND EFFECTS OF USING MORE THAN ONE GENOTYPE ON RISK ASSESSMENT SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH LA English DT Article ID TOXIC-SUBSTANCES; MICE; SUSCEPTIBILITY; YELLOW AB Several F1 mouse hybrids were used in a chronic bioassay to determine whether such an experimental design would provide greater statistical power than using only the B6C3F1 hybrid. For this purpose, the dose response of formation of hepatocellular and bladder tumors after 30 mo of feeding 2-acetylaminofluorene (2-AAF) in the diet was assessed in 4 F1 mouse hybrids, including the B6C3F1 hybrid. No strain background-related differences in frequency of bladder neoplasms between any F1 hybrids were detected. Bladder tumors occurred only at the highest 2-AAF dose in female mice. In males the lowest dose was already sufficient to induce bladder neoplasms with incidences of 25-48% adjusted for different nontumor mortality patterns across doses. No marked strain-related differences in hepatocellular tumor rates were apparent in either sex. Higher frequencies of hepatocellular neoplasms were observed among the untreated control males of the B6C3, AY, and CVA F1 hybrids than among the comparable females. Among treated mice, the lowest 2-AAF dose increased liver tumor incidence, more so among the females than among the males. The different background genomes resulted in somewhat different risk assessments for liver tumor formation in males due to differences in the time-to-tumor curves. Except for the much higher background liver tumor rate in the CVY mice, the adjusted liver tumor incidences were similar across the four hybrids. Hence, the levels of statistical significance obtained for dose-response trends and comparisons of treated and control groups were similar using 48 animals per dose group with B6C3 mice, or combinations of 24 animals per dose from 2 genotypes, or 12 animals per dose from the 4 hybrid genotypes. Estimates of carcinogenic potency for bladder tumors were similar, within a factor of two, across the four hybrids. However, estimates of liver tumor potency across genotypes varied by a factor of two and six for females and males, respectively. Thus, the mean of cancer potency estimates across these genotypes would be more representative for mice than results from any single genotype. As in chronic carcinogenesis studies with other test agents, neoplasms developed in only a certain proportion, rather than in all, of the genetically identical animals exposed to a given dose of the toxicant for the same length of time under the same controlled environmental conditions. This phenotypic variability in toxic responses may reflect differential regulation of gene expression among the genetically identical test animals. C1 NATL CTR TOXICOL RES,PATHOL ASSOCIATES INC,JEFFERSON,AR 72079. NATL CTR TOXICOL RES,COMP BASED SYST INC,JEFFERSON,AR 72079. RP WOLFF, GL (reprint author), US FDA,NATL CTR TOXICOL RES,DIV COMPARAT TOXICOL,JEFFERSON,AR 72079, USA. NR 31 TC 7 Z9 7 U1 0 U2 0 PU TAYLOR & FRANCIS PI BRISTOL PA 1900 FROST ROAD, SUITE 101, BRISTOL, PA 19007-1598 SN 0098-4108 J9 J TOXICOL ENV HEALTH JI J. Toxicol. Environ. Health PY 1991 VL 33 IS 3 BP 327 EP 348 PG 22 WC Environmental Sciences; Public, Environmental & Occupational Health; Toxicology SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology GA FY148 UT WOS:A1991FY14800008 PM 1856880 ER PT J AU KODELL, RL GAYLOR, DW CHEN, JJ AF KODELL, RL GAYLOR, DW CHEN, JJ TI CARCINOGENIC POTENCY CORRELATIONS - REAL OR ARTIFACTUAL SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH LA English DT Article ID RATS; MICE AB It has been suggested by various investigators that observed interspecies correlations of carcinogenic potency estimates based on bioassays are to a degree due to tautologous aspects of experimental designs. Some authors have even suggested that carcinogenic potency estimates derived from chronic bioassays are little more than experimental design artifacts. In this paper it is argued that constraints imposed by the use of the one-hit model to estimate carcinogenic potency are more restrictive than potential experimental design constraints. RP KODELL, RL (reprint author), US FDA,NATL CTR TOXICOL RES,BIOMETRY STAFF,HFT-20,JEFFERSON,AR 72079, USA. NR 11 TC 8 Z9 8 U1 0 U2 0 PU TAYLOR & FRANCIS PI BRISTOL PA 1900 FROST ROAD, SUITE 101, BRISTOL, PA 19007-1598 SN 0098-4108 J9 J TOXICOL ENV HEALTH JI J. Toxicol. Environ. Health PY 1991 VL 32 IS 1 BP 1 EP 9 PG 9 WC Environmental Sciences; Public, Environmental & Occupational Health; Toxicology SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology GA EU614 UT WOS:A1991EU61400001 PM 1987359 ER PT J AU KURT, TL AF KURT, TL TI ADVERSE DRUG REACTION SO JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY LA English DT Letter ID DATA-COLLECTION SYSTEM C1 UNIV TEXAS,INTERNAL MED,DALLAS,TX 75230. N TEXAS POISON CTR,DALLAS,TX. RP KURT, TL (reprint author), US FDA,WASHINGTON,DC 20204, USA. NR 22 TC 0 Z9 0 U1 0 U2 0 PU MARCEL DEKKER INC PI NEW YORK PA 270 MADISON AVE, NEW YORK, NY 10016 SN 0731-3810 J9 J TOXICOL-CLIN TOXIC JI J. Toxicol.-Clin. Toxicol. PY 1991 VL 29 IS 4 BP 559 EP 564 PG 6 WC Toxicology SC Toxicology GA GV795 UT WOS:A1991GV79500017 PM 1749060 ER PT J AU FLIGIEL, S BEALS, T TASHKIN, D PAULE, M ALI, S SCALLET, A BAILEY, J SLIKKER, W AF FLIGIEL, S BEALS, T TASHKIN, D PAULE, M ALI, S SCALLET, A BAILEY, J SLIKKER, W TI LUNG PATHOLOGY IN MARIJUANA EXPOSURE SO LABORATORY INVESTIGATION LA English DT Meeting Abstract C1 VET ADM MED CTR,ALLEN PK,MI 48101. VET ADM MED CTR,ANN ARBOR,MI 48105. UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 1 PU WILLIAMS & WILKINS PI BALTIMORE PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 SN 0023-6837 J9 LAB INVEST JI Lab. Invest. PD JAN PY 1991 VL 64 IS 1 BP A115 EP A115 PG 1 WC Medicine, Research & Experimental; Pathology SC Research & Experimental Medicine; Pathology GA EV366 UT WOS:A1991EV36600693 ER PT J AU GRAMLICH, TL CRAWFORD, LJ RADER, JI STERNBERG, EM DESCHRYVERKECSKEMETI, K AF GRAMLICH, TL CRAWFORD, LJ RADER, JI STERNBERG, EM DESCHRYVERKECSKEMETI, K TI GASTROINTESTINAL (GI) LESIONS IN LEWIS RATS AFTER EXPOSURE TO IMPLICATED L-TRYPTOPHAN (L-TRP) SO LABORATORY INVESTIGATION LA English DT Meeting Abstract C1 CASE WESTERN RESERVE UNIV,INST SMALL ANIM MED & SURG,CLEVELAND,OH 44106. NIH,BETHESDA,MD 20892. NIMH,BETHESDA,MD 20892. US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU WILLIAMS & WILKINS PI BALTIMORE PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 SN 0023-6837 J9 LAB INVEST JI Lab. Invest. PD JAN PY 1991 VL 64 IS 1 BP A36 EP A36 PG 1 WC Medicine, Research & Experimental; Pathology SC Research & Experimental Medicine; Pathology GA EV366 UT WOS:A1991EV36600222 ER PT J AU EDIGER, MN AF EDIGER, MN TI EXCIMER-LASER-INDUCED FLUORESCENCE OF RABBIT CORNEA - RADIOMETRIC MEASUREMENT THROUGH THE CORNEA SO LASERS IN SURGERY AND MEDICINE LA English DT Article DE CATARACTS; PHOTOABLATION; PHOTOREFRACTIVE SURGERY; ULTRAVIOLET-B ID SINGLE-STRAND BREAKS; ULTRAVIOLET-RADIATION; UV-RADIATION; 193 NM; CATARACT FORMATION; CYTO-TOXICITY; 308 NM; CELLS; DNA; MUTAGENICITY AB The laser-induced fluorescence spectrum of rabbit cornea irradiated at ablative intensities was measured. This system directly measured the radiant exposure of fluorescence transmitted through the cornea when the anterior surface of the cornea was irradiated by an ArF excimer laser. Evidence of changing spectral characteristics as a function of total laser dose suggests photochemical changes in the cornea may be occurring. Results are compared with previous data of laser-induced fluorescence in other models and detection schemes. RP EDIGER, MN (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,1901 CHAPMAN AVE,ROCKVILLE,MD 20857, USA. NR 22 TC 11 Z9 12 U1 0 U2 1 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0196-8092 J9 LASER SURG MED JI Lasers Surg. Med. PY 1991 VL 11 IS 2 BP 93 EP 98 DI 10.1002/lsm.1900110202 PG 6 WC Dermatology; Surgery SC Dermatology; Surgery GA FE653 UT WOS:A1991FE65300001 PM 2034015 ER PT J AU MATCHETTE, LS FAALAND, RW ROYSTON, DD EDIGER, MN AF MATCHETTE, LS FAALAND, RW ROYSTON, DD EDIGER, MN TI INVITRO PRODUCTION OF VIABLE BACTERIOPHAGE IN CARBON-DIOXIDE AND ARGON-LASER PLUMES SO LASERS IN SURGERY AND MEDICINE LA English DT Article DE ABLATION; CONTINUOUS WAVE; PARTICLE DISPERSION; PARTICLE DISTRIBUTION ID PAPILLOMAVIRUS AB Both CO2 and argon laser ablation of an agar substrate containing high titres of bacteriophage phi-X174 create plumes which disperse viable phage particles. Irradiances at the beam impact site ranged from 73 to 215 W/cm2 for the CO2 laser and from 40 to 227 W/cm2 for the argon laser. To increase the absorption of argon laser radiation, oxidized hemoglobin was added to the target material. Plume-borne viable phage were observed to be associated with particles large enough to settle out from the plume within 100 mm of the beam impact site. The ratio of the number of dispersed viable phage to the number of viable phage potentially dispersible by a single, 1-second laser exposure was on the order of 10(-6) to 10(-5). C1 OFF SCI & TECHNOL,CTR DEVICES & RADIOL HLTH,ROCKVILLE,MD 20857. NR 5 TC 5 Z9 5 U1 0 U2 0 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0196-8092 J9 LASER SURG MED JI Lasers Surg. Med. PY 1991 VL 11 IS 4 BP 380 EP 384 PG 5 WC Dermatology; Surgery SC Dermatology; Surgery GA FZ427 UT WOS:A1991FZ42700010 PM 1832731 ER PT J AU PETTIT, GH EDIGER, MN WEIBLINGER, RP AF PETTIT, GH EDIGER, MN WEIBLINGER, RP TI EXCIMER LASER CORNEAL ABLATION - ABSENCE OF A SIGNIFICANT INCUBATION EFFECT SO LASERS IN SURGERY AND MEDICINE LA English DT Article DE PHOTOABLATION; PHOTOREFRACTIVE SURGERY; PHOTOACOUSTIC DETECTION; TIME-RESOLVED REFLECTOMETRY ID POLY(METHYL METHACRYLATE); 193 NM; DYNAMICS; POLYMERS; FILMS AB Pulse-to-pulse consistency of excimer laser etching of cornea has been examined via two noncontact techniques: photoacoustic probe beam deflection, and time-resolved excimer pulse reflectometry. These methods clearly document the incubation phenomenon accompanying excimer laser ablation of polymethylmethacrylate and the absence of the effect during polyimide ablation. In comparison, results for corneal ablation indicate consistent tissue etching over a train of pulses. Consequently, incubation appears to have negligible impact on corneal ablation. RP PETTIT, GH (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,1901 CHAPMAN AVE,HFZ-134,ROCKVILLE,MD 20857, USA. NR 23 TC 15 Z9 15 U1 1 U2 2 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0196-8092 J9 LASER SURG MED JI Lasers Surg. Med. PY 1991 VL 11 IS 5 BP 411 EP 418 DI 10.1002/lsm.1900110505 PG 8 WC Dermatology; Surgery SC Dermatology; Surgery GA GJ895 UT WOS:A1991GJ89500004 PM 1816475 ER PT J AU GUEDON, JPV BIZAIS, YJ AF GUEDON, JPV BIZAIS, YJ TI SPLINE-BASED REGULARIZATION FOR DISCRETE FBP RECONSTRUCTION SO LECTURE NOTES IN COMPUTER SCIENCE LA English DT Article DE B-SPLINES; FILTERED BACK-PROJECTION; PIXEL INTENSITY DISTRIBUTION MODEL AB In this paper, we show that tomographic images are degraded by the unsuitable discretisation of continuous schemes, and the non-trivial null space in the case of angular sampling. Usually these two types of degradations are not studied separately. However, discretisation can be performed properly, while the null space is irreducible. For this reason, we study the relationships between continuous and discrete versions of a direct reconstruction method (FBP). They are characterized by an interpolation / sampling kernel, called the Pixel Intensity Distribution Model (PIDM). By defining the latter as B-spline functions, the existence and the uniqueness of the solution is guaranteed. It follows that projections must be oversampled. We test the robustness of this exact solution (for an infinite number of projections) by decreasing the number of angles. PIDM results are much better then FBP ones, showing that FBP reconstructed images are degraded not only by the null space, but also by unsuitable discretisation. We also analyze the influence of degradations induced by an imaging device (mechanical instability and blur) and by projection noise in SPECT. Discretisation-related degradations depend on projection sampling. For this reason, proper oversampling is achieved when the corresponding degradations are negligible in comparison to the ones induced by the imaging device. Our algorithm is constrained by the amount of information input to the system and controlled by the number of projection angles and the PIDM order. Optimal values of these parameters could be found for a predefined task using the ROC curve methodology. C1 US FDA,CTR DEVICES & RADIOL HLTH,ROCKVILLE,MD 20857. RP GUEDON, JPV (reprint author), FAC MED NANTES,IMAGERIE MED MULTIMODAL,NANTES,FRANCE. NR 20 TC 0 Z9 0 U1 0 U2 1 PU SPRINGER VERLAG PI NEW YORK PA 175 FIFTH AVE, NEW YORK, NY 10010 SN 0302-9743 J9 LECT NOTES COMPUT SC JI Lect. Notes Comput. Sci. PY 1991 VL 511 BP 55 EP 64 PG 10 WC Computer Science, Theory & Methods SC Computer Science GA GA066 UT WOS:A1991GA06600005 ER PT J AU MUNDY, W TANDON, P ALI, S TILSON, H AF MUNDY, W TANDON, P ALI, S TILSON, H TI AGE-RELATED-CHANGES IN RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN VARIOUS REGIONS OF RAT-BRAIN SO LIFE SCIENCES LA English DT Note ID PHORBOL ESTERS; DYSFUNCTION; HIPPOCAMPUS; METABOLISM; TURNOVER; EXPOSURE; NEURONS; SLICES; SYSTEM AB The effects of age on cholinergic markers and receptor-stimulated phosphoinositide hydrolysis was examined in the frontal cortex and striatum of male Fischer-344 rats. Choline acetyltransferase activity was decreased 27% in the striatum of aged (24 month) rats compared to young (3 month) controls. Muscarinic receptor density as measured by [H-3]-quinuclidinyl benzilate binding showed a similar 26% decrease in the striatum of aged rats. Phosphoinositide hydrolysis was measured by the release of inositol phosphate (IP) from tissue slices prelabeled with [H-3]myoinositol in response to carbachol, norepinephrine, and quisqualate. In the cortex, stimulated IP release was significantly greater in slices from aged rats compared to young rats for all three agonists. In contrast, stimulated IP release was significantly decreased in striatal slices from aged rats compared to young for all three agonists. These data indicate a differential effect of age on agonist-stimulated phosphoinositide hydrolysis in the cortex and striatum. The decreased responsiveness in the latter area may result from the age-related loss of postsynaptic receptors. C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079. RP MUNDY, W (reprint author), US EPA,DIV NEUROTOXICOL,MD-74B,RES TRIANGLE PK,NC 27711, USA. NR 25 TC 14 Z9 14 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0024-3205 J9 LIFE SCI JI Life Sci. PY 1991 VL 49 IS 14 BP PL97 EP PL102 DI 10.1016/0024-3205(91)90308-X PG 6 WC Medicine, Research & Experimental; Pharmacology & Pharmacy SC Research & Experimental Medicine; Pharmacology & Pharmacy GA GD059 UT WOS:A1991GD05900009 PM 1653884 ER PT J AU LANDY, RB LAMBERTSEN, RH PALSSON, PA KROOK, L NEVIUS, A ECKERLIN, R AF LANDY, RB LAMBERTSEN, RH PALSSON, PA KROOK, L NEVIUS, A ECKERLIN, R TI FLUORIDE IN THE BONE AND DIET OF FIN WHALES, BALAENOPTERA-PHYSALUS SO MARINE ENVIRONMENTAL RESEARCH LA English DT Note ID KRILL EUPHAUSIA-SUPERBA; MEGANYCTIPHANES-NORVEGICA; ANTARCTIC KRILL AB Bone samples were taken from fin whales Balaenoptera physalus from the North Atlantic to examine the relationship between fluoride concentration in skeletal tissue and age, sex, body length and anatomic location. By the use of an ion-selective electrode, the fluoride concentration in these samples were found to be higher than that normally occurring in any mammalian species, ranging from 4340 to 18 570 ppm. The positive correlation observed with age, along with high fluoride concentrations found in krill taken from the stomachs of these whales, indicated a probable bioaccumulation of fluoride from dietary sources. These results confirmed and extended earlier findings that bone tissue in fin whales naturally contains very high concentrations of fluoride and indicate that this baleen whale is tolerant to a significant extent of the high fluoride concentrations found in krill. C1 CORNELL UNIV,NEW YORK STATE COLL VET MED,DEPT PATHOL,ITHACA,NY 14853. CORNELL UNIV,NEW YORK STATE COLL VET MED,DEPT AVIAN & AQUAT MED,ITHACA,NY 14853. ECOSYST INT,PHILADELPHIA,PA 19104. UNIV ICELAND,DEPT EXPTL PATHOL,REYKJAVIK,ICELAND. US FDA,CTR VET MED,ROCKVILLE,MD 20857. CORNELL UNIV,NEW YORK STATE COLL VET MED,NEW YORK STATE EQUINE DRUG TESTING & TOXICOL LAB,ITHACA,NY 14850. NR 22 TC 7 Z9 8 U1 1 U2 5 PU ELSEVIER SCI LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB SN 0141-1136 J9 MAR ENVIRON RES JI Mar. Environ. Res. PY 1991 VL 31 IS 3 BP 241 EP 247 DI 10.1016/0141-1136(91)90014-Y PG 7 WC Environmental Sciences; Marine & Freshwater Biology; Toxicology SC Environmental Sciences & Ecology; Marine & Freshwater Biology; Toxicology GA GL089 UT WOS:A1991GL08900006 ER PT J AU WALSETH, TF YUEN, PST MOOS, MC AF WALSETH, TF YUEN, PST MOOS, MC TI PREPARATION OF ALPHA-P-32-LABELED NUCLEOSIDE TRIPHOSPHATES, NICOTINAMIDE ADENINE-DINUCLEOTIDE, AND CYCLIC-NUCLEOTIDES FOR USE IN DETERMINING ADENYLYL AND GUANYLYL CYCLASES AND CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE SO METHODS IN ENZYMOLOGY LA English DT Review ID ENZYMATIC PREPARATION; EUKARYOTIC CELLS; ASSAY; TOXIN; GTP; 100/50,000 seeded cells) was observed at a concentration of 50 ng/ml, and a variable, but decreased, response was seen at higher and lower exposures. MNU co-treatment served to maintain the transformation response at higher (mu-g/ml) saccharin levels at which saccharin alone was not effective. Thus, sodium saccharin demonstrated significant transforming activity over a wide dose range, both when used alone, and in combination with MNU. RP WEST, RW (reprint author), NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,JEFFERSON,AR 72079, USA. NR 25 TC 0 Z9 0 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0887-2333 J9 TOXICOL IN VITRO JI Toxicol. Vitro PY 1991 VL 5 IS 3 BP 257 EP 262 DI 10.1016/0887-2333(91)90026-A PG 6 WC Toxicology SC Toxicology GA FW550 UT WOS:A1991FW55000011 PM 20732024 ER PT J AU MAHAR, J LUKACS, GL LI, Y HALL, S MOCZYDLOWSKI, E AF MAHAR, J LUKACS, GL LI, Y HALL, S MOCZYDLOWSKI, E TI PHARMACOLOGICAL AND BIOCHEMICAL-PROPERTIES OF SAXIPHILIN, A SOLUBLE SAXITOXIN-BINDING PROTEIN FROM THE BULLFROG (RANA-CATESBEIANA) SO TOXICON LA English DT Article ID INSENSITIVE SODIUM-CHANNELS; APHANIZOMENON-FLOS-AQUAE; RAT SKELETAL-MUSCLE; ELECTROPHORUS-ELECTRICUS; MOLECULAR-WEIGHT; TETRODOTOXIN; PURIFICATION; HEART; TOXINS; CELLS AB Supernatant fractions of various tissues and plasma from the North American bullfrog, Rana catesbeiana, specifically bind saxitoxin with high affinity. Binding of [H-3]saxitoxin to bullfrog plasma follows single-site behavior with an equilibrium dissociation constant of K(d) = 0.16 +/- 0.03 nM at 0-degrees-C and a maximum binding capacity of 380 +/- 60 pmole/ml plasma. High-affinity binding of [H-3]saxitoxin is chemically specific since it is unaffected by tetrodotoxin and a variety of cationic peptides amino acids and drugs. the structure-activity dependence of binding to this site was investigated with eight different natural and synthetic derivatives of saxitoxin. Substitution of the carbamoyl side chain or the C-12 beta-hydroxyl group of saxitoxin with a hydrogen atom had little effect on binding affinity, but addition of a hydroxyl group at the N-1 position decreased the binding affinity from 430- to 710-fold in three different molecular pairs. High performance size exclusion chromatography of supernatant from bullfrog skeletal muscle showed that the [H-3]saxitoxin-binding component migrates with an apparent molecular weight of M(r) = 74,000 +/- 8000 or a Stokes radius of 35 +/- 2Angstrom. The [H-3]saxitoxin-binding protein in skeletal muscle extract or plasma is retained on a cation-exchange column at pH 6.0, suggesting that the protein contains a region of exposed basic residues. Column isoelectric focusing of a sample from plasma indicated that the protein has a basic isoelectric point near pH = 10.7. These pharmacological and biochemical properties imply that this soluble saxitoxin-binding activity is associated with a novel protein named saxiphilin that is structurally distinct from known subtypes of functional sodium channel proteins which are the biological target of saxitoxin's paralyzing effect. C1 YALE UNIV, SCH MED, DEPT PHARMACOL, 333 CEDAR ST, NEW HAVEN, CT 06510 USA. YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA. US FDA, WASHINGTON, DC 20204 USA. RI Moczydlowski, Edward/D-1734-2013 FU NHLBI NIH HHS [HL38156]; NIAMS NIH HHS [AR38796] NR 58 TC 45 Z9 46 U1 0 U2 2 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND SN 0041-0101 J9 TOXICON JI Toxicon PY 1991 VL 29 IS 1 BP 53 EP 71 DI 10.1016/0041-0101(91)90039-T PG 19 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA EQ364 UT WOS:A1991EQ36400005 PM 1851343 ER PT J AU GUEST, GB AF GUEST, GB TI IR-4/FDA WORKSHOP FOR MINOR USE DRUGS - FOCUS ON AQUACULTURE OPENING REMARKS SO VETERINARY AND HUMAN TOXICOLOGY LA English DT Article; Proceedings Paper CT WORKSHOP FOR MINOR USE DRUGS : FOCUS ON AQUACULTURE CY OCT 15-16, 1990 CL BETHESDA, MD SP US DEPT HHS US FDA, CTR VET MED, USDA, INTERREG PROJECT ANIM DRUG PROGRAM RP GUEST, GB (reprint author), US FDA,CTR VET MED,HFV-1,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 0 TC 5 Z9 5 U1 0 U2 0 PU COMPARATIVE TOXICOLOGY LAB KANSAS STATE UNIV PI MANHATTAN PA MANHATTAN, KS 66506 SN 0145-6296 J9 VET HUM TOXICOL JI Vet. Human Toxicol. PY 1991 VL 33 SU 1 BP 2 EP 3 PG 2 WC Toxicology; Veterinary Sciences SC Toxicology; Veterinary Sciences GA FU862 UT WOS:A1991FU86200002 PM 1926742 ER PT J AU MITCHELL, GA AF MITCHELL, GA TI COMPLIANCE ISSUES AND PROPER ANIMAL DRUG-USE IN AQUACULTURE SO VETERINARY AND HUMAN TOXICOLOGY LA English DT Article; Proceedings Paper CT WORKSHOP FOR MINOR USE DRUGS : FOCUS ON AQUACULTURE CY OCT 15-16, 1990 CL BETHESDA, MD SP US DEPT HHS US FDA, CTR VET MED, USDA, INTERREG PROJECT ANIM DRUG PROGRAM RP MITCHELL, GA (reprint author), US FDA,CVM,OFF SURVEILLANCE & COMPLIANCE,HFV-200,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 0 TC 9 Z9 9 U1 0 U2 0 PU COMPARATIVE TOXICOLOGY LAB KANSAS STATE UNIV PI MANHATTAN PA MANHATTAN, KS 66506 SN 0145-6296 J9 VET HUM TOXICOL JI Vet. Human Toxicol. PY 1991 VL 33 SU 1 BP 9 EP 10 PG 2 WC Toxicology; Veterinary Sciences SC Toxicology; Veterinary Sciences GA FU862 UT WOS:A1991FU86200006 PM 1926755 ER PT J AU GUARINO, AM AF GUARINO, AM TI REGULATORY AND SCIENTIFIC ROLES FOR BIODISTRIBUTION STUDIES IN AQUATIC SPECIES SO VETERINARY AND HUMAN TOXICOLOGY LA English DT Article; Proceedings Paper CT WORKSHOP FOR MINOR USE DRUGS : FOCUS ON AQUACULTURE CY OCT 15-16, 1990 CL BETHESDA, MD SP US DEPT HHS US FDA, CTR VET MED, USDA, INTERREG PROJECT ANIM DRUG PROGRAM ID CATFISH ICTALURUS-PUNCTATUS; SOLE PAROPHRYS-VETULUS; TISSUE DISTRIBUTION; RAINBOW-TROUT; DISPOSITION; METABOLISM; FISH; ACID; XENOBIOTICS; EXCRETION AB The advantage of focusing on biliary excretion of drugs and other xenobiotics is emphasized in this discussion of the regulatory and scientific roles for biodistribution studies in aquatic species. The role of the hepatobiliary system in the overall disposition of absorbed chemicals is briefly reviewed. The present survey includes 18 drugs, 6 petroleum hydrocarbons, and 16 different fish species. The fact that aquatic species concentrate most xenobiotics and their metabolites into bile to as much as several orders of magnitude underscores the advantage of using bile rather than tissue to determine whether aquatic species are being exposed to given chemicals. Until these advantages are recognized, analysis of edible muscle tissue remains the method of choice for assessment of human exposure to chemicals. RP GUARINO, AM (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV SEAFOOD RES,POB 158,DAUPHIN ISL,AL 36525, USA. NR 48 TC 3 Z9 3 U1 0 U2 0 PU COMPARATIVE TOXICOLOGY LAB KANSAS STATE UNIV PI MANHATTAN PA MANHATTAN, KS 66506 SN 0145-6296 J9 VET HUM TOXICOL JI Vet. Human Toxicol. PY 1991 VL 33 SU 1 BP 54 EP 59 PG 6 WC Toxicology; Veterinary Sciences SC Toxicology; Veterinary Sciences GA FU862 UT WOS:A1991FU86200016 PM 1926750 ER PT J AU RAUSCH, DM HWANG, KM PADGETT, M VOLTZ, AH RIVAS, A ENGLEMAN, E GASTON, I MCGRATH, M FRASER, B KALYANARAMAN, VS NARA, PL DUNLOP, N MARTIN, L MURPHEYCORB, M KIBORT, T LIFSON, JD EIDEN, LE AF RAUSCH, DM HWANG, KM PADGETT, M VOLTZ, AH RIVAS, A ENGLEMAN, E GASTON, I MCGRATH, M FRASER, B KALYANARAMAN, VS NARA, PL DUNLOP, N MARTIN, L MURPHEYCORB, M KIBORT, T LIFSON, JD EIDEN, LE TI PEPTIDES DERIVED FROM THE CDR3-HOMOLOGOUS DOMAIN OF THE CD4 MOLECULE ARE SPECIFIC INHIBITORS OF HIV-1 AND SIV INFECTION, VIRUS-INDUCED CELL-FUSION, AND POSTINFECTION VIRAL TRANSMISSION INVITRO - IMPLICATIONS FOR THE DESIGN OF SMALL-PEPTIDE ANTI-HIV THERAPEUTIC AGENTS SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES LA English DT Article ID HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE-DEFICIENCY SYNDROME; RECOMBINANT SOLUBLE CD4; PNEUMOCYSTIS-CARINII PNEUMONIA; RETROVIRUS HTLV-III/LAV; HUMAN PERIPHERAL-BLOOD; T-CELL; MONOCLONAL-ANTIBODY; SYNCYTIUM FORMATION; AIDS VIRUS C1 NIMH, CELL BIOL LAB, BLDG 36, ROOM 3A-17, BETHESDA, MD 20892 USA. GENELABS INC, REDWOOD CITY, CA USA. STANFORD UNIV, CTR BLOOD, PALO ALTO, CA 94304 USA. UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, SAN FRANCISCO, CA 94110 USA. CTR BIOL EVALUAT & RES FOOD & DRUG ADM, BETHESDA, MD USA. BIONET RES LABS INC, ROCKVILLE, MD USA. NCI, TUMOR CELL BIOL LAB, FREDERICK, MD 21701 USA. TULANE UNIV, DELTA PRIMATE CTR, COVINGTON, LA 70433 USA. NR 80 TC 1 Z9 1 U1 0 U2 0 PU NEW YORK ACAD SCIENCES PI NEW YORK PA 2 E 63RD ST, NEW YORK, NY 10021 USA SN 0077-8923 J9 ANN NY ACAD SCI JI Ann.NY Acad.Sci. PD DEC 26 PY 1990 VL 616 BP 125 EP 148 PG 24 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA FM709 UT WOS:A1990FM70900013 ER PT J AU BEAUCAGE, SL IYER, RP EGAN, W REGAN, JB AF BEAUCAGE, SL IYER, RP EGAN, W REGAN, JB TI AN IMPROVED SULFURIZATION REAGENT FOR THE SYNTHESIS OF SULFUR-CONTAINING OLIGONUCLEOTIDES SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES LA English DT Article ID OLIGODEOXYNUCLEOTIDES; EXPRESSION RP BEAUCAGE, SL (reprint author), US FDA, CTR BIOL EVALUAT & RES, DIV BIOCHEM & BIOPHYS, BETHESDA, MD 20892 USA. NR 9 TC 0 Z9 0 U1 1 U2 1 PU NEW YORK ACAD SCIENCES PI NEW YORK PA 2 E 63RD ST, NEW YORK, NY 10021 USA SN 0077-8923 J9 ANN NY ACAD SCI JI Ann.NY Acad.Sci. PD DEC 26 PY 1990 VL 616 BP 483 EP 485 PG 3 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA FM709 UT WOS:A1990FM70900050 ER PT J AU BLACK, PL USSERY, MA RANKIN, JT CHIRIGOS, MA AF BLACK, PL USSERY, MA RANKIN, JT CHIRIGOS, MA TI THERAPEUTIC ACTIVITY OF REVERSE-TRANSCRIPTASE INHIBITORS IN MURINE RETROVIRUS MODELS SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES LA English DT Article C1 US FDA, ROCKVILLE, MD 20857 USA. USA, MED RES INST INFECT DIS, FREDERICK, MD 21701 USA. RP BLACK, PL (reprint author), SO RES INST, FREDERICK RES CTR, 431 AVIAT WAY, FREDERICK, MD 21701 USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU NEW YORK ACAD SCIENCES PI NEW YORK PA 2 E 63RD ST, NEW YORK, NY 10021 USA SN 0077-8923 J9 ANN NY ACAD SCI JI Ann.NY Acad.Sci. PD DEC 26 PY 1990 VL 616 BP 486 EP 489 PG 4 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA FM709 UT WOS:A1990FM70900051 ER PT J AU RHEINSTEIN, PH AF RHEINSTEIN, PH TI TREATMENT FAILURE AFTER SUBSTITUTION OF GENERIC PANCRELIPASE CAPSULES - REPLY SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Letter RP RHEINSTEIN, PH (reprint author), CTR DRUG EVALUAT & RES,ROCKVILLE,MD, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD DEC 26 PY 1990 VL 264 IS 24 BP 3149 EP 3149 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EN614 UT WOS:A1990EN61400032 ER PT J AU KASHIWAGI, K TANEJA, SK LIU, TY TABOR, CW TABOR, H AF KASHIWAGI, K TANEJA, SK LIU, TY TABOR, CW TABOR, H TI SPERMIDINE BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE - BIOSYNTHESIS AND PROCESSING OF A PROENZYME FORM OF S-ADENOSYLMETHIONINE DECARBOXYLASE SO JOURNAL OF BIOLOGICAL CHEMISTRY LA English DT Article ID DOUBLE-STRANDED-RNA; ESCHERICHIA-COLI; HISTIDINE-DECARBOXYLASE; SEQUENCE-ANALYSIS; ALPHA-CHAIN; RAT-LIVER; PYRUVATE; YEAST; LACTOBACILLUS-30A; PLASMID AB We have cloned and sequenced the Saccharomyces cerevisiae gene for S-adenosylmethionine decarboxylase. This enzyme contains covalently bound pyruvate which is essential for enzymatic activity. We have shown that this enzyme is synthesized as a M(r) 46,000 proenzyme which is then cleaved post-translationally to form two polypeptide chains: a beta-subunit (M(r) 10,000) from the amino-terminal portion and an alpha-subunit (M(r) 36,000) from the carboxyl-terminal portion. The protein was overexpressed in Escherichia coli and purified to homogeneity. The purified enzyme contains both the alpha and beta-subunits. About half of the alpha-subunits have pyruvate blocking the amino-terminal end; the remaining-alpha-subunits have alanine in this position. From a comparison of the amino acid sequence deduced from the nucleotide sequence with the amino acid sequence of the amino-terminal portion of each subunit (determined by Edman degradation), we have identified the cleavage site of the proenzyme as the peptide bond between glutamic acid 87 and serine 88. The pyruvate moiety, which is essential for activity, is generated from serine 88 during the cleavage. The amino acid sequence of the yeast enzyme has essentially no homology with S-adenosylmethionine decarboxylase of E. coli (Tabor, C. W., and Tabor, H. (1987) J. Biol. Chem. 262, 16037-16040) and only a moderate degree of homology with the human and rat enzymes (Pajunen, A., Crozat, A., Janne, O. A., Ihalainen, R., Laitinen, P. H., Stanley, B., Madhubala, R., and Pegg, A. E. (1988) J. Biol. Chem. 263, 17040-17049); all of these enzymes are pyruvoyl-containing proteins. Despite this limited overall homology the cleavage site of the yeast proenzyme is identical to the cleavage sites in the human and rat proenzymes, and seven of the eight amino acids adjacent to the cleavage site are identical in the three eukaryote enzymes. C1 NIDDK,BIOCHEM PHARMACOL LAB,PHARMACOL SECT,BLDG 8,RM 223,BETHESDA,MD 20892. US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,BETHESDA,MD 20892. NR 48 TC 60 Z9 63 U1 0 U2 0 PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0021-9258 J9 J BIOL CHEM JI J. Biol. Chem. PD DEC 25 PY 1990 VL 265 IS 36 BP 22321 EP 22328 PG 8 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EP556 UT WOS:A1990EP55600044 PM 2266128 ER PT J AU THOMPSON, P SALSBURY, PA ADAMS, C ARCHER, DL AF THOMPSON, P SALSBURY, PA ADAMS, C ARCHER, DL TI UNITED-STATES FOOD LEGISLATION SO LANCET LA English DT Article C1 US FOOD SAFETY & INSPECT SERV,WASHINGTON,DC 20250. RP THOMPSON, P (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA. NR 8 TC 1 Z9 1 U1 0 U2 1 PU LANCET LTD PI LONDON PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL SN 0140-6736 J9 LANCET JI Lancet PD DEC 22 PY 1990 VL 336 IS 8730 BP 1557 EP 1559 DI 10.1016/0140-6736(90)93320-O PG 3 WC Medicine, General & Internal SC General & Internal Medicine GA EP037 UT WOS:A1990EP03700015 PM 1979377 ER PT J AU PIERCE, LR WYSOWSKI, DK GROSS, TP AF PIERCE, LR WYSOWSKI, DK GROSS, TP TI MYOPATHY AND RHABDOMYOLYSIS WITH LOVASTATIN TAKEN WITH GEMFIBROZIL - REPLY SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Letter RP PIERCE, LR (reprint author), US FDA,ROCKVILLE,MD 20857, USA. NR 3 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD DEC 19 PY 1990 VL 264 IS 23 BP 2992 EP 2992 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EM763 UT WOS:A1990EM76300009 ER PT J AU CLIFFORD, RH MONTASER, A DOLAN, SP CAPAR, SG AF CLIFFORD, RH MONTASER, A DOLAN, SP CAPAR, SG TI CONVERSION OF AN ULTRASONIC HUMIDIFIER TO A CONTINUOUS-TYPE ULTRASONIC NEBULIZER FOR ATOMIC SPECTROMETRY SO ANALYTICAL CHEMISTRY LA English DT Note C1 GEORGE WASHINGTON UNIV,DEPT CHEM,WASHINGTON,DC 20052. US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. NR 19 TC 17 Z9 18 U1 2 U2 4 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0003-2700 J9 ANAL CHEM JI Anal. Chem. PD DEC 15 PY 1990 VL 62 IS 24 BP 2745 EP 2749 DI 10.1021/ac00223a019 PG 5 WC Chemistry, Analytical SC Chemistry GA EN073 UT WOS:A1990EN07300021 ER PT J AU BILLEDEAU, SM HOLDER, CL GETEK, TA AF BILLEDEAU, SM HOLDER, CL GETEK, TA TI HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF THE ANTIHISTAMINE PYRILAMINE AND ITS N-OXIDE USING ELECTROCHEMICAL DETECTION SO JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS LA English DT Article ID PHENYLPROPANOLAMINE HYDROCHLORIDE; PHENIRAMINE MALEATE; METABOLITES; PLASMA; PROMETHAZINE; ASSAY AB The electrochemical behavior of the over-the-counter antihistamine drug pyrilamine and its N-oxide analogue, have been studied by several voltammetric methods. Cyclic voltammograms of pyrilamine maleate in 0.1 M ammonium acetate at pH 7.0 indicated a quasi-reversible electrode process by observing a wave at + 0.85 V and + 1.30 V in the initial anodic sweep followed by a wave at - 1.30 V versus Ag/AgCl. Differential pulse and hydrodynamic voltammetry of pyrilamine and the N-oxide were examined to determine oxidation potentials for use in high-performance liquid chromatography with electrochemical detection (HPLC-ED). Differentiation between pyrilamine and its N-oxide was achieved in HPLC-ED analyses at a detection potential of + 0.7 V and + 0.9 V versus Ag/AgCl with tandem ultraviolet detection at 254 nm. Utility of the HPLC-ED method was demonstrated by the analysis of pyrilamine and the N-oxide in microbial biotransformation samples. RP BILLEDEAU, SM (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 16 TC 3 Z9 3 U1 0 U2 11 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0378-4347 J9 J CHROMATOGR-BIOMED JI J. Chromatogr.-Biomed. Appl. PD DEC 14 PY 1990 VL 534 BP 151 EP 159 DI 10.1016/S0378-4347(00)82157-X PG 9 WC Chemistry, Analytical SC Chemistry GA ET068 UT WOS:A1990ET06800015 PM 2094702 ER PT J AU GLAUDEMANS, CPJ LERNER, L DAVES, GD KOVAC, P VENABLE, R BAX, A AF GLAUDEMANS, CPJ LERNER, L DAVES, GD KOVAC, P VENABLE, R BAX, A TI SIGNIFICANT CONFORMATIONAL-CHANGES IN AN ANTIGENIC CARBOHYDRATE EPITOPE UPON BINDING TO A MONOCLONAL-ANTIBODY SO BIOCHEMISTRY LA English DT Article C1 NIDDKD,CHEM PHYS LAB,BETHESDA,MD 20892. US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. RP GLAUDEMANS, CPJ (reprint author), NIDDKD,CHEM LAB,BETHESDA,MD 20892, USA. NR 50 TC 61 Z9 61 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0006-2960 J9 BIOCHEMISTRY-US JI Biochemistry PD DEC 11 PY 1990 VL 29 IS 49 BP 10906 EP 10911 DI 10.1021/bi00501a007 PG 6 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EM296 UT WOS:A1990EM29600007 PM 1703008 ER PT J AU PONZONI, M DEBELL, KE HOFFMAN, T BONVINI, E AF PONZONI, M DEBELL, KE HOFFMAN, T BONVINI, E TI DIFFERENTIAL CHANGES IN LIPID-METABOLISM OF MYELOID AND LYMPHOID-CELL LINES INDUCED BY TREATMENT WITH 12-O-TETRADECANOYLPHORBOL-13-ACETATE (TPA) SO FEBS LETTERS LA English DT Article DE PHORBOL ESTER; LIPID METABOLISM; CELL DIFFERENTIATION ID PROMYELOCYTIC LEUKEMIA-CELLS; PROTEIN KINASE-C; PHORBOL ESTER; PHOSPHOLIPID-METABOLISM; TUMOR PROMOTERS; MECHANISM; INDUCTION; DIESTER; TRANSLOCATION; ESTABLISHMENT AB Treatment of the myeloid cell lines, U-937 or HL-60, with 10 nM of the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), for 24 h increased the rate of incorporation of ]H-3[glycerol into total chloroform extracts. A proportionally greater labeling of the non-polar lipid (NL) fraction compared to the polar, phospholipid (PL), fraction was observed. Chromatographic analysis showed a 6-fold increase in the labeling of triacylglycerols (TAG), a 2-fold increase in diacylglycerols, and no changes in monoacylglycerols. PL labeling showed a 3-fold increase in phosphatidylcholine (PC). The effect of TPA on TAG labeling was selectively observed in myeloid cell lines. No such a change was found in the lymphoid cell line, MOLT-3, which did respond to TPA with increased PC labeling. Incorporation of [H-3]arachidonic acid (AA) into TAG by U-937 cells was selectively increased (2.5-fold) after treatment with TPA for 24 h. Treatment of U-937 cells with TPA in serum-free medium resulted in no increased labeling of TAG. These studies suggest that changes in TAG metabolism may be characteristic of myeloid differentiation and depend on the presence of serum factor(s). C1 US FDA,CBER,DBBP,CELL BIOL LAB,BLDG 29,RM 231,8800 ROCKVILLE PIKE,BETHESDA,MD 20205. RI Ponzoni, Mirco/J-7713-2016 OI Ponzoni, Mirco/0000-0002-6164-4286 NR 28 TC 0 Z9 0 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0014-5793 J9 FEBS LETT JI FEBS Lett. PD DEC 10 PY 1990 VL 276 IS 1-2 BP 25 EP 28 DI 10.1016/0014-5793(90)80498-8 PG 4 WC Biochemistry & Molecular Biology; Biophysics; Cell Biology SC Biochemistry & Molecular Biology; Biophysics; Cell Biology GA EP342 UT WOS:A1990EP34200007 PM 2125010 ER PT J AU BARTSCH, H CAPORASO, N CODA, M KADLUBAR, F MALAVEILLE, C SKIPPER, P TALASKA, G TANNENBAUM, SR VINEIS, P AF BARTSCH, H CAPORASO, N CODA, M KADLUBAR, F MALAVEILLE, C SKIPPER, P TALASKA, G TANNENBAUM, SR VINEIS, P TI CARCINOGEN HEMOGLOBIN ADDUCTS, URINARY MUTAGENICITY, AND METABOLIC PHENOTYPE IN ACTIVE AND PASSIVE CIGARETTE SMOKERS SO JOURNAL OF THE NATIONAL CANCER INSTITUTE LA English DT Article C1 DIPARTIMENTO SCI BIOMED & ONCOL UMANA,CANC EPIDEMIOL UNIT,VIA SANTENA 7,I-10126 TURIN,ITALY. INT AGCY RES CANC,F-69372 LYONS,FRANCE. NCI,DIV CANC ETIOL,FAMILY STUDIES SECT,BETHESDA,MD 20892. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. MIT,DEPT CHEM,DIV TOXICOL,CAMBRIDGE,MA 02139. UNIV CINCINNATI,CINCINNATI,OH 45221. NR 31 TC 126 Z9 126 U1 1 U2 5 PU NATL CANCER INSTITUTE PI BETHESDA PA 9030 OLD GEORGETOWN RD, BETHESDA, MD 20814 SN 0027-8874 J9 J NATL CANCER I JI J. Natl. Cancer Inst. PD DEC 5 PY 1990 VL 82 IS 23 BP 1826 EP 1831 DI 10.1093/jnci/82.23.1826 PG 6 WC Oncology SC Oncology GA EL292 UT WOS:A1990EL29200012 PM 2250298 ER PT J AU MARCUSSEKURA, CJ WOERNER, AM ZWEIG, M COURT, DL LEVIN, JG KLUTCH, M AF MARCUSSEKURA, CJ WOERNER, AM ZWEIG, M COURT, DL LEVIN, JG KLUTCH, M TI EXPRESSION OF HIV-1 INTEGRASE IN ESCHERICHIA-COLI - IMMUNOLOGICAL ANALYSIS OF THE RECOMBINANT PROTEIN SO AIDS RESEARCH AND HUMAN RETROVIRUSES LA English DT Article ID IMMUNE-DEFICIENCY SYNDROME; RETROVIRUSES HTLV-III; MURINE LEUKEMIA-VIRUS; DNA-BINDING PROTEIN; POL GENE-PRODUCTS; ESCHERICHIA-COLI; REVERSE-TRANSCRIPTASE; FUSION PROTEINS; AVIAN-SARCOMA; MONOCLONAL-ANTIBODIES AB Sequences encoding the human immunodeficiency virus type 1 (HIV-1) integrase gene have been cloned and expressed in Escherichia coli. The expressed protein is a lambda-cII fusion protein of 37 kD containing the carboxyl-terminal 27 amino acids of reverse transcriptase fused to the entire integrase sequence and is insoluble, a feature which allows partial purification away from soluble bacterial proteins. As judged by its reactivity with HIV positive sera in Western blot and in enzyme-linked immunosorbent assay (ELISA), the recombinant integrase retains antigenicity similar to native protein. Additionally, ELISA data obtained with the cloned protein indicate that patients infected with HIV-1 who are at different stages of progression to AIDS have antibodies reactive with the cloned integrase. HIV-2 positive human sera are also reactive with the cloned integrase. Rabbit antibodies produced against the recombinant protein react both by ELISA and Western blot with the homologous bacterially expressed protein, recognize both virion HIV-1 integrase and reverse transcriptase in Western blots, and immunoprecipitate an HIV-1 virion protein of 34 kD. Unlike human antisera from patients infected with HIV-1 or HIV-2 which are frequently reactive with both HIV-1 and HIV-2 integrase, the rabbit antibodies are type specific, reacting with HIV-1, but not with HIV-2 integrase by Western blot. C1 PROGRAM RESOURCES INC,FREDERICK,MD. NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21701. NICHHD,MOLEC GENET LAB,BETHESDA,MD 20892. RP MARCUSSEKURA, CJ (reprint author), CTR BIOL EVALUAT & RES,DIV VIROL,BETHESDA,MD 20892, USA. NR 49 TC 10 Z9 10 U1 0 U2 1 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0889-2229 J9 AIDS RES HUM RETROV JI Aids Res. Hum. Retrovir. PD DEC PY 1990 VL 6 IS 12 BP 1399 EP 1408 DI 10.1089/aid.1990.6.1399 PG 10 WC Immunology; Infectious Diseases; Virology SC Immunology; Infectious Diseases; Virology GA ET189 UT WOS:A1990ET18900006 PM 2078417 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI SEAFOOD SAFETY SO AMERICAN FAMILY PHYSICIAN LA English DT Article RP NIGHTINGALE, SL (reprint author), US FDA,HLTH AFFAIRS,ROCKVILLE,MD 20857, USA. NR 0 TC 1 Z9 1 U1 0 U2 1 PU AMER ACAD FAMILY PHYSICIANS PI KANSAS CITY PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 SN 0002-838X J9 AM FAM PHYSICIAN JI Am. Fam. Physician PD DEC PY 1990 VL 42 IS 6 BP 1657 EP 1658 PG 2 WC Primary Health Care; Medicine, General & Internal SC General & Internal Medicine GA EL698 UT WOS:A1990EL69800015 PM 2244553 ER PT J AU KNOBEN, JE SCOTT, GR TONELLI, RJ AF KNOBEN, JE SCOTT, GR TONELLI, RJ TI AN OVERVIEW OF THE FDA PUBLICATION APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS SO AMERICAN JOURNAL OF HOSPITAL PHARMACY LA English DT Article RP KNOBEN, JE (reprint author), US FDA,DRUG INFORMAT SERV BRANCH,DIV DRUG INFORMAT RESOURCES,WASHINGTON,DC 20204, USA. NR 4 TC 7 Z9 7 U1 0 U2 1 PU AMER SOC HEALTH-SYSTEM PHARMACISTS PI BETHESDA PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 SN 0002-9289 J9 AM J HOSP PHARM JI Am. J. Hosp. Pharm. PD DEC PY 1990 VL 47 IS 12 BP 2696 EP 2700 PG 5 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EK415 UT WOS:A1990EK41500018 PM 2278285 ER PT J AU KAWALEK, JC FETTERER, RH AF KAWALEK, JC FETTERER, RH TI EFFECT OF HAEMONCHUS-CONTORTUS INFECTION ON THE CLEARANCE OF ANTIPYRINE, SULFOBROMOPHTHALEIN, CHLORAMPHENICOL, AND SULFATHIAZOLE IN LAMBS SO AMERICAN JOURNAL OF VETERINARY RESEARCH LA English DT Article C1 USDA ARS,BELTSVILLE AGR RES CTR,INST LIVESTOCK & POULTRY SCI,BELTSVILLE,MD 20705. RP KAWALEK, JC (reprint author), FDA,AGR RES CTR E,CTR VET MED,DIV VET MED RES,VET PHARMACOL TOXICOL BRANCH,BLDG 328A,BELTSVILLE,MD 20705, USA. NR 17 TC 9 Z9 10 U1 0 U2 2 PU AMER VETERINARY MEDICAL ASSOC PI SCHAUMBURG PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 SN 0002-9645 J9 AM J VET RES JI Am. J. Vet. Res. PD DEC PY 1990 VL 51 IS 12 BP 2044 EP 2049 PG 6 WC Veterinary Sciences SC Veterinary Sciences GA EL696 UT WOS:A1990EL69600027 PM 2085232 ER PT J AU HEDAYAT, A ZHAO, W AF HEDAYAT, A ZHAO, W TI OPTIMAL 2-PERIOD REPEATED MEASUREMENTS DESIGNS SO ANNALS OF STATISTICS LA English DT Article C1 SCHERING PLOUGH CORP,BIOSTAT,KENILWORTH,NJ 07033. RP HEDAYAT, A (reprint author), US FDA,CTR DRUG EVALUAT & RES,ROCKVILLE,MD 20910, USA. NR 24 TC 27 Z9 27 U1 0 U2 0 PU INST MATHEMATICAL STATISTICS PI HAYWARD PA IMS BUSINESS OFFICE-SUITE 6 3401 INVESTMENT BLVD, HAYWARD, CA 94545 SN 0090-5364 J9 ANN STAT JI Ann. Stat. PD DEC PY 1990 VL 18 IS 4 BP 1805 EP 1816 DI 10.1214/aos/1176347879 PG 12 WC Statistics & Probability SC Mathematics GA EL125 UT WOS:A1990EL12500015 ER PT J AU DATTA, AR WENTZ, BA RUSSELL, J AF DATTA, AR WENTZ, BA RUSSELL, J TI CLONING OF THE LISTERIOLYSIN-O GENE AND DEVELOPMENT OF SPECIFIC GENE PROBES FOR LISTERIA-MONOCYTOGENES SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Note RP DATTA, AR (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 20 TC 30 Z9 31 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD DEC PY 1990 VL 56 IS 12 BP 3874 EP 3877 PG 4 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA EM073 UT WOS:A1990EM07300040 PM 2128013 ER PT J AU FRICKE, WA EPSTEIN, JS AF FRICKE, WA EPSTEIN, JS TI CURRENT SAFETY OF CLOTTING FACTOR CONCENTRATES - REPLY SO ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE LA English DT Letter RP FRICKE, WA (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU COLLEGE AMER PATHOLOGISTS PI NORTHFIELD PA C/O KIMBERLY GACKI, 325 WAUKEGAN RD, NORTHFIELD, IL 60093-2750 SN 0003-9985 J9 ARCH PATHOL LAB MED JI Arch. Pathol. Lab. Med. PD DEC PY 1990 VL 114 IS 12 BP 1188 EP 1189 PG 2 WC Medical Laboratory Technology; Medicine, Research & Experimental; Pathology SC Medical Laboratory Technology; Research & Experimental Medicine; Pathology GA EN302 UT WOS:A1990EN30200004 ER PT J AU BURNS, AL MAGENDZO, K SRIVASTAVA, M ROJAS, E PARRA, C DELAFUENTE, M CULTRARO, C SHIRVAN, A VOGEL, T HELDMAN, J CAOHUY, H TOMBACCINI, D POLLARD, HB AF BURNS, AL MAGENDZO, K SRIVASTAVA, M ROJAS, E PARRA, C DELAFUENTE, M CULTRARO, C SHIRVAN, A VOGEL, T HELDMAN, J CAOHUY, H TOMBACCINI, D POLLARD, HB TI HUMAN SYNEXIN (ANNEXIN-VII) POLYMORPHISMS - TISSUE-SPECIFICITY AND EXPRESSION IN ESCHERICHIA-COLI SO BIOCHEMICAL SOCIETY TRANSACTIONS LA English DT Article; Proceedings Paper CT COLLOQUIUM AT THE 635TH MEETING OF THE BIOCHEMICAL SOC : LIPIDS, LIPOPROTEINS AND ANTIOXIDANTS IN CARDIOVASCULAR DYSFUNCTION CY JUL, 1990 CL ABERDEEN, SCOTLAND SP BIOCHEM SOC ID CHROMAFFIN GRANULES; MEMBRANE-FUSION; CALCIUM; AGGREGATION; VESICLES; PROTEIN; CA-2+ C1 US FDA,DIV CARDIORENAL,BETHESDA,MD 20892. RP BURNS, AL (reprint author), NIDDKD,CELL BIOL & GENET LAB,BETHESDA,MD 20892, USA. NR 15 TC 8 Z9 8 U1 0 U2 0 PU PORTLAND PRESS PI LONDON PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ SN 0300-5127 J9 BIOCHEM SOC T JI Biochem. Soc. Trans. PD DEC PY 1990 VL 18 IS 6 BP 1118 EP 1121 PG 4 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EQ255 UT WOS:A1990EQ25500033 PM 2150946 ER PT J AU Kelley, I Freeman, JP Cerniglia, CE AF Kelley, Ingrid Freeman, James P. Cerniglia, Carl E. TI Identification of metabolites from degradation of naphthalene by a Mycobacterium sp. SO BIODEGRADATION LA English DT Article DE bioremediation; metabolites; microbial degradation; naphthalene AB A Mycobacterium sp. isolated from oil-contaminated sediments was previously shown to mineralize 55% of the added naphthalene to carbon dioxide after 7 days of incubation. In this paper, we report the initial steps of the degradation of naphthalene by a Mycobacterium sp. as determined by isolation of metabolites and incorporation of oxygen from O-18(2) into the metabolites. The results indicate that naphthalene is initially converted to cis- and trans-1,2-dihydroxy-1,2-dihydronaphthalene by dioxygenase and monooxygenase catalyzed reactions, respectively. The ratio of the cis to trans-naphthalene dihydrodiol isomers was approximately 25:1. Thin layer and high pressure liquid chromatographic and mass spectrometric techniques indicated that besides the cis- and trans-1,2-dihydroxy-1,2-dihydronaphthalene, minor amounts of ring cleavage products salicylate and catechol were also formed. Thus the formation of both cis and trans-naphthalene dihydrodiols by the Mycobacterium sp. is unique. The down-stream reactions to ring cleavage products proceed through analogous dioxygenase reactions previously reported for the bacterial degradation of naphthalene. C1 [Kelley, Ingrid; Freeman, James P.; Cerniglia, Carl E.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA. RP Cerniglia, CE (reprint author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA. NR 25 TC 47 Z9 50 U1 2 U2 7 PU SPRINGER PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 USA SN 0923-9820 J9 BIODEGRADATION JI Biodegradation PD DEC PY 1990 VL 1 IS 4 BP 283 EP 290 DI 10.1007/BF00119765 PG 8 WC Biotechnology & Applied Microbiology SC Biotechnology & Applied Microbiology GA V27AP UT WOS:000208586400007 PM 1368473 ER PT J AU BIRX, DL REDFIELD, RR TENCER, K FOWLER, A BURKE, DS TOSATO, G AF BIRX, DL REDFIELD, RR TENCER, K FOWLER, A BURKE, DS TOSATO, G TI INDUCTION OF INTERLEUKIN-6 DURING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION SO BLOOD LA English DT Article C1 WALTER REED ARMY MED CTR,DIV RETROVIROL,WASHINGTON,DC 20307. WALTER REED ARMY MED CTR,SRA TECHNOL,RETROVIRAL RES GRP,WASHINGTON,DC 20307. US FDA,CTR BIOL EVALUAT & RES IMMUNOL LAB,BETHESDA,MD 20014. OI /0000-0002-5704-8094 NR 50 TC 182 Z9 183 U1 0 U2 1 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0006-4971 J9 BLOOD JI Blood PD DEC 1 PY 1990 VL 76 IS 11 BP 2303 EP 2310 PG 8 WC Hematology SC Hematology GA EK727 UT WOS:A1990EK72700021 PM 2257304 ER PT J AU KLETZEL, M THOMPSON, H KEARNS, GL AF KLETZEL, M THOMPSON, H KEARNS, GL TI PHARMACOKINETIC (PK) AND TOXICITY OF HIGH-DOSE (HD) THIOTEPA (TT) WITH AUTOLOGOUS BONE-MARROW RESCUE (ABMR) IN CHILDREN SO CLINICAL RESEARCH LA English DT Meeting Abstract C1 UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,LITTLE ROCK,AR 72205. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 0 PU SLACK INC PI THOROFARE PA 6900 GROVE RD, THOROFARE, NJ 08086 SN 0009-9279 J9 CLIN RES JI Clin. Res. PD DEC PY 1990 VL 38 IS 4 BP A998 EP A998 PG 1 WC Medicine, Research & Experimental SC Research & Experimental Medicine GA EN539 UT WOS:A1990EN53900436 ER PT J AU SATCHITHANANDAM, S CASSIDY, MM KHARROUBI, AT CALVERT, RJ LEEDS, AR VAHOUNY, GV AF SATCHITHANANDAM, S CASSIDY, MM KHARROUBI, AT CALVERT, RJ LEEDS, AR VAHOUNY, GV TI ALTERATIONS IN RAT INTESTINAL MUCIN PATTERNS FOLLOWING LUMINAL INFUSION OF ACETYLSALICYLIC-ACID AND PROSTAGLANDIN DERIVATIVES SO DIGESTIVE DISEASES AND SCIENCES LA English DT Article C1 GEORGE WASHINGTON UNIV,MED CTR,DEPT BIOCHEM,WASHINGTON,DC 20037. GEORGE WASHINGTON UNIV,MED CTR,DEPT PHYSIOL,WASHINGTON,DC 20037. UNIV LONDON,KINGS COLL,DEPT NUTR,LONDON W8 7AH,ENGLAND. RP SATCHITHANANDAM, S (reprint author), US FDA,DIV NUTR,HFF-268,200 C ST SW,WASHINGTON,DC 20204, USA. NR 40 TC 14 Z9 14 U1 0 U2 1 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0163-2116 J9 DIGEST DIS SCI JI Dig. Dis. Sci. PD DEC PY 1990 VL 35 IS 12 BP 1518 EP 1527 DI 10.1007/BF01540570 PG 10 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA EN665 UT WOS:A1990EN66500012 PM 1701376 ER PT J AU GOERING, PL REHM, S AF GOERING, PL REHM, S TI INHIBITION OF LIVER, KIDNEY, AND ERYTHROCYTE DELTA-AMINOLEVULINIC-ACID DEHYDRATASE (PORPHOBILINOGEN SYNTHASE) BY GALLIUM IN THE RAT SO ENVIRONMENTAL RESEARCH LA English DT Article ID LEAD-BINDING PROTEIN; INDIUM CHLORIDE; TOXICITY; ZINC; METABOLISM; EXPOSURE; EXCRETION; ALUMINUM; ARSENIDE; TISSUES C1 NCI,FREDERICK CANC RES FACIL,COMPARAT CARCINOGENESIS LAB,FREDERICK,MD 21701. RP GOERING, PL (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,DIV LIFE SCI,OFF SCI & TECHNOL,ROCKVILLE,MD 20857, USA. NR 60 TC 10 Z9 10 U1 0 U2 4 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0013-9351 J9 ENVIRON RES JI Environ. Res. PD DEC PY 1990 VL 53 IS 2 BP 135 EP 151 DI 10.1016/S0013-9351(05)80115-X PG 17 WC Environmental Sciences; Public, Environmental & Occupational Health SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health GA EP129 UT WOS:A1990EP12900003 PM 2253599 ER PT J AU COLLINS, TFX BLACK, TN BROWN, LH BULHACK, P AF COLLINS, TFX BLACK, TN BROWN, LH BULHACK, P TI STUDY OF THE TERATOGENIC POTENTIAL OF FD-AND-C YELLOW-5 WHEN GIVEN BY GAVAGE TO RATS SO FOOD AND CHEMICAL TOXICOLOGY LA English DT Article ID CHRONIC TOXICITY CARCINOGENICITY; CERTIFIED COLORS; NO-5 TARTRAZINE AB FD & C Yellow No. 5 (tartrazine) was given to Osborne-Mendel rats by gavage at dose levels of 0, 60, 100, 200, 400, 600 or 1000 mg/kg body weight/day on days 0-19 of gestation. No maternal or developmental toxicity was observed when the rats were killed on day 20. The mean daily food consumption for the entire period of gestation was significantly greater in the females given 1000 mg/kg body weight/day than in the controls, but maternal body-weight gain was not affected. No dose-related effects were observed in implantations, foetal viability or external foetal development. Foetal skeletal and visceral development was similar among foetuses from all groups. At the doses given, FD & C Yellow No. 5 was neither toxic nor teratogenic. RP COLLINS, TFX (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA. NR 18 TC 10 Z9 12 U1 0 U2 2 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0278-6915 J9 FOOD CHEM TOXICOL JI Food Chem. Toxicol. PD DEC PY 1990 VL 28 IS 12 BP 821 EP 827 DI 10.1016/0278-6915(90)90055-R PG 7 WC Food Science & Technology; Toxicology SC Food Science & Technology; Toxicology GA EV595 UT WOS:A1990EV59500005 PM 2276704 ER PT J AU FAALAND, RW SUN, ZQ LI, J AF FAALAND, RW SUN, ZQ LI, J TI TRANSMISSION OF A GAUSSIAN SCANNING BEAM THROUGH CIRCULAR, SQUARE, AND SLIT APERTURES .2. EXPERIMENTAL RESULTS FOR TRANSMISSION THROUGH A CIRCULAR APERTURE SO HEALTH PHYSICS LA English DT Article C1 BEIJING INST OPT ELECTR TECHNOL, BEIJING LASER PARAMETER TESTING CTR, BEIJING, PEOPLES R CHINA. RP FAALAND, RW (reprint author), US FDA, CTR DEVICES & RADIOL HLTH, ELECTRO OPT BRANCH, HFZ 134, 5600 FISHERS LA, ROCKVILLE, MD 20857 USA. NR 14 TC 2 Z9 2 U1 0 U2 2 PU LIPPINCOTT WILLIAMS & WILKINS PI PHILADELPHIA PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA SN 0017-9078 EI 1538-5159 J9 HEALTH PHYS JI Health Phys. PD DEC PY 1990 VL 59 IS 6 BP 901 EP 909 DI 10.1097/00004032-199012000-00013 PG 9 WC Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging GA EK935 UT WOS:A1990EK93500014 PM 2228617 ER PT J AU RONK, RJ MARYANKSI, JH THOMPSON, P AF RONK, RJ MARYANKSI, JH THOMPSON, P TI GOVERNMENTAL REGULATORY ISSUES - REDUCING UNCERTAINTIES IN FOOD SAFETY SO HORTSCIENCE LA English DT Article; Proceedings Paper CT 2ND INTERNATIONAL SYMP ON HORTICULTURE AND HUMAN HEALTH CY NOV 02-05, 1989 CL ALEXANDRIA, VA SP AMER SOC HORT SCI RP RONK, RJ (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,200 C ST SW,WASHINGTON,DC 20204, USA. NR 7 TC 3 Z9 3 U1 0 U2 0 PU AMER SOC HORTICULTURAL SCIENCE PI ALEXANDRIA PA 701 NORTH SAINT ASAPH STREET, ALEXANDRIA, VA 22314-1998 SN 0018-5345 J9 HORTSCIENCE JI Hortscience PD DEC PY 1990 VL 25 IS 12 BP 1482 EP 1484 PG 3 WC Horticulture SC Agriculture GA EP975 UT WOS:A1990EP97500007 ER PT J AU STEINBERG, AD KRIEG, AM GOURLEY, MF KLINMAN, DM AF STEINBERG, AD KRIEG, AM GOURLEY, MF KLINMAN, DM TI THEORETICAL AND EXPERIMENTAL APPROACHES TO GENERALIZED AUTOIMMUNITY SO IMMUNOLOGICAL REVIEWS LA English DT Article ID SYSTEMIC LUPUS-ERYTHEMATOSUS; ANTI-DNA AUTOANTIBODIES; ZEALAND BLACK MICE; RECOMBINANT INBRED LINES; B-CELL ACTIVATION; MRL-LPR/LPR MICE; NZB MICE; MURINE LUPUS; T-CELLS; TOLERANCE INDUCTION C1 US FDA,CBER,RETROVIRUS RES LAB,BETHESDA,MD 20014. RP STEINBERG, AD (reprint author), NIAMS,ARB,CELLULAR IMMUNOL SECT,BLDG 10,ROOM 9N-218,BETHESDA,MD 20892, USA. NR 101 TC 74 Z9 75 U1 0 U2 0 PU MUNKSGAARD INT PUBL LTD PI COPENHAGEN PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK SN 0105-2896 J9 IMMUNOL REV JI Immunol. Rev. PD DEC PY 1990 VL 118 BP 129 EP 163 DI 10.1111/j.1600-065X.1990.tb00815.x PG 35 WC Immunology SC Immunology GA EU700 UT WOS:A1990EU70000006 PM 2079325 ER PT J AU ENDOH, M NAGAI, M BURNS, DL MANCLARK, CR NAKASE, Y AF ENDOH, M NAGAI, M BURNS, DL MANCLARK, CR NAKASE, Y TI INHIBITION OF HEAT-LABILE TOXIN FROM BORDETELLA-PARAPERTUSSIS BY FATTY-ACIDS SO INFECTION AND IMMUNITY LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. RP ENDOH, M (reprint author), KITASATO UNIV,SCH PHARMACEUT SCI,DEPT MICROBIOL,TOKYO 108,JAPAN. NR 19 TC 4 Z9 4 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD DEC PY 1990 VL 58 IS 12 BP 4045 EP 4048 PG 4 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA EK781 UT WOS:A1990EK78100034 PM 2254029 ER PT J AU SHAHIN, RD WITVLIET, MH MANCLARK, CR AF SHAHIN, RD WITVLIET, MH MANCLARK, CR TI MECHANISM OF PERTUSSIS TOXIN-B OLIGOMER-MEDIATED PROTECTION AGAINST BORDETELLA-PERTUSSIS RESPIRATORY-INFECTION SO INFECTION AND IMMUNITY LA English DT Article C1 NATL INST PUBL & ENVIRONM PROTECTION,BACTERIAL VACCINES LAB,BILTHOVEN,NETHERLANDS. RP SHAHIN, RD (reprint author), US FDA,CTR BIOL EVALUAT & RES,PERTUSSIS LAB,BETHESDA,MD 20892, USA. FU NHLBI NIH HHS [BST-5947-P-HI-4265] NR 30 TC 27 Z9 28 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD DEC PY 1990 VL 58 IS 12 BP 4063 EP 4068 PG 6 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA EK781 UT WOS:A1990EK78100037 PM 2254030 ER PT J AU LINNEKIN, D BOWLES, CA MURANO, G MACVITTIE, TJ AF LINNEKIN, D BOWLES, CA MURANO, G MACVITTIE, TJ TI MIGRATION OF DOG POLYMORPHONUCLEAR NEUTROPHILIC LEUKOCYTES TO FORMYLATED PEPTIDES SO INFLAMMATION LA English DT Article ID METHIONYL-LEUCYL-PHENYLALANINE; PLATELET-ACTIVATING FACTOR; CHEMOTACTIC PEPTIDES; RABBIT NEUTROPHILS; RECEPTOR; PHE; LEUKOTRIENE-B4; CHEMOATTRACTANTS; GRANULOCYTES; RECRUITMENT AB Formylated peptides are potent stimulants of polymorphonuclear neutrophilic leukocyte (PMN) migration from species such as humans and rabbits. Interestingly, PMNs from dogs, cats, pigs and cows have been reported as refractory to N-formyl-1-methionyl-1-leucyl-1-phenylalanine (FMLP) and generally are believed not to express formylpeptide receptors. Formylpeptides are a major component of conditioned media from E. coli cultures and believed to be a significant element in inflammatory responses elicited by E. coli. Our studies have found that E. coli filtrate was a potent stimulant of dog PMN migration. Inhibition of migration to E. coli filtrates by the antagonist t-botyloxycarbonyl-1-methionyl-1-leucyl-1-phenylalanine (t-boc-MLP) demonstrated that the migration was mediated through the formylated peptide receptor. Migration in response to peptides with higher affinity for the formylpeptide receptor than FMLP was further evidence for these receptors on the dog PMN. PMNs from dogs migrated in response to FMLP at high concentrations (100-mu-M); however, pretreatment with phorbol myristate acetate resulted in increased migration of dog PMNs in response to concentrations of FMLP as low as 1 pM. These results demonstrate that dog PMNs are responsive to formylpeptides and that these responses can be up-regulated by PMA. Thus PMNs from a species previously thought incapable of responding to formylpeptides can respond to formylpeptide analogs with high affinity for the receptor as well as be primed for enhanced migration to FMLP by PMA. C1 ARMED FORCES RADIOBIOL RES INST,DEPT EXPTL HEMATOL,BETHESDA,MD 20814. MERRIFIELD LABS,FAIRFAX,VA. US FDA,OFF BIOL,BETHESDA,MD 20014. RP LINNEKIN, D (reprint author), UNIFORMED SERV UNIV HLTH SCI,DEPT PHYSIOL,BETHESDA,MD 20814, USA. NR 33 TC 5 Z9 5 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0360-3997 J9 INFLAMMATION JI Inflammation PD DEC PY 1990 VL 14 IS 6 BP 691 EP 703 DI 10.1007/BF00916372 PG 13 WC Cell Biology; Immunology SC Cell Biology; Immunology GA ER159 UT WOS:A1990ER15900007 PM 2128632 ER PT J AU GERSTMAN, BB PIPER, JM FREIMAN, JP TOMITA, DK KENNEDY, DL FERGUSON, WJ BENNETT, RC AF GERSTMAN, BB PIPER, JM FREIMAN, JP TOMITA, DK KENNEDY, DL FERGUSON, WJ BENNETT, RC TI ORAL-CONTRACEPTIVE ESTROGEN AND PROGESTIN POTENCIES AND THE INCIDENCE OF DEEP VENOUS THROMBOEMBOLISM SO INTERNATIONAL JOURNAL OF EPIDEMIOLOGY LA English DT Article ID UNITED-STATES; VEIN-THROMBOSIS; MEDICAID DATA; DISEASE; RESOURCE; TRENDS; SAFETY AB To assess possible differences in the incidence of venous thrombosis and pulmonary embolism associated with oral contraceptives of varying hormonal potencies, the authors conducted a retrospective cohort study in the 15-44 year old Michigan Medicaid population. Cohorts were defined by the progestin- and oestrogen-potencies of oral contraceptives in use at the time of follow-up as classified by an oral contraceptive potency scheme. Using the low-oestrogen-/low-progestin-potency formulations for reference (rate ratio = 1), adjusted rate ratios of 0.8 (95% Cl: 0.5 to 1.3, P = 0.41) and 0.6 (95% Cl 0.4 to 1.2, P = 0.13) were observed for intermediate-progestin-potency and high-progestin-potency formulations, respectively. Adjusted rate ratios of 1.4 (95% Cl: 0.8 to 2.3, P = 0.21) and 2.6 (95% Cl: 1.2 to 5.5, P = 0.01) were observed for intermediate- and high-oestrogen-potency formulations. These data suggest a dose-response relationship between oral contraceptive oestrogen potency and venous thromboembolism, whereas no such evidence for a dose-response relationship between oral contraceptive progestin potency and venous thromboembolism was found. C1 US FDA,OFF EPIDEMIOL & BIOSTAT,ROCKVILLE,MD 20857. US FDA,DIV ENDOCRINE & METAB DRUGS,ROCKVILLE,MD 20857. VANDERBILT UNIV,MED CTR,SCH MED,DEPT PREVENT MED,NASHVILLE,TN 37232. NR 36 TC 49 Z9 49 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0300-5771 J9 INT J EPIDEMIOL JI Int. J. Epidemiol. PD DEC PY 1990 VL 19 IS 4 BP 931 EP 936 DI 10.1093/ije/19.4.931 PG 6 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA ET595 UT WOS:A1990ET59500024 PM 2084024 ER PT J AU HSU, LY MINAH, GE PETERSON, DE WINGARD, JR MERZ, WG ALTOMONTE, V TYLENDA, CA AF HSU, LY MINAH, GE PETERSON, DE WINGARD, JR MERZ, WG ALTOMONTE, V TYLENDA, CA TI COAGGREGATION OF ORAL CANDIDA ISOLATES WITH BACTERIA FROM BONE-MARROW TRANSPLANT RECIPIENTS SO JOURNAL OF CLINICAL MICROBIOLOGY LA English DT Article C1 UNIV MARYLAND,SCH DENT,DEPT MICROBIOL,BALTIMORE,MD 21201. US FDA,OFF DEVICE EVALUAT,ROCKVILLE,MD 20850. UNIV CONNECTICUT,CTR HLTH,SCH DENT MED,DEPT ORAL DIAG,FARMINGTON,CT 06032. NATL TAIWAN UNIV,SCH MED,DEPT MICROBIOL,TAIPEI,TAIWAN. JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21205. NR 35 TC 26 Z9 28 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0095-1137 J9 J CLIN MICROBIOL JI J. Clin. Microbiol. PD DEC PY 1990 VL 28 IS 12 BP 2621 EP 2626 PG 6 WC Microbiology SC Microbiology GA EJ459 UT WOS:A1990EJ45900008 PM 2279992 ER PT J AU PENNINGTON, JAT AF PENNINGTON, JAT TI IODINE CONCENTRATIONS IN UNITED-STATES MILK - VARIATION DUE TO TIME, SEASON, AND REGION SO JOURNAL OF DAIRY SCIENCE LA English DT Article DE MILK IODINE; UNITED-STATES MILK; IODINE VARIATION ID DAIRY-PRODUCTS; IODOPHORS; RESIDUES; SAMPLES; CATTLE; HERDS; DIET; FOOD AB The iodine content of milk is influenced primarily by the iodine added to animal feed and by iodophor sanitizing solutions used in the dairy industry. Variability of these practices may result in variation of iodine concentrations in milk. Some seasonal and perhaps regional variation in iodine concentrations in milk may reflect the amount of indoor feeding (i.e., iodine-supplemented feed) during the colder months versus outdoor pasture feeding during the warmer months. The proportion of indoor versus outdoor feeding depends upon the climate of the particular geographical area. Milks and other dairy products from the Food and Drug Administration's Total Diet Study were analyzed for iodine quarterly from 1982 to 1990. The iodine concentrations in fluid milks were evaluated over time, by season (summer, spring, winter, and fall), and by region (East, South, Central, and West). Iodine in fluid milks averaged 23 mu-g/100 g and ranged from 16-mu-g/100 g in the summer and fall in the East to 34-mu-g/100 g in the winter in the East. Iodine was highest in the winter (27-mu-g/100 g) and lowest in the summer (19-mu-g/100 g) and higher in western and central states (25 and 27-mu-g/100 g, respectively) than in eastern states (18-mu-g/100 g). RP PENNINGTON, JAT (reprint author), US FDA,DIV NUTR,WASHINGTON,DC 20204, USA. NR 31 TC 42 Z9 43 U1 1 U2 8 PU AMER DAIRY SCIENCE ASSN PI CHAMPAIGN PA 309 W CLARK ST, CHAMPAIGN, IL 61820 SN 0022-0302 J9 J DAIRY SCI JI J. Dairy Sci. PD DEC PY 1990 VL 73 IS 12 BP 3421 EP 3427 PG 7 WC Agriculture, Dairy & Animal Science; Food Science & Technology SC Agriculture; Food Science & Technology GA EX354 UT WOS:A1990EX35400010 ER PT J AU BRADSHAW, JG SHAH, DB FORNEY, E MADDEN, JM AF BRADSHAW, JG SHAH, DB FORNEY, E MADDEN, JM TI GROWTH OF SALMONELLA-ENTERITIDIS IN YOLK OF SHELL EGGS FROM NORMAL AND SEROPOSITIVE HENS SO JOURNAL OF FOOD PROTECTION LA English DT Article C1 US FDA,DIV MICROBIOL,CINCINNATI,OH 45226. US FDA,DIV MICROBIOL,WASHINGTON,DC 20204. US FDA,CINCINNATI DIST OFF,CINCINNATI,OH 45202. NR 15 TC 56 Z9 56 U1 0 U2 2 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD DEC PY 1990 VL 53 IS 12 BP 1033 EP 1036 PG 4 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EN417 UT WOS:A1990EN41700006 ER PT J AU BEGLEY, TH HOLLIFIELD, HC AF BEGLEY, TH HOLLIFIELD, HC TI MIGRATION OF DIBENZOATE PLASTICIZERS AND POLYETHYLENE TEREPHTHALATE CYCLIC OLIGOMERS FROM MICROWAVE SUSCEPTOR PACKAGING INTO FOOD-SIMULATING LIQUIDS AND FOOD SO JOURNAL OF FOOD PROTECTION LA English DT Article RP BEGLEY, TH (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204, USA. NR 10 TC 28 Z9 28 U1 2 U2 4 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD DEC PY 1990 VL 53 IS 12 BP 1062 EP 1066 PG 5 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EN417 UT WOS:A1990EN41700012 ER PT J AU CSERMELY, P BALINT, E GRIMLEY, PM ASZALOS, A AF CSERMELY, P BALINT, E GRIMLEY, PM ASZALOS, A TI PROTEIN-KINASE-C IS INVOLVED IN THE EARLY SIGNALS OF INTERFERON-ALPHA BUT NOT OF INTERFERON-GAMMA IN U937 CELLS SO JOURNAL OF INTERFERON RESEARCH LA English DT Article ID PHORBOL ESTER; IFN-GAMMA; LYMPHOCYTES; MODULATION; INHIBITION; ACTIVATION; EXPRESSION; MEMBRANES; BINDING; GROWTH AB Increasing interest is being focused on the role of protein kinase C (PKC) in the mode of action of interferons (IFNs). Here we report that IFN-alpha-induced a transient translocation of PKC from the cytosol to the particulate fraction of U937 cells. In contrast, after IFN-gamma-treatment, no significant change in PKC activity could be observed. IFN-induced changes in membrane potential were also examined by means of a potential sensitive oxonol dye and flow cytometry. Hyperpolarization was induced by both IFN-alpha and IFN-gamma. The protein kinase inhibitor H-7 blocked the hyperpolarization induced by IFN-alpha but not by IFN-gamma. These concordant results suggest that PKC is involved in the early signals of IFN-alpha but not of IFN-gamma in U937 cells. C1 UNIFORMED SERV UNIV HLTH SCI,F EDWARD HERBERT SCH MED,DEPT PATHOL,BETHESDA,MD 20814. US FDA,DIV RES & TESTING,WASHINGTON,DC 20204. NR 27 TC 18 Z9 18 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0197-8357 J9 J INTERFERON RES JI J. Interferon Res. PD DEC PY 1990 VL 10 IS 6 BP 605 EP 611 DI 10.1089/jir.1990.10.605 PG 7 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EN850 UT WOS:A1990EN85000007 PM 2128303 ER PT J AU PRODOUZ, KN HABRAKEN, JW MOROFF, G AF PRODOUZ, KN HABRAKEN, JW MOROFF, G TI RESISTANCE OF PLATELET PROTEINS TO EFFECTS OF IONIZING-RADIATION SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE LA English DT Article C1 AMER RED CROSS,BIOMED RES & DEV LAB,JEROME HOLLAND LABS,ROCKVILLE,MD. RP PRODOUZ, KN (reprint author), US FDA,CTR BIOL EVALUAT & RES,NIH BLDG 29,ROOM 329,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 17 TC 6 Z9 6 U1 0 U2 0 PU MOSBY-YEAR BOOK INC PI ST LOUIS PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 SN 0022-2143 J9 J LAB CLIN MED JI J. Lab. Clin. Med. PD DEC PY 1990 VL 116 IS 6 BP 766 EP 770 PG 5 WC Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental SC Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine GA EM314 UT WOS:A1990EM31400005 PM 2246551 ER PT J AU HALPERN, JL HABIG, WH TRENCHARD, H RUSSELL, JT AF HALPERN, JL HABIG, WH TRENCHARD, H RUSSELL, JT TI EFFECT OF TETANUS TOXIN ON OXYTOCIN AND VASOPRESSIN RELEASE FROM NERVE-ENDINGS OF THE NEUROHYPOPHYSIS SO JOURNAL OF NEUROCHEMISTRY LA English DT Article C1 NICHHD,DEV NEUROBIOL LAB,BETHESDA,MD 20892. RP HALPERN, JL (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,BLDG 29,ROOM 103,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 38 TC 18 Z9 18 U1 0 U2 0 PU LIPPINCOTT-RAVEN PUBL PI PHILADELPHIA PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 SN 0022-3042 J9 J NEUROCHEM JI J. Neurochem. PD DEC PY 1990 VL 55 IS 6 BP 2072 EP 2078 DI 10.1111/j.1471-4159.1990.tb05797.x PG 7 WC Biochemistry & Molecular Biology; Neurosciences SC Biochemistry & Molecular Biology; Neurosciences & Neurology GA EK015 UT WOS:A1990EK01500034 PM 2172468 ER PT J AU IWAI, Y COHEN, RB BICKEL, M PLUZNIK, DH AF IWAI, Y COHEN, RB BICKEL, M PLUZNIK, DH TI THE ROLE OF PROTEIN-KINASE-C (PKC) PATHWAY AND INTRACELLULAR CA++ IN GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) MESSENGER-RNA EXPRESSION BY A PHORBOL ESTER (TPA) AND CONCANAVALIN-A (CONA) IN A MURINE T-CELL LINE (EL-4) SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CBER,DIV CYTOKINE BIOL,BETHESDA,MD 20014. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 575 EP 575 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500051 ER PT J AU FELDMAN, GM RUHL, S PLUZNIK, DH FINBLOOM, DS BICKEL, M AF FELDMAN, GM RUHL, S PLUZNIK, DH FINBLOOM, DS BICKEL, M TI MECHANISM OF INTERLEUKIN-4 RECEPTOR REGULATION DURING MACROPHAGE ACTIVATION BY IL-6 SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CTR BIOLOG EVALUAT & RES,BETHESDA,MD 20014. UNIV BERN,SCH DENT,CH-3000 BERN,SWITZERLAND. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 581 EP 581 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500069 ER PT J AU RUHL, S SCHWABE, M PLUZNIK, DH AF RUHL, S SCHWABE, M PLUZNIK, DH TI INTERLEUKIN-1 AUGMENTS THE EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON DIFFERENTIATING MACROPHAGES SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 NCI,FREDERICK CANC RES FACIL,BRMP,BIOCHEM PHYSIOL LAB,FREDERICK,MD 21701. US FDA,CBER,DIV CYTOKINE,BIOL,BETHESDA,MD 20014. NR 0 TC 2 Z9 2 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 591 EP 591 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500106 ER PT J AU CLOUSE, KA PYLE, SW POTHEN, S COSENTINO, LM WEIH, KA PEARSON, GR AF CLOUSE, KA PYLE, SW POTHEN, S COSENTINO, LM WEIH, KA PEARSON, GR TI MONOKINES CAPABLE OF REGULATING HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. NCI,REPROD MED & PHYSIOL BRANCH,FREDERICK,MD 21701. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 596 EP 596 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500129 ER PT J AU DONNELLY, RP FENTON, MJ KAUFMAN, JD GERRARD, TL AF DONNELLY, RP FENTON, MJ KAUFMAN, JD GERRARD, TL TI MOLECULAR ANALYSIS OF THE INHIBITORY EFFECT OF IL-4 ON IL-1 EXPRESSION BY HUMAN MONOCYTES SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. BOSTON UNIV,SCH MED,BOSTON,MA 02118. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 597 EP 597 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500131 ER PT J AU WEBB, DSA MOSTOWSKI, HS GERRARD, TL AF WEBB, DSA MOSTOWSKI, HS GERRARD, TL TI CYTOKINE-INDUCED ENHANCEMENT OF ICAM-1 SENSITIZES TUMOR-CELLS TO MONOCYTE-MEDIATED LYSIS SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,DIV CYTOKINE BIOL,BETHESDA,MD 20014. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 597 EP 597 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500130 ER PT J AU PURI, RK LELAND, P AF PURI, RK LELAND, P TI SYSTEMIC ADMINISTRATION OF RECOMBINANT INTERLEUKIN-6 (IL-6) INDUCES PROLIFERATION OF LYMPHOID-CELLS INVIVO AND AUGMENTS ANTIGEN SPECIFIC CTL RESPONSE IN THE SPLEEN OF MICE SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CBER,DIV CYTOKINE BIOL,BETHESDA,MD 20205. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 606 EP 606 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500167 ER PT J AU AKAHANE, K COHEN, RB BICKEL, M PLUZNIK, DH AF AKAHANE, K COHEN, RB BICKEL, M PLUZNIK, DH TI INTERLEUKIN-1 (IL-1) INDUCES GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) GENE-EXPRESSION IN MURINE LYMPHOCYTES-B VIA MESSENGER-RNA STABILIZATION SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CBER,DIV CYTOKINE BIOL,BETHESDA,MD 20014. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 615 EP 615 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500193 ER PT J AU GRUBER, MF GERRARD, TL AF GRUBER, MF GERRARD, TL TI REGULATION OF M-CSF MESSAGE AND SECRETION BY HUMAN MONOCYTES SO LYMPHOKINE RESEARCH LA English DT Meeting Abstract C1 US FDA,CBER,DIV CYTOKINE BIOL,BETHESDA,MD 20014. NR 0 TC 0 Z9 0 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0277-6766 J9 LYMPHOKINE RES PD WIN PY 1990 VL 9 IS 4 BP 617 EP 617 PG 1 WC Immunology SC Immunology GA EA865 UT WOS:A1990EA86500203 ER PT J AU FU, PP JUNG, HW VONTUNGELN, LS HEFLICH, RH AF FU, PP JUNG, HW VONTUNGELN, LS HEFLICH, RH TI MUTAGENICITY OF MONONITRODIHYDROBENZO[A]PYRENES SO MUTATION RESEARCH LA English DT Article RP FU, PP (reprint author), NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 34 TC 6 Z9 7 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0921-8262 J9 MUTAT RES PD DEC PY 1990 VL 245 IS 4 BP 277 EP 285 DI 10.1016/0165-7992(90)90157-F PG 9 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA EM520 UT WOS:A1990EM52000007 PM 2266979 ER PT J AU BELAND, FA FULLERTON, NF MARQUES, MM MELCHIOR, WB SMITH, BA POIRIER, C AF BELAND, FA FULLERTON, NF MARQUES, MM MELCHIOR, WB SMITH, BA POIRIER, C TI DNA ADDUCT FORMATION IN RELATION TO TUMORIGENESIS IN MICE CONTINUOUSLY ADMINISTERED AROMATIC AMINE CARCINOGENS SO MUTATION RESEARCH LA English DT Meeting Abstract C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NCI,BETHESDA,MD 20892. RI Marques, M. Matilde/E-2535-2012 OI Marques, M. Matilde/0000-0002-7526-4962 NR 0 TC 0 Z9 0 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0921-8262 J9 MUTAT RES PD DEC PY 1990 VL 234 IS 6 BP 371 EP 371 DI 10.1016/0165-1161(90)90054-R PG 1 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA EK540 UT WOS:A1990EK54000006 ER PT J AU ZHANG, WQ ROGERS, BC TANDON, P HUDSON, PM SOBOTKA, TJ HONG, JS TILSON, HA AF ZHANG, WQ ROGERS, BC TANDON, P HUDSON, PM SOBOTKA, TJ HONG, JS TILSON, HA TI SYSTEMIC ADMINISTRATION OF KAINIC ACID INCREASES GABA LEVELS IN PERFUSATE FROM THE HIPPOCAMPUS OF RATS INVIVO SO NEUROTOXICOLOGY LA English DT Article DE KAINIC ACID; AMINO ACID RELEASE; GABA; HIPPOCAMPUS; MICRODIALYSIS ID SUSTAINED ELECTRICAL-STIMULATION; TEMPORAL-LOBE EPILEPSY; PERFORANT PATH; BRAIN-REGIONS; AMINO-ACIDS; KAINATE; RELEASE; ASPARTATE; RECEPTORS; DAMAGE AB The ventral hippocampi of male, Fischer-344 rats were implanted with microdialysis probes and the effects of systemically administered kainic acid (KA) (8 mg/kg, s.c.) on the in vivo release of amino acids were measured for four hours after administration. In order to measure GABA release in vivo, gamma-vinyl-GABA (GVG), an irreversible inhibitor of GABA transaminase, was injected intrahippocampally prior to perfusion. GVG pretreatment resulted in measurable levels of GABA in the perfusate without significant effects on the release of aspartate, glutamate, glutamine, glycine or taurine. Following GVG pretreatment systemic administration of KA produced a time-dependent increase in GABA, as well as all other amino acids except glutamine, which was initially decreased. These results show for the first time that systemically administered KA increases extracellular GABA levels, an effect previously reported only in vitro. These data suggest that prior to destruction of GABA-containing interneurons in the hippocampus, there is an increased activity of those GABA interneuros reflected as an increase in extracellular GABA levels. C1 US EPA,HLTH EFFECTS RES LAB,DIV NEUROTOXICOL MD74B,RES TRIANGLE PK,NC 27711. NIEHS,MOLEC & INTEGRAT NEUROSCI LAB,RES TRIANGLE PK,NC 27709. US FDA,NEUROBEHAV TOXICOL TEAM,WASHINGTON,DC 20204. FU FDA HHS [FDA 224-87-2436] NR 36 TC 23 Z9 24 U1 0 U2 0 PU INTOX PRESS INC PI LITTLE ROCK PA PO BOX 24865, LITTLE ROCK, AR 72221 SN 0161-813X J9 NEUROTOXICOLOGY JI Neurotoxicology PD WIN PY 1990 VL 11 IS 4 BP 593 EP 600 PG 8 WC Neurosciences; Pharmacology & Pharmacy; Toxicology SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology GA EQ384 UT WOS:A1990EQ38400003 PM 2087285 ER PT J AU ZMUDZKA, BZ BEER, JZ AF ZMUDZKA, BZ BEER, JZ TI ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY ULTRAVIOLET-RADIATION SO PHOTOCHEMISTRY AND PHOTOBIOLOGY LA English DT Review RP ZMUDZKA, BZ (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,RADIAT BIOL BRANCH,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 66 TC 59 Z9 59 U1 0 U2 0 PU AMER SOC PHOTOBIOLOGY PI AUGUSTA PA BIOTECH PARK, 1021 15TH ST, SUITE 9, AUGUSTA, GA 30901-3158 SN 0031-8655 J9 PHOTOCHEM PHOTOBIOL JI Photochem. Photobiol. PD DEC PY 1990 VL 52 IS 6 BP 1153 EP 1162 DI 10.1111/j.1751-1097.1990.tb08454.x PG 10 WC Biochemistry & Molecular Biology; Biophysics SC Biochemistry & Molecular Biology; Biophysics GA EL688 UT WOS:A1990EL68800009 PM 2087502 ER PT J AU MALY, FE URWYLER, A TENGLER, R STEINITZ, M GOLDING, B DEWECK, AL AF MALY, FE URWYLER, A TENGLER, R STEINITZ, M GOLDING, B DEWECK, AL TI OXIDATIVE BURST IN HUMAN EPSTEIN-BARR VIRUS-TRANSFORMED B-CELL LINES TRIGGERED BY IMMOBILIZED SPECIFIC ANTIGEN SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY LA English DT Article C1 HADASSAH UNIV,DEPT PATHOL,JERUSALEM,ISRAEL. US FDA,BETHESDA,MD 20014. RP MALY, FE (reprint author), INSELSPITAL BERN,INST KLIN IMMUNOL,FREIBURGSTR,CH-3010 BERN,SWITZERLAND. NR 15 TC 5 Z9 5 U1 0 U2 0 PU BLACKWELL SCIENCE LTD PI OXFORD PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL SN 0300-9475 J9 SCAND J IMMUNOL JI Scand. J. Immunol. PD DEC PY 1990 VL 32 IS 6 BP 661 EP 667 DI 10.1111/j.1365-3083.1990.tb03208.x PG 7 WC Immunology SC Immunology GA EK254 UT WOS:A1990EK25400011 PM 2176740 ER PT J AU AIKMAN, B AF AIKMAN, B TI UNREPENTANT DEALER SENTENCED FOR FRAUDULENT ANIMAL DRUGS SO VETERINARY AND HUMAN TOXICOLOGY LA English DT Note RP AIKMAN, B (reprint author), US FDA,PRESS OFF,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU COMPARATIVE TOXICOLOGY LAB KANSAS STATE UNIV PI MANHATTAN PA MANHATTAN, KS 66506 SN 0145-6296 J9 VET HUM TOXICOL JI Vet. Human Toxicol. PD DEC PY 1990 VL 32 IS 6 BP 583 EP 583 PG 1 WC Toxicology; Veterinary Sciences SC Toxicology; Veterinary Sciences GA EJ589 UT WOS:A1990EJ58900026 PM 2264274 ER PT J AU SHIH, C YU, MYW LI, LS SHIH, JWK AF SHIH, C YU, MYW LI, LS SHIH, JWK TI HEPATITIS-B VIRUS PROPAGATED IN A RAT HEPATOMA-CELL LINE IS INFECTIOUS IN A PRIMATE MODEL SO VIROLOGY LA English DT Note C1 NIH,WARREN GRANT MAGNUSON CLIN CTR,DEPT TRANSFUS MED,BETHESDA,MD 20892. UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104. US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,BETHESDA,MD 20205. FU NCI NIH HHS [R01 CA 48198] NR 14 TC 9 Z9 10 U1 0 U2 0 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0042-6822 J9 VIROLOGY JI Virology PD DEC PY 1990 VL 179 IS 2 BP 871 EP 873 DI 10.1016/0042-6822(90)90158-N PG 3 WC Virology SC Virology GA EK040 UT WOS:A1990EK04000036 PM 2238476 ER PT J AU STORM, JE BRONAUGH, RL CARLIN, AS SIMMONS, JE AF STORM, JE BRONAUGH, RL CARLIN, AS SIMMONS, JE TI CUTANEOUS METABOLISM OF NITROGLYCERIN IN VIABLE RAT SKIN INVITRO SO INTERNATIONAL JOURNAL OF PHARMACEUTICS LA English DT Note DE CUTANEOUS METABOLISM; TRANSDERMAL PENETRATION; NITROGLYCERIN; MINIMAL ESSENTIAL MEDIUM; PHOSPHATE-BUFFERED SALINE; PERFUSED SKIN; ABSORBED NITRATE ID PERCUTANEOUS-ABSORPTION; TOPICAL BIOAVAILABILITY; DIFFUSION; BARRIER AB Percutaneous penetration and metabolism of nitroglycerin (GTN) in vitro were compared in viable rat skin (perfused with minimal essential medium (MEM)) and nonviable rat skin (perfused with phosphate-buffered saline (PBSA)) in flow-through diffusion cells. The fraction of nitrates penetrating as dinitrate metabolites was significantly greater in MEM-perfused skin than in PBSA-perfused skin, while the fraction of nitrates penetrating as GTN was significantly less. Moreover, differences between MEM and PBSA in the fraction of absorbed nitrates present as GTN coincided in time with the loss of metabolizing capacity in PBSA-perfused skin, supporting the notion that it was the loss of metabolic capacity which led to an increase in GTN penetration. Over the 24 h experimental period, 29% of the GTN penetrating the MEM-perfused skin was metabolized and 71% of the absorbed dose was present as GTN, whereas only 14% of GTN penetrating PBSA-perfused skin was metabolized and 86% of the absorbed dose was present as GTN. These results demonstrate that metabolic viability of skin in vitro can affect not only the degree of cutaneous metabolism of penetrating compounds but also their rates of penetration. RP STORM, JE (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR HFF164,200 C ST SW,WASHINGTON,DC 20204, USA. NR 14 TC 2 Z9 2 U1 1 U2 2 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0378-5173 J9 INT J PHARM JI Int. J. Pharm. PD NOV 30 PY 1990 VL 65 IS 3 BP 265 EP 268 DI 10.1016/0378-5173(90)90152-T PG 4 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA ER061 UT WOS:A1990ER06100015 ER PT J AU ROSA, F AF ROSA, F TI OVULATION INDUCTION AND NEURAL-TUBE DEFECTS SO LANCET LA English DT Letter RP ROSA, F (reprint author), US FDA,ROCKVILLE,MD 20857, USA. NR 2 TC 4 Z9 4 U1 0 U2 1 PU LANCET LTD PI LONDON PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL SN 0140-6736 J9 LANCET JI Lancet PD NOV 24 PY 1990 VL 336 IS 8726 BP 1327 EP 1327 DI 10.1016/0140-6736(90)93016-I PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EJ943 UT WOS:A1990EJ94300058 PM 1978153 ER PT J AU ADAMS, AA BEEH, JL WEKELL, MM AF ADAMS, AA BEEH, JL WEKELL, MM TI HEALTH RISKS OF SALMON SUSHI SO LANCET LA English DT Letter RP ADAMS, AA (reprint author), US FDA,SEAFOOD PROD RES CTR,POB 3012,22201 23RD DR SE,BOTHELL,WA 98041, USA. NR 8 TC 6 Z9 6 U1 1 U2 17 PU LANCET LTD PI LONDON PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL SN 0140-6736 J9 LANCET JI Lancet PD NOV 24 PY 1990 VL 336 IS 8726 BP 1328 EP 1328 DI 10.1016/0140-6736(90)93019-L PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EJ943 UT WOS:A1990EJ94300061 PM 1978155 ER PT J AU FRENI, SC AF FRENI, SC TI TRENDS IN CANCER MORTALITY SO LANCET LA English DT Letter RP FRENI, SC (reprint author), NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 6 TC 1 Z9 1 U1 0 U2 0 PU LANCET LTD PI LONDON PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL SN 0140-6736 J9 LANCET JI Lancet PD NOV 17 PY 1990 VL 336 IS 8725 BP 1263 EP 1264 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA EJ064 UT WOS:A1990EJ06400056 ER PT J AU GAN, YX WEAVER, JL PINE, PS ZOON, KC ASZALOS, A AF GAN, YX WEAVER, JL PINE, PS ZOON, KC ASZALOS, A TI AURIN TRICARBOXYLIC-ACID, THE ANTI-AIDS COMPOUND, PREVENTS THE BINDING OF INTERFERON-ALPHA TO ITS RECEPTOR SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS LA English DT Article C1 US FDA,DIV CYTOKINE BIOL,WASHINGTON,DC 20204. RP GAN, YX (reprint author), US FDA,CTR DRUG EVALUAT & RES,DIV RES & TESTING,HFD-471,200 C ST SW,WASHINGTON,DC 20204, USA. NR 19 TC 18 Z9 18 U1 0 U2 1 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0006-291X J9 BIOCHEM BIOPH RES CO JI Biochem. Biophys. Res. Commun. PD NOV 15 PY 1990 VL 172 IS 3 BP 1298 EP 1303 DI 10.1016/0006-291X(90)91590-O PG 6 WC Biochemistry & Molecular Biology; Biophysics SC Biochemistry & Molecular Biology; Biophysics GA EJ240 UT WOS:A1990EJ24000051 PM 2147104 ER PT J AU WADZINSKI, BE SHANAHAN, MF SEAMON, KB RUOHO, AE AF WADZINSKI, BE SHANAHAN, MF SEAMON, KB RUOHO, AE TI LOCALIZATION OF THE FORSKOLIN PHOTOLABELING SITE WITHIN THE MONOSACCHARIDE TRANSPORTER OF HUMAN ERYTHROCYTES SO BIOCHEMICAL JOURNAL LA English DT Article C1 UNIV WISCONSIN,SCH MED,DEPT PHARMACOL,MADISON,WI 53706. SO ILLINOIS UNIV,SCH MED,DEPT PHYSIOL,CARBONDALE,IL 62901. US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. FU NIADDK NIH HHS [AM 36855]; NIGMS NIH HHS [GM 33138] NR 46 TC 39 Z9 39 U1 0 U2 0 PU PORTLAND PRESS PI LONDON PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ SN 0264-6021 J9 BIOCHEM J JI Biochem. J. PD NOV 15 PY 1990 VL 272 IS 1 BP 151 EP 158 PG 8 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EK066 UT WOS:A1990EK06600022 PM 2264820 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI HAEMOPHILUS-B CONJUGATE VACCINE LICENSED FOR INFANTS SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material RP NIGHTINGALE, SL (reprint author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD NOV 14 PY 1990 VL 264 IS 18 BP 2372 EP 2372 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EG589 UT WOS:A1990EG58900007 PM 2231988 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI WARNING ABOUT HEPATITIS-B TRANSMISSION VIA SPRING-LOADED LANCET DEVICES SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material RP NIGHTINGALE, SL (reprint author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD NOV 14 PY 1990 VL 264 IS 18 BP 2372 EP 2372 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EG589 UT WOS:A1990EG58900008 PM 2231988 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI TREATMENT IND FOR GMCSF FOR BONE-MARROW GRAFT FAILURE SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material RP NIGHTINGALE, SL (reprint author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD NOV 14 PY 1990 VL 264 IS 18 BP 2372 EP 2372 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EG589 UT WOS:A1990EG58900006 PM 2231988 ER PT J AU PECK, CC RHEINSTEIN, PH AF PECK, CC RHEINSTEIN, PH TI FDA REGULATION OF PRESCRIPTION DRUG ADVERTISING SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. RP PECK, CC (reprint author), US FDA,CTR DRUG EVALUAT & RES,5600 FISHER LN,HFD-1,ROOM 13B-45,ROCKVILLE,MD 20857, USA. NR 8 TC 5 Z9 5 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD NOV 14 PY 1990 VL 264 IS 18 BP 2424 EP 2425 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA EG589 UT WOS:A1990EG58900033 PM 2232001 ER PT J AU ALTER, HJ EPSTEIN, JS SWENSON, SG VANRADEN, MJ WARD, JW KASLOW, RA MENITOVE, JE KLEIN, HG SANDLER, SG SAYERS, MH HEWLETT, IK CHERNOFF, AI AF ALTER, HJ EPSTEIN, JS SWENSON, SG VANRADEN, MJ WARD, JW KASLOW, RA MENITOVE, JE KLEIN, HG SANDLER, SG SAYERS, MH HEWLETT, IK CHERNOFF, AI TI PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 P24 ANTIGEN IN UNITED-STATES BLOOD-DONORS - AN ASSESSMENT OF THE EFFICACY OF TESTING IN DONOR SCREENING SO NEW ENGLAND JOURNAL OF MEDICINE LA English DT Article C1 CTR DIS CONTROL,ATLANTA,GA 30333. PUGET SOUND BLOOD CTR,SEATTLE,WA 98104. MILWAUKEE BLOOD CTR INC,MILWAUKEE,WI 53233. US FDA,WARREN G MAGNUSON CLIN CTR,BETHESDA,MD 20014. BLOOD SYST CENT LAB,SCOTTSDALE,AZ. AMER RED CROSS,WASHINGTON,DC. AMER ASSOC BLOOD BANKS,ARLINGTON,VA. RP ALTER, HJ (reprint author), NIH,BETHESDA,MD 20892, USA. FU PHS HHS [223-89-1000] NR 25 TC 105 Z9 108 U1 0 U2 1 PU MASS MEDICAL SOC PI BOSTON PA 10 SHATTUCK, BOSTON, MA 02115 SN 0028-4793 J9 NEW ENGL J MED JI N. Engl. J. Med. PD NOV 8 PY 1990 VL 323 IS 19 BP 1312 EP 1317 DI 10.1056/NEJM199011083231905 PG 6 WC Medicine, General & Internal SC General & Internal Medicine GA EG588 UT WOS:A1990EG58800005 PM 2120589 ER PT J AU SIEGEL, JP AF SIEGEL, JP TI EDITORIAL REVIEW OF PROTOCOLS FOR CLINICAL-TRIALS SO NEW ENGLAND JOURNAL OF MEDICINE LA English DT Letter RP SIEGEL, JP (reprint author), US FDA,BETHESDA,MD 20892, USA. NR 0 TC 11 Z9 13 U1 0 U2 0 PU MASS MEDICAL SOC PI BOSTON PA 10 SHATTUCK, BOSTON, MA 02115 SN 0028-4793 J9 NEW ENGL J MED JI N. Engl. J. Med. PD NOV 8 PY 1990 VL 323 IS 19 BP 1355 EP 1355 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EG588 UT WOS:A1990EG58800030 PM 2215630 ER PT J AU MCELVAINE, MD HARDER, EM JOHNSON, L BAER, RD SATZGER, RD AF MCELVAINE, MD HARDER, EM JOHNSON, L BAER, RD SATZGER, RD TI LEAD-POISONING FROM THE USE OF INDIAN FOLK MEDICINES SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Letter C1 US FDA,BOTHELL,WA. UNIV S FLORIDA,TAMPA,FL 33620. US FDA,CINCINNATI,OH 45267. RP MCELVAINE, MD (reprint author), CTR DIS CONTROL,ATLANTA,GA 30333, USA. NR 6 TC 23 Z9 23 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD NOV 7 PY 1990 VL 264 IS 17 BP 2212 EP 2213 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA EF488 UT WOS:A1990EF48800018 PM 2214097 ER PT J AU FRATANTONI, JC POINDEXTER, BJ AF FRATANTONI, JC POINDEXTER, BJ TI MEASURING PLATELET-AGGREGATION WITH MICROPLATE READER - A NEW TECHNICAL APPROACH TO PLATELET-AGGREGATION STUDIES SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY LA English DT Article RP FRATANTONI, JC (reprint author), CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 13 TC 35 Z9 36 U1 1 U2 4 PU LIPPINCOTT-RAVEN PUBL PI PHILADELPHIA PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 SN 0002-9173 J9 AM J CLIN PATHOL JI Am. J. Clin. Pathol. PD NOV PY 1990 VL 94 IS 5 BP 613 EP 617 PG 5 WC Pathology SC Pathology GA EH588 UT WOS:A1990EH58800014 PM 2239825 ER PT J AU KAWALEK, JC ELSAID, KR AF KAWALEK, JC ELSAID, KR TI MATURATIONAL DEVELOPMENT OF DRUG-METABOLIZING-ENZYMES IN SHEEP SO AMERICAN JOURNAL OF VETERINARY RESEARCH LA English DT Article RP KAWALEK, JC (reprint author), US FDA,AGR RES CTR,CTR VET MED,DIV VET MED RES,VET PHARMACOL TOXICOL BRANCH,E BLDG 328A,BELTSVILLE,MD 20705, USA. NR 26 TC 23 Z9 23 U1 0 U2 1 PU AMER VETERINARY MEDICAL ASSOC PI SCHAUMBURG PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 SN 0002-9645 J9 AM J VET RES JI Am. J. Vet. Res. PD NOV PY 1990 VL 51 IS 11 BP 1736 EP 1741 PG 6 WC Veterinary Sciences SC Veterinary Sciences GA EF812 UT WOS:A1990EF81200007 PM 2240798 ER PT J AU KAWALEK, JC ELSAID, KR AF KAWALEK, JC ELSAID, KR TI MATURATIONAL DEVELOPMENT OF DRUG-METABOLIZING-ENZYMES IN DOGS SO AMERICAN JOURNAL OF VETERINARY RESEARCH LA English DT Article RP KAWALEK, JC (reprint author), US FDA,AGR RES CTR,CTR VET MED,DIV VET MED RES,VET PHARMACOL TOXICOL BRANCH,E BLDG 328A,BELTSVILLE,MD 20705, USA. NR 12 TC 23 Z9 23 U1 1 U2 3 PU AMER VETERINARY MEDICAL ASSOC PI SCHAUMBURG PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 SN 0002-9645 J9 AM J VET RES JI Am. J. Vet. Res. PD NOV PY 1990 VL 51 IS 11 BP 1742 EP 1745 PG 4 WC Veterinary Sciences SC Veterinary Sciences GA EF812 UT WOS:A1990EF81200008 PM 2122781 ER PT J AU DAFT, JL AF DAFT, JL TI RECOVERY OF 1,3-DICHLOROPROPENE, 2,3-DICHLOROPROPENE, 1,2-DIBROMO-3-CHLOROPROPANE, AND ORTHO-DICHLOROBENZENE,PARA-DICHLOROBENZENES FROM FATTY AND NONFAT FOODSTUFFS BY LIQUID EXTRACTION TECHNIQUE SO ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY LA English DT Article RP DAFT, JL (reprint author), US FDA,KANSAS CITY,MO 64106, USA. NR 21 TC 2 Z9 2 U1 0 U2 0 PU SPRINGER VERLAG PI NEW YORK PA 175 FIFTH AVE, NEW YORK, NY 10010 SN 0090-4341 J9 ARCH ENVIRON CON TOX JI Arch. Environ. Contam. Toxicol. PD NOV-DEC PY 1990 VL 19 IS 6 BP 921 EP 925 PG 5 WC Environmental Sciences; Toxicology SC Environmental Sciences & Ecology; Toxicology GA EF806 UT WOS:A1990EF80600019 PM 2256707 ER PT J AU LITTLE, LF GAFFNEY, IC ROSEN, KH BENDER, MM AF LITTLE, LF GAFFNEY, IC ROSEN, KH BENDER, MM TI CORPORATE INSTABILITY IS RELATED TO AIRLINE PILOTS STRESS SYMPTOMS SO AVIATION SPACE AND ENVIRONMENTAL MEDICINE LA English DT Article C1 VIRGINIA POLYTECH INST & STATE UNIV,CTR FAMILY SERV,FALLS CHURCH,VA. US FDA,DIV CONSUMER STUDIES,WASHINGTON,DC 20204. RP LITTLE, LF (reprint author), VIRGINIA POLYTECH INST & STATE UNIV,NO VIRGINIA GRAD CTR,DEPT FAMILY & CHILD DEV,FALLS CHURCH,VA 22042, USA. NR 30 TC 18 Z9 19 U1 1 U2 1 PU AEROSPACE MEDICAL ASSOC PI ALEXANDRIA PA 320 S HENRY ST, ALEXANDRIA, VA 22314-3579 SN 0095-6562 J9 AVIAT SPACE ENVIR MD JI Aviat. Space Environ. Med. PD NOV PY 1990 VL 61 IS 11 BP 977 EP 982 PG 6 WC Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences SC Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences GA EG428 UT WOS:A1990EG42800001 PM 2256885 ER PT J AU PRASANNA, HR LU, MH HART, RW AF PRASANNA, HR LU, MH HART, RW TI STATUS OF DEHYDROEPIANDROSTERONE AND HEPATIC-METABOLISM OF AFLATOXIN-B1 IN FOOD RESTRICTED RATS SO BIOCHEMICAL ARCHIVES LA English DT Article RP PRASANNA, HR (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 25 TC 2 Z9 2 U1 0 U2 0 PU MBR PRESS INC PI KENYON PA PO BOX P, KENYON, MN 55946-000P SN 0749-5331 J9 BIOCHEM ARCH JI Biochem. Arch. PD NOV PY 1990 VL 6 IS 4 BP 419 EP 427 PG 9 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EM089 UT WOS:A1990EM08900011 ER PT J AU MARQUES, MM BELAND, FA AF MARQUES, MM BELAND, FA TI SYNTHESIS, CHARACTERIZATION, AND SOLUTION PROPERTIES OF RAS SEQUENCES MODIFIED BY ARYLAMINE CARCINOGENS AT THE 1ST BASE OF CODON-61 SO CHEMICAL RESEARCH IN TOXICOLOGY LA English DT Article C1 NATL CTR TOXICOL RES, JEFFERSON, AR 72079 USA. RP MARQUES, MM (reprint author), Univ Tecn Lisboa, CTR QUIM ESTRUTURAL, INST SUPER TECN, COMPLEX I, AV ROVISCO PAIS, P-1096 LISBON, PORTUGAL. RI Marques, M. Matilde/E-2535-2012 OI Marques, M. Matilde/0000-0002-7526-4962 NR 52 TC 14 Z9 14 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA SN 0893-228X J9 CHEM RES TOXICOL JI Chem. Res. Toxicol. PD NOV-DEC PY 1990 VL 3 IS 6 BP 559 EP 565 DI 10.1021/tx00018a011 PG 7 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology SC Pharmacology & Pharmacy; Chemistry; Toxicology GA EK640 UT WOS:A1990EK64000012 PM 2103327 ER PT J AU KELLY, DW HOLDER, CL KORFMACHER, WA SLIKKER, W AF KELLY, DW HOLDER, CL KORFMACHER, WA SLIKKER, W TI PLASMA ELIMINATION AND URINARY-EXCRETION OF METHAPYRILENE IN THE RAT SO DRUG METABOLISM AND DISPOSITION LA English DT Article C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,HFT-132,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & TOXICOL,LITTLE ROCK,AR 72205. NR 28 TC 6 Z9 6 U1 0 U2 0 PU WILLIAMS & WILKINS PI BALTIMORE PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 SN 0090-9556 J9 DRUG METAB DISPOS JI Drug Metab. Dispos. PD NOV-DEC PY 1990 VL 18 IS 6 BP 1018 EP 1024 PG 7 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EK105 UT WOS:A1990EK10500032 PM 1981507 ER PT J AU BEGLEY, TH DENNISON, JL HOLLIFIELD, HC AF BEGLEY, TH DENNISON, JL HOLLIFIELD, HC TI MIGRATION INTO FOOD OF POLYETHYLENE TEREPHTHALATE (PET) CYCLIC OLIGOMERS FROM PET MICROWAVE SUSCEPTOR PACKAGING SO FOOD ADDITIVES AND CONTAMINANTS LA English DT Article RP BEGLEY, TH (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204, USA. NR 0 TC 31 Z9 34 U1 4 U2 14 PU TAYLOR & FRANCIS LTD PI LONDON PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE SN 0265-203X J9 FOOD ADDIT CONTAM JI Food Addit. Contam. PD NOV-DEC PY 1990 VL 7 IS 6 BP 797 EP 803 PG 7 WC Chemistry, Applied; Food Science & Technology; Toxicology SC Chemistry; Food Science & Technology; Toxicology GA EL664 UT WOS:A1990EL66400004 PM 2150379 ER PT J AU HOFFMANN, BL NOWELL, LH AF HOFFMANN, BL NOWELL, LH TI THE FDAS ENVIRONMENTAL-IMPACT ANALYSIS REQUIREMENTS - FOOD-PACKAGING AND SOLID-WASTE MANAGEMENT SO FOOD AND DRUG LAW JOURNAL LA English DT Article; Proceedings Paper CT SEMINAR OF THE FOOD AND DRUG LAW INST ON THE SOLID WASTE CRISIS CY JAN 19, 1990 CL WASHINGTON, DC SP FOOD & DRUG LAW INST AB The Food and Drug Administration (FDA) conducts a premarket review of proposed food additives, including food packaging materials and components of food packaging. This review includes an evaluation of the enviromental impacts of agency approval as required by the National Enviromental Policy Act of 1969 (NEPA). The FDA's environmental review process begins when an industry sponsor provides the agency with an environmental assessment containing information for the public record about the manufacture, use, and disposal of the proposed food packaging material. The agency uses this information to evaluate whether approval of this material may have significant environmental effects, including impacts on solid waste management (source reduction, recycling, incineration, and landfilling). The magnitude of the solid waste problem today creates a new context for assessing the significance of impacts on disposal. For some actions involving food packaging, more detailed information on disposal is needed to determine whether there will be significant impacts on solid waste management. The majority of the FDA actions involving food packaging will not have adverse effects on solid waste management, and for these actions environmental requirements are abbreviated. For petitions that may affect solid waste management, the FDA strives to do a technically sound and complete analysis of potential impact to meet the letter and spirit of NEPA. RP HOFFMANN, BL (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,ENVIRONM IMPACT SECT,WASHINGTON,DC, USA. NR 0 TC 2 Z9 2 U1 0 U2 4 PU FOOD DRUG LAW INST PI WASHINGTON PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 J9 FOOD DRUG LAW J JI Food Drug Law J. PD NOV PY 1990 VL 45 IS 6 BP 615 EP 621 PG 7 WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology & Pharmacy SC Food Science & Technology; Government & Law; Nutrition & Dietetics; Pharmacology & Pharmacy GA EP326 UT WOS:A1990EP32600004 ER PT J AU WILSON, RL AF WILSON, RL TI PROTECTION OF HUMAN-SUBJECTS IN RESEARCH - THE FDAS VIEW SO FOOD AND DRUG LAW JOURNAL LA English DT Article; Proceedings Paper CT SEMINAR OF THE FOOD AND DRUG LAW INST ON THE SOLID WASTE CRISIS CY JAN 19, 1990 CL WASHINGTON, DC SP FOOD & DRUG LAW INST AB The Department of Health and Human Services' (HHS') and the Food and Drug Administration's (FDA's) regulations govern the protection of human subjects in research. Their purpose is to ensure that the rights of research subjects are fully protected. The FDA's regulatory requirements are applicable to research involving FDA regulated products such as drugs, medical devices, and biological products. Although both the HHS and the FDA regulations deal with the requirements for the structure and function of institutional review boards (IRBs) and the required elements of informed consent, there are differences between the two regulations. A primary difference is that HHS uses the assurance mechanism as a method of registering and accrediting the IRBs which review studies funded by HHS. The FDA uses a compliance program, the Bioresearch Monitoring Program, that is intended to ensure the quality and integrity of data submitted to the agency for regulatory decisionmaking. Four inspection areas-sponsors, laboratories, clinical investigators, and IRBs-are the most pertinent inspection programs involving human subject protection. Another important protection of human subjects in clinical research is the FDA's and the National Institutes of Health's (NIH's) educational program to provide an understanding of the regulations to IRB members and clinical investigators. The two agencies have worked together since 1974 in the development of regional IRB workshops. As part of this effort, the FDA has published twenty-eight information sheets on subjects of interest to IRB members and clinical investigators. There are also interagency agreements that serve to protect human subjects involved in clinical research. For example, since 1974, the FDA and the Department of Defense have had a Memorandum of Understanding that establishes procedures to be followed regarding the investigational use of drugs, biologics, and medical devices. The FDA has an interagency agreement with the NIH to implement its joint educational program on the protection of human subjects. The FDA and HHS regulations, Bioresearch Monitoring Program, educational activities, and interagency agreements are all important parts of the mission to protect human subjects involved in clinical research. RP WILSON, RL (reprint author), US FDA,OFF HLTH AFFAIRS,WASHINGTON,DC, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU FOOD DRUG LAW INST PI WASHINGTON PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 J9 FOOD DRUG LAW J JI Food Drug Law J. PD NOV PY 1990 VL 45 IS 6 BP 631 EP 637 PG 7 WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology & Pharmacy SC Food Science & Technology; Government & Law; Nutrition & Dietetics; Pharmacology & Pharmacy GA EP326 UT WOS:A1990EP32600006 ER PT J AU SCARBROUGH, FE AF SCARBROUGH, FE TI UNDER THE REPROPOSED RULE, HOW MUCH SCIENTIFIC EVIDENCE DOES A COMPANY NEED TO JUSTIFY ITS CLAIM AND WHAT ARE THE FOOD-AND-DRUG-ADMINISTRATIONS INTERIM RULES SO FOOD AND DRUG LAW JOURNAL LA English DT Article; Proceedings Paper CT SEMINAR OF THE FOOD AND DRUG LAW INST ON THE SOLID WASTE CRISIS CY JAN 19, 1990 CL WASHINGTON, DC SP FOOD & DRUG LAW INST AB Perhaps the most difficult problem the Food and Drug Administration (FDA) faces in regulating claims on food labels is establishing standards to measure the quality and quantity of scientific evidence needed to support a health message. To measure the degree of scientific agreement in any given diet/health topic area, the agency has proposed to establish a process that involves the creation of scientific summaries which will be subjected to review by a Public Health Service committee on health messages. The committee will be guided in their reviews by basic principles to be established through notice and comment rulemaking. The FDA's articulation of an interim enforcement policy provides further guidance on how health messages on food labels will be regulated in the future. RP SCARBROUGH, FE (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,OFF NUTR & APPL FOOD SCI,WASHINGTON,DC, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU FOOD DRUG LAW INST PI WASHINGTON PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 J9 FOOD DRUG LAW J JI Food Drug Law J. PD NOV PY 1990 VL 45 IS 6 BP 647 EP 653 PG 7 WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology & Pharmacy SC Food Science & Technology; Government & Law; Nutrition & Dietetics; Pharmacology & Pharmacy GA EP326 UT WOS:A1990EP32600008 ER PT J AU GERGELY, P ASZALOS, A AF GERGELY, P ASZALOS, A TI EFFECT OF CYCLOSPORINE-A ON THE ANTI-CD3 ANTIBODY-INDUCED AND CONCANAVALIN-A-INDUCED ACTIVATION AND MEMBRANE-POTENTIAL OF HUMAN LYMPHOCYTES-T SO IMMUNOPHARMACOLOGY LA English DT Article C1 US FDA,DIV RES & TESTING,HFD-471,200 C ST SW,WASHINGTON,DC 20204. NR 37 TC 6 Z9 6 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0162-3109 J9 IMMUNOPHARMACOLOGY JI Immunopharmacology PD NOV-DEC PY 1990 VL 20 IS 3 BP 191 EP 200 DI 10.1016/0162-3109(90)90034-C PG 10 WC Immunology; Pharmacology & Pharmacy SC Immunology; Pharmacology & Pharmacy GA EM916 UT WOS:A1990EM91600006 PM 2149721 ER PT J AU SIITONEN, PH THOMPSON, HC AF SIITONEN, PH THOMPSON, HC TI CADMIUM CONTAMINATION IN CEREAL-BASED DIETS AND DIET INGREDIENTS SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY LA English DT Article RP SIITONEN, PH (reprint author), NATL CTR TOXICOL RES,DIV CHEM,OFF RES SERV,JEFFERSON,AR 72079, USA. NR 4 TC 1 Z9 1 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0021-8561 J9 J AGR FOOD CHEM JI J. Agric. Food Chem. PD NOV PY 1990 VL 38 IS 11 BP 2009 EP 2010 DI 10.1021/jf00101a004 PG 2 WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology SC Agriculture; Chemistry; Food Science & Technology GA EJ399 UT WOS:A1990EJ39900004 ER PT J AU LOCKEY, RF TURKELTAUB, PC OLIVE, ES HUBBARD, JM BAIRDWARREN, IA BUKANTZ, SC AF LOCKEY, RF TURKELTAUB, PC OLIVE, ES HUBBARD, JM BAIRDWARREN, IA BUKANTZ, SC TI THE HYMENOPTERA VENOM STUDY .3. SAFETY OF VENOM IMMUNOTHERAPY SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY LA English DT Article C1 UNIV S FLORIDA,CTR COMP,TAMPA,FL 33620. US FDA,ALLERGEN PROD LAB,OFF BIOL RES,BETHESDA,MD 20014. RP LOCKEY, RF (reprint author), UNIV S FLORIDA,COLL MED,JAMES A HALEY VET ADM HOSP,DEPT MED,DIV ALLERGY & IMMUNOL,TAMPA,FL 33612, USA. NR 11 TC 128 Z9 129 U1 0 U2 1 PU MOSBY-YEAR BOOK INC PI ST LOUIS PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 SN 0091-6749 J9 J ALLERGY CLIN IMMUN JI J. Allergy Clin. Immunol. PD NOV PY 1990 VL 86 IS 5 BP 775 EP 780 DI 10.1016/S0091-6749(05)80182-4 PG 6 WC Allergy; Immunology SC Allergy; Immunology GA EJ631 UT WOS:A1990EJ63100010 PM 2229842 ER PT J AU BULL, TE AF BULL, TE TI QUANTUM STATISTICAL WEIGHTS FOR REORIENTATIONAL CORRELATION-FUNCTIONS IN THE NUCLEAR-MAGNETIC-RESONANCE RELAXATION OF METHYL-GROUPS SO JOURNAL OF CHEMICAL PHYSICS LA English DT Article RP BULL, TE (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,BIOPHYS LAB,BETHESDA,MD 20892, USA. NR 22 TC 4 Z9 4 U1 0 U2 3 PU AMER INST PHYSICS PI WOODBURY PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 SN 0021-9606 J9 J CHEM PHYS JI J. Chem. Phys. PD NOV 1 PY 1990 VL 93 IS 9 BP 6824 EP 6833 DI 10.1063/1.458927 PG 10 WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical SC Chemistry; Physics GA EG251 UT WOS:A1990EG25100075 ER PT J AU CROFFORD, LJ RADER, JI DALAKAS, MC HILL, RH PAGE, SW NEEDHAM, LL BRADY, LS HEYES, MP WILDER, RL GOLD, PW ILLA, I SMITH, C STERNBERG, EM AF CROFFORD, LJ RADER, JI DALAKAS, MC HILL, RH PAGE, SW NEEDHAM, LL BRADY, LS HEYES, MP WILDER, RL GOLD, PW ILLA, I SMITH, C STERNBERG, EM TI L-TRYPTOPHAN IMPLICATED IN HUMAN EOSINOPHILIA-MYALGIA-SYNDROME CAUSES FASCIITIS AND PERIMYOSITIS IN THE LEWIS RAT SO JOURNAL OF CLINICAL INVESTIGATION LA English DT Note C1 NIMH, BLDG 10, ROOM 35231, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA. NIAMSD, BETHESDA, MD 20892 USA. NINCDS, BETHESDA, MD 20892 USA. US FDA, CTR FOOD SAFETY & APPL NUTR, WASHINGTON, DC 20204 USA. CTR DIS CONTROL, ATLANTA, GA 30333 USA. RI Needham, Larry/E-4930-2011; Crofford, Leslie/J-8010-2013 NR 39 TC 113 Z9 113 U1 0 U2 1 PU AMER SOC CLINICAL INVESTIGATION INC PI ANN ARBOR PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA SN 0021-9738 EI 1558-8238 J9 J CLIN INVEST JI J. Clin. Invest. PD NOV PY 1990 VL 86 IS 5 BP 1757 EP 1763 DI 10.1172/JCI114902 PG 7 WC Medicine, Research & Experimental SC Research & Experimental Medicine GA EJ186 UT WOS:A1990EJ18600052 PM 2243145 ER PT J AU MURTHY, GK BRADSHAW, JG PEELER, JT AF MURTHY, GK BRADSHAW, JG PEELER, JT TI THERMAL INACTIVATION OF PHOSPHATASE BY THE AOAC-V METHOD SO JOURNAL OF FOOD PROTECTION LA English DT Article C1 US FDA,DIV MICROBIOL,HFF-8,200 C ST SW,WASHINGTON,DC 20204. NR 14 TC 9 Z9 10 U1 1 U2 1 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD NOV PY 1990 VL 53 IS 11 BP 969 EP 971 PG 3 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EH616 UT WOS:A1990EH61600013 ER PT J AU CHEN, RT MARKOWITZ, LE ALBRECHT, P STEWART, JA MOFENSON, LM PREBLUD, SR ORENSTEIN, WA AF CHEN, RT MARKOWITZ, LE ALBRECHT, P STEWART, JA MOFENSON, LM PREBLUD, SR ORENSTEIN, WA TI MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS SO JOURNAL OF INFECTIOUS DISEASES LA English DT Article C1 CTR DIS CONTROL,CTR INFECT DIS,DIV VIRAL DIS,ATLANTA,GA 30333. US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20014. MASSACHUSETTS DEPT PUBL HLTH,DIV COMMUNICABLE DIS CONTROL,BOSTON,MA. RP CHEN, RT (reprint author), CTR DIS CONTROL,CTR PREVENT SERV,DIV IMMUNIZAT,TECH INFORMAT SERV E06,ATLANTA,GA 30333, USA. OI Mofenson, Lynne/0000-0002-2818-9808 NR 41 TC 375 Z9 381 U1 1 U2 14 PU UNIV CHICAGO PRESS PI CHICAGO PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637 SN 0022-1899 J9 J INFECT DIS JI J. Infect. Dis. PD NOV PY 1990 VL 162 IS 5 BP 1036 EP 1042 PG 7 WC Immunology; Infectious Diseases; Microbiology SC Immunology; Infectious Diseases; Microbiology GA EE046 UT WOS:A1990EE04600006 PM 2230231 ER PT J AU ARMSTRONG, RC HARVATH, L DUBOISDALCQ, ME AF ARMSTRONG, RC HARVATH, L DUBOISDALCQ, ME TI TYPE-1 ASTROCYTES AND OLIGODENDROCYTE-TYPE-2 ASTROCYTE GLIAL PROGENITORS MIGRATE TOWARD DISTINCT MOLECULES SO JOURNAL OF NEUROSCIENCE RESEARCH LA English DT Note C1 US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,BETHESDA,MD 20014. RP ARMSTRONG, RC (reprint author), NINCDS,VIRAL & MOLEC PATHOGENESIS LAB,BLDG 36,RM 5D04,BETHESDA,MD 20892, USA. NR 45 TC 251 Z9 254 U1 1 U2 3 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0360-4012 J9 J NEUROSCI RES JI J. Neurosci. Res. PD NOV PY 1990 VL 27 IS 3 BP 400 EP 407 DI 10.1002/jnr.490270319 PG 8 WC Neurosciences SC Neurosciences & Neurology GA EH879 UT WOS:A1990EH87900018 PM 2097382 ER PT J AU GUILFOYLE, DE ROOS, R CARITO, SL AF GUILFOYLE, DE ROOS, R CARITO, SL TI AN EVALUATION OF PRESERVATIVE ADSORPTION ONTO NYLON MEMBRANE FILTERS SO JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY LA English DT Article RP GUILFOYLE, DE (reprint author), US FDA,850 3RD AVE,BROOKLYN,NY 11232, USA. NR 0 TC 13 Z9 13 U1 2 U2 5 PU PARENTERAL DRUG ASSOC, INC PI BETHESDA PA 7500 OLD GEORGETOWN RD, STE, 620, BETHESDA, MD 20814 SN 0279-7976 J9 J PARENT SCI TECHN PD NOV-DEC PY 1990 VL 44 IS 6 BP 314 EP 319 PG 6 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EM087 UT WOS:A1990EM08700007 PM 2277319 ER PT J AU JOHNSON, K AF JOHNSON, K TI THE SYSTEMATIC STUDY OF DRUG-THERAPY IN RHEUMATOID-ARTHRITIS SO JOURNAL OF RHEUMATOLOGY LA English DT Article; Proceedings Paper CT CONF ON CHALLENGING THE PYRAMID : A NEW LOOK AT THERAPEUTIC APPROACHES FOR RHEUMATOID ARTHRITIS CY MAR 09-10, 1990 CL MIAMI, FL C1 US FDA,ROCKVILLE,MD 20857. NR 6 TC 3 Z9 3 U1 1 U2 1 PU J RHEUMATOL PUBL CO PI TORONTO PA 920 YONGE ST, SUITE 115, TORONTO ON M4W 3C7, CANADA SN 0315-162X J9 J RHEUMATOL JI J. Rheumatol. PD NOV PY 1990 VL 17 SU 25 BP 34 EP 38 PG 5 WC Rheumatology SC Rheumatology GA EL487 UT WOS:A1990EL48700008 ER PT J AU PENNINGTON, JAT AF PENNINGTON, JAT TI A REVIEW OF IODINE TOXICITY REPORTS SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION LA English DT Review RP PENNINGTON, JAT (reprint author), CTR FOOD SAFETY & APPL NUTR,DIV NUTR,FOOD & DRUG ADM,WASHINGTON,DC 20204, USA. NR 156 TC 92 Z9 96 U1 0 U2 6 PU AMER DIETETIC ASSN PI CHICAGO PA 216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995 SN 0002-8223 J9 J AM DIET ASSOC JI J. Am. Diet. Assoc. PD NOV PY 1990 VL 90 IS 11 BP 1571 EP 1581 PG 11 WC Nutrition & Dietetics SC Nutrition & Dietetics GA EH591 UT WOS:A1990EH59100008 PM 2229854 ER PT J AU SMEDLEY, MD WEBER, JD AF SMEDLEY, MD WEBER, JD TI LIQUID-CHROMATOGRAPHIC DETERMINATION OF MULTIPLE SULFONAMIDE RESIDUES IN BOVINE-MILK SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP SMEDLEY, MD (reprint author), US FDA,CTR VET MED,DIV VET MED RES,BLDG 328A,BARC E,BELTSVILLE,MD 20705, USA. NR 10 TC 39 Z9 42 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 875 EP 879 PG 5 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900010 PM 2289918 ER PT J AU TAI, SSC CARGILE, N BARNES, CJ KIJAK, P AF TAI, SSC CARGILE, N BARNES, CJ KIJAK, P TI DETERMINATION OF PYRANTEL IN SWINE LIVER BY FLAME IONIZATION GAS-CHROMATOGRAPHY AND CONFIRMATION BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 US FDA,DIV VET MED RES,BARC E,BLDG 328A,CTR RD,BELTSVILLE,MD 20705. NIST,DIV ORGAN ANALYT RES,GAITHERSBURG,MD 20899. BASF,RES TRIANGLE PK,NC 27709. FU PHS HHS [223-85-7036] NR 3 TC 4 Z9 4 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 883 EP 886 PG 4 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900012 PM 2289920 ER PT J AU WALTERS, MJ AYERS, RJ BROWN, DJ AF WALTERS, MJ AYERS, RJ BROWN, DJ TI ANALYSIS OF ILLEGALLY DISTRIBUTED ANABOLIC-STEROID PRODUCTS BY LIQUID-CHROMATOGRAPHY WITH IDENTITY CONFIRMATION BY MASS-SPECTROMETRY OR INFRARED SPECTROPHOTOMETRY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP WALTERS, MJ (reprint author), US FDA,1560 E JEFFERSON AVE,DETROIT,MI 48207, USA. NR 11 TC 25 Z9 25 U1 1 U2 3 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 904 EP 926 PG 23 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900017 PM 2289923 ER PT J AU ROYBAL, JE MUNNS, RK HURLBUT, JA SHIMODA, W AF ROYBAL, JE MUNNS, RK HURLBUT, JA SHIMODA, W TI DETERMINATION OF GENTIAN-VIOLET, ITS DEMETHYLATED METABOLITES, AND LEUCOGENTIAN VIOLET IN CHICKEN TISSUE BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP ROYBAL, JE (reprint author), US FDA,ANIM DRUG RES CTR,DENVER FED CTR,POB 25087,DENVER,CO 80225, USA. NR 11 TC 9 Z9 10 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 940 EP 946 PG 7 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900021 PM 2289926 ER PT J AU MCCLURE, FD AF MCCLURE, FD TI DESIGN AND ANALYSIS OF QUALITATIVE COLLABORATIVE STUDIES - MINIMUM COLLABORATIVE PROGRAM SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP MCCLURE, FD (reprint author), US FDA,DIV MATH,200 C ST SW,WASHINGTON,DC 20204, USA. NR 9 TC 99 Z9 100 U1 0 U2 2 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 953 EP 960 PG 8 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900023 PM 2289928 ER PT J AU DAFT, J HOPPER, M HENSLEY, D SISK, R AF DAFT, J HOPPER, M HENSLEY, D SISK, R TI A DISPLACEMENT PUMP PROCEDURE TO LOAD EXTRACTS FOR AUTOMATED GEL-PERMEATION CHROMATOGRAPHY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Note RP DAFT, J (reprint author), US FDA,KANSAS CITY DIST OFF,1009 CHERRY ST,KANSAS CITY,MO 64106, USA. NR 8 TC 5 Z9 5 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD NOV-DEC PY 1990 VL 73 IS 6 BP 992 EP 994 PG 3 WC Chemistry, Analytical SC Chemistry GA EK589 UT WOS:A1990EK58900030 PM 2289932 ER PT J AU WAGNER, LK ARCHER, BR CERRA, F AF WAGNER, LK ARCHER, BR CERRA, F TI ON THE MEASUREMENT OF HALF-VALUE LAYER IN FILM-SCREEN MAMMOGRAPHY SO MEDICAL PHYSICS LA English DT Article C1 BAYLOR UNIV,DEPT RADIOL,HOUSTON,TX 77030. US FDA,CTR DEVICES & RADIOL HLTH,ROCKVILLE,MD 20857. RP WAGNER, LK (reprint author), UNIV TEXAS,SCH MED,DEPT RADIOL,HOUSTON,TX 77030, USA. NR 7 TC 31 Z9 32 U1 0 U2 0 PU AMER INST PHYSICS PI WOODBURY PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 SN 0094-2405 J9 MED PHYS JI Med. Phys. PD NOV-DEC PY 1990 VL 17 IS 6 BP 989 EP 997 DI 10.1118/1.596444 PG 9 WC Radiology, Nuclear Medicine & Medical Imaging SC Radiology, Nuclear Medicine & Medical Imaging GA EJ431 UT WOS:A1990EJ43100005 PM 2280742 ER PT J AU PLOTKIN, SA HALSEY, NA LEPOW, ML MARCUSE, EK MCCRACKEN, GH NANKERVIS, GA PHILLIPS, CF SCOTT, GB STEELE, RW WRIGHT, HT PETER, G HARDEGREE, C HINMAN, AR LAMONTAGNE, JR GOLD, R ORENSTEIN, W EASTON, JG DAUM, RS AF PLOTKIN, SA HALSEY, NA LEPOW, ML MARCUSE, EK MCCRACKEN, GH NANKERVIS, GA PHILLIPS, CF SCOTT, GB STEELE, RW WRIGHT, HT PETER, G HARDEGREE, C HINMAN, AR LAMONTAGNE, JR GOLD, R ORENSTEIN, W EASTON, JG DAUM, RS TI HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES - IMMUNIZATION OF CHILDREN AT 15 MONTHS OF AGE SO PEDIATRICS LA English DT Article C1 CTR DIS CONTROL,ATLANTA,GA 30333. RP PLOTKIN, SA (reprint author), US FDA,WASHINGTON,DC 20204, USA. RI Steele, Russell/A-6075-2011 NR 10 TC 1 Z9 1 U1 0 U2 0 PU AMER ACAD PEDIATRICS PI ELK GROVE VILLAGE PA 141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098 SN 0031-4005 J9 PEDIATRICS JI Pediatrics PD NOV PY 1990 VL 86 IS 5 BP 794 EP 796 PG 3 WC Pediatrics SC Pediatrics GA EF347 UT WOS:A1990EF34700026 ER PT J AU KAUFFMAN, RE BANNER, W BLUMER, JL GORMAN, RL LAMBERT, GH SNODGRASS, W BENNETT, DR CORDERO, JF DOOLEY, S LICATA, SA PETERSON, R PETRICCIANI, JC TROENDLE, G AF KAUFFMAN, RE BANNER, W BLUMER, JL GORMAN, RL LAMBERT, GH SNODGRASS, W BENNETT, DR CORDERO, JF DOOLEY, S LICATA, SA PETERSON, R PETRICCIANI, JC TROENDLE, G TI CLIOQUINOL (IODOCHLORHYDROXYQUIN, VIOFORM) AND IODOQUINOL (DIIODOHYDROXYQUIN) - BLINDNESS AND NEUROPATHY SO PEDIATRICS LA English DT Article C1 AMER COLL OBSTET & GYNECOLOGISTS,WASHINGTON,DC. PHARMACEUT MANUFACTURERS ASSOC,WASHINGTON,DC. CTR DIS CONTROL,ATLANTA,GA 30333. HLTH & WELF CANADA,HLTH PROTECT BRANCH,OTTAWA K1A 0L2,ONTARIO,CANADA. US FDA,WASHINGTON,DC 20204. RP KAUFFMAN, RE (reprint author), AMER MED ASSOC,CHICAGO,IL 60610, USA. NR 13 TC 14 Z9 14 U1 0 U2 0 PU AMER ACAD PEDIATRICS PI ELK GROVE VILLAGE PA 141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098 SN 0031-4005 J9 PEDIATRICS JI Pediatrics PD NOV PY 1990 VL 86 IS 5 BP 797 EP 798 PG 2 WC Pediatrics SC Pediatrics GA EF347 UT WOS:A1990EF34700027 ER PT J AU ELARINI, SK SHIU, GK SKELLY, JP AF ELARINI, SK SHIU, GK SKELLY, JP TI THEOPHYLLINE-CONTROLLED RELEASE PREPARATIONS AND FATTY FOOD - AN INVITRO STUDY USING THE ROTATING DIALYSIS CELL METHOD SO PHARMACEUTICAL RESEARCH LA English DT Article C1 US FDA,BIOPHARMACEUT RES BRANCH,WASHINGTON,DC 20204. US FDA,OFF RES RESOURCES,ROCKVILLE,MD 20857. NR 17 TC 13 Z9 13 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0724-8741 J9 PHARMACEUT RES JI Pharm. Res. PD NOV PY 1990 VL 7 IS 11 BP 1134 EP 1140 PG 7 WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Chemistry; Pharmacology & Pharmacy GA EF742 UT WOS:A1990EF74200006 PM 2293211 ER PT J AU NATHAN, D SAKR, A LICHTIN, JL BRONAUGH, RL AF NATHAN, D SAKR, A LICHTIN, JL BRONAUGH, RL TI INVITRO SKIN ABSORPTION AND METABOLISM OF BENZOIC-ACID, P-AMINOBENZOIC ACID, AND BENZOCAINE IN THE HAIRLESS GUINEA-PIG SO PHARMACEUTICAL RESEARCH LA English DT Article C1 US FDA,DIV TOXICOL STUDIES,WASHINGTON,DC 20204. UNIV CINCINNATI,COLL PHARM,CINCINNATI,OH 45221. NR 17 TC 32 Z9 33 U1 0 U2 8 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0724-8741 J9 PHARMACEUT RES JI Pharm. Res. PD NOV PY 1990 VL 7 IS 11 BP 1147 EP 1151 DI 10.1023/A:1015980209159 PG 5 WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Chemistry; Pharmacology & Pharmacy GA EF742 UT WOS:A1990EF74200008 PM 2293213 ER PT J AU CONWAY, BJ MCCROHAN, JL RUETER, FG SULEIMAN, OH AF CONWAY, BJ MCCROHAN, JL RUETER, FG SULEIMAN, OH TI MAMMOGRAPHY IN THE 80S SO RADIOLOGY LA English DT Article RP CONWAY, BJ (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,HFZ-240,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 13 TC 38 Z9 38 U1 0 U2 1 PU RADIOLOGICAL SOC NORTH AMER PI EASTON PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 SN 0033-8419 J9 RADIOLOGY JI Radiology PD NOV PY 1990 VL 177 IS 2 BP 335 EP 339 PG 5 WC Radiology, Nuclear Medicine & Medical Imaging SC Radiology, Nuclear Medicine & Medical Imaging GA EE799 UT WOS:A1990EE79900008 PM 2217765 ER PT J AU RUETER, FG CONWAY, BJ MCCROHAN, JL SULEIMAN, OH AF RUETER, FG CONWAY, BJ MCCROHAN, JL SULEIMAN, OH TI AVERAGE RADIATION EXPOSURE VALUES FOR 3 DIAGNOSTIC RADIOGRAPHIC EXAMINATIONS SO RADIOLOGY LA English DT Article RP RUETER, FG (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,5600 FISHERS LN,HFZ-240,ROCKVILLE,MD 20857, USA. NR 13 TC 20 Z9 21 U1 0 U2 0 PU RADIOLOGICAL SOC NORTH AMER PI EASTON PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042 SN 0033-8419 J9 RADIOLOGY JI Radiology PD NOV PY 1990 VL 177 IS 2 BP 341 EP 345 PG 5 WC Radiology, Nuclear Medicine & Medical Imaging SC Radiology, Nuclear Medicine & Medical Imaging GA EE799 UT WOS:A1990EE79900009 PM 2217766 ER PT J AU JELOVSEK, FR MATTISON, DR YOUNG, JF AF JELOVSEK, FR MATTISON, DR YOUNG, JF TI ELICITING PRINCIPLES OF HAZARD IDENTIFICATION FROM EXPERTS SO TERATOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079. RP JELOVSEK, FR (reprint author), UNIV ARKANSAS MED SCI HOSP,DEPT OBSTET & GYNECOL,4301 W MARKHAM 518,LITTLE ROCK,AR 72205, USA. RI Mattison, Donald/C-2015-2009; Mattison, Donald/L-4661-2013 OI Mattison, Donald/0000-0001-5623-0874 NR 16 TC 9 Z9 9 U1 0 U2 0 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0040-3709 J9 TERATOLOGY JI Teratology PD NOV PY 1990 VL 42 IS 5 BP 521 EP 533 DI 10.1002/tera.1420420509 PG 13 WC Developmental Biology; Toxicology SC Developmental Biology; Toxicology GA EG979 UT WOS:A1990EG97900008 PM 2278027 ER PT J AU LIN, JK ARMSTRONG, DJ AF LIN, JK ARMSTRONG, DJ TI PROCESS VARIABLES AFFECTING RESIDENCE TIME DISTRIBUTIONS OF CEREALS IN AN INTERMESHING, COUNTER-ROTATING, TWIN-SCREW EXTRUDER SO TRANSACTIONS OF THE ASAE LA English DT Article DE CEREAL; RESIDENCE TIME DISTRIBUTION AB The effect of process variables on the residence time distributions of cereals in an intermeshing counter-rotating twin-screw extruder was measured using a red dye tracer. The tracer concentration was determined following the method of Bounie (1988) with some modifications. Among the extrusion variables studied, changes in feed moisture, barrel temperature, and screw speed affected the residence time. The flow behavior was near plug flow. None of the extrusion variables had any significant effect on the degree of fill and the degree of backmixing in the extruder. RP LIN, JK (reprint author), US FDA,SUMMITARGO,IL, USA. NR 22 TC 11 Z9 11 U1 0 U2 1 PU AMER SOC AGR ENGINEERS PI ST JOSEPH PA 2950 NILES RD, ST JOSEPH, MI 49085-9659 SN 0001-2351 J9 T ASAE JI Trans. ASAE PD NOV-DEC PY 1990 VL 33 IS 6 BP 1971 EP 1978 PG 8 WC Agricultural Engineering SC Agriculture GA FD152 UT WOS:A1990FD15200032 ER PT J AU HEYES, MP GRAVELL, M LONDON, WT ECKHAUS, M VICKERS, JH YERGEY, JA APRIL, M BLACKMORE, D MARKEY, SP AF HEYES, MP GRAVELL, M LONDON, WT ECKHAUS, M VICKERS, JH YERGEY, JA APRIL, M BLACKMORE, D MARKEY, SP TI SUSTAINED INCREASES IN CEREBROSPINAL-FLUID QUINOLINIC ACID CONCENTRATIONS IN RHESUS MACAQUES (MACACA-MULATTA) NATURALLY INFECTED WITH SIMIAN RETROVIRUS TYPE-D SO BRAIN RESEARCH LA English DT Article C1 NIEHS,COMPARAT MED BRANCH,RES TRIANGLE PK,NC 27709. NIH,CTR ANIM,POOLESVILLE,MD. US FDA,CTR BIOL EVALUAT & RES,PATHOBIOL & PRIMATOL LAB,BETHESDA,MD 20892. VET RESOURCES BRANCH,COMPARAT PATHOL SECT,BETHESDA,MD 20892. NIAAA,CLIN STUDIES LAB,ANALYT CHEM SECT,BETHESDA,MD 20892. GEORGETOWN UNIV,ROCKVILLE,MD 20852. NINCDS,CENT NERVOUS SYST STUDIES LAB,BETHESDA,MD 20892. RP HEYES, MP (reprint author), NIMH,CLIN SCI LAB,ANALYT BIOCHEM SECT,BLDG 10,ROOM 3D-40,BETHESDA,MD 20892, USA. NR 58 TC 31 Z9 31 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0006-8993 J9 BRAIN RES JI Brain Res. PD OCT 29 PY 1990 VL 531 IS 1-2 BP 148 EP 158 DI 10.1016/0006-8993(90)90768-7 PG 11 WC Neurosciences SC Neurosciences & Neurology GA EH435 UT WOS:A1990EH43500018 PM 1963097 ER PT J AU SORIANO, V HEWLETT, I TOR, J DEAMO, C LAZARO, I MUGA, R CLOTET, R RIBASMUNDO, M FOZ, M AF SORIANO, V HEWLETT, I TOR, J DEAMO, C LAZARO, I MUGA, R CLOTET, R RIBASMUNDO, M FOZ, M TI EVALUATION OF HETEROSEXUAL HIV TRANSMISSION WITH NUCLEIC-ACID AMPLIFICATION TECHNIQUES SO MEDICINA CLINICA LA Spanish DT Article AB Heterosexual couples of individuals infected by HIV represent a group of high risk of virus infection. We have investigated the presence of fragments of the HIV genoma with a new nucleic acid amplification technique (PCR or polymerase chain reaction) in lymphocytes from 33 seronegative couples with antiHIV antibodies, most of which were heroin addicts. 12 of the 33 couples (36 %) had positive PCR for a gag HIV amplimer in the absence of antibodies. 4 of them (12 %) also showed reactivity for sequences from an env amplimer. A control group of 7 patients with AIDS and 4 seropositive couples showed reactivity to gag and env in all. It is concluded that silent HIV infection may frequently develop in heterosexual couples of infected individuals. RP SORIANO, V (reprint author), NIH,RETROVIROL LAB,BLDG 29 FDA,RM 332,BETHESDA,MD 20892, USA. NR 0 TC 3 Z9 3 U1 0 U2 0 PU EDICIONES DOYMA S/A PI BARCELONA PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN SN 0025-7753 J9 MED CLIN-BARCELONA JI Med. Clin. PD OCT 27 PY 1990 VL 95 IS 14 BP 535 EP 537 PG 3 WC Medicine, General & Internal SC General & Internal Medicine GA EV855 UT WOS:A1990EV85500004 PM 2084433 ER PT J AU MILLER, HI BURRIS, RH VIDAVER, AK WIVEL, NA AF MILLER, HI BURRIS, RH VIDAVER, AK WIVEL, NA TI RISK-BASED OVERSIGHT OF EXPERIMENTS IN THE ENVIRONMENT SO SCIENCE LA English DT Editorial Material C1 NIH,OFF RECOMBINANT DNA ACT,BETHESDA,MD 20892. UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53706. UNIV NEBRASKA,DEPT PLANT PATHOL,LINCOLN,NE 68583. RP MILLER, HI (reprint author), US FDA,OFF BIOTECHNOL,ROCKVILLE,MD 20857, USA. NR 10 TC 21 Z9 21 U1 0 U2 1 PU AMER ASSOC ADVANCEMENT SCIENCE PI WASHINGTON PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 SN 0036-8075 J9 SCIENCE JI Science PD OCT 26 PY 1990 VL 250 IS 4980 BP 490 EP 491 DI 10.1126/science.2237398 PG 2 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA EE660 UT WOS:A1990EE66000002 PM 2237398 ER PT J AU GREENE, RF COLLINS, JM AF GREENE, RF COLLINS, JM TI EFFECTS OF LEUCOVORIN ON IDOXURIDINE CYTOTOXICITY AND DNA INCORPORATION SO CANCER RESEARCH LA English DT Article C1 US FDA,CTR DRUG EVALUAT & RES,OFF RES RESOURCES,ROCKVILLE,MD 20857. GEORGE WASHINGTON UNIV,DEPT PHARMACOL,WASHINGTON,DC 20037. NR 22 TC 22 Z9 22 U1 1 U2 1 PU AMER ASSOC CANCER RESEARCH PI PHILADELPHIA PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106 SN 0008-5472 J9 CANCER RES JI Cancer Res. PD OCT 15 PY 1990 VL 50 IS 20 BP 6652 EP 6656 PG 5 WC Oncology SC Oncology GA EC410 UT WOS:A1990EC41000039 PM 2208128 ER PT J AU HICKMAN, CJ CRIM, JA MOSTOWSKI, HS SIEGEL, JP AF HICKMAN, CJ CRIM, JA MOSTOWSKI, HS SIEGEL, JP TI REGULATION OF HUMAN CYTOTOXIC LYMPHOCYTE-T DEVELOPMENT BY IL-7 SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,CELLULAR IMMUNOL LAB,BETHESDA,MD 20892. NR 34 TC 84 Z9 84 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD OCT 15 PY 1990 VL 145 IS 8 BP 2415 EP 2420 PG 6 WC Immunology SC Immunology GA ED005 UT WOS:A1990ED00500006 PM 2145359 ER PT J AU RAYBOURNE, RB WILLIAMS, KM AF RAYBOURNE, RB WILLIAMS, KM TI MONOCLONAL-ANTIBODIES AGAINST AN HLA-B27-DERIVED PEPTIDE REACT WITH AN EPITOPE PRESENT ON BACTERIAL PROTEINS SO JOURNAL OF IMMUNOLOGY LA English DT Article RP RAYBOURNE, RB (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV MICROBIOL,IMMUNOBIOL SECT,200 C ST SW,WASHINGTON,DC 20204, USA. NR 27 TC 8 Z9 8 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD OCT 15 PY 1990 VL 145 IS 8 BP 2539 EP 2544 PG 6 WC Immunology SC Immunology GA ED005 UT WOS:A1990ED00500025 PM 1698856 ER PT J AU DHOOSTELAERE, LA KLINMAN, D AF DHOOSTELAERE, LA KLINMAN, D TI CHARACTERIZATION OF NEW MOUSE VK GROUPS SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND. US FDN,CBER,DIV VIROL,BETHESDA,MD 20892. RP DHOOSTELAERE, LA (reprint author), US FDA,CBER,DIV PROD QUAL CONTROL,BLDG 29A,ROOM 1B-14,BETHESDA,MD 20892, USA. NR 52 TC 19 Z9 19 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD OCT 15 PY 1990 VL 145 IS 8 BP 2706 EP 2712 PG 7 WC Immunology SC Immunology GA ED005 UT WOS:A1990ED00500049 PM 1976702 ER PT J AU KOZAK, RW LORBERBOUMGALSKI, H JONES, L PURI, RK WILLINGHAM, MC MALEK, T FITZGERALD, DJ WALDMANN, TA PASTAN, I AF KOZAK, RW LORBERBOUMGALSKI, H JONES, L PURI, RK WILLINGHAM, MC MALEK, T FITZGERALD, DJ WALDMANN, TA PASTAN, I TI IL-2-PE40 PREVENTS THE DEVELOPMENT OF TUMORS IN MICE INJECTED WITH IL-2 RECEPTOR EXPRESSING EL4 TRANSFECTANT TUMOR-CELLS SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 NCI,METAB BRANCH,BETHESDA,MD 20892. UNIV MIAMI,SCH MED,DEPT MICROBIOL & IMMUNOL,MIAMI,FL 33101. RP KOZAK, RW (reprint author), US FDA,CBER,DIV CYTOKINE BIOL,BLDG 29A,ROOM 2A11,HFB-800,ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 25 TC 23 Z9 24 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD OCT 15 PY 1990 VL 145 IS 8 BP 2766 EP 2771 PG 6 WC Immunology SC Immunology GA ED005 UT WOS:A1990ED00500058 PM 2212661 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI FENTANYL TRANSDERMAL SYSTEM APPROVED FOR CHRONIC PAIN SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 4 Z9 4 U1 0 U2 1 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD OCT 10 PY 1990 VL 264 IS 14 BP 1802 EP 1802 DI 10.1001/jama.264.14.1802 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EB429 UT WOS:A1990EB42900006 PM 2169534 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI DISTRIBUTION OF CAL-BAN DIET PILLS HALTED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 4 Z9 4 U1 0 U2 1 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD OCT 10 PY 1990 VL 264 IS 14 BP 1802 EP 1802 DI 10.1001/jama.264.14.1802 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EB429 UT WOS:A1990EB42900007 PM 2169534 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI NEW THERAPY FOR NEONATAL RDS APPROVED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 1 TC 4 Z9 4 U1 0 U2 1 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD OCT 10 PY 1990 VL 264 IS 14 BP 1802 EP 1802 DI 10.1001/jama.264.14.1802 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA EB429 UT WOS:A1990EB42900005 PM 2169534 ER PT J AU ZHANG, WQ TANDON, P SOBOTKA, TJ HONG, JS TILSON, HA AF ZHANG, WQ TANDON, P SOBOTKA, TJ HONG, JS TILSON, HA TI ALTERATIONS IN ACETYLCHOLINE-INDUCED STIMULATION OF INOSITOL PHOSPHOLIPID HYDROLYSIS IN THE DORSAL HIPPOCAMPUS OF KINDLED RATS SO NEUROSCIENCE LETTERS LA English DT Article C1 NIEHS,MOLEC & INTEGRAT NEUROSCI LAB,POB 12233,RES TRIANGLE PK,NC 27709. US FDA,WASHINGTON,DC 20204. NR 25 TC 5 Z9 5 U1 0 U2 0 PU ELSEVIER SCI IRELAND LTD PI CLARE PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND SN 0304-3940 J9 NEUROSCI LETT JI Neurosci. Lett. PD OCT 2 PY 1990 VL 118 IS 1 BP 57 EP 60 DI 10.1016/0304-3940(90)90248-8 PG 4 WC Neurosciences SC Neurosciences & Neurology GA EE954 UT WOS:A1990EE95400015 PM 2175410 ER PT J AU TURKELTAUB, PC CAMPBELL, G MOSIMANN, JE AF TURKELTAUB, PC CAMPBELL, G MOSIMANN, JE TI COMPARATIVE SAFETY AND EFFICACY OF SHORT RAGWEED EXTRACTS DIFFERING IN POTENCY AND COMPOSITION IN THE TREATMENT OF FALL HAY-FEVER - USE OF ALLERGENICALLY BIOEQUIVALENT DOSES BY PARALLEL LINE BIOASSAY TO EVALUATE COMPARATIVE SAFETY AND EFFICACY SO ALLERGY LA English DT Article C1 NIH,DIV COMP RES & TECHNOL,STAT & MATH METHODOL LAB,BETHESDA,MD 20892. RP TURKELTAUB, PC (reprint author), US FDA,CTR BIOL EVALUAT & RES,ALLERGEN PROD LAB,BLDG 29,RM 212,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 48 TC 19 Z9 19 U1 0 U2 2 PU MUNKSGAARD INT PUBL LTD PI COPENHAGEN PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK SN 0105-4538 J9 ALLERGY JI Allergy PD OCT PY 1990 VL 45 IS 7 BP 528 EP 546 DI 10.1111/j.1398-9995.1990.tb00529.x PG 19 WC Allergy; Immunology SC Allergy; Immunology GA EC542 UT WOS:A1990EC54200007 PM 2252164 ER PT J AU KIEN, GA JEFFRIES, B KATZ, HV HERMAN, BA CAREY, RF CHWIRUT, DJ BUSHAR, HF AF KIEN, GA JEFFRIES, B KATZ, HV HERMAN, BA CAREY, RF CHWIRUT, DJ BUSHAR, HF TI DIGITAL ACOUSTICAL ANALYSIS OF NORMAL AND BIMODAL BJORK-SHILEY 60-DEGREES CONVEXO-CONCAVE HEART-VALVES SO AMERICAN JOURNAL OF CARDIOLOGY LA English DT Article C1 INT ACOUST INC,PALATINE,IL. US FDA,CTR DEVICE & RADIOL HLTH,ROCKVILLE,MD 20857. NR 28 TC 7 Z9 7 U1 0 U2 2 PU EXCERPTA MEDICA INC PI NEW YORK PA 245 WEST 17TH STREET, NEW YORK, NY 10011 SN 0002-9149 J9 AM J CARDIOL JI Am. J. Cardiol. PD OCT 1 PY 1990 VL 66 IS 10 BP 849 EP 854 DI 10.1016/0002-9149(90)90363-6 PG 6 WC Cardiac & Cardiovascular Systems SC Cardiovascular System & Cardiology GA EA300 UT WOS:A1990EA30000014 PM 2220584 ER PT J AU GERSTMAN, BB PIPER, JM TOMITA, DK FERGUSON, WJ STADEL, BV LUNDIN, FE AF GERSTMAN, BB PIPER, JM TOMITA, DK FERGUSON, WJ STADEL, BV LUNDIN, FE TI ORAL-CONTRACEPTIVE ESTROGEN DOSE AND THE RISK OF DEEP VENOUS THROMBOEMBOLIC DISEASE SO AMERICAN JOURNAL OF EPIDEMIOLOGY LA English DT Meeting Abstract C1 US FDA,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER J EPIDEMIOLOGY PI BALTIMORE PA 624 N BROADWAY RM 225, BALTIMORE, MD 21205 SN 0002-9262 J9 AM J EPIDEMIOL JI Am. J. Epidemiol. PD OCT PY 1990 VL 132 IS 4 BP 800 EP 800 PG 1 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA EB314 UT WOS:A1990EB31400198 ER PT J AU MOORE, RM KACZMAREK, RG AF MOORE, RM KACZMAREK, RG TI OCCUPATIONAL HAZARDS TO HEALTH-CARE WORKERS - DIVERSE, ILL-DEFINED, AND NOT FULLY APPRECIATED SO AMERICAN JOURNAL OF INFECTION CONTROL LA English DT Article RP MOORE, RM (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,DIV BIOMETR SCI,HF2-116,12200 WILKINS AVE,ROCKVILLE,MD 20852, USA. NR 0 TC 16 Z9 16 U1 0 U2 2 PU MOSBY-YEAR BOOK INC PI ST LOUIS PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 SN 0196-6553 J9 AM J INFECT CONTROL JI Am. J. Infect. Control PD OCT PY 1990 VL 18 IS 5 BP 316 EP 327 DI 10.1016/0196-6553(90)90231-G PG 12 WC Public, Environmental & Occupational Health; Infectious Diseases SC Public, Environmental & Occupational Health; Infectious Diseases GA EF665 UT WOS:A1990EF66500004 PM 2174654 ER PT J AU BROWN, ML KESSLER, LG RUETER, FG AF BROWN, ML KESSLER, LG RUETER, FG TI IS THE SUPPLY OF MAMMOGRAPHY MACHINES OUTSTRIPPING NEED AND DEMAND - AN ECONOMIC-ANALYSIS SO ANNALS OF INTERNAL MEDICINE LA English DT Article C1 NCI,BETHESDA,MD 20892. US FDA,CTR DEVICES & RADIOL HLTH,OFF TRAINING & ASSISTANCE,ROCKVILLE,MD 20857. NR 41 TC 55 Z9 55 U1 1 U2 1 PU AMER COLL PHYSICIANS PI PHILADELPHIA PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 SN 0003-4819 J9 ANN INTERN MED JI Ann. Intern. Med. PD OCT 1 PY 1990 VL 113 IS 7 BP 547 EP 552 PG 6 WC Medicine, General & Internal SC General & Internal Medicine GA EA850 UT WOS:A1990EA85000011 PM 2393209 ER PT J AU POTHULURI, JV FREEMAN, JP EVANS, FE CERNIGLIA, CE AF POTHULURI, JV FREEMAN, JP EVANS, FE CERNIGLIA, CE TI FUNGAL TRANSFORMATION OF FLUORANTHENE SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 US FDA,NATL CTR TOXICOL RES,DIV MICROBIOL,JEFFERSON,AR 72079. NR 28 TC 44 Z9 44 U1 0 U2 5 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD OCT PY 1990 VL 56 IS 10 BP 2974 EP 2983 PG 10 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA EB611 UT WOS:A1990EB61100005 PM 2285310 ER PT J AU BUNNING, VK CRAWFORD, RG TIERNEY, JT PEELER, JT AF BUNNING, VK CRAWFORD, RG TIERNEY, JT PEELER, JT TI THERMOTOLERANCE OF LISTERIA-MONOCYTOGENES AND SALMONELLA-TYPHIMURIUM AFTER SUBLETHAL HEAT-SHOCK SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article RP BUNNING, VK (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 29 TC 103 Z9 104 U1 2 U2 9 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD OCT PY 1990 VL 56 IS 10 BP 3216 EP 3219 PG 4 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA EB611 UT WOS:A1990EB61100044 PM 2126703 ER PT J AU WYSOWSKI, DK GROSS, TP AF WYSOWSKI, DK GROSS, TP TI DEATHS DUE TO ACCIDENTS AND VIOLENCE IN 2 RECENT TRIALS OF CHOLESTEROL-LOWERING DRUGS SO ARCHIVES OF INTERNAL MEDICINE LA English DT Article RP WYSOWSKI, DK (reprint author), US FDA,CTR DRUG EVALUAT & RES,DIV EPIDEMIOL & SURVEILLANCE,ROCKVILLE,MD 20857, USA. NR 20 TC 99 Z9 99 U1 0 U2 1 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0003-9926 J9 ARCH INTERN MED JI Arch. Intern. Med. PD OCT PY 1990 VL 150 IS 10 BP 2169 EP 2172 DI 10.1001/archinte.150.10.2169 PG 4 WC Medicine, General & Internal SC General & Internal Medicine GA EC395 UT WOS:A1990EC39500027 PM 2222103 ER PT J AU ENDOH, M NAGAI, M BURNS, DL MANCLARK, CR NAKASE, Y AF ENDOH, M NAGAI, M BURNS, DL MANCLARK, CR NAKASE, Y TI DEVELOPMENT OF A CELL-CULTURE ASSAY FOR BORDETELLA-PARAPERTUSSIS HEAT-LABILE TOXIN SO BIOLOGICALS LA English DT Article C1 KITASATO UNIV,SCH PHARMACEUT SCI,DEPT MICROBIOL,TOKYO 108,JAPAN. RP ENDOH, M (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,PERTUSSIS LAB,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 21 TC 6 Z9 6 U1 0 U2 0 PU ACADEMIC PRESS LTD PI LONDON PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX SN 1045-1056 J9 BIOLOGICALS JI Biologicals PD OCT PY 1990 VL 18 IS 4 BP 309 EP 313 DI 10.1016/1045-1056(90)90035-X PG 5 WC Biochemical Research Methods; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Pharmacology & Pharmacy GA EK853 UT WOS:A1990EK85300009 PM 2285503 ER PT J AU SMITH, BA KORFMACHER, WA BELAND, FA AF SMITH, BA KORFMACHER, WA BELAND, FA TI DNA ADDUCT FORMATION IN TARGET TISSUES OF SPRAGUE-DAWLEY RATS, CD-1 MICE AND A/J MICE FOLLOWING TUMORIGENIC DOSES OF 1-NITROPYRENE SO CARCINOGENESIS LA English DT Article C1 NATL CTR TOXICOL RES,HFT 110,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,LITTLE ROCK,AR 72205. NR 38 TC 46 Z9 46 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD OCT PY 1990 VL 11 IS 10 BP 1705 EP 1710 DI 10.1093/carcin/11.10.1705 PG 6 WC Oncology SC Oncology GA EC415 UT WOS:A1990EC41500004 PM 2208586 ER PT J AU RUGGERA, PS FAHY, GM AF RUGGERA, PS FAHY, GM TI RAPID AND UNIFORM ELECTROMAGNETIC HEATING OF AQUEOUS CRYOPROTECTANT SOLUTIONS FROM CRYOGENIC TEMPERATURES SO CRYOBIOLOGY LA English DT Article C1 AMER RED CROSS,TRANSPLANTAT LAB,JEROME HOLLAND LAB BIOMED SCI,ROCKVILLE,MD 20855. RP RUGGERA, PS (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,HFZ-133,12721 TWINBROOK PKWY,ROCKVILLE,MD 20857, USA. FU NCRR NIH HHS [2507 RR05737]; NIGMS NIH HHS [GM-17959] NR 30 TC 18 Z9 21 U1 1 U2 3 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0011-2240 J9 CRYOBIOLOGY JI Cryobiology PD OCT PY 1990 VL 27 IS 5 BP 465 EP 478 DI 10.1016/0011-2240(90)90035-3 PG 14 WC Biology; Physiology SC Life Sciences & Biomedicine - Other Topics; Physiology GA EA571 UT WOS:A1990EA57100001 PM 2249450 ER PT J AU BLOOM, ET UMEHARA, H BLEACKLEY, RC OKUMURA, K MOSTOWSKI, H BABBITT, JT AF BLOOM, ET UMEHARA, H BLEACKLEY, RC OKUMURA, K MOSTOWSKI, H BABBITT, JT TI AGE-RELATED DECREMENT IN CYTOTOXIC LYMPHOCYTE-T (CTL) ACTIVITY IS ASSOCIATED WITH DECREASED LEVELS OF MESSENGER-RNA ENCODED BY 2 CTL-ASSOCIATED SERINE ESTERASE GENES AND THE PERFORIN GENE IN MICE SO EUROPEAN JOURNAL OF IMMUNOLOGY LA English DT Article C1 VET ADM MED CTR BRENTWOOD,CTR GERIAT RES EDUC & CLIN,LOS ANGELES,CA 90073. UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024. UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2E1,ALBERTA,CANADA. JUNTENDO UNIV,DEPT IMMUNOL,TOKYO 113,JAPAN. UNIV CALIF LOS ANGELES,SCH PUBL HLTH,LOS ANGELES,CA 90024. RP BLOOM, ET (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,8800 ROCKVILLE PIKE,BETHESDA,MD 20205, USA. FU NCI NIH HHS [CA 30187] NR 64 TC 36 Z9 37 U1 0 U2 0 PU VCH PUBLISHERS INC PI DEERFIELD BEACH PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788 SN 0014-2980 J9 EUR J IMMUNOL JI Eur. J. Immunol. PD OCT PY 1990 VL 20 IS 10 BP 2309 EP 2316 DI 10.1002/eji.1830201021 PG 8 WC Immunology SC Immunology GA EJ441 UT WOS:A1990EJ44100020 PM 2242759 ER PT J AU SHANK, FR CARSON, KL AF SHANK, FR CARSON, KL TI LIGHT DAIRY-PRODUCTS - REGULATORY ISSUES SO FOOD TECHNOLOGY LA English DT Article; Proceedings Paper CT SYMP AT THE 1990 ANNUAL MEETING OF THE INST OF FOOD TECHNOLOGY - LIGHT DAIRY PRODUCTS : ISSUES AND TECHNOLOGY CY JUN 16-20, 1990 CL ANAHEIM, CA SP INST FOOD TECHNOL, DAIRY PROD SPECIALIZED TECHNOL GRP RP SHANK, FR (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,200 C ST SW,WASHINGTON,DC 20204, USA. NR 14 TC 1 Z9 1 U1 0 U2 0 PU INST FOOD TECHNOLOGISTS PI CHICAGO PA SUITE 300 221 N LASALLE ST, CHICAGO, IL 60601-1291 SN 0015-6639 J9 FOOD TECHNOL-CHICAGO JI Food Technol. PD OCT PY 1990 VL 44 IS 10 BP 88 EP 92 PG 5 WC Food Science & Technology SC Food Science & Technology GA EC451 UT WOS:A1990EC45100010 ER PT J AU FONG, TL DIBISCEGLIE, AM WAGGONER, JG BISWAS, R HOOFNAGLE, JH AF FONG, TL DIBISCEGLIE, AM WAGGONER, JG BISWAS, R HOOFNAGLE, JH TI HIGH-LEVELS OF SERUM HBV-DNA AND HBSAG IN ACUTE HEPATITIS-B VIRUS-INFECTION PREDICT PROGRESSION TO CHRONICITY SO HEPATOLOGY LA English DT Meeting Abstract C1 NIH,BETHESDA,MD 20892. CTR BIOL EVALUAT & RES,BETHESDA,MD. NR 0 TC 0 Z9 0 U1 0 U2 0 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0270-9139 J9 HEPATOLOGY JI Hepatology PD OCT PY 1990 VL 12 IS 4 BP 845 EP 845 PN 2 PG 1 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA ED299 UT WOS:A1990ED29900030 ER PT J AU SHINDO, M DIBISCEGLIE, AM CHEUNG, L SHIH, JW BAKER, B FEINSTONE, SM CRISTIANO, K HOOFNAGLE, JH AF SHINDO, M DIBISCEGLIE, AM CHEUNG, L SHIH, JW BAKER, B FEINSTONE, SM CRISTIANO, K HOOFNAGLE, JH TI CHANGES IN HEPATITIS-C VIRUS-RNA IN SERUM ASSOCIATED WITH ALPHA-INTERFERON THERAPY SO HEPATOLOGY LA English DT Meeting Abstract C1 NIH,BETHESDA,MD 20892. CTR BIOL EVALUAT & RES,BETHESDA,MD. NR 0 TC 6 Z9 6 U1 0 U2 0 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0270-9139 J9 HEPATOLOGY JI Hepatology PD OCT PY 1990 VL 12 IS 4 BP 884 EP 884 PN 2 PG 1 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA ED299 UT WOS:A1990ED29900187 ER PT J AU NEDJAR, S HEWLETT, IK BISWAS, RM AF NEDJAR, S HEWLETT, IK BISWAS, RM TI SIMULTANEOUS DETECTION OF HCV AND HIV-1 SPECIFIC SEQUENCES IN A SINGLE POLYMERASE CHAIN-REACTION ASSAY SO HEPATOLOGY LA English DT Meeting Abstract C1 US FDA,HEPATITIS LAB,DBBP,CBER,BETHESDA,MD 20892. US FDA,CBER,DBBP,RETROVIROL LAB,BETHESDA,MD 20892. NR 0 TC 0 Z9 0 U1 0 U2 0 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0270-9139 J9 HEPATOLOGY JI Hepatology PD OCT PY 1990 VL 12 IS 4 BP 951 EP 951 PN 2 PG 1 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA ED299 UT WOS:A1990ED29900455 ER PT J AU NEDJAR, S HEWLETT, IK WILSON, LT BISWAS, RM AF NEDJAR, S HEWLETT, IK WILSON, LT BISWAS, RM TI SIGNIFICANCE OF THE POLYMERASE CHAIN-REACTION (PCR) ASSAY IN THE DETECTION OF HCV-SPECIFIC SEQUENCES SO HEPATOLOGY LA English DT Meeting Abstract C1 US FDA,CBER,DBBP,HEPATITIS LAB,BETHESDA,MD 20892. US FDA,CBER,DBBP,RETROVIROL LAB,BETHESDA,MD 20892. NR 0 TC 0 Z9 0 U1 0 U2 0 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0270-9139 J9 HEPATOLOGY JI Hepatology PD OCT PY 1990 VL 12 IS 4 BP 952 EP 952 PN 2 PG 1 WC Gastroenterology & Hepatology SC Gastroenterology & Hepatology GA ED299 UT WOS:A1990ED29900456 ER PT J AU KLINMAN, DM AF KLINMAN, DM TI POLYCLONAL-B CELL ACTIVATION IN LUPUS-PRONE MICE PRECEDES AND PREDICTS THE DEVELOPMENT OF AUTOIMMUNE-DISEASE SO JOURNAL OF CLINICAL INVESTIGATION LA English DT Article RP KLINMAN, DM (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV VIROL,RETROVIRUS RES LAB,BLDG 29A,RM 3D 16,BETHESDA,MD 20892, USA. NR 46 TC 106 Z9 107 U1 0 U2 0 PU ROCKEFELLER UNIV PRESS PI NEW YORK PA 222 E 70TH STREET, NEW YORK, NY 10021 SN 0021-9738 J9 J CLIN INVEST JI J. Clin. Invest. PD OCT PY 1990 VL 86 IS 4 BP 1249 EP 1254 DI 10.1172/JCI114831 PG 6 WC Medicine, Research & Experimental SC Research & Experimental Medicine GA EE199 UT WOS:A1990EE19900029 PM 2212009 ER PT J AU RELLAHAN, BL JONES, LA KRUISBEEK, AM FRY, AM MATIS, LA AF RELLAHAN, BL JONES, LA KRUISBEEK, AM FRY, AM MATIS, LA TI INVIVO INDUCTION OF ANERGY IN PERIPHERAL V-BETA-8+ T-CELLS BY STAPHYLOCOCCAL ENTEROTOXIN-B SO JOURNAL OF EXPERIMENTAL MEDICINE LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BETHESDA,MD 20014. NIH,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,BETHESDA,MD 20892. NR 56 TC 398 Z9 402 U1 0 U2 2 PU ROCKEFELLER UNIV PRESS PI NEW YORK PA 222 E 70TH STREET, NEW YORK, NY 10021 SN 0022-1007 J9 J EXP MED JI J. Exp. Med. PD OCT 1 PY 1990 VL 172 IS 4 BP 1091 EP 1100 DI 10.1084/jem.172.4.1091 PG 10 WC Immunology; Medicine, Research & Experimental SC Immunology; Research & Experimental Medicine GA EA454 UT WOS:A1990EA45400011 PM 2212944 ER PT J AU NOJIMA, Y HUMPHRIES, MJ MOULD, AP KOMORIYA, A YAMADA, KM SCHLOSSMAN, SF MORIMOTO, C AF NOJIMA, Y HUMPHRIES, MJ MOULD, AP KOMORIYA, A YAMADA, KM SCHLOSSMAN, SF MORIMOTO, C TI VLA-4 MEDIATES CD3-DEPENDENT CD4+ T-CELL ACTIVATION VIA THE CS1 ALTERNATIVELY SPLICED DOMAIN OF FIBRONECTIN SO JOURNAL OF EXPERIMENTAL MEDICINE LA English DT Article C1 HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,44 BINNEY ST,BOSTON,MA 02115. US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,CELL BIOL LAB,BETHESDA,MD 20892. NCI,MOLEC BIOL LAB,MEMBRANE BIOCHEM SECT,BETHESDA,MD 20894. HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115. UNIV MANCHESTER,SCH MED,DEPT BIOCHEM & MOLEC BIOL,MANCHESTER M13 9PT,LANCS,ENGLAND. OI Yamada, Kenneth/0000-0003-1512-6805 FU NIAID NIH HHS [AI-12069]; NIAMS NIH HHS [AR-33713]; Wellcome Trust NR 39 TC 240 Z9 243 U1 0 U2 2 PU ROCKEFELLER UNIV PRESS PI NEW YORK PA 222 E 70TH STREET, NEW YORK, NY 10021 SN 0022-1007 J9 J EXP MED JI J. Exp. Med. PD OCT 1 PY 1990 VL 172 IS 4 BP 1185 EP 1192 DI 10.1084/jem.172.4.1185 PG 8 WC Immunology; Medicine, Research & Experimental SC Immunology; Research & Experimental Medicine GA EA454 UT WOS:A1990EA45400021 PM 1976737 ER PT J AU SOLOMON, HM KAUTTER, DA LILLY, T RHODEHAMEL, EJ AF SOLOMON, HM KAUTTER, DA LILLY, T RHODEHAMEL, EJ TI OUTGROWTH OF CLOSTRIDIUM-BOTULINUM IN SHREDDED CABBAGE AT ROOM-TEMPERATURE UNDER A MODIFIED ATMOSPHERE SO JOURNAL OF FOOD PROTECTION LA English DT Article RP SOLOMON, HM (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 12 TC 46 Z9 46 U1 1 U2 2 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD OCT PY 1990 VL 53 IS 10 BP 831 EP & PG 0 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EB652 UT WOS:A1990EB65200002 ER PT J AU ABEYTA, C KAYSNER, CA WEKELL, MM STOTT, RF AF ABEYTA, C KAYSNER, CA WEKELL, MM STOTT, RF TI INCIDENCE OF MOTILE AEROMONADS FROM UNITED-STATES WEST-COAST SHELLFISH GROWING ESTUARIES SO JOURNAL OF FOOD PROTECTION LA English DT Article RP ABEYTA, C (reprint author), US FDA,SEAFOOD PROD RES CTR,BOTHELL,WA 98041, USA. NR 51 TC 15 Z9 18 U1 0 U2 0 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD OCT PY 1990 VL 53 IS 10 BP 849 EP 855 PG 7 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EB652 UT WOS:A1990EB65200006 ER PT J AU GECAN, JS CICHOWICZ, SM BRICKEY, PM AF GECAN, JS CICHOWICZ, SM BRICKEY, PM TI ANALYTICAL TECHNIQUES FOR GLASS CONTAMINATION OF FOOD - A GUIDE FOR ADMINISTRATORS AND ANALYSTS SO JOURNAL OF FOOD PROTECTION LA English DT Article C1 DEPT TREASURY,BUR ENGRAVING & PRINTING,WASHINGTON,DC 20044. RP GECAN, JS (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 45 TC 1 Z9 1 U1 0 U2 1 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD OCT PY 1990 VL 53 IS 10 BP 895 EP 899 PG 5 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA EB652 UT WOS:A1990EB65200014 ER PT J AU SATCHITHANANDAM, S VARGOFCAKAPKER, M CALVERT, RJ LEEDS, AR CASSIDY, MM AF SATCHITHANANDAM, S VARGOFCAKAPKER, M CALVERT, RJ LEEDS, AR CASSIDY, MM TI ALTERATION OF GASTROINTESTINAL MUCIN BY FIBER FEEDING IN RATS SO JOURNAL OF NUTRITION LA English DT Article C1 UNIV LONDON,KINGS COLL,DEPT NUTR,LONDON W8 7AH,ENGLAND. GEORGE WASHINGTON UNIV,MED CTR,DEPT PHYSIOL,WASHINGTON,DC 20037. RP SATCHITHANANDAM, S (reprint author), US FDA,DIV NUTR,WASHINGTON,DC 20204, USA. NR 31 TC 102 Z9 104 U1 0 U2 5 PU AMER INST NUTRITION PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-3166 J9 J NUTR JI J. Nutr. PD OCT PY 1990 VL 120 IS 10 BP 1179 EP 1184 PG 6 WC Nutrition & Dietetics SC Nutrition & Dietetics GA EE247 UT WOS:A1990EE24700009 PM 2170600 ER PT J AU MITCHELL, GV GRUNDEL, E JENKINS, M BLAKELY, SR AF MITCHELL, GV GRUNDEL, E JENKINS, M BLAKELY, SR TI EFFECTS OF GRADED DIETARY LEVELS OF SPIRULINA MAXIMA ON VITAMIN-A AND VITAMIN-E IN MALE-RATS SO JOURNAL OF NUTRITION LA English DT Article RP US FDA, DIV NUTR, WASHINGTON, DC 20204 USA. NR 27 TC 21 Z9 22 U1 0 U2 1 PU AMER SOC NUTRITION-ASN PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA SN 0022-3166 EI 1541-6100 J9 J NUTR JI J. Nutr. PD OCT PY 1990 VL 120 IS 10 BP 1235 EP 1240 PG 6 WC Nutrition & Dietetics SC Nutrition & Dietetics GA EE247 UT WOS:A1990EE24700017 PM 2213251 ER PT J AU MCGILVERAY, IJ MIDHA, KK SKELLY, JP DIGHE, S DOLUISIO, JT FRENCH, IW KARIM, A BURFORD, R AF MCGILVERAY, IJ MIDHA, KK SKELLY, JP DIGHE, S DOLUISIO, JT FRENCH, IW KARIM, A BURFORD, R TI CONSENSUS REPORT FROM BIO-INTERNATIONAL 89 - ISSUES IN THE EVALUATION OF BIOAVAILABILITY DATA SO JOURNAL OF PHARMACEUTICAL SCIENCES LA English DT Letter C1 UNIV SASKATCHEWAN,COLL PHARM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA. US FDA,ROCKVILLE,MD 20857. UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712. SEARLE LABS,CHICAGO,IL 60680. TRIMEL CORP,ETOBICOKE,ONTARIO,CANADA. AMER CLIN RES CONSULTANTS,WILTON,CT. RP MCGILVERAY, IJ (reprint author), SIR FREDERICK BANTING RES CTR,BUR DRUG RES,TUNNEYS PASTURE,OTTAWA KLA OL2,ONTARIO,CANADA. NR 2 TC 19 Z9 19 U1 0 U2 0 PU AMER PHARMACEUTICAL ASSN PI WASHINGTON PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037 SN 0022-3549 J9 J PHARM SCI JI J. Pharm. Sci. PD OCT PY 1990 VL 79 IS 10 BP 945 EP 946 DI 10.1002/jps.2600791022 PG 2 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Pharmacology & Pharmacy; Chemistry GA EC731 UT WOS:A1990EC73100021 PM 2280368 ER PT J AU RONK, RJ AF RONK, RJ TI FOOD CONTROL IN THE DECADE OF 1990S SO JOURNAL OF THE FOOD HYGIENIC SOCIETY OF JAPAN LA English DT Article RP RONK, RJ (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,PROD POLICY STAFF,BETHESDA,MD 20014, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU FOOD HYG SOC JPN PI TOKYO PA 6-1 JINGU-MAE 2-CHOME SHIBUYA-KU, TOKYO JAPAN SN 0015-6426 J9 J FOOD HYG SOC JPN JI J. Food Hyg. Soc. Jpn. PD OCT PY 1990 VL 31 IS 5 BP 351 EP 355 PG 5 WC Food Science & Technology SC Food Science & Technology GA EH036 UT WOS:A1990EH03600001 ER PT J AU BUSHAR, G SAGRIPANTI, JL AF BUSHAR, G SAGRIPANTI, JL TI METHOD FOR IMPROVING ACCURACY OF VIRUS TITRATION - STANDARDIZATION OF PLAQUE-ASSAY FOR JUNIN VIRUS SO JOURNAL OF VIROLOGICAL METHODS LA English DT Article RP BUSHAR, G (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,DIV LIFE SCI,MOLEC BIOL BRANCH,ROCKVILLE,MD 20857, USA. NR 13 TC 12 Z9 13 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0166-0934 J9 J VIROL METHODS JI J. Virol. Methods PD OCT PY 1990 VL 30 IS 1 BP 99 EP 107 DI 10.1016/0166-0934(90)90047-J PG 9 WC Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology GA EH188 UT WOS:A1990EH18800009 PM 1707890 ER PT J AU BARANOWSKI, T TSONG, Y BRODWICK, M AF BARANOWSKI, T TSONG, Y BRODWICK, M TI SCALING OF RESPONSE SCALE ADVERBS AMONG BLACK-AMERICAN ADULTS SO PERCEPTUAL AND MOTOR SKILLS LA English DT Article C1 UNIV TEXAS,MED BRANCH,MED BRANCH,DEPT PREVENT MED & COMMUNITY HLTH,DIV SOCIOMED SCI,GALVESTON,TX 77550. US FDA,CTR DRUGS & BIOL,DIV BIOSTAT,ROCKVILLE,MD 20857. UNIV TEXAS,MED BRANCH,MED BRANCH,DIV EPIDEMIOL & BIOSTAT,GALVESTON,TX 77550. FU NHLBI NIH HHS [HL-35131] NR 22 TC 2 Z9 2 U1 1 U2 1 PU PERCEPTUAL MOTOR SKILLS PI MISSOULA PA PO BOX 9229, MISSOULA, MT 59807 SN 0031-5125 J9 PERCEPT MOTOR SKILL JI Percept. Mot. Skills PD OCT PY 1990 VL 71 IS 2 BP 547 EP 559 PG 13 WC Psychology, Experimental SC Psychology GA ED778 UT WOS:A1990ED77800039 PM 2251088 ER PT J AU SCALZO, FM ALI, SF FRAMBES, NA SPEAR, LP AF SCALZO, FM ALI, SF FRAMBES, NA SPEAR, LP TI WEANLING RATS EXPOSED PRENATALLY TO COCAINE EXHIBIT AN INCREASE IN STRIATAL D2 DOPAMINE BINDING ASSOCIATED WITH AN INCREASE IN LIGAND AFFINITY SO PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR LA English DT Note C1 UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,LITTLE ROCK,AR 72205. SUNY BINGHAMTON,CTR DEV PSYCHOBIOL,DEPT PSYCHOL,BINGHAMTON,NY 13910. RP SCALZO, FM (reprint author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,HFT 130,JEFFERSON,AR 72079, USA. FU NIDA NIH HHS [R01-DA04478, KO2-DA00140] NR 28 TC 99 Z9 99 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0091-3057 J9 PHARMACOL BIOCHEM BE JI Pharmacol. Biochem. Behav. PD OCT PY 1990 VL 37 IS 2 BP 371 EP 373 DI 10.1016/0091-3057(90)90350-Q PG 3 WC Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy SC Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy GA EB182 UT WOS:A1990EB18200029 PM 2150444 ER PT J AU KARPAS, A HEWLETT, IK HILL, F GRAY, J BYRON, N GILGEN, D BALLY, V OATES, JK GAZZARD, B EPSTEIN, JE AF KARPAS, A HEWLETT, IK HILL, F GRAY, J BYRON, N GILGEN, D BALLY, V OATES, JK GAZZARD, B EPSTEIN, JE TI POLYMERASE CHAIN-REACTION EVIDENCE FOR HUMAN IMMUNODEFICIENCY VIRUS-1 NEUTRALIZATION BY PASSIVE-IMMUNIZATION IN PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,RETROVIROL LAB,BETHESDA,MD 20892. ADDENBROOKE HOSP,PUBL HLTH LAB SERV,CAMBRIDGE CB2 2QH,ENGLAND. ST STEPHENS & WESTMINSTER HOSP,LONDON SW1P 2AP,ENGLAND. RP KARPAS, A (reprint author), UNIV CAMBRIDGE,SCH CLIN,CTR MRC,DEPT HAEMATOL,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND. NR 25 TC 58 Z9 58 U1 1 U2 1 PU NATL ACAD SCIENCES PI WASHINGTON PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 SN 0027-8424 J9 P NATL ACAD SCI USA JI Proc. Natl. Acad. Sci. U. S. A. PD OCT PY 1990 VL 87 IS 19 BP 7613 EP 7617 DI 10.1073/pnas.87.19.7613 PG 5 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA EB299 UT WOS:A1990EB29900056 PM 2145579 ER PT J AU REICKS, M RADER, JI AF REICKS, M RADER, JI TI EFFECTS OF DIETARY TIN AND COPPER ON RAT HEPATOCELLULAR ANTIOXIDANT PROTECTION SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE LA English DT Article RP REICKS, M (reprint author), US FDA,DIV NUTR,WASHINGTON,DC 20204, USA. NR 25 TC 14 Z9 14 U1 0 U2 0 PU BLACKWELL SCIENCE INC PI CAMBRIDGE PA 238 MAIN ST, CAMBRIDGE, MA 02142 SN 0037-9727 J9 P SOC EXP BIOL MED JI Proc. Soc. Exp. Biol. Med. PD OCT PY 1990 VL 195 IS 1 BP 123 EP 128 PG 6 WC Medicine, Research & Experimental SC Research & Experimental Medicine GA DZ817 UT WOS:A1990DZ81700022 PM 2399253 ER PT J AU VOISIN, EM RUTHSATZ, M COLLINS, JM HOYLE, PC AF VOISIN, EM RUTHSATZ, M COLLINS, JM HOYLE, PC TI EXTRAPOLATION OF ANIMAL TOXICITY TO HUMANS - INTERSPECIES COMPARISONS IN DRUG DEVELOPMENT SO REGULATORY TOXICOLOGY AND PHARMACOLOGY LA English DT Article RP VOISIN, EM (reprint author), US FDA,DIV ANTIVIRAL DRUG PROD,HFD-530,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 55 TC 62 Z9 64 U1 0 U2 3 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0273-2300 J9 REGUL TOXICOL PHARM JI Regul. Toxicol. Pharmacol. PD OCT PY 1990 VL 12 IS 2 BP 107 EP 116 DI 10.1016/S0273-2300(05)80052-2 PG 10 WC Medicine, Legal; Pharmacology & Pharmacy; Toxicology SC Legal Medicine; Pharmacology & Pharmacy; Toxicology GA ED386 UT WOS:A1990ED38600001 PM 2259752 ER PT J AU HUNGERFORD, JM WALKER, KD TORKELSON, JD STEINBRECHER, K WEKELL, MM AF HUNGERFORD, JM WALKER, KD TORKELSON, JD STEINBRECHER, K WEKELL, MM TI DETERMINATION OF TRI-NORMAL-BUTYLTIN IN OYSTERS BY REACTION GAS-CHROMATOGRAPHY OF HYDRIDE DERIVATIVES SO TALANTA LA English DT Article C1 US FDA,SCI BRANCH,BOTHELL,WA 98041. RP HUNGERFORD, JM (reprint author), US FDA,SEAFOOD PROD RES CTR,22201 23RD DR SE,POB 3012,BOTHELL,WA 98041, USA. NR 23 TC 7 Z9 7 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0039-9140 J9 TALANTA JI Talanta PD OCT PY 1990 VL 37 IS 10 BP 975 EP 979 DI 10.1016/0039-9140(90)80137-5 PG 5 WC Chemistry, Analytical SC Chemistry GA EC475 UT WOS:A1990EC47500004 PM 18965052 ER PT J AU MORRIS, D MCHUGHSUTKOWSKI, E MOOS, M SIMONDS, WF SPIEGEL, AM SEAMON, KB AF MORRIS, D MCHUGHSUTKOWSKI, E MOOS, M SIMONDS, WF SPIEGEL, AM SEAMON, KB TI IMMUNOPRECIPITATION OF ADENYLATE-CYCLASE WITH AN ANTIBODY TO A CARBOXYL-TERMINAL PEPTIDE FROM GS-ALPHA SO BIOCHEMISTRY LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,MOLEC PHARMACOL LAB,8800 ROCKVILLE PIKE,BETHESDA,MD 20892. NIDDKD,MOLEC PATHOPHYSIOL BRANCH,BETHESDA,MD 20892. RI Moos, Malcolm/F-3673-2011 OI Moos, Malcolm/0000-0002-9575-9938 NR 25 TC 28 Z9 28 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0006-2960 J9 BIOCHEMISTRY-US JI Biochemistry PD SEP 25 PY 1990 VL 29 IS 38 BP 9079 EP 9084 DI 10.1021/bi00490a027 PG 6 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA EA267 UT WOS:A1990EA26700027 PM 2125472 ER PT J AU HUNGERFORD, JM WALKER, KD WEKELL, MM LAROSE, JE THROM, HR AF HUNGERFORD, JM WALKER, KD WEKELL, MM LAROSE, JE THROM, HR TI SELECTIVE DETERMINATION OF HISTAMINE BY FLOW-INJECTION ANALYSIS SO ANALYTICAL CHEMISTRY LA English DT Article C1 US FDA,SCI BRANCH,BOTHELL,WA 98041. RP HUNGERFORD, JM (reprint author), US FDA,SEAFOOD PROD RES CTR,BOTHELL,WA 98041, USA. NR 33 TC 32 Z9 32 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0003-2700 J9 ANAL CHEM JI Anal. Chem. PD SEP 15 PY 1990 VL 62 IS 18 BP 1971 EP 1976 DI 10.1021/ac00217a014 PG 6 WC Chemistry, Analytical SC Chemistry GA DZ209 UT WOS:A1990DZ20900015 PM 2240576 ER PT J AU SKELLY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A AF SKELLY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A TI REPORT OF THE WORKSHOP ON - INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED RELEASE DOSAGE FORMS SO INTERNATIONAL JOURNAL OF PHARMACEUTICS LA English DT Article C1 US FDA,CTR DRUG EVALUAT & RES,DIV BIOPHARMACEUT,5600 FISHERS LANE,ROCKVILLE,MD 20857. UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109. VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298. UNIV CALIF SAN FRANCISCO,SCH PHARM S-926,SAN FRANCISCO,CA 94143. JANSSEN PHARMACEUT INC,PISCATAWAY,NJ 08854. UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706. AMER CYANAMID CO,PEARL RIVER,NY 10965. RI Benet, Leslie/K-8286-2016 NR 0 TC 10 Z9 10 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0378-5173 J9 INT J PHARM JI Int. J. Pharm. PD SEP 15 PY 1990 VL 63 IS 2 BP 83 EP 93 DI 10.1016/0378-5173(90)90157-Y PG 11 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EE681 UT WOS:A1990EE68100001 ER PT J AU SMITH, BJ MATTISON, DR SIPES, IG AF SMITH, BJ MATTISON, DR SIPES, IG TI THE ROLE OF EPOXIDATION IN 4-VINYLCYCLOHEXENE-INDUCED OVARIAN TOXICITY SO TOXICOLOGY AND APPLIED PHARMACOLOGY LA English DT Article C1 UNIV ARIZONA,DEPT PHARMACOL & TOXICOL,TUCSON,AZ 85721. UNIV ARKANSAS MED SCI HOSP,DEPT OBSTET & GYNECOL,LITTLE ROCK,AR 72205. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. RI Mattison, Donald/C-2015-2009; Mattison, Donald/L-4661-2013 OI Mattison, Donald/0000-0001-5623-0874 FU NIEHS NIH HHS [ES-85230] NR 39 TC 70 Z9 71 U1 0 U2 2 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0041-008X J9 TOXICOL APPL PHARM JI Toxicol. Appl. Pharmacol. PD SEP 15 PY 1990 VL 105 IS 3 BP 372 EP 381 DI 10.1016/0041-008X(90)90141-G PG 10 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA EF154 UT WOS:A1990EF15400003 PM 2237912 ER PT J AU MCMILLAN, DC MCRAE, TA HINSON, JA AF MCMILLAN, DC MCRAE, TA HINSON, JA TI PROPANIL-INDUCED METHEMOGLOBINEMIA AND HEMOGLOBIN BINDING IN THE RAT SO TOXICOLOGY AND APPLIED PHARMACOLOGY LA English DT Note C1 UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & INTERDISCIPLINARY TOXICOL,4301 W MARKHAM,SLOT 638,LITTLE ROCK,AR 72205. NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,JEFFERSON,AR 72079. NR 21 TC 25 Z9 25 U1 0 U2 0 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0041-008X J9 TOXICOL APPL PHARM JI Toxicol. Appl. Pharmacol. PD SEP 15 PY 1990 VL 105 IS 3 BP 503 EP 507 DI 10.1016/0041-008X(90)90153-L PG 5 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA EF154 UT WOS:A1990EF15400015 PM 2237922 ER PT J AU SIEGEL, JP MOSTOWSKI, HS AF SIEGEL, JP MOSTOWSKI, HS TI A BIOASSAY FOR THE MEASUREMENT OF HUMAN INTERLEUKIN-4 SO JOURNAL OF IMMUNOLOGICAL METHODS LA English DT Article RP SIEGEL, JP (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,CELLULAR IMMUNOL LAB,BETHESDA,MD 20014, USA. NR 20 TC 39 Z9 39 U1 0 U2 2 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0022-1759 J9 J IMMUNOL METHODS JI J. Immunol. Methods PD SEP 14 PY 1990 VL 132 IS 2 BP 287 EP 295 DI 10.1016/0022-1759(90)90040-3 PG 9 WC Biochemical Research Methods; Immunology SC Biochemistry & Molecular Biology; Immunology GA DZ700 UT WOS:A1990DZ70000016 PM 1698879 ER PT J AU WEBB, DSA SHIMIZU, Y VANSEVENTER, GA SHAW, S GERRARD, TL AF WEBB, DSA SHIMIZU, Y VANSEVENTER, GA SHAW, S GERRARD, TL TI LFA-3, CD44, AND CD45 - PHYSIOLOGICAL TRIGGERS OF HUMAN MONOCYTE TNF AND IL-1 RELEASE SO SCIENCE LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BETHESDA,MD 20892. NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892. NR 38 TC 306 Z9 309 U1 0 U2 1 PU AMER ASSOC ADVANCEMENT SCIENCE PI WASHINGTON PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 SN 0036-8075 J9 SCIENCE JI Science PD SEP 14 PY 1990 VL 249 IS 4974 BP 1295 EP 1297 DI 10.1126/science.1697984 PG 3 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DY351 UT WOS:A1990DY35100038 PM 1697984 ER PT J AU NIGHTENGALE, SL AF NIGHTENGALE, SL TI CHANGES IN FOOD LABELING PROPOSED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 2 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD SEP 12 PY 1990 VL 264 IS 10 BP 1239 EP 1239 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DX719 UT WOS:A1990DX71900005 PM 2388369 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI MAJOR ADDITIONAL USE FOR TAMOXIFEN CITRATE APPROVED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD SEP 12 PY 1990 VL 264 IS 10 BP 1239 EP 1239 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DX719 UT WOS:A1990DX71900007 PM 2388369 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI CONDOMS AND STDS - ESPECIALLY AIDS BROCHURE SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD SEP 12 PY 1990 VL 264 IS 10 BP 1239 EP 1239 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DX719 UT WOS:A1990DX71900008 PM 2388369 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI TREATMENT IND FOR GAUCHERS-DISEASE THERAPY SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD SEP 12 PY 1990 VL 264 IS 10 BP 1239 EP 1239 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DX719 UT WOS:A1990DX71900006 PM 2388369 ER PT J AU OKUNIEFF, P NEURINGER, L LEVINE, RA EVANS, FE AF OKUNIEFF, P NEURINGER, L LEVINE, RA EVANS, FE TI NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY OF PLASMA FOR THE DETECTION OF MALIGNANT-TUMORS SO NEW ENGLAND JOURNAL OF MEDICINE LA English DT Letter C1 MIT,CAMBRIDGE,MA 02139. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. RP OKUNIEFF, P (reprint author), MASSACHUSETTS GEN HOSP,BOSTON,MA 02114, USA. NR 15 TC 0 Z9 0 U1 0 U2 0 PU MASS MEDICAL SOC PI BOSTON PA 10 SHATTUCK, BOSTON, MA 02115 SN 0028-4793 J9 NEW ENGL J MED JI N. Engl. J. Med. PD SEP 6 PY 1990 VL 323 IS 10 BP 680 EP 681 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA DW787 UT WOS:A1990DW78700017 ER PT J AU SRIVASTAVA, M MCBRIDE, OW FLEMING, PJ POLLARD, HB BURNS, AL AF SRIVASTAVA, M MCBRIDE, OW FLEMING, PJ POLLARD, HB BURNS, AL TI GENOMIC ORGANIZATION AND CHROMOSOMAL LOCALIZATION OF THE HUMAN NUCLEOLIN GENE SO JOURNAL OF BIOLOGICAL CHEMISTRY LA English DT Article C1 NIDDKD,CELL BIOL & GENET LAB,BETHESDA,MD 20892. NCI,BIOCHEM LAB,BETHESDA,MD 20892. GEORGETOWN UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,WASHINGTON,DC 20007. RP SRIVASTAVA, M (reprint author), US FDA,DIV CARDIORENAL,BETHESDA,MD 20892, USA. NR 71 TC 67 Z9 69 U1 0 U2 0 PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0021-9258 J9 J BIOL CHEM JI J. Biol. Chem. PD SEP 5 PY 1990 VL 265 IS 25 BP 14922 EP 14931 PG 10 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DX400 UT WOS:A1990DX40000043 PM 2394707 ER PT J AU WALTERS, SM AF WALTERS, SM TI CLEANUP TECHNIQUES FOR PESTICIDES IN FATTY FOODS SO ANALYTICA CHIMICA ACTA LA English DT Article RP WALTERS, SM (reprint author), PESTICIDES & IND CHEM RES CTR,FOOD & DRUG ADM,1560 E JEFFERSON AVE,DETROIT,MI 48207, USA. NR 24 TC 46 Z9 47 U1 0 U2 2 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0003-2670 J9 ANAL CHIM ACTA JI Anal. Chim. Acta PD SEP 3 PY 1990 VL 236 IS 1 BP 77 EP 82 DI 10.1016/S0003-2670(00)83301-2 PG 6 WC Chemistry, Analytical SC Chemistry GA DZ729 UT WOS:A1990DZ72900006 ER PT J AU WEAVER, JL GERGELY, P PINE, PS PATZER, E ASZALOS, A AF WEAVER, JL GERGELY, P PINE, PS PATZER, E ASZALOS, A TI POLYIONIC COMPOUNDS SELECTIVELY ALTER AVAILABILITY OF CD4 RECEPTORS FOR HIV COAT PROTEIN RGP120 SO AIDS RESEARCH AND HUMAN RETROVIRUSES LA English DT Article C1 US FDA,HFD 471,200 C ST SW,WASHINGTON,DC 20204. SEMMELWEIS UNIV,DEPT MED,H-1088 BUDAPEST,HUNGARY. GENENTECH INC,SAN FRANCISCO,CA 94080. NR 22 TC 31 Z9 31 U1 0 U2 0 PU MARY ANN LIEBERT INC PUBL PI LARCHMONT PA 2 MADISON AVENUE, LARCHMONT, NY 10538 SN 0889-2229 J9 AIDS RES HUM RETROV JI Aids Res. Hum. Retrovir. PD SEP PY 1990 VL 6 IS 9 BP 1125 EP 1130 DI 10.1089/aid.1990.6.1125 PG 6 WC Immunology; Infectious Diseases; Virology SC Immunology; Infectious Diseases; Virology GA DZ420 UT WOS:A1990DZ42000010 PM 1979910 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI CHANGES IN FOOD LABELING SO AMERICAN FAMILY PHYSICIAN LA English DT Article RP NIGHTINGALE, SL (reprint author), US FDA,HLTH AFFAIRS,ROCKVILLE,MD 20850, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU AMER ACAD FAMILY PHYSICIANS PI KANSAS CITY PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 SN 0002-838X J9 AM FAM PHYSICIAN JI Am. Fam. Physician PD SEP PY 1990 VL 42 IS 3 BP 833 EP 835 PG 3 WC Primary Health Care; Medicine, General & Internal SC General & Internal Medicine GA DX221 UT WOS:A1990DX22100025 PM 2392970 ER PT J AU BECKSAGUE, CM JARVIS, WR BLAND, LA ARDUINO, MJ AGUERO, SM VEROSIC, G AF BECKSAGUE, CM JARVIS, WR BLAND, LA ARDUINO, MJ AGUERO, SM VEROSIC, G TI OUTBREAK OF GRAM-NEGATIVE BACTEREMIA AND PYROGENIC REACTIONS IN A HEMODIALYSIS CENTER SO AMERICAN JOURNAL OF NEPHROLOGY LA English DT Article C1 US FDA,PHOENIX,AZ. RP BECKSAGUE, CM (reprint author), CTR DIS CONTROL,CTR INFECT DIS,HOSP INFECT PROGRAM,ROOM 5044,MAILSTOP C-10,ATLANTA,GA 30333, USA. RI Arduino, Matthew/C-1461-2012 OI Arduino, Matthew/0000-0001-7072-538X NR 17 TC 38 Z9 39 U1 0 U2 0 PU KARGER PI BASEL PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND SN 0250-8095 J9 AM J NEPHROL JI Am. J. Nephrol. PD SEP-OCT PY 1990 VL 10 IS 5 BP 397 EP 403 DI 10.1159/000168155 PG 7 WC Urology & Nephrology SC Urology & Nephrology GA EF433 UT WOS:A1990EF43300007 PM 2080790 ER PT J AU HANNA, GM LAUCAM, CA AF HANNA, GM LAUCAM, CA TI DETERMINATION OF THE ENANTIOMERIC COMPOSITION OF CYCLOPROFEN BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY WITH A EUROPIUM(III) SHIFT-REAGENT SO ANALYST LA English DT Article C1 ST JOHNS UNIV,COLL PHARM & ALLIED HLTH PROFESS,JAMAICA,NY 11439. RP HANNA, GM (reprint author), US FDA,NEW YORK REG LAB,BROOKLYN,NY 11232, USA. NR 19 TC 5 Z9 5 U1 0 U2 0 PU ROYAL SOC CHEMISTRY PI CAMBRIDGE PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF SN 0003-2654 J9 ANALYST JI Analyst PD SEP PY 1990 VL 115 IS 9 BP 1157 EP 1160 DI 10.1039/an9901501157 PG 4 WC Chemistry, Analytical SC Chemistry GA DZ782 UT WOS:A1990DZ78200002 ER PT J AU BEEBE, DP WOOD, LL AF BEEBE, DP WOOD, LL TI FURTHER CHARACTERIZATION OF TISSUE PLASMINOGEN-ACTIVATOR BINDING-PROTEINS ON ENDOTHELIAL AND OTHER CELL-TYPES SO ARTERIOSCLEROSIS LA English DT Meeting Abstract C1 CTR BIOL EVALUAT & RES,BETHESDA,MD. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER HEART ASSOC PI DALLAS PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596 SN 0276-5047 J9 ARTERIOSCLEROSIS PD SEP-OCT PY 1990 VL 10 IS 5 BP A927 EP A927 PG 1 WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease SC Cardiovascular System & Cardiology GA DZ229 UT WOS:A1990DZ22900881 ER PT J AU PURI, RK TRAVIS, WD ROSENBERG, SA AF PURI, RK TRAVIS, WD ROSENBERG, SA TI INVIVO ADMINISTRATION OF INTERFERON-ALPHA AND INTERLEUKIN-2 INDUCES PROLIFERATION OF LYMPHOID-CELLS IN THE ORGANS OF MICE SO CANCER RESEARCH LA English DT Article C1 NCI,DIV CANC TREATMENT,SURG BRANCH,BETHESDA,MD 20892. NCI,DIV CANC TREATMENT,PATHOL LAB,BETHESDA,MD 20892. RP PURI, RK (reprint author), NCI,FDA,CBER,DIV CYTOKIN BIOL,CELLULAR IMMUNOL LAB,BLDG 29A,ROOM 2B20,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 60 TC 8 Z9 8 U1 0 U2 0 PU AMER ASSOC CANCER RESEARCH PI PHILADELPHIA PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106 SN 0008-5472 J9 CANCER RES JI Cancer Res. PD SEP 1 PY 1990 VL 50 IS 17 BP 5543 EP 5550 PG 8 WC Oncology SC Oncology GA DW264 UT WOS:A1990DW26400055 PM 2386960 ER PT J AU HERMAN, EH FERRANS, VJ AF HERMAN, EH FERRANS, VJ TI EXAMINATION OF THE POTENTIAL LONG-LASTING PROTECTIVE EFFECT OF ICRF-187 AGAINST ANTHRACYCLINE-INDUCED CHRONIC CARDIOMYOPATHY SO CANCER TREATMENT REVIEWS LA English DT Review ID CHRONIC DOXORUBICIN CARDIOTOXICITY; VITAMIN-E; REDUCTION; RABBITS; PRETREATMENT C1 NHLBI,PATHOL BRANCH,BETHESDA,MD 20892. RP HERMAN, EH (reprint author), US FDA,DIV DRUG RES & TESTING,200 C ST SW,WASHINGTON,DC 20204, USA. NR 13 TC 21 Z9 21 U1 0 U2 1 PU W B SAUNDERS CO LTD PI LONDON PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX SN 0305-7372 J9 CANCER TREAT REV JI Cancer Treat. Rev. PD SEP PY 1990 VL 17 IS 2-3 BP 155 EP 160 DI 10.1016/0305-7372(90)90040-M PG 6 WC Oncology SC Oncology GA EU103 UT WOS:A1990EU10300008 PM 2125530 ER PT J AU NISHIZAWA, Y SEAMON, KB DALY, JW ARONSTAM, RS AF NISHIZAWA, Y SEAMON, KB DALY, JW ARONSTAM, RS TI EFFECTS OF FORSKOLIN AND ANALOGS ON NICOTINIC RECEPTOR-MEDIATED SODIUM FLUX, VOLTAGE-DEPENDENT CALCIUM FLUX, AND VOLTAGE-DEPENDENT RUBIDIUM EFFLUX IN PHEOCHROMOCYTOMA PC12 CELLS SO CELLULAR AND MOLECULAR NEUROBIOLOGY LA English DT Article C1 NIDDKD,BIOORGAN CHEM LAB,BLDG 8A,ROOM 1A17,BETHESDA,MD 20892. US FDA,MOLEC PHARMACOL LAB,BETHESDA,MD 20892. MED COLL GEORGIA,DEPT PHARMACOL & TOXICOL,AUGUSTA,GA 30912. NR 41 TC 12 Z9 12 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0272-4340 J9 CELL MOL NEUROBIOL JI Cell. Mol. Neurobiol. PD SEP PY 1990 VL 10 IS 3 BP 351 EP 368 DI 10.1007/BF00711180 PG 18 WC Cell Biology; Neurosciences SC Cell Biology; Neurosciences & Neurology GA DX842 UT WOS:A1990DX84200005 PM 1701359 ER PT J AU WHITTAKER, P OLOGUNDE, MO AF WHITTAKER, P OLOGUNDE, MO TI STUDY OF IRON BIOAVAILABILITY IN A NATIVE NIGERIAN GRAIN AMARANTH CEREAL FOR YOUNG-CHILDREN, USING A RAT MODEL SO CEREAL CHEMISTRY LA English DT Article RP WHITTAKER, P (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV NUTR HFF268,200 C ST SW,WASHINGTON,DC 20204, USA. NR 28 TC 2 Z9 4 U1 0 U2 1 PU AMER ASSOC CEREAL CHEMISTS PI ST PAUL PA 3340 PILOT KNOB RD, ST PAUL, MN 55121-2097 SN 0009-0352 J9 CEREAL CHEM JI Cereal Chem. PD SEP-OCT PY 1990 VL 67 IS 5 BP 505 EP 508 PG 4 WC Chemistry, Applied; Food Science & Technology SC Chemistry; Food Science & Technology GA EC608 UT WOS:A1990EC60800020 ER PT J AU CHO, BP KADLUBAR, FF CULP, SJ EVANS, FE AF CHO, BP KADLUBAR, FF CULP, SJ EVANS, FE TI N-15 NUCLEAR-MAGNETIC-RESONANCE STUDIES ON THE TAUTOMERISM OF 8-HYDROXY-2'-DEOXYGUANOSINE, 8-HYDROXYGUANOSINE, AND OTHER C8-SUBSTITUTED GUANINE NUCLEOSIDES SO CHEMICAL RESEARCH IN TOXICOLOGY LA English DT Article RP CHO, BP (reprint author), US FDA,NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,JEFFERSON,AR 72079, USA. NR 42 TC 67 Z9 67 U1 0 U2 3 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0893-228X J9 CHEM RES TOXICOL JI Chem. Res. Toxicol. PD SEP-OCT PY 1990 VL 3 IS 5 BP 445 EP 452 DI 10.1021/tx00017a010 PG 8 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology SC Pharmacology & Pharmacy; Chemistry; Toxicology GA DZ761 UT WOS:A1990DZ76100010 PM 2133096 ER PT J AU AZIZ, K AF AZIZ, K TI DRUGS-OF-ABUSE TESTING - SCREENING AND CONFIRMATION SO CLINICS IN LABORATORY MEDICINE LA English DT Article RP AZIZ, K (reprint author), USFDA,DIV CLIN LAB DEVICES,CLIN CHEM TOXICOL BRANCH,1390 PICCARD DR,ROCKVILLE,MD 20850, USA. NR 0 TC 4 Z9 4 U1 0 U2 0 PU W B SAUNDERS CO PI PHILADELPHIA PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 SN 0272-2712 J9 CLIN LAB MED JI Clin. Lab. Med. PD SEP PY 1990 VL 10 IS 3 BP 493 EP 502 PG 10 WC Medical Laboratory Technology SC Medical Laboratory Technology GA DY137 UT WOS:A1990DY13700006 PM 2253446 ER PT J AU PLAKAS, SM JAMES, MO AF PLAKAS, SM JAMES, MO TI BIOAVAILABILITY, METABOLISM, AND RENAL EXCRETION OF BENZOIC-ACID IN THE CHANNEL CATFISH (ICTALURUS-PUNCTATUS) SO DRUG METABOLISM AND DISPOSITION LA English DT Article C1 UNIV FLORIDA,DEPT MED CHEM,GAINESVILLE,FL 32611. RP PLAKAS, SM (reprint author), US FDA,FISHERY RES BRANCH,POB 158,DAUPHIN ISL,AL 36528, USA. RI James, Margaret/A-8232-2011 OI James, Margaret/0000-0001-8778-9427 NR 22 TC 7 Z9 10 U1 0 U2 0 PU WILLIAMS & WILKINS PI BALTIMORE PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 SN 0090-9556 J9 DRUG METAB DISPOS JI Drug Metab. Dispos. PD SEP-OCT PY 1990 VL 18 IS 5 BP 552 EP 556 PG 5 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA EA915 UT WOS:A1990EA91500003 PM 1981701 ER PT J AU WARNER, CR DANIELS, DH FITZGERALD, MC JOE, FL DIACHENKO, GW AF WARNER, CR DANIELS, DH FITZGERALD, MC JOE, FL DIACHENKO, GW TI DETERMINATION OF FREE AND REVERSIBLY BOUND SULFITE IN FOODS BY REVERSE-PHASE, ION-PAIRING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY SO FOOD ADDITIVES AND CONTAMINANTS LA English DT Article RP WARNER, CR (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,200 C ST SW,WASHINGTON,DC 20204, USA. NR 0 TC 11 Z9 11 U1 0 U2 8 PU TAYLOR & FRANCIS LTD PI LONDON PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE SN 0265-203X J9 FOOD ADDIT CONTAM JI Food Addit. Contam. PD SEP-OCT PY 1990 VL 7 IS 5 BP 575 EP 581 PG 7 WC Chemistry, Applied; Food Science & Technology; Toxicology SC Chemistry; Food Science & Technology; Toxicology GA ED291 UT WOS:A1990ED29100001 PM 2174807 ER PT J AU BANERJEEBHATNAGAR, N FRASCH, CE AF BANERJEEBHATNAGAR, N FRASCH, CE TI EXPRESSION OF NEISSERIA-MENINGITIDIS IRON-REGULATED OUTER-MEMBRANE PROTEINS, INCLUDING A 70-KILODALTON TRANSFERRIN RECEPTOR, AND THEIR POTENTIAL FOR USE AS VACCINES SO INFECTION AND IMMUNITY LA English DT Article C1 CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,BETHESDA,MD 20892. NR 25 TC 45 Z9 45 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD SEP PY 1990 VL 58 IS 9 BP 2875 EP 2881 PG 7 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA DX607 UT WOS:A1990DX60700023 PM 2117572 ER PT J AU SHEPPARD, BS SHEN, WL CARUSO, JA HEITKEMPER, DT FRICKE, FL AF SHEPPARD, BS SHEN, WL CARUSO, JA HEITKEMPER, DT FRICKE, FL TI ELIMINATION OF THE ARGON CHLORIDE INTERFERENCE ON ARSENIC SPECIATION IN INDUCTIVELY COUPLED PLASMA MASS-SPECTROMETRY USING ION CHROMATOGRAPHY SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY LA English DT Article; Proceedings Paper CT 1990 WINTER CONF ON PLASMA SPECTROCHEMISTRY CY JAN 08-13, 1990 CL ST PETERSBURG, FL C1 UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221. US FDA,NATL FORENS CHEM,CINCINNATI,OH 45202. NR 16 TC 81 Z9 82 U1 1 U2 4 PU ROYAL SOC CHEMISTRY PI CAMBRIDGE PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF SN 0267-9477 J9 J ANAL ATOM SPECTROM JI J. Anal. At. Spectrom. PD SEP PY 1990 VL 5 IS 6 BP 431 EP 435 DI 10.1039/ja9900500431 PG 5 WC Chemistry, Analytical; Spectroscopy SC Chemistry; Spectroscopy GA EC879 UT WOS:A1990EC87900004 ER PT J AU WANG, JS SHEN, WL SHEPPARD, BS EVANS, EH CARUSO, JA FRICKE, FL AF WANG, JS SHEN, WL SHEPPARD, BS EVANS, EH CARUSO, JA FRICKE, FL TI EFFECT OF ION-LENS TUNING AND FLOW-INJECTION ON NONSPECTROSCOPIC MATRIX INTERFERENCES IN INDUCTIVELY COUPLED PLASMA MASS-SPECTROMETRY SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY LA English DT Article; Proceedings Paper CT 1990 WINTER CONF ON PLASMA SPECTROCHEMISTRY CY JAN 08-13, 1990 CL ST PETERSBURG, FL C1 UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221. US FDA,ELEMENTAL ANALYS RES CTR,CINCINNATI,OH 45202. NR 22 TC 37 Z9 38 U1 1 U2 3 PU ROYAL SOC CHEMISTRY PI CAMBRIDGE PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF SN 0267-9477 J9 J ANAL ATOM SPECTROM JI J. Anal. At. Spectrom. PD SEP PY 1990 VL 5 IS 6 BP 445 EP 449 DI 10.1039/ja9900500445 PG 5 WC Chemistry, Analytical; Spectroscopy SC Chemistry; Spectroscopy GA EC879 UT WOS:A1990EC87900006 ER PT J AU SHEN, WL CARUSO, JA FRICKE, FL SATZGER, RD AF SHEN, WL CARUSO, JA FRICKE, FL SATZGER, RD TI ELECTROTHERMAL VAPORIZATION INTERFACE FOR SAMPLE INTRODUCTION IN INDUCTIVELY COUPLED PLASMA MASS-SPECTROMETRY SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY LA English DT Article; Proceedings Paper CT 1990 WINTER CONF ON PLASMA SPECTROCHEMISTRY CY JAN 08-13, 1990 CL ST PETERSBURG, FL C1 UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221. US FDA,CINCINNATI,OH 45201. NR 22 TC 55 Z9 55 U1 0 U2 0 PU ROYAL SOC CHEMISTRY PI CAMBRIDGE PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF SN 0267-9477 J9 J ANAL ATOM SPECTROM JI J. Anal. At. Spectrom. PD SEP PY 1990 VL 5 IS 6 BP 451 EP 455 DI 10.1039/ja9900500451 PG 5 WC Chemistry, Analytical; Spectroscopy SC Chemistry; Spectroscopy GA EC879 UT WOS:A1990EC87900007 ER PT J AU SMITH, CM KOCH, WH FRANKLIN, SB FOSTER, PL CEBULA, TA EISENSTADT, E AF SMITH, CM KOCH, WH FRANKLIN, SB FOSTER, PL CEBULA, TA EISENSTADT, E TI SEQUENCE-ANALYSIS AND MAPPING OF THE SALMONELLA-TYPHIMURIUM LT2 UMUDC OPERON SO JOURNAL OF BACTERIOLOGY LA English DT Article C1 HARVARD UNIV,SCH PUBL HLTH,INTERDISCIPLINARY PROGRAMS HLTH,BOSTON,MA 02115. US FDA,MOLEC BIOL BRANCH,WASHINGTON,DC 20204. HARVARD UNIV,SCH PUBL HLTH,CHARLES A DANA LAB TOXICOL,BOSTON,MA 02115. BOSTON UNIV,SCH PUBL HLTH,DIV ENVIRONM HLTH,BOSTON,MA 02118. HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,BOSTON,MA 02115. OFF NAVAL RES,DIV BIOL SCI,ARLINGTON,VA 22217. OI Foster, Patricia/0000-0002-7236-4378 FU NCI NIH HHS [CA37880] NR 70 TC 55 Z9 58 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0021-9193 J9 J BACTERIOL JI J. Bacteriol. PD SEP PY 1990 VL 172 IS 9 BP 4964 EP 4978 PG 15 WC Microbiology SC Microbiology GA DX478 UT WOS:A1990DX47800029 PM 2144275 ER PT J AU LOVETT, J WESLEY, IV VANDERMAATEN, MJ BRADSHAW, JG FRANCIS, DW CRAWFORD, RG DONNELLY, CW MESSER, JW AF LOVETT, J WESLEY, IV VANDERMAATEN, MJ BRADSHAW, JG FRANCIS, DW CRAWFORD, RG DONNELLY, CW MESSER, JW TI HIGH-TEMPERATURE SHORT-TIME PASTEURIZATION INACTIVATES LISTERIA-MONOCYTOGENES SO JOURNAL OF FOOD PROTECTION LA English DT Article C1 US FDA,DIV MICROBIOL,1090 TUSCULUM AVE,CINCINNATI,OH 45226. USDA,CTR NATL ANIM DIS,AMES,IA 50010. UNIV VERMONT,COLL AGR,DEPT ANIM SCI,BURLINGTON,VT 05405. NR 22 TC 31 Z9 31 U1 2 U2 2 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD SEP PY 1990 VL 53 IS 9 BP 734 EP 738 PG 5 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA DY169 UT WOS:A1990DY16900001 ER PT J AU RAFII, F CERNIGLIA, CE AF RAFII, F CERNIGLIA, CE TI AN ANAEROBIC NONDENATURING GEL ASSAY FOR THE DETECTION OF AZOREDUCTASE FROM ANAEROBIC-BACTERIA SO JOURNAL OF MICROBIOLOGICAL METHODS LA English DT Article C1 NATL CTR TOXICOL RES,DIV MICROBIOL,JEFFERSON,AR 72079. NR 18 TC 7 Z9 8 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0167-7012 J9 J MICROBIOL METH JI J. Microbiol. Methods PD SEP PY 1990 VL 12 IS 2 BP 139 EP 148 PG 10 WC Biochemical Research Methods; Microbiology SC Biochemistry & Molecular Biology; Microbiology GA EE029 UT WOS:A1990EE02900010 ER PT J AU YAO, J HARVATH, L GILBERT, DL COLTON, CA AF YAO, J HARVATH, L GILBERT, DL COLTON, CA TI CHEMOTAXIS BY A CNS MACROPHAGE, THE MICROGLIA SO JOURNAL OF NEUROSCIENCE RESEARCH LA English DT Article C1 GEORGETOWN UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,WASHINGTON,DC 20007. US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,BETHESDA,MD 20014. NINCDS,BIOPHYS LAB,BETHESDA,MD 20205. NR 36 TC 183 Z9 184 U1 0 U2 1 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0360-4012 J9 J NEUROSCI RES JI J. Neurosci. Res. PD SEP PY 1990 VL 27 IS 1 BP 36 EP 42 DI 10.1002/jnr.490270106 PG 7 WC Neurosciences SC Neurosciences & Neurology GA DW848 UT WOS:A1990DW84800005 PM 2254955 ER PT J AU SKELLEY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A AF SKELLEY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A TI REPORT OF THE WORKSHOP ON INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED-RELEASE DOSAGE FORMS SO JOURNAL OF PHARMACEUTICAL SCIENCES LA English DT Letter C1 JANSSEN PHARMACEUT INC,PISCATAWAY,NJ. AMER CYANAMID CO,PEARL RIVER,NY. UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706. UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109. VIRGINIA COMMONWEALTH UNIV,DEPT BIOSTAT,RICHMOND,VA 23284. UNIV CALIF SAN FRANCISCO,SCH PHARM S-926,SAN FRANCISCO,CA 94143. RP SKELLEY, JP (reprint author), US FDA,DIV BIOPHARMACEUT,CTR DRUG EVALUAT & RES,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. RI Benet, Leslie/K-8286-2016 NR 2 TC 28 Z9 28 U1 0 U2 0 PU AMER PHARMACEUTICAL ASSN PI WASHINGTON PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037 SN 0022-3549 J9 J PHARM SCI JI J. Pharm. Sci. PD SEP PY 1990 VL 79 IS 9 BP 849 EP 854 DI 10.1002/jps.2600790923 PG 6 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Pharmacology & Pharmacy; Chemistry GA DY185 UT WOS:A1990DY18500022 PM 1980308 ER PT J AU DAVIS, GB SCHROEDER, LW AF DAVIS, GB SCHROEDER, LW TI INFLUENCE OF CONTACT ANGLES ON THE LEAKAGE OF LATEX CONDOMS SO JOURNAL OF TESTING AND EVALUATION LA English DT Article C1 US FDA,CTR DEVICES & RADIOL HLTH,DIV MECH MAT SCI,ROCKVILLE,MD 20852. RP DAVIS, GB (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,DIV MECH & MAT SCI,PUBL HLTH SERV,ROCKVILLE,MD 20852, USA. NR 19 TC 6 Z9 6 U1 0 U2 0 PU AMER SOC TESTING MATERIALS PI W CONSHOHOCKEN PA 100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 SN 0090-3973 J9 J TEST EVAL JI J. Test. Eval. PD SEP PY 1990 VL 18 IS 5 BP 352 EP 358 PG 7 WC Materials Science, Characterization & Testing SC Materials Science GA DV602 UT WOS:A1990DV60200007 ER PT J AU CARON, D QUEILLEROUSSEL, C SHAH, VP SCHAEFER, H AF CARON, D QUEILLEROUSSEL, C SHAH, VP SCHAEFER, H TI CORRELATION BETWEEN THE DRUG PENETRATION AND THE BLANCHING EFFECT OF TOPICALLY APPLIED HYDROCORTISONE CREAMS IN HUMAN-BEINGS SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY LA English DT Article C1 HOP LOUIS PASTEUR,CTR PHARMACOL CLIN APPL DERMATOL,F-06031 NICE,FRANCE. US FDA,CTR DRUG EVALUAT & RES,OFF RES RESOURCES,ROCKVILLE,MD 20857. RP CARON, D (reprint author), CTR INT RECH DERMATOL,F-06560 VALBONNE,FRANCE. NR 5 TC 32 Z9 32 U1 1 U2 1 PU MOSBY-YEAR BOOK INC PI ST LOUIS PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 SN 0190-9622 J9 J AM ACAD DERMATOL JI J. Am. Acad. Dermatol. PD SEP PY 1990 VL 23 IS 3 BP 458 EP 462 DI 10.1016/0190-9622(90)70240-I PN 1 PG 5 WC Dermatology SC Dermatology GA DX712 UT WOS:A1990DX71200008 PM 2212144 ER PT J AU HORWITZ, W ALBERT, R DEUTSCH, MJ THOMPSON, JN AF HORWITZ, W ALBERT, R DEUTSCH, MJ THOMPSON, JN TI PRECISION PARAMETERS OF METHODS OF ANALYSIS REQUIRED FOR NUTRITION LABELING .1. MAJOR NUTRIENTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 HLTH PROTECT BRANCH,DIV NUTR RES,OTTAWA K1A 0L2,ONTARIO,CANADA. RP HORWITZ, W (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA. NR 27 TC 69 Z9 69 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 661 EP 680 PG 20 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200006 PM 2272990 ER PT J AU MURTHY, GK KAYLOR, LO AF MURTHY, GK KAYLOR, LO TI EVALUATION OF APHA AND AOAC-II METHODS FOR PHOSPHATASE IN BUTTER AND DIFFERENTIATION OF MILK AND MICROBIAL PHOSPHATASES BY AGAROSE-GEL ELECTROPHORESIS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 US FDA,DIV MICROBIOL,CINCINNATI,OH 45226. NR 15 TC 5 Z9 5 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 681 EP 687 PG 7 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200007 PM 2177055 ER PT J AU CARLSON, M AF CARLSON, M TI LIQUID-CHROMATOGRAPHIC DETERMINATION OF PENTAERYTHRITOL TETRANITRATE IN PHARMACEUTICALS - COLLABORATIVE STUDY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP CARLSON, M (reprint author), US FDA,240 HENNEPIN AVE,MINNEAPOLIS,MN 55401, USA. NR 11 TC 0 Z9 0 U1 1 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 693 EP 697 PG 5 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200009 PM 2272991 ER PT J AU NEWKIRK, DR RIGHTER, HF SCHENCK, FJ OKRASINSKI, JL BARNES, CJ AF NEWKIRK, DR RIGHTER, HF SCHENCK, FJ OKRASINSKI, JL BARNES, CJ TI GAS-CHROMATOGRAPHIC DETERMINATION OF INCURRED DIMETRIDAZOLE RESIDUES IN SWINE TISSUES SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 US FDA,CTR VET MED,DIV VET MED RES,BARC-E,BELTSVILLE,MD 20705. US FDA,CTR VET MED,DIV CHEM,ROCKVILLE,MD 20857. US FDA,SCIENCE BRANCH,BALTIMORE,MD 21201. NR 7 TC 26 Z9 31 U1 1 U2 4 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 702 EP 704 PG 3 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200011 PM 2272993 ER PT J AU MUNNS, RK ROYBAL, JE HURLBUT, JA SHIMODA, W AF MUNNS, RK ROYBAL, JE HURLBUT, JA SHIMODA, W TI RAPID METHOD FOR DETERMINATION OF LEUCOGENTIAN VIOLET IN CHICKEN FAT BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP MUNNS, RK (reprint author), US FDA,DENVER FED CTR,ANIM DRUG RES CTR,POB 25087,DENVER,CO 80225, USA. NR 11 TC 12 Z9 12 U1 0 U2 0 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 705 EP 708 PG 4 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200012 PM 2272994 ER PT J AU GILVYDIS, DM WALTERS, SM AF GILVYDIS, DM WALTERS, SM TI ION-PAIRING LIQUID-CHROMATOGRAPHIC DETERMINATION OF BENZIMIDAZOLE FUNGICIDES IN FOODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP GILVYDIS, DM (reprint author), US FDA,PESTICIDES & IND CHEM RES CTR,DETROIT,MI 48207, USA. NR 19 TC 44 Z9 46 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 753 EP 761 PG 9 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200021 PM 2273000 ER PT J AU MCDONOUGH, FE STEINKE, FH SARWAR, G EGGUM, BO BRESSANI, R HUTH, PJ BARBEAU, WE MITCHELL, GV PHILLIPS, JG AF MCDONOUGH, FE STEINKE, FH SARWAR, G EGGUM, BO BRESSANI, R HUTH, PJ BARBEAU, WE MITCHELL, GV PHILLIPS, JG TI INVIVO RAT ASSAY FOR TRUE PROTEIN DIGESTIBILITY - COLLABORATIVE STUDY SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 PROT TECHNOL INT,ST LOUIS,MO 63164. HLTH & WELF CANADA,HLTH PROTECT BRANCH,OTTAWA K1A 0L2,ONTARIO,CANADA. NATL INST ANIM SCI ANIM PHYSIOL & BIOCHEM,8830 TJELE,DENMARK. INST NUTR CENT AMER & PANAMA,GUATEMALA CITY,GUATEMALA. KRAFT GEN FOODS INC,GLENVIEW,IL 60025. VIRGINIA POLYTECH INST & STATE UNIV,BLACKSBURG,VA 24061. US FDA,DIV NUTR,WASHINGTON,DC 20204. USDA ARS,EASTERN REG RES CTR,PHILADELPHIA,PA 19118. RP MCDONOUGH, FE (reprint author), USDA,BELTSVILLE HUMAN NUTR RES CTR,ENERGY & PROT NUTR LAB,BELTSVILLE,MD 20705, USA. NR 18 TC 28 Z9 29 U1 0 U2 8 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 801 EP 805 PG 5 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200031 PM 2273008 ER PT J AU MARTIN, JI LANDEN, WO SOLIMAN, AGM EITENMILLER, RR AF MARTIN, JI LANDEN, WO SOLIMAN, AGM EITENMILLER, RR TI APPLICATION OF A TRI-ENZYME EXTRACTION FOR TOTAL FOLATE DETERMINATION IN FOODS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 UNIV GEORGIA,DEPT FOOD SCI & TECHNOL,ATHENS,GA 30602. RP MARTIN, JI (reprint author), US FDA,ATLANTA CTR NUTRIENT ANAL,60 8TH ST,ATLANTA,GA 30309, USA. NR 13 TC 82 Z9 85 U1 0 U2 4 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP 805 EP 808 PG 4 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200032 PM 2125600 ER PT J AU YESS, NJ AF YESS, NJ TI FOOD-AND-DRUG-ADMINISTRATION PESTICIDE PROGRAM - RESIDUES IN FOODS - 1989 SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP YESS, NJ (reprint author), US FDA,DIV CONTAMINANTS CHEM,HFF-420,200 C ST SW,WASHINGTON,DC 20204, USA. NR 15 TC 8 Z9 8 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD SEP-OCT PY 1990 VL 73 IS 5 BP A127 EP A146 PG 20 WC Chemistry, Analytical SC Chemistry GA EA812 UT WOS:A1990EA81200004 ER PT J AU SCALZO, FM HOLSON, RR PAULE, MG AF SCALZO, FM HOLSON, RR PAULE, MG TI METHODS IN BEHAVIORAL-TOXICOLOGY AND TERATOLOGY - INTRODUCTION SO NEUROTOXICOLOGY AND TERATOLOGY LA English DT Editorial Material RP SCALZO, FM (reprint author), NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0892-0362 J9 NEUROTOXICOL TERATOL JI Neurotoxicol. Teratol. PD SEP-OCT PY 1990 VL 12 IS 5 BP 411 EP 412 DI 10.1016/0892-0362(90)90001-S PG 2 WC Neurosciences; Toxicology SC Neurosciences & Neurology; Toxicology GA DZ847 UT WOS:A1990DZ84700001 ER PT J AU PAULE, MG AF PAULE, MG TI USE OF THE NCTR OPERANT TEST BATTERY IN NONHUMAN-PRIMATES SO NEUROTOXICOLOGY AND TERATOLOGY LA English DT Article RP PAULE, MG (reprint author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,PRIMATE RES FACILITY,JEFFERSON,AR 72079, USA. NR 12 TC 49 Z9 50 U1 0 U2 3 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0892-0362 J9 NEUROTOXICOL TERATOL JI Neurotoxicol. Teratol. PD SEP-OCT PY 1990 VL 12 IS 5 BP 413 EP 418 DI 10.1016/0892-0362(90)90002-T PG 6 WC Neurosciences; Toxicology SC Neurosciences & Neurology; Toxicology GA DZ847 UT WOS:A1990DZ84700002 PM 2247027 ER PT J AU ALLEN, RR SLIKKER, W PAULE, MG AF ALLEN, RR SLIKKER, W PAULE, MG TI REPEATED MEASURES DESIGNS IN BEHAVIORAL-TOXICOLOGY - APPLICATION TO CHRONIC MARIJUANA SMOKE EXPOSURE SO NEUROTOXICOLOGY AND TERATOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079. RP ALLEN, RR (reprint author), NATL CTR TOXICOL RES,COMP BASED SYST INC,DIV BIOMETRY,JEFFERSON,AR 72079, USA. NR 6 TC 2 Z9 2 U1 0 U2 1 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0892-0362 J9 NEUROTOXICOL TERATOL JI Neurotoxicol. Teratol. PD SEP-OCT PY 1990 VL 12 IS 5 BP 441 EP 448 DI 10.1016/0892-0362(90)90005-W PG 8 WC Neurosciences; Toxicology SC Neurosciences & Neurology; Toxicology GA DZ847 UT WOS:A1990DZ84700005 PM 2247030 ER PT J AU PAULE, MG FORRESTER, TM MAHER, MA CRANMER, JM ALLEN, RR AF PAULE, MG FORRESTER, TM MAHER, MA CRANMER, JM ALLEN, RR TI MONKEY VERSUS HUMAN-PERFORMANCE IN THE NCTR OPERANT TEST BATTERY SO NEUROTOXICOLOGY AND TERATOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,COMP BASED SYST INC,DIV BIOMETRY,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,LITTLE ROCK,AR 72205. RP PAULE, MG (reprint author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079, USA. NR 11 TC 50 Z9 51 U1 0 U2 4 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0892-0362 J9 NEUROTOXICOL TERATOL JI Neurotoxicol. Teratol. PD SEP-OCT PY 1990 VL 12 IS 5 BP 503 EP 507 DI 10.1016/0892-0362(90)90014-4 PG 5 WC Neurosciences; Toxicology SC Neurosciences & Neurology; Toxicology GA DZ847 UT WOS:A1990DZ84700014 PM 2247039 ER PT J AU BLAKELY, SR GRUNDEL, E JENKINS, MY MITCHELL, GV AF BLAKELY, SR GRUNDEL, E JENKINS, MY MITCHELL, GV TI ALTERATIONS IN BETA-CAROTENE AND VITAMIN-E STATUS IN RATS FED BETA-CAROTENE AND EXCESS VITAMIN-A SO NUTRITION RESEARCH LA English DT Article RP BLAKELY, SR (reprint author), US FDA,DIV NUTR,HFF-268,200 C ST SW,WASHINGTON,DC 20204, USA. NR 38 TC 27 Z9 27 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0271-5317 J9 NUTR RES JI Nutr. Res. PD SEP PY 1990 VL 10 IS 9 BP 1035 EP 1044 DI 10.1016/S0271-5317(05)80045-4 PG 10 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DW766 UT WOS:A1990DW76600009 ER PT J AU RAZZAQUE, A AF RAZZAQUE, A TI ONCOGENIC POTENTIAL OF HUMAN HERPESVIRUS-6 DNA SO ONCOGENE LA English DT Article RP RAZZAQUE, A (reprint author), US FDA,CBER,DIV VIROL,DNA VIRUS RES LAB,BETHESDA,MD 20892, USA. NR 36 TC 70 Z9 73 U1 0 U2 0 PU STOCKTON PRESS PI BASINGSTOKE PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS SN 0950-9232 J9 ONCOGENE JI Oncogene PD SEP PY 1990 VL 5 IS 9 BP 1365 EP 1370 PG 6 WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity GA EC241 UT WOS:A1990EC24100013 PM 2170897 ER PT J AU DAVIS, JL MITTAL, KK FREIDLIN, V MELLOW, SR OPTICAN, DC PALESTINE, AG NUSSENBLATT, RB AF DAVIS, JL MITTAL, KK FREIDLIN, V MELLOW, SR OPTICAN, DC PALESTINE, AG NUSSENBLATT, RB TI HLA ASSOCIATIONS AND ANCESTRY IN VOGT-KOYANAGI-HARADA DISEASE AND SYMPATHETIC OPHTHALMIA SO OPHTHALMOLOGY LA English DT Article C1 NEI,IMMUNOL LAB,BETHESDA,MD 20892. US FDA,BUR BIOL,BETHESDA,MD 20014. NEI,BIOMETRY & EPIDEMIOL PROGRAM,BETHESDA,MD 20892. NR 31 TC 67 Z9 71 U1 0 U2 3 PU LIPPINCOTT-RAVEN PUBL PI PHILADELPHIA PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 SN 0161-6420 J9 OPHTHALMOLOGY JI Ophthalmology PD SEP PY 1990 VL 97 IS 9 BP 1137 EP 1142 PG 6 WC Ophthalmology SC Ophthalmology GA DZ064 UT WOS:A1990DZ06400016 PM 2234843 ER PT J AU SKELLY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A AF SKELLY, JP AMIDON, GL BARR, WH BENET, LZ CARTER, JE ROBINSON, JR SHAH, VP YACOBI, A TI INVITRO AND INVIVO TESTING AND CORRELATION FOR ORAL CONTROLLED MODIFIED-RELEASE DOSAGE FORMS SO PHARMACEUTICAL RESEARCH LA English DT Editorial Material C1 JANSSEN PHARMACEUT INC,PISCATAWAY,NJ 08854. UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706. UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109. VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298. AMER CYANAMID CO,PEARL RIVER,NY 10965. UNIV CALIF SAN FRANCISCO,SCH PHARM S926,SAN FRANCISCO,CA 94143. RP SKELLY, JP (reprint author), US FDA,CTR DRUG EVALUAT,DIV,ROCKVILLE,MD 20857, USA. RI Benet, Leslie/K-8286-2016 NR 1 TC 70 Z9 73 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0724-8741 J9 PHARMACEUT RES JI Pharm. Res. PD SEP PY 1990 VL 7 IS 9 BP 975 EP 982 DI 10.1023/A:1015970512368 PG 8 WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Chemistry; Pharmacology & Pharmacy GA DZ095 UT WOS:A1990DZ09500016 ER PT J AU HUPPI, K SIWARSKI, D SKURLA, R KLINMAN, D MUSHINSKI, JF AF HUPPI, K SIWARSKI, D SKURLA, R KLINMAN, D MUSHINSKI, JF TI PVT-1 TRANSCRIPTS ARE FOUND IN NORMAL-TISSUES AND ARE ALTERED BY RECIPROCAL(6-15) TRANSLOCATIONS IN MOUSE PLASMACYTOMAS SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA LA English DT Article C1 US FDA,CTR BIOL EVOLUT & RES,DIV VIROL,BETHESDA,MD 20892. RP HUPPI, K (reprint author), NCI,GENET LAB,BETHESDA,MD 20892, USA. NR 28 TC 32 Z9 33 U1 0 U2 1 PU NATL ACAD SCIENCES PI WASHINGTON PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 SN 0027-8424 J9 P NATL ACAD SCI USA JI Proc. Natl. Acad. Sci. U. S. A. PD SEP PY 1990 VL 87 IS 18 BP 6964 EP 6968 DI 10.1073/pnas.87.18.6964 PG 5 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DZ453 UT WOS:A1990DZ45300008 PM 2402486 ER PT J AU BURTON, J GOLDMAN, CK RAO, P MOOS, M WALDMANN, TA AF BURTON, J GOLDMAN, CK RAO, P MOOS, M WALDMANN, TA TI ASSOCIATION OF INTERCELLULAR-ADHESION MOLECULE-1 WITH THE MULTICHAIN HIGH-AFFINITY INTERLEUKIN-2 RECEPTOR SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA LA English DT Article C1 BUR BIOLOG,DIV BIOCHEM & BIOPHYS,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. ORTHO PHARMACEUT CORP,DIV IMMUNOL,RARITAN,NJ 08869. RP BURTON, J (reprint author), NCI,METAB BRANCH,BETHESDA,MD 20892, USA. NR 36 TC 83 Z9 83 U1 0 U2 0 PU NATL ACAD SCIENCES PI WASHINGTON PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 SN 0027-8424 J9 P NATL ACAD SCI USA JI Proc. Natl. Acad. Sci. U. S. A. PD SEP PY 1990 VL 87 IS 18 BP 7329 EP 7333 DI 10.1073/pnas.87.18.7329 PG 5 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DZ453 UT WOS:A1990DZ45300083 PM 1976256 ER PT J AU MOORE, RM JENG, LL KACZMAREK, RG PLACEK, PJ AF MOORE, RM JENG, LL KACZMAREK, RG PLACEK, PJ TI USE OF DIAGNOSTIC-IMAGING PROCEDURES AND FETAL MONITORING DEVICES IN THE CARE OF PREGNANT-WOMEN SO PUBLIC HEALTH REPORTS LA English DT Article C1 US PHS,CTR DEVICES & RADIOL HLTH FOOD & DRUG ADM,WASHINGTON,DC. CTR DIS CONTROL,NATL CTR HLTH STAT,FOLLOWBACK SURVEY BRANCH,ATLANTA,GA 30333. NR 14 TC 15 Z9 15 U1 0 U2 0 PU US GOVERNMENT PRINTING OFFICE PI WASHINGTON PA SUPT OF DOCUMENTS, WASHINGTON, DC 20402-9325 SN 0033-3549 J9 PUBLIC HEALTH REP JI Public Health Rep. PD SEP-OCT PY 1990 VL 105 IS 5 BP 471 EP 475 PG 5 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA EF688 UT WOS:A1990EF68800006 PM 2120723 ER PT J AU BORTOLOTTI, A TRAINA, GL GUAITANI, A MARZI, E LATINI, R YOUNG, JF BONATI, M AF BORTOLOTTI, A TRAINA, GL GUAITANI, A MARZI, E LATINI, R YOUNG, JF BONATI, M TI INVIVO AND PERFUSED LIVER CAFFEINE KINETICS IN THE RAT SO RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV TERATOGENESIS RES,JEFFERSON,AR 72079. RP BORTOLOTTI, A (reprint author), MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY. NR 29 TC 5 Z9 5 U1 2 U2 2 PU P J D PUBLICATIONS LTD PI WESTBURY PA PO BOX 966, WESTBURY, NY 11590 SN 0034-5164 J9 RES COMMUN CHEM PATH PD SEP PY 1990 VL 69 IS 3 BP 285 EP 295 PG 11 WC Pathology; Pharmacology & Pharmacy SC Pathology; Pharmacology & Pharmacy GA DZ623 UT WOS:A1990DZ62300003 PM 2236898 ER PT J AU BLUESTONE, JA MATIS, LA AF BLUESTONE, JA MATIS, LA TI ARE TCR-ALPHA-BETA-CELLS AND TCR-GAMMA-DELTA-CELLS THAT DIFFERENT SO RESEARCH IN IMMUNOLOGY LA English DT Article ID DENDRITIC EPIDERMAL-CELLS; GAMMA-DELTA-RECEPTORS; T-CELLS; LYMPHOCYTES-T; LIMITED DIVERSITY; ANTIGEN RECEPTOR; CYTO-TOXICITY; SPECIFICITY; RECOGNITION; CLONES C1 US FDA,DIV CYTOGENET,BETHESDA,MD 20014. RP BLUESTONE, JA (reprint author), UNIV CHICAGO,CHICAGO,IL 60637, USA. NR 31 TC 1 Z9 1 U1 0 U2 0 PU EDITIONS SCIENTIFIQUES ELSEVIER PI PARIS CEDEX 15 PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE SN 0923-2494 J9 RES IMMUNOL JI Res. Immunol. PD SEP PY 1990 VL 141 IS 7 BP 606 EP 610 DI 10.1016/0923-2494(90)90066-8 PG 5 WC Immunology SC Immunology GA EW097 UT WOS:A1990EW09700009 PM 1710364 ER PT J AU DESOUZA, VAUF PANNUTI, CS DEGODOY, CVF ALBRECHT, P LOPES, MH MENDONCA, JD AF DESOUZA, VAUF PANNUTI, CS DEGODOY, CVF ALBRECHT, P LOPES, MH MENDONCA, JD TI COMPARISON OF INDIRECT IMMUNOFLUORESCENCE TEST FOR MEASLES ANTIBODIES WITH HEMAGGLUTINATION INHIBITION AND PLAQUE NEUTRALIZATION TESTS SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO LA English DT Article C1 HOSP SERV PUBL ESTADO SAO PAULO,SAO PAULO,BRAZIL. UNIV SAO PAULO,FAC MED,SAO PAULO,BRAZIL. US FDA,DIV VIROL,BETHESDA,MD 20014. RP DESOUZA, VAUF (reprint author), INST MED TROP SAO PAULO,AV DR ENEAS DE CARVALHO AGUIAR 470,BR-05403 SAO PAULO,BRAZIL. RI Pannuti, Claudio/B-7649-2012; Lopes, Marta/J-3285-2012 NR 14 TC 0 Z9 0 U1 0 U2 0 PU INST MEDICINA TROPICAL PI SAO PAULO PA AV DR ENEIAS C AGUIAR CAIXA POSTAL 2921, SAO PAULO, BRAZIL SN 0036-4665 J9 REV I MED TROP PD SEP-OCT PY 1990 VL 32 IS 5 BP 360 EP 363 PG 4 WC Tropical Medicine SC Tropical Medicine GA EK929 UT WOS:A1990EK92900009 PM 2135477 ER PT J AU TOLLEFSON, L LORENTZEN, RJ BROWN, RN SPRINGER, JA AF TOLLEFSON, L LORENTZEN, RJ BROWN, RN SPRINGER, JA TI COMPARISON OF THE CANCER RISK OF METHYLENE-CHLORIDE PREDICTED FROM ANIMAL BIOASSAY DATA WITH THE EPIDEMIOLOGIC EVIDENCE SO RISK ANALYSIS LA English DT Article RP TOLLEFSON, L (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,OFF NUTR & FOOD SCI,WASHINGTON,DC 20204, USA. NR 17 TC 12 Z9 12 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0272-4332 J9 RISK ANAL JI Risk Anal. PD SEP PY 1990 VL 10 IS 3 BP 429 EP 435 DI 10.1111/j.1539-6924.1990.tb00526.x PG 7 WC Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods SC Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences GA DY447 UT WOS:A1990DY44700012 PM 2236746 ER PT J AU PLACENCIA, AM PEELER, JT AF PLACENCIA, AM PEELER, JT TI RELATIONSHIP OF BUBBLE POINT TO MICROBIAL PENETRATION IN MEDICAL PACKAGING SO TAPPI JOURNAL LA English DT Article C1 US FDA,CTR FOOD SAFETY & APPL NUT,WASHINGTON,DC 20204. RP PLACENCIA, AM (reprint author), US FDA,STERIL ANAL RES CTR,240 HENNEPIN AVE,MINNEAPOLIS,MN 55401, USA. NR 8 TC 0 Z9 0 U1 0 U2 0 PU TECH ASSN PULP PAPER IND INC PI NORCROSS PA 15 TECHNOLOGY PARK SOUTH, NORCROSS, GA 30092 SN 0734-1415 J9 TAPPI J JI TAPPI J. PD SEP PY 1990 VL 73 IS 9 BP 255 EP 257 PG 3 WC Materials Science, Paper & Wood SC Materials Science GA DY263 UT WOS:A1990DY26300033 ER PT J AU MORRIS, SL ROUSE, DA MALIK, A CHAPARAS, SD WITEBSKY, FG AF MORRIS, SL ROUSE, DA MALIK, A CHAPARAS, SD WITEBSKY, FG TI CHARACTERIZATION OF PLASMIDS EXTRACTED FROM AIDS - ASSOCIATED MYCOBACTERIUM-AVIUM ISOLATES SO TUBERCLE LA English DT Article C1 NIH,WARREN GRANT MAGNUSON CLIN CTR,BETHESDA,MD 20892. RP MORRIS, SL (reprint author), US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892, USA. NR 14 TC 9 Z9 9 U1 0 U2 0 PU CHURCHILL LIVINGSTONE PI EDINBURGH PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF SN 0041-3879 J9 TUBERCLE PD SEP PY 1990 VL 71 IS 3 BP 181 EP 185 DI 10.1016/0041-3879(90)90073-H PG 5 WC Respiratory System SC Respiratory System GA DY727 UT WOS:A1990DY72700006 PM 2238124 ER PT J AU WESLEY, IV WESLEY, RD HEISICK, J HARRELL, F WAGNER, D AF WESLEY, IV WESLEY, RD HEISICK, J HARRELL, F WAGNER, D TI CHARACTERIZATION OF LISTERIA-MONOCYTOGENES ISOLATES BY SOUTHERN BLOT HYBRIDIZATION SO VETERINARY MICROBIOLOGY LA English DT Article; Proceedings Paper CT WORKSHOP ON NUCLEIC ACID PROBES IN VETERINARY INFECTIOUS DISEASES : METHODS AND APPLICATIONS CY NOV 10, 1988 CL CHICAGO, IL SP AMER COLL VET MICROBIOLOGISTS C1 US FDA,MINNEAPOLIS,MN. RP WESLEY, IV (reprint author), USDA ARS,NATL ANIM DIS CTR,PHYSIOPATHOL RES UNIT,AMES,IA 50010, USA. NR 20 TC 15 Z9 15 U1 0 U2 2 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0378-1135 J9 VET MICROBIOL JI Vet. Microbiol. PD SEP PY 1990 VL 24 IS 3-4 BP 341 EP 353 DI 10.1016/0378-1135(90)90182-U PG 13 WC Microbiology; Veterinary Sciences SC Microbiology; Veterinary Sciences GA EC863 UT WOS:A1990EC86300011 PM 1979702 ER PT J AU LIANG, CM HENRY, S LIANG, SM EPSTEIN, JS AF LIANG, CM HENRY, S LIANG, SM EPSTEIN, JS TI AN ANTI-P24 MONOCLONAL-ANTIBODY SHOWS CROSS-REACTIVITY WITH MULTIPLE HIV-1 PROTEINS SO JOURNAL OF IMMUNOLOGICAL METHODS LA English DT Article RP LIANG, CM (reprint author), US FDA,CTR BIOL EVALUAT & RES,DBBP,BLDG 29,ROOM 309,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 19 TC 3 Z9 3 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0022-1759 J9 J IMMUNOL METHODS JI J. Immunol. Methods PD AUG 28 PY 1990 VL 132 IS 1 BP 57 EP 62 PG 6 WC Biochemical Research Methods; Immunology SC Biochemistry & Molecular Biology; Immunology GA DW263 UT WOS:A1990DW26300007 PM 2118162 ER PT J AU JERUSSI, RA AF JERUSSI, RA TI THE REVIEW OF GENERIC DRUGS AT FDA - PAST, PRESENT AND FUTURE SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV GENER DRUGS,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 3 EP CHAL PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04201133 ER PT J AU PATEL, RM AF PATEL, RM TI ABBREVIATED NEW DRUG APPLICATION REGULATIONS - CHEMISTRY, MANUFACTURING, AND CONTROLS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 4 EP CHAL PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04201134 ER PT J AU MCCOWIN, GL AF MCCOWIN, GL TI FOOD ADDITIVE REGULATION - AN HISTORICAL-PERSPECTIVE SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV FOOD & COLOR ADDIT,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 11 EP HIST PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04201785 ER PT J AU SHANK, FR AF SHANK, FR TI WHAT IS SAFE FOOD SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 19 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200019 ER PT J AU YESS, NJ GUNDERSON, EL HOUSTON, MG ROY, RR AF YESS, NJ GUNDERSON, EL HOUSTON, MG ROY, RR TI FOOD AND DRUG ADMINISTRATION PESTICIDE PROGRAM - RESIDUES IN FOODS - 1989 SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,WASHINGTON,DC 20204. US FDA,KANSAS CITY,MO 64106. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 23 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200023 ER PT J AU HEIKES, DL AF HEIKES, DL TI CHARACTERIZATION OF REACTION-PRODUCTS OF CHLORINE DIOXIDE WITH FATTY-ACIDS OF WHEAT-FLOUR USING GC/MS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,TOTAL DIET RES CTR,KANSAS CITY,MO 64106. NR 0 TC 0 Z9 0 U1 0 U2 2 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 25 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200025 ER PT J AU GROVE, EA AF GROVE, EA TI FDA REGULATION OF ANIMAL SOMATOTROPINS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR VET MED,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 40 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200256 ER PT J AU DOYLE, TC AF DOYLE, TC TI ANALYTICAL CRITERIA FOR CHIRAL HPLC - WHERE WE ARE NOW SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV RES & TESTING,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 44 EP ANYL PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200403 ER PT J AU HAUSMAN, SZ MANCLARK, C BURNS, D AF HAUSMAN, SZ MANCLARK, C BURNS, D TI STUDIES ON THE ENTRY OF PERTUSSIS TOXIN INTO CHO CELLS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 44 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200044 ER PT J AU BROWNING, M AF BROWNING, M TI ASSURING LABORATORY SOFTWARE QUALITY SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,OFF REGULATORY AFFAIRS,DIV FIELD INVEST,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 55 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200271 ER PT J AU GAO, P CHOU, MW AF GAO, P CHOU, MW TI EFFECT OF DIETARY RESTRICTION ON EPOXIDE HYDROLASE WHICH INFLUENCES AFLATOXIN-B1 ACTIVATION AND MUTAGENICITY SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 58 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200274 ER PT J AU OWNBY, C HALPERN, J COLBERG, T HABIG, W AF OWNBY, C HALPERN, J COLBERG, T HABIG, W TI PREPARATION OF A MONOCLONAL-ANTIBODY TO A HEMORRHAGIC TOXIN FROM PRAIRIE RATTLESNAKE (CROTALUS-VIRIDIS-VIRIDIS) VENOM - ITS CHARACTERISTICS AND USE IN ISOLATING THE TOXIN SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 OKLAHOMA STATE UNIV,DEPT PHYSIOL SCI,STILLWATER,OK 74078. US FDA,CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,BACTERIAL TOXINS LAB,BETHESDA,MD 20014. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 58 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200058 ER PT J AU PAULI, GH AF PAULI, GH TI FDA GUIDELINES FOR FOOD INGREDIENT SAFETY EVALUATION SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV FOOD & COLOR ADDIT,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 68 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200068 ER PT J AU EKELMAN, KB AF EKELMAN, KB TI REVISING FDAS TOXICITY TESTING GUIDELINES FOR FOOD AND COLOR ADDITIVES SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL REVIEW & EVALUAT,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 71 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200071 ER PT J AU PAGE, SW HALL, S AF PAGE, SW HALL, S TI SHELLFISH POISONS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 82 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200081 ER PT J AU HOLLIFIELD, HC AF HOLLIFIELD, HC TI OVERVIEW OF FDA STUDIES ON HIGH-TEMPERATURE FOOD-PACKAGING SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 86 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200085 ER PT J AU BEGLEY, TH HOLLIFIELD, HC AF BEGLEY, TH HOLLIFIELD, HC TI APPLICATION OF A SINGLE SIDED MIGRATION CELL FOR MEASURING MIGRATION THROUGH MICROWAVE SUSCEPTOR FILMS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 1 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 88 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200087 ER PT J AU CHANG, LS CARUSO, J WOLNIK, K HEITKEMPER, D DEUTSCH, E AF CHANG, LS CARUSO, J WOLNIK, K HEITKEMPER, D DEUTSCH, E TI A NEW AND RAPID METHOD FOR THE DETERMINATION OF TC-99 IN ENVIRONMENTAL-SAMPLES USING ICP-MS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 UNIV CINCINNATI,BIOMED CHEM RES CTR,CINCINNATI,OH 45221. US FDA,CTR FORENS CHEM,CINCINNATI,OH 45267. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 94 EP ENVR PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04201512 ER PT J AU BORODINSKY, L AF BORODINSKY, L TI TOWARD A THRESHOLD OF REGULATION FOR PACKAGING COMPONENTS - A FEASIBILITY STUDY SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 108 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200107 ER PT J AU HINSON, JA AF HINSON, JA TI DEVELOPMENT OF AN IMMUNOLOGICAL ASSAY TO DETECT ACETAMINOPHEN-PROTEIN ADDUCTS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 110 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200326 ER PT J AU KORFMACHER, WA LAY, JO BRYANT, MS HEINZE, TM FREEMAN, JP AF KORFMACHER, WA LAY, JO BRYANT, MS HEINZE, TM FREEMAN, JP TI MASS-SPECTROMETRY OF CARCINOGEN-DNA ADDUCTS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 NATL CTR TOXICOL RES,MASS SPECTROMETRY LAB,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 111 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200327 ER PT J AU TRUCKSESS, MW AF TRUCKSESS, MW TI LABORATORY SAFETY CONSIDERATIONS IN THE HANDLING OF NATURAL TOXINS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 122 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200121 ER PT J AU STARUSZKIEWICZ, WF AF STARUSZKIEWICZ, WF TI SEAFOOD SAFETY SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 123 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200122 ER PT J AU WOOD, GE POHLAND, AE AF WOOD, GE POHLAND, AE TI MYCOTOXINS IN FOODS AND THEIR SAFETY RAMIFICATIONS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 138 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200137 ER PT J AU DIACHENKO, GW CANAS, BJ JOE, FL AF DIACHENKO, GW CANAS, BJ JOE, FL TI UPDATE ON INVESTIGATIONS RELATED TO ETHYL CARBAMATE IN ALCOHOLIC BEVERAGES AND FERMENTED FOODS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 140 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200139 ER PT J AU KISHORE, R SHEININ, EB AF KISHORE, R SHEININ, EB TI IMPLICATIONS OF THE FOOD, DRUG, AND COSMETIC ACT ON THE QUALITY ASSURANCE OF RADIOPHARMACEUTICALS USED IN THE UNITED-STATES SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 141 EP NUCL PN 2 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU043 UT WOS:A1990DU04300140 ER PT J AU WEBER, NE AF WEBER, NE TI FDA DRAFT GUIDELINE FOR SAFETY ASSESSMENT OF BOUND RESIDUES SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR VET MED,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 143 EP AGRO PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200358 ER PT J AU FIFER, EK GIBSON, G SHAIKH, AU HEFLICH, RH AF FIFER, EK GIBSON, G SHAIKH, AU HEFLICH, RH TI STRUCTURE-MUTAGENICITY RELATIONSHIPS OF NITROPHENYLFURANS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 UNIV ARKANSAS MED SCI HOSP,DEPT BIOPHARMACEUT SCI,LITTLE ROCK,AR 72205. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. UNIV ARKANSAS,DEPT CHEM,LITTLE ROCK,AR 72204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 152 EP MEDI PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04202563 ER PT J AU SHEININ, EB KISHORE, R AF SHEININ, EB KISHORE, R TI NEW DRUG APPROVAL PROCESS FOR RADIOPHARMACEUTICALS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 157 EP NUCL PN 2 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU043 UT WOS:A1990DU04300156 ER PT J AU KISHORE, R AF KISHORE, R TI ABBREVIATED NEW DRUG APPLICATIONS (ANDAS) - FUTURE TREND IN RADIOPHARMACEUTICALS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,ROCKVILLE,MD 20857. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 158 EP NUCL PN 2 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU043 UT WOS:A1990DU04300157 ER PT J AU HATTAN, DG AF HATTAN, DG TI USE OF ACUTE AND CHRONIC TESTING FOR SAFETY ASSESSMENT OF FOOD-ADDITIVES SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL REVIEW & EVALUAT,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 162 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200161 ER PT J AU RULIS, AM AF RULIS, AM TI THRESHOLD OF REGULATION - A LOOK AT SOME OPTIONS FOR HANDLING MINIMAL RISK SITUATIONS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 163 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200162 ER PT J AU FRY, FS CHAMBERS, TL ALBERT, RA PAGE, SW DUSOLD, LR FISHBACK, V AF FRY, FS CHAMBERS, TL ALBERT, RA PAGE, SW DUSOLD, LR FISHBACK, V TI USE OF PATTERN-RECOGNITION TECHNIQUES FOR THE DETECTION OF ADULTERATION OF ORANGE JUICES SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204. INFOMETRIX INC,SEATTLE,WA 98121. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 172 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200171 ER PT J AU YANG, GC YASAEI, P WRIGHT, P KU, Y AF YANG, GC YASAEI, P WRIGHT, P KU, Y TI DETECTION OF LIPID HYDROPEROXIDES IN FOODS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 177 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200176 ER PT J AU WARNER, CR YANG, GC DANIELS, DH YASAEI, P MOSSOBA, M CHEN, JY KU, Y AF WARNER, CR YANG, GC DANIELS, DH YASAEI, P MOSSOBA, M CHEN, JY KU, Y TI SINGLET OXYGEN OXIDATION OF LIPIDS IN THE PRESENCE OF ANTIOXIDANTS SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 178 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200177 ER PT J AU MCLAUGHLIN, MA CASTERLINE, JL AF MCLAUGHLIN, MA CASTERLINE, JL TI EQUILIBRIUM DIALYSIS BINDING-STUDIES OF BILE-ACIDS BY VARIOUS TYPES OF FIBER SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY LA English DT Meeting Abstract C1 US FDA,FOOD FORMULAT BRANCH,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0065-7727 J9 ABSTR PAP AM CHEM S JI Abstr. Pap. Am. Chem. Soc. PD AUG 26 PY 1990 VL 200 BP 216 EP AGFD PN 1 PG 0 WC Chemistry, Multidisciplinary SC Chemistry GA DU042 UT WOS:A1990DU04200215 ER PT J AU JUSKEVICH, JC GUYER, CG AF JUSKEVICH, JC GUYER, CG TI BOVINE GROWTH-HORMONE - HUMAN FOOD SAFETY EVALUATION SO SCIENCE LA English DT Article C1 US FDA,CTR VET MED,OFF NEW ANIM DRUG EVALUAT,DIV CHEM,5600 FISHERS LANE,ROOM 8-8,ROCKVILLE,MD 20857. US FDA,CTR VET MED,OFF NEW ANIM DRUG EVALUAT,DIV TOXICOL,ROCKVILLE,MD 20857. NR 89 TC 131 Z9 137 U1 0 U2 27 PU AMER ASSOC ADVANCEMENT SCIENCE PI WASHINGTON PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 SN 0036-8075 J9 SCIENCE JI Science PD AUG 24 PY 1990 VL 249 IS 4971 BP 875 EP 884 DI 10.1126/science.2203142 PG 10 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DV751 UT WOS:A1990DV75100034 PM 2203142 ER PT J AU CUMMINS, RO CHESEMORE, K WHITE, RD AF CUMMINS, RO CHESEMORE, K WHITE, RD TI DEFIBRILLATOR FAILURES - CAUSES OF PROBLEMS AND RECOMMENDATIONS FOR IMPROVEMENT SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Article C1 US FDA,HFZ-250,5600 FISHERS LN,ROCKVILLE,MD 20857. MAYO CLIN & HOSP,DEPT ANESTHESIOL,ROCHESTER,MN. UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195. NR 41 TC 29 Z9 30 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD AUG 22 PY 1990 VL 264 IS 8 BP 1019 EP 1025 DI 10.1001/jama.264.8.1019 PG 7 WC Medicine, General & Internal SC General & Internal Medicine GA DU589 UT WOS:A1990DU58900037 PM 2376873 ER PT J AU COLLINS, JM GRIESHABER, CK CHABNER, BA AF COLLINS, JM GRIESHABER, CK CHABNER, BA TI PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT SO JOURNAL OF THE NATIONAL CANCER INSTITUTE LA English DT Review C1 NCI,DIV CANC TREATMENT,BETHESDA,MD 20205. RP COLLINS, JM (reprint author), US FDA,CTR DRUG EVALUAT & RES,PARKLAWN BLDG,RM 13B21,ROCKVILLE,MD 20857, USA. NR 31 TC 145 Z9 147 U1 0 U2 7 PU NATL CANCER INSTITUTE PI BETHESDA PA 9030 OLD GEORGETOWN RD, BETHESDA, MD 20814 SN 0027-8874 J9 J NATL CANCER I JI J. Natl. Cancer Inst. PD AUG 15 PY 1990 VL 82 IS 16 BP 1321 EP 1326 DI 10.1093/jnci/82.16.1321 PG 6 WC Oncology SC Oncology GA DU146 UT WOS:A1990DU14600002 PM 2143234 ER PT J AU HATHCOCK, JN HATTAN, DG JENKINS, MY MCDONALD, JT SUNDARESAN, PR WILKENING, VL AF HATHCOCK, JN HATTAN, DG JENKINS, MY MCDONALD, JT SUNDARESAN, PR WILKENING, VL TI EVALUATION OF VITAMIN-A TOXICITY SO AMERICAN JOURNAL OF CLINICAL NUTRITION LA English DT Review C1 US FDA,DIST OFF,SAN FRANCISCO,CA 94102. RP HATHCOCK, JN (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,HFF-268,200 C ST SW,WASHINGTON,DC 20204, USA. NR 225 TC 222 Z9 226 U1 0 U2 13 PU AMER SOC CLIN NUTRITION INC PI BETHESDA PA 9650 ROCKVILLE PIKE SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998 SN 0002-9165 J9 AM J CLIN NUTR JI Am. J. Clin. Nutr. PD AUG PY 1990 VL 52 IS 2 BP 183 EP 202 PG 20 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DQ603 UT WOS:A1990DQ60300001 PM 2197848 ER PT J AU LEWIS, CJ MCDOWELL, MA SEMPOS, CT LEWIS, KC YETLEY, EA AF LEWIS, CJ MCDOWELL, MA SEMPOS, CT LEWIS, KC YETLEY, EA TI RELATIONSHIP BETWEEN AGE AND SERUM VITAMIN-A IN CHILDREN AGED 4-11 Y SO AMERICAN JOURNAL OF CLINICAL NUTRITION LA English DT Article C1 NATL CTR HLTH STAT,CTR DIS CONTROL,HYATTSVILLE,MD 20782. NCI,BETHESDA,MD 20205. RP LEWIS, CJ (reprint author), US FDA,HFF-265,200 C ST SW,WASHINGTON,DC 20204, USA. NR 27 TC 13 Z9 14 U1 1 U2 1 PU AMER SOC CLIN NUTRITION INC PI BETHESDA PA 9650 ROCKVILLE PIKE SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998 SN 0002-9165 J9 AM J CLIN NUTR JI Am. J. Clin. Nutr. PD AUG PY 1990 VL 52 IS 2 BP 353 EP 360 PG 8 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DQ603 UT WOS:A1990DQ60300025 PM 2375301 ER PT J AU CLARK, JA ZIMMERMAN, HJ TANNER, LA AF CLARK, JA ZIMMERMAN, HJ TANNER, LA TI LABETALOL HEPATOTOXICITY SO ANNALS OF INTERNAL MEDICINE LA English DT Article C1 US FDA,OFF EPIDEMIOL & BIOSTAT,HFD-735,5600 FISHERS LANE,ROCKVILLE,MD 20857. ARMED FORCES INST PATHOL,WASHINGTON,DC 20306. NR 11 TC 49 Z9 49 U1 0 U2 1 PU AMER COLL PHYSICIANS PI PHILADELPHIA PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 SN 0003-4819 J9 ANN INTERN MED JI Ann. Intern. Med. PD AUG 1 PY 1990 VL 113 IS 3 BP 210 EP 213 PG 4 WC Medicine, General & Internal SC General & Internal Medicine GA DQ421 UT WOS:A1990DQ42100007 PM 2375555 ER PT J AU DEPAOLA, A HOPKINS, LH PEELER, JT WENTZ, B MCPHEARSON, RM AF DEPAOLA, A HOPKINS, LH PEELER, JT WENTZ, B MCPHEARSON, RM TI INCIDENCE OF VIBRIO-PARAHAEMOLYTICUS IN UNITED-STATES COASTAL WATERS AND OYSTERS SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 US FDA,DIV MICROBIOL,WASHINGTON,DC 20204. JACKSONVILLE STATE UNIV,DEPT BIOL,JACKSONVILLE,AL 36265. RP DEPAOLA, A (reprint author), US FDA,FISHERY RES BRANCH,DAUPHIN ISL,AL 36528, USA. NR 27 TC 162 Z9 171 U1 0 U2 4 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD AUG PY 1990 VL 56 IS 8 BP 2299 EP 2302 PG 4 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA DR576 UT WOS:A1990DR57600005 PM 2403249 ER PT J AU SUTHERLAND, JB FREEMAN, JP SELBY, AL FU, PP MILLER, DW CERNIGLIA, CE AF SUTHERLAND, JB FREEMAN, JP SELBY, AL FU, PP MILLER, DW CERNIGLIA, CE TI STEREOSELECTIVE FORMATION OF A K-REGION DIHYDRODIOL FROM PHENANTHRENE BY STREPTOMYCES-FLAVOVIRENS SO ARCHIVES OF MICROBIOLOGY LA English DT Article C1 US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NR 46 TC 40 Z9 46 U1 2 U2 3 PU SPRINGER VERLAG PI NEW YORK PA 175 FIFTH AVE, NEW YORK, NY 10010 SN 0302-8933 J9 ARCH MICROBIOL JI Arch. Microbiol. PD AUG PY 1990 VL 154 IS 3 BP 260 EP 266 DI 10.1007/BF00248965 PG 7 WC Microbiology SC Microbiology GA DW079 UT WOS:A1990DW07900010 PM 2222121 ER PT J AU PRASANNA, HR NAKAMURA, KD LU, MH HART, RW AF PRASANNA, HR NAKAMURA, KD LU, MH HART, RW TI EFFECT OF DEHYDROEPIANDROSTERONE ON THE GROWTH, BIOCHEMICAL-CHANGES, AND METABOLISM OF AFLATOXIN-B1 IN HUMAN FIBROBLAST CELL-CULTURES SO BIOCHEMICAL ARCHIVES LA English DT Article RP PRASANNA, HR (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 19 TC 2 Z9 2 U1 0 U2 0 PU MBR PRESS INC PI KENYON PA PO BOX P, KENYON, MN 55946-000P SN 0749-5331 J9 BIOCHEM ARCH JI Biochem. Arch. PD AUG PY 1990 VL 6 IS 3 BP 253 EP 260 PG 8 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DX296 UT WOS:A1990DX29600003 ER PT J AU PUMFORD, NR ROBERTS, DW BENSON, RW HINSON, JA AF PUMFORD, NR ROBERTS, DW BENSON, RW HINSON, JA TI IMMUNOCHEMICAL QUANTITATION OF 3-(CYSTEIN-S-YL)ACETAMINOPHEN PROTEIN ADDUCTS IN SUBCELLULAR LIVER FRACTIONS FOLLOWING A HEPATOTOXIC DOSE OF ACETAMINOPHEN SO BIOCHEMICAL PHARMACOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,HFT-110,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,DIV INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205. NR 29 TC 42 Z9 44 U1 1 U2 1 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0006-2952 J9 BIOCHEM PHARMACOL JI Biochem. Pharmacol. PD AUG 1 PY 1990 VL 40 IS 3 BP 573 EP 579 DI 10.1016/0006-2952(90)90558-3 PG 7 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DU455 UT WOS:A1990DU45500023 PM 2200409 ER PT J AU CRESPI, CL PENMAN, BW LEAKEY, JAE ARLOTTO, MP STARK, A PARKINSON, A TURNER, T STEIMEL, DT RUDO, K DAVIES, RL LANGENBACH, R AF CRESPI, CL PENMAN, BW LEAKEY, JAE ARLOTTO, MP STARK, A PARKINSON, A TURNER, T STEIMEL, DT RUDO, K DAVIES, RL LANGENBACH, R TI HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1 SO CARCINOGENESIS LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. TEL AVIV UNIV,IL-69978 TEL AVIV,ISRAEL. UNIV KANSAS,MED CTR,DEPT PHARMACOL TOXICOL & THERAPEUT,KANSAS CITY,KS 66103. NIEHS,RES TRIANGLE PK,NC 27709. RP CRESPI, CL (reprint author), GENTEST CORP,6 HENSHAW ST,WOBURN,MA 01801, USA. FU NIEHS NIH HHS [ES00166, ES03765] NR 44 TC 139 Z9 140 U1 0 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD AUG PY 1990 VL 11 IS 8 BP 1293 EP 1300 DI 10.1093/carcin/11.8.1293 PG 8 WC Oncology SC Oncology GA DV687 UT WOS:A1990DV68700009 PM 2117502 ER PT J AU FULLERTON, FR HOOVER, K MIKOL, YB CREASIA, DA POIRIER, LA AF FULLERTON, FR HOOVER, K MIKOL, YB CREASIA, DA POIRIER, LA TI THE INHIBITION BY METHIONINE AND CHOLINE OF LIVER-CARCINOMA FORMATION IN MALE C3H MICE DOSED WITH DIETHYLNITROSAMINE AND FED PHENOBARBITAL SO CARCINOGENESIS LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. FREDERICK CANC RES FACIL,FREDERICK,MD 21701. NR 34 TC 19 Z9 19 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD AUG PY 1990 VL 11 IS 8 BP 1301 EP 1305 DI 10.1093/carcin/11.8.1301 PG 5 WC Oncology SC Oncology GA DV687 UT WOS:A1990DV68700010 PM 2387015 ER PT J AU PELUSO, M CASTEGNARO, M MALAVEILLE, C TALASKA, G VINEIS, P KADLUBAR, F BARTSCH, H AF PELUSO, M CASTEGNARO, M MALAVEILLE, C TALASKA, G VINEIS, P KADLUBAR, F BARTSCH, H TI P-32 POSTLABELING ANALYSIS OF DNA ADDUCTED WITH URINARY MUTAGENS FROM SMOKERS OF BLACK TOBACCO SO CARCINOGENESIS LA English DT Article C1 INT AGCY RES CANC,150 COURS ALBERT THOMAS,F-69372 LYONS,FRANCE. NATL CTR TOXICOL RES,JEFFERSON,AR 72079. UNIV TURIN,I-10126 TURIN,ITALY. NR 26 TC 44 Z9 45 U1 1 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD AUG PY 1990 VL 11 IS 8 BP 1307 EP 1311 DI 10.1093/carcin/11.8.1307 PG 5 WC Oncology SC Oncology GA DV687 UT WOS:A1990DV68700011 PM 2387016 ER PT J AU POIRIER, MC FULLERTON, NF PATTERSON, ED BELAND, FA AF POIRIER, MC FULLERTON, NF PATTERSON, ED BELAND, FA TI DNA ADDUCT FORMATION AND REMOVAL IN HEPATIC CHROMATIN FRACTIONS FROM RATS CHRONICALLY FED 2-ACETYLAMINOFLUORENE SO CARCINOGENESIS LA English DT Article C1 NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,JEFFERSON,AR 72079. RP POIRIER, MC (reprint author), NCI,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,BETHESDA,MD 20892, USA. NR 38 TC 15 Z9 15 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD AUG PY 1990 VL 11 IS 8 BP 1343 EP 1347 DI 10.1093/carcin/11.8.1343 PG 5 WC Oncology SC Oncology GA DV687 UT WOS:A1990DV68700016 PM 2387020 ER PT J AU AKAI, H LARNER, AC AF AKAI, H LARNER, AC TI CHARACTERIZATION OF 2 INDEPENDENT MECHANISMS BY WHICH INTERFERON-INDUCED GENE-EXPRESSION IS DOWN REGULATED SO CELL REGULATION LA English DT Article RP AKAI, H (reprint author), NIH,CTR BIOL EVALUAT & RES,CYTOKINE RES LAB,BETHESDA,MD 20892, USA. NR 25 TC 6 Z9 6 U1 0 U2 0 PU AMER SOC CELL BIOL PI BETHESDA PA PUBL OFFICE 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 1044-2030 J9 CELL REGUL PD AUG PY 1990 VL 1 IS 9 BP 707 EP 713 PG 7 WC Cell Biology SC Cell Biology GA DZ340 UT WOS:A1990DZ34000009 PM 2127700 ER PT J AU VINCENT, JP KASSIS, JA OFARRELL, PH AF VINCENT, JP KASSIS, JA OFARRELL, PH TI A SYNTHETIC HOMEODOMAIN BINDING-SITE ACTS AS A CELL TYPE SPECIFIC, PROMOTER SPECIFIC ENHANCER IN DROSOPHILA EMBRYOS SO EMBO JOURNAL LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892. RP VINCENT, JP (reprint author), UNIV CALIF SAN FRANCISCO,MED CTR,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA. OI Kassis, Judith/0000-0001-9268-3213; O'Farrell, Patrick/0000-0003-0011-2734 FU NIGMS NIH HHS [GM37193, R01 GM037193] NR 36 TC 43 Z9 43 U1 0 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0261-4189 J9 EMBO J JI Embo J. PD AUG PY 1990 VL 9 IS 8 BP 2573 EP 2578 PG 6 WC Biochemistry & Molecular Biology; Cell Biology SC Biochemistry & Molecular Biology; Cell Biology GA DP595 UT WOS:A1990DP59500030 PM 1973384 ER PT J AU FEHRINGER, NV WALTERS, SW AF FEHRINGER, NV WALTERS, SW TI HRGC-FPD AND HRGC/MS-ITD CHARACTERIZATION OF PENTYL DERIVATIVES OF THE PHENYL-TIN AND CYCLOHEXYL-TIN PESTICIDES AND THEIR METABOLITES SO HRC-JOURNAL OF HIGH RESOLUTION CHROMATOGRAPHY LA English DT Note RP FEHRINGER, NV (reprint author), US FDA,PESTICIDES & IND CHEM RES CTR,1560 E JEFFERSON,DETROIT,MI 48207, USA. NR 5 TC 5 Z9 5 U1 0 U2 0 PU DR ALFRED HUTHIG VERLAG GMBH PI HEIDELBERG 1 PA POSTFACH 102869, W-69018 HEIDELBERG 1, GERMANY SN 0935-6304 J9 HRC-J HIGH RES CHROM JI HRC-J. High Resolut. Chromatogr. PD AUG PY 1990 VL 13 IS 8 BP 575 EP 579 PG 5 WC Chemistry, Analytical SC Chemistry GA DZ570 UT WOS:A1990DZ57000013 ER PT J AU EPSTEIN, SL ARN, JS SACHS, DH AF EPSTEIN, SL ARN, JS SACHS, DH TI 7 NEW MHC RECOMBINANT STRAINS DEFINING NEW H-2 HAPLOTYPES SO IMMUNOGENETICS LA English DT Article C1 NCI,IMMUNOL BRANCH,BETHESDA,MD 20892. RP EPSTEIN, SL (reprint author), US FDA,CBER,OBRR,DBB,MOLEC IMMUNOL,BETHESDA,MD 20892, USA. FU NCI NIH HHS [N01-CB-25585] NR 12 TC 2 Z9 2 U1 0 U2 1 PU SPRINGER VERLAG PI NEW YORK PA 175 FIFTH AVE, NEW YORK, NY 10010 SN 0093-7711 J9 IMMUNOGENETICS JI Immunogenetics PD AUG PY 1990 VL 32 IS 2 BP 142 EP 145 PG 4 WC Genetics & Heredity; Immunology SC Genetics & Heredity; Immunology GA DW480 UT WOS:A1990DW48000011 PM 2397934 ER PT J AU PURI, RK FINBLOOM, DS LELAND, P MOSTOWSKI, H SIEGEL, JP AF PURI, RK FINBLOOM, DS LELAND, P MOSTOWSKI, H SIEGEL, JP TI EXPRESSION OF HIGH-AFFINITY IL-4 RECEPTORS ON MURINE TUMOR INFILTRATING LYMPHOCYTES AND THEIR UP-REGULATION BY IL-2 SO IMMUNOLOGY LA English DT Article RP PURI, RK (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,CELLULAR IMMUNOL LAB,BETHESDA,MD 20892, USA. NR 24 TC 23 Z9 23 U1 0 U2 0 PU BLACKWELL SCIENCE LTD PI OXFORD PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL SN 0019-2805 J9 IMMUNOLOGY JI Immunology PD AUG PY 1990 VL 70 IS 4 BP 492 EP 497 PG 6 WC Immunology SC Immunology GA DT096 UT WOS:A1990DT09600012 PM 2203676 ER PT J AU TRAN, AT HITCHINS, AD COLLIER, SW AF TRAN, AT HITCHINS, AD COLLIER, SW TI DIRECT CONTACT MEMBRANE METHOD FOR EVALUATING PRESERVATIVE EFFICACY IN SOLID COSMETICS SO INTERNATIONAL JOURNAL OF COSMETIC SCIENCE LA English DT Article RP TRAN, AT (reprint author), US FDA,200 C ST SW,WASHINGTON,DC 20204, USA. NR 7 TC 3 Z9 3 U1 1 U2 1 PU CHAPMAN HALL LTD PI LONDON PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN SN 0142-5463 J9 INT J COSMETIC SCI PD AUG PY 1990 VL 12 IS 4 BP 175 EP 183 DI 10.1111/j.1467-2494.1990.tb00533.x PG 9 WC Chemistry, Applied; Dermatology SC Chemistry; Dermatology GA EM728 UT WOS:A1990EM72800004 PM 19291044 ER PT J AU BICKEL, M COHEN, RB PLUZNIK, DH AF BICKEL, M COHEN, RB PLUZNIK, DH TI POSTTRANSCRIPTIONAL REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SYNTHESIS IN MURINE T-CELLS SO JOURNAL OF IMMUNOLOGY LA English DT Article RP BICKEL, M (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BLDG 29A,RM 3B19,HFB-800,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 34 TC 75 Z9 75 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD AUG 1 PY 1990 VL 145 IS 3 BP 840 EP 845 PG 6 WC Immunology SC Immunology GA DQ569 UT WOS:A1990DQ56900008 PM 2197329 ER PT J AU FELDMAN, GM FINBLOOM, DS AF FELDMAN, GM FINBLOOM, DS TI INDUCTION AND REGULATION OF IL-4 RECEPTOR EXPRESSION ON MURINE MACROPHAGE CELL-LINES AND BONE MARROW-DERIVED MACROPHAGES BY IFN-GAMMA SO JOURNAL OF IMMUNOLOGY LA English DT Article RP FELDMAN, GM (reprint author), US FDA,DIV CYTOKINE BIOL,CYTOKINE RES LAB,BLDG 29A,RM 2B02,BETHESDA,MD 20892, USA. NR 61 TC 22 Z9 22 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD AUG 1 PY 1990 VL 145 IS 3 BP 854 EP 859 PG 6 WC Immunology SC Immunology GA DQ569 UT WOS:A1990DQ56900010 PM 2115545 ER PT J AU GOUVEA, V HO, MS GLASS, R WOODS, P FORRESTER, B ROBINSON, C ASHLEY, R RIEPENHOFFTALTY, M CLARK, HF TANIGUCHI, K MEDDIX, E MCKELLAR, B PICKERING, L AF GOUVEA, V HO, MS GLASS, R WOODS, P FORRESTER, B ROBINSON, C ASHLEY, R RIEPENHOFFTALTY, M CLARK, HF TANIGUCHI, K MEDDIX, E MCKELLAR, B PICKERING, L TI SEROTYPES AND ELECTROPHEROTYPES OF HUMAN ROTAVIRUS IN THE USA - 1987-1989 SO JOURNAL OF INFECTIOUS DISEASES LA English DT Article C1 SK&F LABS,ATLANTA,GA. US FDA,WASHINGTON,DC 20204. CHILDRENS HOSP DENVER,DENVER,CO. UNIV WASHINGTON,SEATTLE,WA 98195. CHILDRENS HOSP BUFFALO,BUFFALO,NY. CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA. SAPPORO MED COLL,SAPPORO,HOKKAIDO 060,JAPAN. UNIV CALIF SAN DIEGO,MED CTR,LA JOLLA,CA 92093. UNIV TEXAS,SCH MED,HOUSTON,TX 77025. RP GOUVEA, V (reprint author), CTR DIS CONTROL,VIRAL GASTROENTERITIS UNIT,G04,1600 CLIFTON RD,ATLANTA,GA 30333, USA. NR 31 TC 59 Z9 60 U1 0 U2 1 PU UNIV CHICAGO PRESS PI CHICAGO PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637 SN 0022-1899 J9 J INFECT DIS JI J. Infect. Dis. PD AUG PY 1990 VL 162 IS 2 BP 362 EP 367 PG 6 WC Immunology; Infectious Diseases; Microbiology SC Immunology; Infectious Diseases; Microbiology GA DQ926 UT WOS:A1990DQ92600011 PM 2165108 ER PT J AU HART, RW TURTURRO, A NEWBERNE, PM SCHRAGER, TF HATHCOCK, JN CALDWELL, J SUTTON, JD HOWES, AJ AF HART, RW TURTURRO, A NEWBERNE, PM SCHRAGER, TF HATHCOCK, JN CALDWELL, J SUTTON, JD HOWES, AJ TI NUTRITIONAL MODULATION OF XENOBIOTIC METABOLISM - CALORIC RESTRICTION - EFFECTS ON PHARMACODYNAMICS - METHYL-GROUP METABOLISM AND AFLATOXIN-B1 IN HEPATOCARCINOGENESIS - METABOLIC DEPLETION OF NUTRIENTS BY DRUGS - COMPARATIVE-STUDIES ON THE METABOLISM OF FOOD-ADDITIVES - CASE EXAMPLES IN THE SAFETY EVALUATION OF THE ALLYLBENZENE NATURAL FLAVORS SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY LA English DT Article C1 BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02118. US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079. US FDA,EXPTL NUTR BRANCH,WASHINGTON,DC 20204. ST MARYS HOSP,SCH MED,DEPT PHARMACOL & TOXICOL,LONDON,ENGLAND. NR 106 TC 1 Z9 1 U1 0 U2 0 PU BUTTERWORTH-HEINEMANN PI WOBURN PA 225 WILDWOOD AVE #UNITB PO BOX 4500, WOBURN, MA 01801-2084 SN 0955-2863 J9 J NUTR BIOCHEM JI J. Nutr. Biochem. PD AUG PY 1990 VL 1 IS 8 BP 396 EP 409 PG 14 WC Biochemistry & Molecular Biology; Nutrition & Dietetics SC Biochemistry & Molecular Biology; Nutrition & Dietetics GA DT016 UT WOS:A1990DT01600001 ER PT J AU SHANK, FR AF SHANK, FR TI ISSUES OF INSPECTION AND SAFETY OF SEAFOOD EXAMINED SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION LA English DT Letter RP SHANK, FR (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AMER DIETETIC ASSN PI CHICAGO PA 216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995 SN 0002-8223 J9 J AM DIET ASSOC JI J. Am. Diet. Assoc. PD AUG PY 1990 VL 90 IS 8 BP 1054 EP 1054 PG 1 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DT623 UT WOS:A1990DT62300001 PM 2380451 ER PT J AU COOK, KK GREGORY, NR WEAVER, CM AF COOK, KK GREGORY, NR WEAVER, CM TI AGREEMENT BETWEEN ANALYTICAL VALUES AND LABEL DECLARATIONS OF SODIUM CONTENT OF PROCESSED PACKAGED FOODS SO JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION LA English DT Article RP COOK, KK (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR DIV NUTR,NUTRIENT SURVEILLANCE BRANCH,WASHINGTON,DC 20204, USA. NR 10 TC 5 Z9 5 U1 0 U2 0 PU AMER DIETETIC ASSN PI CHICAGO PA 216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995 SN 0002-8223 J9 J AM DIET ASSOC JI J. Am. Diet. Assoc. PD AUG PY 1990 VL 90 IS 8 BP 1085 EP 1088 PG 4 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DT623 UT WOS:A1990DT62300010 PM 2380456 ER PT J AU NARA, PL SMIT, L DUNLOP, N HATCH, W MERGES, M WATERS, D KELLIHER, J GALLO, RC FISCHINGER, PJ GOUDSMIT, J AF NARA, PL SMIT, L DUNLOP, N HATCH, W MERGES, M WATERS, D KELLIHER, J GALLO, RC FISCHINGER, PJ GOUDSMIT, J TI EMERGENCE OF VIRUSES RESISTANT TO NEUTRALIZATION BY V3-SPECIFIC ANTIBODIES IN EXPERIMENTAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-IIIB INFECTION OF CHIMPANZEES SO JOURNAL OF VIROLOGY LA English DT Article C1 PROGRAM RESOURCES INC,FREDERICK,MD 21701. US FDA,WASHINGTON,DC 20202. UNIV AMSTERDAM,ACAD MED CTR,HUMAN RETROVIRUS LAB,1105 AZ AMSTERDAM,NETHERLANDS. YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461. MED UNIV S CAROLINA,CHARLESTON,SC 29425. RP NARA, PL (reprint author), NCI,FREDERICK CANC RES FACIL,FREDERICK,MD 21701, USA. FU NCI NIH HHS [N01-CO-74102] NR 57 TC 242 Z9 242 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0022-538X J9 J VIROL JI J. Virol. PD AUG PY 1990 VL 64 IS 8 BP 3779 EP 3791 PG 13 WC Virology SC Virology GA DR597 UT WOS:A1990DR59700026 PM 2370681 ER PT J AU MAYER, VW AGUILERA, A AF MAYER, VW AGUILERA, A TI HIGH-LEVELS OF CHROMOSOME INSTABILITY IN POLYPLOIDS OF SACCHAROMYCES-CEREVISIAE SO MUTATION RESEARCH LA English DT Article C1 NYU MED CTR,DEPT BIOCHEM,NEW YORK,NY 10016. RP MAYER, VW (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL STUDIES,WASHINGTON,DC 20204, USA. NR 67 TC 84 Z9 85 U1 1 U2 5 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0921-8262 J9 MUTAT RES PD AUG PY 1990 VL 231 IS 2 BP 177 EP 186 DI 10.1016/0027-5107(90)90024-X PG 10 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA DV946 UT WOS:A1990DV94600007 PM 2200955 ER PT J AU IYER, RP PHILLIPS, LR EGAN, W REGAN, JB BEAUCAGE, SL AF IYER, RP PHILLIPS, LR EGAN, W REGAN, JB BEAUCAGE, SL TI THE AUTOMATED SYNTHESIS OF SULFUR-CONTAINING OLIGODEOXYRIBONUCLEOTIDES USING 3H-1,2-BENZODITHIOL-3-ONE 1,1-DIOXIDE AS A SULFUR-TRANSFER REAGENT SO JOURNAL OF ORGANIC CHEMISTRY LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,8800 ROCKVILLE PIKE,BETHESDA,MD 20892. NR 40 TC 247 Z9 249 U1 3 U2 13 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0022-3263 J9 J ORG CHEM JI J. Org. Chem. PD JUL 20 PY 1990 VL 55 IS 15 BP 4693 EP 4699 DI 10.1021/jo00302a039 PG 7 WC Chemistry, Organic SC Chemistry GA DP939 UT WOS:A1990DP93900039 ER PT J AU WOHLLEB, JC HUNTER, CF BLASS, B KADLUBAR, FF CHU, DZJ LANG, NP AF WOHLLEB, JC HUNTER, CF BLASS, B KADLUBAR, FF CHU, DZJ LANG, NP TI AROMATIC AMINE ACETYLTRANSFERASE AS A MARKER FOR COLORECTAL-CANCER - ENVIRONMENTAL AND DEMOGRAPHIC ASSOCIATIONS SO INTERNATIONAL JOURNAL OF CANCER LA English DT Article C1 NATL CTR TOXICOL RES,OFF RES HFT 100,JEFFERSON,AR 72079. ARKANSAS DEPT HLTH,EPIDEMIOL SECT,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,SCH MED,DEPT SURG,LITTLE ROCK,AR 72205. NR 53 TC 97 Z9 97 U1 0 U2 0 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0020-7136 J9 INT J CANCER JI Int. J. Cancer PD JUL 15 PY 1990 VL 46 IS 1 BP 22 EP 30 DI 10.1002/ijc.2910460107 PG 9 WC Oncology SC Oncology GA DN991 UT WOS:A1990DN99100006 PM 2365498 ER PT J AU DONNELLY, RP FENTON, MJ FINBLOOM, DS GERRARD, TL AF DONNELLY, RP FENTON, MJ FINBLOOM, DS GERRARD, TL TI DIFFERENTIAL REGULATION OF IL-1 PRODUCTION IN HUMAN MONOCYTES BY IFN-GAMMA AND IL-4 SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118. RP DONNELLY, RP (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BLDG 29A,HFB 800,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 34 TC 149 Z9 149 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD JUL 15 PY 1990 VL 145 IS 2 BP 569 EP 575 PG 7 WC Immunology SC Immunology GA DN531 UT WOS:A1990DN53100023 PM 2114443 ER PT J AU BEEBE, DP WOOD, LL MOOS, M AF BEEBE, DP WOOD, LL MOOS, M TI CHARACTERIZATION OF TISSUE PLASMINOGEN-ACTIVATOR BINDING-PROTEINS ISOLATED FROM ENDOTHELIAL-CELLS AND OTHER CELL-TYPES SO THROMBOSIS RESEARCH LA English DT Article RP BEEBE, DP (reprint author), US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892, USA. RI Moos, Malcolm/F-3673-2011 OI Moos, Malcolm/0000-0002-9575-9938 NR 22 TC 16 Z9 16 U1 0 U2 0 PU PERGAMON-ELSEVIER SCIENCE LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB SN 0049-3848 J9 THROMB RES JI Thromb. Res. PD JUL 15 PY 1990 VL 59 IS 2 BP 339 EP 350 DI 10.1016/0049-3848(90)90136-Z PG 12 WC Hematology; Peripheral Vascular Disease SC Hematology; Cardiovascular System & Cardiology GA DV494 UT WOS:A1990DV49400011 PM 2122540 ER PT J AU BRANDO, C HOFFMAN, T BONVINI, E AF BRANDO, C HOFFMAN, T BONVINI, E TI HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF INOSITOL PHOSPHATE ISOMERS EMPLOYING A REVERSED-PHASE COLUMN AND A MICELLAR MOBILE PHASE SO JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS LA English DT Article RP BRANDO, C (reprint author), US FDA,CTR BIOLOG EVALUAT & RES,DIV BLOOD & BLOOD PROD,CELL BIOL LAB,BETHESDA,MD 20892, USA. NR 20 TC 19 Z9 19 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0378-4347 J9 J CHROMATOGR-BIOMED JI J. Chromatogr.-Biomed. Appl. PD JUL 13 PY 1990 VL 529 IS 1 BP 65 EP 80 DI 10.1016/S0378-4347(00)83808-6 PG 16 WC Chemistry, Analytical SC Chemistry GA DT009 UT WOS:A1990DT00900006 PM 2211942 ER PT J AU PIERCE, LR WYSOWSKI, DK GROSS, TP AF PIERCE, LR WYSOWSKI, DK GROSS, TP TI MYOPATHY AND RHABDOMYOLYSIS ASSOCIATED WITH LOVASTATIN-GEMFIBROZIL COMBINATION THERAPY SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Article C1 US FDA,DIV EPIDEMIOL & BIOSTAT,ROCKVILLE,MD 20857. RP PIERCE, LR (reprint author), US FDA,DIV METAB & ENDOCRINE DRUG PROD,OFF DRUG EVALUAT 2,HFD 510,ROCKVILLE,MD 20857, USA. NR 40 TC 365 Z9 370 U1 1 U2 10 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD JUL 4 PY 1990 VL 264 IS 1 BP 71 EP 75 DI 10.1001/jama.264.1.71 PG 5 WC Medicine, General & Internal SC General & Internal Medicine GA DL320 UT WOS:A1990DL32000028 PM 2355431 ER PT J AU HAUSMAN, SZ MANCLARK, CR BURNS, DL AF HAUSMAN, SZ MANCLARK, CR BURNS, DL TI BINDING OF ATP BY PERTUSSIS TOXIN AND ISOLATED TOXIN SUBUNITS SO BIOCHEMISTRY LA English DT Article RP HAUSMAN, SZ (reprint author), CTR BIOL EVALUAT & RES,BETHESDA,MD 20892, USA. NR 37 TC 17 Z9 17 U1 0 U2 0 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0006-2960 J9 BIOCHEMISTRY-US JI Biochemistry PD JUL 3 PY 1990 VL 29 IS 26 BP 6128 EP 6131 DI 10.1021/bi00478a003 PG 4 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DL889 UT WOS:A1990DL88900003 PM 1698450 ER PT J AU COLBURN, KG KAYSNER, CA ABEYTA, C WEKELL, MM AF COLBURN, KG KAYSNER, CA ABEYTA, C WEKELL, MM TI LISTERIA SPECIES IN A CALIFORNIA COAST ESTUARINE ENVIRONMENT SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 US FDA,SEAFOOD PROD RES CTR,22201 23RD DR SE,POB 3012,BOTHELL,WA 98041. NR 26 TC 68 Z9 72 U1 1 U2 6 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD JUL PY 1990 VL 56 IS 7 BP 2007 EP 2011 PG 5 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA DN833 UT WOS:A1990DN83300004 PM 2117874 ER PT J AU RAFII, F FRANKLIN, W CERNIGLIA, CE AF RAFII, F FRANKLIN, W CERNIGLIA, CE TI AZOREDUCTASE ACTIVITY OF ANAEROBIC-BACTERIA ISOLATED FROM HUMAN INTESTINAL MICROFLORA SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 US FDA,NATL CTR TOXICOL RES,DIV MICROBIOL,JEFFERSON,AR 72079. NR 29 TC 167 Z9 174 U1 0 U2 4 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD JUL PY 1990 VL 56 IS 7 BP 2146 EP 2151 PG 6 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA DN833 UT WOS:A1990DN83300026 PM 2202258 ER PT J AU ANDERSON, DL CUNNINGHAM, WC MACKEY, EA AF ANDERSON, DL CUNNINGHAM, WC MACKEY, EA TI NEUTRON-CAPTURE PROMPT-GAMMA ACTIVATION-ANALYSIS OF FOODS SO BIOLOGICAL TRACE ELEMENT RESEARCH LA English DT Article C1 UNIV MARYLAND,DEPT CHEM & BIOCHEM,COLLEGE PK,MD 20742. RP ANDERSON, DL (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 11 TC 7 Z9 7 U1 0 U2 0 PU HUMANA PRESS INC PI TOTOWA PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 SN 0163-4984 J9 BIOL TRACE ELEM RES JI Biol. Trace Elem. Res. PD JUL-DEC PY 1990 VL 26-7 BP 613 EP 622 DI 10.1007/BF02992717 PG 10 WC Biochemistry & Molecular Biology; Endocrinology & Metabolism SC Biochemistry & Molecular Biology; Endocrinology & Metabolism GA EM701 UT WOS:A1990EM70100067 PM 1704768 ER PT J AU ECKHOFF, C WITTFOHT, W NAU, H SLIKKER, W AF ECKHOFF, C WITTFOHT, W NAU, H SLIKKER, W TI CHARACTERIZATION OF OXIDIZED AND GLUCURONIDATED METABOLITES OF RETINOL IN MONKEY PLASMA BY THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY SO BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. RP ECKHOFF, C (reprint author), FREE UNIV BERLIN,INST TOXIKOL & EMBRYONALPHARMAKOL,GARYSTR 5,W-1000 BERLIN 33,GERMANY. NR 30 TC 37 Z9 37 U1 0 U2 0 PU JOHN WILEY & SONS LTD PI W SUSSEX PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD SN 0887-6134 J9 BIOMED ENVIRON MASS PD JUL PY 1990 VL 19 IS 7 BP 428 EP 433 DI 10.1002/bms.1200190708 PG 6 WC Spectroscopy SC Spectroscopy GA DN939 UT WOS:A1990DN93900007 PM 2400853 ER PT J AU MCGOWAN, AT AF MCGOWAN, AT TI USER AND INFORMATION DYNAMICS - MANAGING CHANGE SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION LA English DT Book Review RP MCGOWAN, AT (reprint author), CTR FOOD SAFETY & APPL NUTR,FOOD & DRUG ADM,WASHINGTON,DC, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU MED LIBRARY ASSN PI CHICAGO PA SUITE 300 6 N MICHIGAN AVE, CHICAGO, IL 60602 SN 0025-7338 J9 B MED LIBR ASSOC JI Bull. Med. Libr. Assoc. PD JUL PY 1990 VL 78 IS 3 BP 327 EP 329 PG 3 WC Information Science & Library Science SC Information Science & Library Science GA DQ474 UT WOS:A1990DQ47400026 ER PT J AU MOREAU, M RICHARDS, JC FOURNIER, JM BYRD, RA KARAKAWA, WW VANN, WF AF MOREAU, M RICHARDS, JC FOURNIER, JM BYRD, RA KARAKAWA, WW VANN, WF TI STRUCTURE OF THE TYPE-5 CAPSULAR POLYSACCHARIDE OF STAPHYLOCOCCUS-AUREUS SO CARBOHYDRATE RESEARCH LA English DT Article C1 US FDA,OFF BIOL RES & REVIEW,BETHESDA,MD 20892. INST PASTEUR,UNITE CHOLERA & VIBR,F-75724 PARIS,FRANCE. NATL RES COUNCIL CANADA,DIV BIOL SCI,OTTAWA K1A 0R6,ONTARIO,CANADA. PENN STATE UNIV,DEPT BIOCHEM,UNIVERSITY PK,PA 16802. RI Byrd, R. Andrew/F-8042-2015 OI Byrd, R. Andrew/0000-0003-3625-4232 NR 45 TC 63 Z9 64 U1 1 U2 8 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0008-6215 J9 CARBOHYD RES JI Carbohydr. Res. PD JUL 1 PY 1990 VL 201 IS 2 BP 285 EP 297 DI 10.1016/0008-6215(90)84244-O PG 13 WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic SC Biochemistry & Molecular Biology; Chemistry GA DN446 UT WOS:A1990DN44600012 PM 2224883 ER PT J AU YANG, SK PRASANNA, P WEEMS, HB JACOBS, MM FU, PP AF YANG, SK PRASANNA, P WEEMS, HB JACOBS, MM FU, PP TI METABOLISM OF THE POTENT CARCINOGEN 3-METHYLCHOLANTHYRLENE BY RAT-LIVER MICROSOMES SO CARCINOGENESIS LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. MITRE CORP,METREK DIV,MCLEAN,VA 22101. RP YANG, SK (reprint author), UNIFORMED SERV UNIV HLTH SCI,F EDWARD HEBERT SCH MED,DEPT PHARMACOL,BETHESDA,MD 20814, USA. FU NCI NIH HHS [CA29133] NR 20 TC 8 Z9 8 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0143-3334 J9 CARCINOGENESIS JI Carcinogenesis PD JUL PY 1990 VL 11 IS 7 BP 1195 EP 1201 DI 10.1093/carcin/11.7.1195 PG 7 WC Oncology SC Oncology GA DR331 UT WOS:A1990DR33100023 PM 2372877 ER PT J AU WAALKES, MP GOERING, PL AF WAALKES, MP GOERING, PL TI METALLOTHIONEIN AND OTHER CADMIUM-BINDING PROTEINS - RECENT DEVELOPMENTS SO CHEMICAL RESEARCH IN TOXICOLOGY LA English DT Review C1 US FDA,CTR DEVICES & RADIOL HLTH,OFF SCI & TECHNOL,DIV LIFE SCI,ROCKVILLE,MD 20857. RP WAALKES, MP (reprint author), NCI,FREDERICK CANC RES FACIL,DIV CANC ETIOL,COMPARAT CARCINOGENESIS LAB,FREDERICK,MD 21701, USA. NR 103 TC 177 Z9 180 U1 0 U2 6 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0893-228X J9 CHEM RES TOXICOL JI Chem. Res. Toxicol. PD JUL-AUG PY 1990 VL 3 IS 4 BP 281 EP 288 DI 10.1021/tx00016a001 PG 8 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology SC Pharmacology & Pharmacy; Chemistry; Toxicology GA DP252 UT WOS:A1990DP25200001 PM 2133072 ER PT J AU MILLER, W OSTELL, J RUDD, KE AF MILLER, W OSTELL, J RUDD, KE TI AN ALGORITHM FOR SEARCHING RESTRICTION MAPS SO COMPUTER APPLICATIONS IN THE BIOSCIENCES LA English DT Article C1 NATL LIB MED,NATL CTR BIOTECHNOL INFORMAT,BETHESDA,MD 20892. US FDA,CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,BACTERIAL TOXINS LAB,BETHESDA,MD 20892. RP MILLER, W (reprint author), PENN STATE UNIV,DEPT COMP SCI,UNIVERSITY PK,PA 16802, USA. FU NLM NIH HHS [LM05110] NR 11 TC 9 Z9 9 U1 0 U2 0 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0266-7061 J9 COMPUT APPL BIOSCI JI Comput. Appl. Biosci. PD JUL PY 1990 VL 6 IS 3 BP 247 EP 252 PG 6 WC Computer Science, Interdisciplinary Applications SC Computer Science GA DU666 UT WOS:A1990DU66600012 PM 2207749 ER PT J AU KAYSNER, CA WEKELL, MM ABEYTA, C AF KAYSNER, CA WEKELL, MM ABEYTA, C TI ENHANCEMENT OF VIRULENCE OF 2 ENVIRONMENTAL STRAINS OF VIBRIO-VULNIFICUS AFTER PASSAGE THROUGH MICE SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE LA English DT Article RP KAYSNER, CA (reprint author), US FDA,SEAFOOD PROD RES CTR,BOTHELL,WA 98041, USA. NR 14 TC 7 Z9 8 U1 0 U2 0 PU ELSEVIER SCIENCE INC PI NEW YORK PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 SN 0732-8893 J9 DIAGN MICR INFEC DIS JI Diagn. Microbiol. Infect. Dis. PD JUL-AUG PY 1990 VL 13 IS 4 BP 285 EP 288 DI 10.1016/0732-8893(90)90018-Q PG 4 WC Infectious Diseases; Microbiology SC Infectious Diseases; Microbiology GA DX029 UT WOS:A1990DX02900002 PM 2076589 ER PT J AU KADLUBAR, FF FU, PP JUNG, H SHAIKH, AU BELAND, FA AF KADLUBAR, FF FU, PP JUNG, H SHAIKH, AU BELAND, FA TI THE METABOLIC N-OXIDATION OF CARCINOGENIC ARYLAMINES IN RELATION TO NITROGEN CHARGE-DENSITY AND OXIDATION POTENTIAL SO ENVIRONMENTAL HEALTH PERSPECTIVES LA English DT Article C1 UNIV ARKANSAS,DEPT CHEM,LITTLE ROCK,AR 72204. RP KADLUBAR, FF (reprint author), NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,JEFFERSON,AR 72079, USA. NR 14 TC 24 Z9 24 U1 0 U2 0 PU NATL INST ENVIRON HEALTH SCI PI RES TRIANGLE PK PA PO BOX 12233, RES TRIANGLE PK, NC 27709 SN 0091-6765 J9 ENVIRON HEALTH PERSP JI Environ. Health Perspect. PD JUL PY 1990 VL 87 BP 233 EP 236 DI 10.2307/3431030 PG 4 WC Environmental Sciences; Public, Environmental & Occupational Health; Toxicology SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Toxicology GA DW476 UT WOS:A1990DW47600033 PM 2269230 ER PT J AU KIM, CS ROE, CR AF KIM, CS ROE, CR TI KINETICS OF L-CARNITINE TRANSPORT IN THE RAT CHOROID-PLEXUS SO EUROPEAN JOURNAL OF PHARMACOLOGY LA English DT Meeting Abstract C1 US FDA,DIV TOXICOL STUDIES,METAB BRANCH HFF169,WASHINGTON,DC 20204. DUKE UNIV,MED CTR,DEPT PEDIAT,DIV GENET & METAB,DURHAM,NC 27710. NR 2 TC 0 Z9 0 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0014-2999 J9 EUR J PHARMACOL JI Eur. J. Pharmacol. PD JUL PY 1990 VL 183 IS 2 BP 372 EP 372 DI 10.1016/0014-2999(90)93246-M PG 1 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DR795 UT WOS:A1990DR79500255 ER PT J AU ALI, SF TANDON, P TILSON, HA LIPE, GW NEWPORT, GD SLIKKER, W AF ALI, SF TANDON, P TILSON, HA LIPE, GW NEWPORT, GD SLIKKER, W TI INTRACEREBRAL AND ORAL-ADMINISTRATION OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA) - DISTRIBUTION AND NEUROCHEMICAL ALTERATIONS IN RAT-BRAIN SO EUROPEAN JOURNAL OF PHARMACOLOGY LA English DT Meeting Abstract C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079. NIEHS,MOLEC INTEGRATED NEUROBIOL BRANCH,RES TRIANGLE PK,NC 27709. US EPA,DIV NEUROTOXICOL,RES TRIANGLE PK,NC 27711. NR 0 TC 2 Z9 2 U1 1 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0014-2999 J9 EUR J PHARMACOL JI Eur. J. Pharmacol. PD JUL PY 1990 VL 183 IS 2 BP 450 EP 451 DI 10.1016/0014-2999(90)93338-Q PG 2 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DR795 UT WOS:A1990DR79500347 ER PT J AU PAULE, MG GILLAM, MP AF PAULE, MG GILLAM, MP TI THE EFFECTS OF PENTOBARBITAL ON COMPLEX BRAIN-FUNCTION IN RHESUS-MONKEYS AS MEASURED BY PERFORMANCE IN AN OPERANT TEST BATTERY SO EUROPEAN JOURNAL OF PHARMACOLOGY LA English DT Meeting Abstract C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079. NR 0 TC 2 Z9 2 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0014-2999 J9 EUR J PHARMACOL JI Eur. J. Pharmacol. PD JUL PY 1990 VL 183 IS 4 BP 1127 EP 1127 DI 10.1016/0014-2999(90)94211-F PG 1 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DU013 UT WOS:A1990DU01300005 ER PT J AU SLIKKER, W CREECHKRAFT, J BAILEY, JR ROBERTS, LG FISCHER, B WITTFOHT, W NAU, H AF SLIKKER, W CREECHKRAFT, J BAILEY, JR ROBERTS, LG FISCHER, B WITTFOHT, W NAU, H TI DISPOSITION AND METABOLISM OF 13-CIS AND ALL-TRANS-RETINOIC ACID IN THE PLASMA OF CYNOMOLGUS MONKEYS - A COMPARISON TO A HUMAN CASE-STUDY WITH 13-CIS-RETINOIC ACID SO EUROPEAN JOURNAL OF PHARMACOLOGY LA English DT Meeting Abstract C1 FREE UNIV BERLIN,INST TOXICOL & EMBRYOPHARMACOL,W-1000 BERLIN 33,GERMANY. NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079. NR 0 TC 0 Z9 0 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0014-2999 J9 EUR J PHARMACOL JI Eur. J. Pharmacol. PD JUL PY 1990 VL 183 IS 5 BP 1873 EP 1874 DI 10.1016/0014-2999(90)92209-2 PG 2 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DU015 UT WOS:A1990DU01500306 ER PT J AU FAZIO, T WARNER, CR AF FAZIO, T WARNER, CR TI A REVIEW OF SULFITES IN FOODS - ANALYTICAL METHODOLOGY AND REPORTED FINDINGS SO FOOD ADDITIVES AND CONTAMINANTS LA English DT Article RP FAZIO, T (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,OFF PHYS SCI,WASHINGTON,DC 20204, USA. NR 0 TC 79 Z9 84 U1 2 U2 26 PU TAYLOR & FRANCIS LTD PI LONDON PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE SN 0265-203X J9 FOOD ADDIT CONTAM JI Food Addit. Contam. PD JUL-AUG PY 1990 VL 7 IS 4 BP 433 EP 454 PG 22 WC Chemistry, Applied; Food Science & Technology; Toxicology SC Chemistry; Food Science & Technology; Toxicology GA DR094 UT WOS:A1990DR09400001 PM 2203650 ER PT J AU BENSON, JS AF BENSON, JS TI STATE OF THE FOOD-AND-DRUG-ADMINISTRATION SO FOOD AND DRUG LAW JOURNAL LA English DT Article RP BENSON, JS (reprint author), US FDA,WASHINGTON,DC 20204, USA. NR 0 TC 1 Z9 1 U1 0 U2 0 PU FOOD DRUG LAW INST PI WASHINGTON PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 J9 FOOD DRUG LAW J JI Food Drug Law J. PD JUL PY 1990 VL 45 IS 4 BP 301 EP 317 PG 17 WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology & Pharmacy SC Food Science & Technology; Government & Law; Nutrition & Dietetics; Pharmacology & Pharmacy GA DR631 UT WOS:A1990DR63100001 ER PT J AU COOPER, EC AF COOPER, EC TI CHANGES IN NORMAL DRUG APPROVAL PROCESS IN RESPONSE TO THE AIDS CRISIS SO FOOD AND DRUG LAW JOURNAL LA English DT Discussion RP COOPER, EC (reprint author), US FDA,CTR DRUG EVALUAT & RES,DIV ANTIVIRAL DRUG PROD,WASHINGTON,DC 20204, USA. NR 0 TC 8 Z9 8 U1 0 U2 0 PU FOOD DRUG LAW INST PI WASHINGTON PA 1000 VERMONT AVE NW, SUITE 1200, WASHINGTON, DC 20005-4903 J9 FOOD DRUG LAW J JI Food Drug Law J. PD JUL PY 1990 VL 45 IS 4 BP 329 EP 338 PG 10 WC Food Science & Technology; Law; Nutrition & Dietetics; Pharmacology & Pharmacy SC Food Science & Technology; Government & Law; Nutrition & Dietetics; Pharmacology & Pharmacy GA DR631 UT WOS:A1990DR63100004 ER PT J AU STORM, JE COLLIER, SW STEWART, RF BRONAUGH, RL AF STORM, JE COLLIER, SW STEWART, RF BRONAUGH, RL TI METABOLISM OF XENOBIOTICS DURING PERCUTANEOUS PENETRATION - ROLE OF ABSORPTION RATE AND CUTANEOUS ENZYME-ACTIVITY SO FUNDAMENTAL AND APPLIED TOXICOLOGY LA English DT Article RP STORM, JE (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL STUDIES,WASHINGTON,DC 20204, USA. NR 27 TC 42 Z9 43 U1 1 U2 3 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0272-0590 J9 FUND APPL TOXICOL JI Fundam. Appl. Toxicol. PD JUL PY 1990 VL 15 IS 1 BP 132 EP 141 DI 10.1016/0272-0590(90)90170-O PG 10 WC Toxicology SC Toxicology GA DP301 UT WOS:A1990DP30100016 PM 2373294 ER PT J AU NASCIMENTO, E MAYRINK, W DACOSTA, CA MICHALICK, MSM MELO, MN BARROS, GC DIAS, M ANTUNES, CMF LIMA, MS TABOADA, DC LIU, TY AF NASCIMENTO, E MAYRINK, W DACOSTA, CA MICHALICK, MSM MELO, MN BARROS, GC DIAS, M ANTUNES, CMF LIMA, MS TABOADA, DC LIU, TY TI VACCINATION OF HUMANS AGAINST CUTANEOUS LEISHMANIASIS - CELLULAR AND HUMORAL IMMUNE-RESPONSES SO INFECTION AND IMMUNITY LA English DT Article C1 US FDA,CTR BIOL EVALUA & RES,DIV BIOCHEM & BIOPHYS,BETHESDA,MD 20892. RP NASCIMENTO, E (reprint author), FED UNIV MINAS GERAIS,INST BIOL SCI,CAIXA POSTAL 2486,BR-30000 BELO HORIZONTE,MG,BRAZIL. NR 37 TC 42 Z9 45 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD JUL PY 1990 VL 58 IS 7 BP 2198 EP 2203 PG 6 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA DL134 UT WOS:A1990DL13400027 PM 2365458 ER PT J AU FATTOM, A LUE, C SZU, SC MESTECKY, J SCHIFFMAN, G BRYLA, D VANN, WF WATSON, D KIMZEY, LM ROBBINS, JB SCHNEERSON, R AF FATTOM, A LUE, C SZU, SC MESTECKY, J SCHIFFMAN, G BRYLA, D VANN, WF WATSON, D KIMZEY, LM ROBBINS, JB SCHNEERSON, R TI SERUM ANTIBODY-RESPONSE IN ADULT VOLUNTEERS ELICITED BY INJECTION OF STREPTOCOCCUS-PNEUMONIAE TYPE-12F POLYSACCHARIDE ALONE OR CONJUGATED TO DIPHTHERIA TOXOID SO INFECTION AND IMMUNITY LA English DT Article C1 UNIV ALABAMA,DEPT MICROBIOL & MED,BIRMINGHAM,AL 35294. SUNY HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,BROOKLYN,NY 11203. US FDA,OFF BIOL RES & REVIEW,ROCKVILLE,MD 20892. RP FATTOM, A (reprint author), NICHHD,BIOMETRY BRANCH,DEV & MOLEC IMMUN LAB,BETHESDA,MD 20892, USA. NR 31 TC 59 Z9 60 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD JUL PY 1990 VL 58 IS 7 BP 2309 EP 2312 PG 4 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA DL134 UT WOS:A1990DL13400043 PM 2365462 ER PT J AU FATTOM, A SCHNEERSON, R SZU, SC VANN, WF SHILOACH, J KARAKAWA, WW ROBBINS, JB AF FATTOM, A SCHNEERSON, R SZU, SC VANN, WF SHILOACH, J KARAKAWA, WW ROBBINS, JB TI SYNTHESIS AND IMMUNOLOGICAL PROPERTIES IN MICE OF VACCINES COMPOSED OF STAPHYLOCOCCUS-AUREUS TYPE-5 AND TYPE-8 CAPSULAR POLYSACCHARIDES CONJUGATED TO PSEUDOMONAS-AERUGINOSA EXOTOXIN-A SO INFECTION AND IMMUNITY LA English DT Article C1 US FDA,DIV BACTERIAL PROD,OFF BIOL RES & REVIEW,BETHESDA,MD 20892. NIDDKD,BETHESDA,MD 20892. PENN STATE UNIV,DEPT MOLEC & CELLULAR BIOL,UNIVERSITY PK,PA 16802. RP FATTOM, A (reprint author), NICHHD,BETHESDA,MD 20892, USA. NR 54 TC 99 Z9 101 U1 1 U2 1 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD JUL PY 1990 VL 58 IS 7 BP 2367 EP 2374 PG 8 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA DL134 UT WOS:A1990DL13400051 PM 2114365 ER PT J AU HOLDER, CL SIITONEN, PH SLIKKER, W BRANSCOMB, CJ KORFMACHER, WA THOMPSON, HC CERNIGLIA, CE GOSNELL, AB LAY, JO AF HOLDER, CL SIITONEN, PH SLIKKER, W BRANSCOMB, CJ KORFMACHER, WA THOMPSON, HC CERNIGLIA, CE GOSNELL, AB LAY, JO TI METABOLISM OF DOXYLAMINE SUCCINATE IN FISCHER-344 RATS .3. CONJUGATED URINARY AND FECAL METABOLITES SO JOURNAL OF ANALYTICAL TOXICOLOGY LA English DT Article RP HOLDER, CL (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. RI Lay, Jackson/G-1007-2011 OI Lay, Jackson/0000-0003-3789-2527 NR 17 TC 3 Z9 3 U1 0 U2 0 PU PRESTON PUBLICATIONS INC PI NILES PA 7800 MERRIMAC AVE PO BOX 48312, NILES, IL 60648 SN 0146-4760 J9 J ANAL TOXICOL JI J. Anal. Toxicol. PD JUL-AUG PY 1990 VL 14 IS 4 BP 247 EP 251 PG 5 WC Chemistry, Analytical; Toxicology SC Chemistry; Toxicology GA DQ151 UT WOS:A1990DQ15100013 PM 1975634 ER PT J AU FINK, PJ BLAIR, MJ MATIS, LA HEDRICK, SM AF FINK, PJ BLAIR, MJ MATIS, LA HEDRICK, SM TI MOLECULAR ANALYSIS OF THE INFLUENCES OF POSITIVE SELECTION, TOLERANCE INDUCTION, AND ANTIGEN PRESENTATION ON THE T-CELL RECEPTOR REPERTOIRE SO JOURNAL OF EXPERIMENTAL MEDICINE LA English DT Article C1 US FDA,DIV CYTOKINE,BETHESDA,MD 20892. UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093. SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037. FU NIGMS NIH HHS [GM-35880]; PHS HHS [A127417, A11372] NR 58 TC 23 Z9 23 U1 0 U2 0 PU ROCKEFELLER UNIV PRESS PI NEW YORK PA 222 E 70TH STREET, NEW YORK, NY 10021 SN 0022-1007 J9 J EXP MED JI J. Exp. Med. PD JUL 1 PY 1990 VL 172 IS 1 BP 139 EP 150 DI 10.1084/jem.172.1.139 PG 12 WC Immunology; Medicine, Research & Experimental SC Immunology; Research & Experimental Medicine GA DL091 UT WOS:A1990DL09100018 PM 2162903 ER PT J AU NAPOLITANO, M SEAMON, KB LEONARD, WJ AF NAPOLITANO, M SEAMON, KB LEONARD, WJ TI IDENTIFICATION OF CELL-SURFACE RECEPTORS FOR THE ACT-2 CYTOKINE SO JOURNAL OF EXPERIMENTAL MEDICINE LA English DT Article C1 NICHHD,CELL BIOL & METAB BRANCH,BLDG 18T,ROOM 101,BETHESDA,MD 20892. US FDA,DIV BIOCHEM & BIOPHYS,BETHESDA,MD 20892. FU NHLBI NIH HHS [HL-35762] NR 13 TC 21 Z9 22 U1 0 U2 0 PU ROCKEFELLER UNIV PRESS PI NEW YORK PA 222 E 70TH STREET, NEW YORK, NY 10021 SN 0022-1007 J9 J EXP MED JI J. Exp. Med. PD JUL 1 PY 1990 VL 172 IS 1 BP 285 EP 289 DI 10.1084/jem.172.1.285 PG 5 WC Immunology; Medicine, Research & Experimental SC Immunology; Research & Experimental Medicine GA DL091 UT WOS:A1990DL09100033 PM 2193098 ER PT J AU SATCHELL, FB STEPHENSON, P ANDREWS, WH ESTELA, L ALLEN, G AF SATCHELL, FB STEPHENSON, P ANDREWS, WH ESTELA, L ALLEN, G TI THE SURVIVAL OF SHIGELLA-SONNEI IN SHREDDED CABBAGE SO JOURNAL OF FOOD PROTECTION LA English DT Article C1 US FDA,DENVER DIST LAB,DENVER,CO 80225. RP SATCHELL, FB (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 19 TC 28 Z9 30 U1 1 U2 5 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JUL PY 1990 VL 53 IS 7 BP 558 EP & PG 0 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA DM732 UT WOS:A1990DM73200003 ER PT J AU ZHANG, J YU, ZX FUJITA, S FERRANS, VJ AF ZHANG, J YU, ZX FUJITA, S FERRANS, VJ TI QUANTITATIVE STUDY OF INTERSTITIAL DENDRITIC CELLS IN EXPERIMENTAL MYOCARDIAL-INFARCTION IN RATS SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY LA English DT Meeting Abstract C1 NHLBI,PATHOL BRANCH,BETHESDA,MD 20205. US FDA,WASHINGTON,DC 20204. NR 0 TC 0 Z9 0 U1 0 U2 0 PU HISTOCHEMICAL SOC INC PI NEW YORK PA MT SINAI MEDICAL CENTER 19 EAST 98TH ST SUTIE 9G, NEW YORK, NY 10029 SN 0022-1554 J9 J HISTOCHEM CYTOCHEM JI J. Histochem. Cytochem. PD JUL PY 1990 VL 38 IS 7 BP 1046 EP 1046 PG 1 WC Cell Biology SC Cell Biology GA DJ785 UT WOS:A1990DJ78500137 ER PT J AU AVALLONE, H AF AVALLONE, H TI CURRENT REGULATORY ISSUES REGARDING STERILE PRODUCTS SO JOURNAL OF PARENTERAL SCIENCE AND TECHNOLOGY LA English DT Editorial Material RP AVALLONE, H (reprint author), US FDA,W ORANGE,NJ 07052, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU PARENTERAL DRUG ASSOC, INC PI BETHESDA PA 7500 OLD GEORGETOWN RD, STE, 620, BETHESDA, MD 20814 SN 0279-7976 J9 J PARENT SCI TECHN PD JUL-AUG PY 1990 VL 44 IS 4 BP 228 EP 230 PG 3 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DT293 UT WOS:A1990DT29300008 PM 2213432 ER PT J AU TYMES, NW SHAH, VP SKELLY, JP AF TYMES, NW SHAH, VP SKELLY, JP TI INVITRO RELEASE PROFILE OF ESTRADIOL TRANSDERMAL THERAPEUTIC SYSTEMS SO JOURNAL OF PHARMACEUTICAL SCIENCES LA English DT Article C1 US FDA,CTR DRUG EVALUAT & RES,ROCKVILLE,MD 20857. BALTIMORE DIST LAB,BALTIMORE,MD 21201. NR 8 TC 13 Z9 13 U1 0 U2 1 PU AMER PHARMACEUTICAL ASSN PI WASHINGTON PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037 SN 0022-3549 J9 J PHARM SCI JI J. Pharm. Sci. PD JUL PY 1990 VL 79 IS 7 BP 601 EP 602 DI 10.1002/jps.2600790711 PG 2 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Pharmacology & Pharmacy; Chemistry GA DN272 UT WOS:A1990DN27200009 PM 2398467 ER PT J AU CARLIN, AS SIMMONS, JE SAGER, AO SHIU, GK SKELLY, JP AF CARLIN, AS SIMMONS, JE SAGER, AO SHIU, GK SKELLY, JP TI CAPILLARY GAS-CHROMATOGRAPHIC ANALYSIS WITH ELECTRON-CAPTURE DETECTION OF MONONITROGLYCERINS FOLLOWING INTRAVENOUS ADMINISTRATION OF DINITROGLYCERINS TO BEAGLES - ISOMER-SPECIFIC METABOLISM SO JOURNAL OF PHARMACEUTICAL SCIENCES LA English DT Note C1 US FDA,CTR DRUG EVALUAT & RES,DIV CARDIORENAL DRUG PROD,ROCKVILLE,MD 20857. US FDA,CTR FOOD SAFETY & APPL NUTR,DIV TOXICOL,METAB BRANCH,BELTSVILLE,MD 20708. US FDA,CTR DRUG EVALUAT & RES,OFF RES RESOURCES,ROCKVILLE,MD 20857. RP CARLIN, AS (reprint author), US FDA,CTR DRUG EVALUAT & RES,DIV BIOPHARMACEUT,BIOPHARMACEUT RES BRANCH,WASHINGTON,DC 20204, USA. NR 24 TC 1 Z9 1 U1 0 U2 0 PU AMER PHARMACEUTICAL ASSN PI WASHINGTON PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037 SN 0022-3549 J9 J PHARM SCI JI J. Pharm. Sci. PD JUL PY 1990 VL 79 IS 7 BP 649 EP 650 DI 10.1002/jps.2600790723 PG 2 WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Pharmacology & Pharmacy; Chemistry GA DN272 UT WOS:A1990DN27200021 PM 2118957 ER PT J AU STEINBRECHER, K SAXTON, WL OEHLER, GA AF STEINBRECHER, K SAXTON, WL OEHLER, GA TI IMPROVED GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF DAMINOZIDE BY ALKALINE-HYDROLYSIS AND 2-NITROBENZALDEHYDE DERIVATIZATION AND SURVEY RESULTS OF DAMINOZIDE IN AGRICULTURAL PRODUCTS SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article RP STEINBRECHER, K (reprint author), US FDA,SEATTLE DIST,BOTHELL,WA 98041, USA. NR 8 TC 9 Z9 9 U1 1 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JUL-AUG PY 1990 VL 73 IS 4 BP 512 EP 515 PG 4 WC Chemistry, Analytical SC Chemistry GA DQ691 UT WOS:A1990DQ69100005 PM 2211471 ER PT J AU MATUSIK, JE STERNAL, RS BARNES, CJ SPHON, JA AF MATUSIK, JE STERNAL, RS BARNES, CJ SPHON, JA TI CONFIRMATION OF IDENTITY BY GAS-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY OF SULFATHIAZOLE, SULFAMETHAZINE, SULFACHLOROPYRIDAZINE, AND SULFADIMETHOXINE FROM BOVINE OR SWINE LIVER EXTRACTS AFTER QUANTITATION BY GAS-CHROMATOGRAPHY ELECTRON-CAPTURE DETECTION SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 US FDA,CTR VET MED,BELTSVILLE,MD 20705. RP MATUSIK, JE (reprint author), US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204, USA. NR 11 TC 30 Z9 30 U1 0 U2 3 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JUL-AUG PY 1990 VL 73 IS 4 BP 529 EP 533 PG 5 WC Chemistry, Analytical SC Chemistry GA DQ691 UT WOS:A1990DQ69100009 PM 2211474 ER PT J AU BEAVER, RW WILSON, DM TRUCKSESS, MW AF BEAVER, RW WILSON, DM TRUCKSESS, MW TI COMPARISON OF POSTCOLUMN DERIVATIZATION LIQUID-CHROMATOGRAPHY WITH THIN-LAYER CHROMATOGRAPHY FOR DETERMINATION OF AFLATOXINS IN NATURALLY CONTAMINATED CORN SO JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS LA English DT Article C1 US FDA,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. RP BEAVER, RW (reprint author), UNIV GEORGIA,COASTAL PLAIN EXPT STN,MYCOTOXIN ANAL RES CTR,TIFTON,GA 31793, USA. NR 9 TC 19 Z9 19 U1 0 U2 1 PU AOAC INTERNATIONAL PI GAITHERSBURG PA 481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 SN 0004-5756 J9 J ASSOC OFF ANA CHEM PD JUL-AUG PY 1990 VL 73 IS 4 BP 579 EP 581 PG 3 WC Chemistry, Analytical SC Chemistry GA DQ691 UT WOS:A1990DQ69100018 PM 2120180 ER PT J AU MYERS, KJ ROLLAND, JP BARRETT, HH WAGNER, RF AF MYERS, KJ ROLLAND, JP BARRETT, HH WAGNER, RF TI APERTURE OPTIMIZATION FOR EMISSION IMAGING - EFFECT OF A SPATIALLY VARYING BACKGROUND SO JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION LA English DT Article C1 UNIV ARIZONA,DEPT RADIOL,TUCSON,AZ 85721. UNIV ARIZONA,CTR OPT SCI,TUCSON,AZ 85724. RP MYERS, KJ (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,HFZ-142,12720 TWINBROOK PKWY,ROCKVILLE,MD 20857, USA. FU NCI NIH HHS [P01 CA 23417] NR 26 TC 72 Z9 72 U1 0 U2 2 PU OPTICAL SOC AMER PI WASHINGTON PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 SN 0740-3232 J9 J OPT SOC AM A JI J. Opt. Soc. Am. A-Opt. Image Sci. Vis. PD JUL PY 1990 VL 7 IS 7 BP 1279 EP 1293 DI 10.1364/JOSAA.7.001279 PG 15 WC Optics SC Optics GA DM904 UT WOS:A1990DM90400015 PM 2370590 ER PT J AU KORFMACHER, WA GETEK, TA HANSEN, EB BLOOM, J AF KORFMACHER, WA GETEK, TA HANSEN, EB BLOOM, J TI CHARACTERIZATION OF DIPHENHYDRAMINE, DOXYLAMINE, AND CARBINOXAMINE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY THERMOSPRAY MASS-SPECTROMETRY SO LC GC-MAGAZINE OF SEPARATION SCIENCE LA English DT Article RP KORFMACHER, WA (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 24 TC 5 Z9 5 U1 0 U2 0 PU ADVANSTAR COMMUNICATIONS PI DULUTH PA 131 W FIRST ST, DULUTH, MN 55802 SN 0888-9090 J9 LC GC-MAG SEP SCI JI LC GC-Mag. Sep. Sci. PD JUL PY 1990 VL 8 IS 7 BP 538 EP 541 PG 4 WC Chemistry, Analytical SC Chemistry GA DL638 UT WOS:A1990DL63800005 ER PT J AU SHADDOCK, JG ROBINSON, BY CASCIANO, DA AF SHADDOCK, JG ROBINSON, BY CASCIANO, DA TI EFFECT OF PRETREATMENT WITH HEPATIC MIXED-FUNCTION OXIDASE INDUCERS ON THE GENOTOXICITY OF 4 RAT CARCINOGENS IN THE HEPATOCYTE DNA-REPAIR ASSAY SO MUTAGENESIS LA English DT Article C1 UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM & MOLEC BIOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205. RP SHADDOCK, JG (reprint author), US FDA,NATL CTR TOXICOL RES,DIV GENET TOXICOL,JEFFERSON,AR 72079, USA. NR 34 TC 12 Z9 13 U1 1 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0267-8357 J9 MUTAGENESIS JI Mutagenesis PD JUL PY 1990 VL 5 IS 4 BP 387 EP 391 DI 10.1093/mutage/5.4.387 PG 5 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA DM810 UT WOS:A1990DM81000012 PM 2169015 ER PT J AU BERANEK, DT AF BERANEK, DT TI DISTRIBUTION OF METHYL AND ETHYL ADDUCTS FOLLOWING ALKYLATION WITH MONOFUNCTIONAL ALKYLATING-AGENTS SO MUTATION RESEARCH LA English DT Article RP BERANEK, DT (reprint author), US FDA, NATL CTR TOXICOL RES, JEFFERSON, AR 72079 USA. NR 110 TC 565 Z9 584 U1 5 U2 32 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0921-8262 J9 MUTAT RES JI Mutat. Res. PD JUL PY 1990 VL 231 IS 1 BP 11 EP 30 DI 10.1016/0027-5107(90)90173-2 PG 20 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA DP399 UT WOS:A1990DP39900003 PM 2195323 ER PT J AU LEE, WR BERANEK, DT BYRNE, BJ TUCKER, AB AF LEE, WR BERANEK, DT BYRNE, BJ TUCKER, AB TI COMPARISON OF DOSE-RESPONSE RELATIONSHIPS FOR ETHYL METHANESULFONATE AND 1-ETHYL-1-NITROSOUREA IN DROSOPHILA-MELANOGASTER SPERMATOZOA SO MUTATION RESEARCH LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. RP LEE, WR (reprint author), LOUISIANA STATE UNIV,DEPT ZOOL & PHYSIOL,INTERDEPT PROGRAM GENET,BATON ROUGE,LA 70803, USA. FU NIEHS NIH HHS [P01-ES03347] NR 59 TC 24 Z9 24 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0921-8262 J9 MUTAT RES PD JUL PY 1990 VL 231 IS 1 BP 31 EP 45 DI 10.1016/0027-5107(90)90174-3 PG 15 WC Genetics & Heredity; Toxicology SC Genetics & Heredity; Toxicology GA DP399 UT WOS:A1990DP39900004 PM 2114533 ER PT J AU HANNA, GM LAUCAM, CA AF HANNA, GM LAUCAM, CA TI OPTICAL PURITY DETERMINATION OF THREO-METHYLPHENIDATE HYDROCHLORIDE USING A CHIRAL EUROPIUM NUCLEAR-MAGNETIC-RESONANCE (NMR) SHIFT-REAGENT SO PHARMACEUTICAL RESEARCH LA English DT Article C1 ST JOHNS UNIV,COLL PHARM & ALLIED HLTH PROFESS,DEPT PHARMACEUT SCI,JAMAICA,NY 11439. RP HANNA, GM (reprint author), US FDA,NEW YORK REG LAB,850 3RD AVE,BROOKLYN,NY 11232, USA. NR 18 TC 4 Z9 4 U1 1 U2 1 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0724-8741 J9 PHARMACEUT RES JI Pharm. Res. PD JUL PY 1990 VL 7 IS 7 BP 726 EP 729 DI 10.1023/A:1015815605583 PG 4 WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy SC Chemistry; Pharmacology & Pharmacy GA DN859 UT WOS:A1990DN85900008 PM 2395800 ER PT J AU BENSON, JS AF BENSON, JS TI USPC 1990 QUINQUENNIAL MEETING, MARCH 8-10, 1990 - CONVENTION ADDRESS REPRESENTING FDA SO PHARMACOPEIAL FORUM LA English DT Editorial Material RP BENSON, JS (reprint author), US FDA,WASHINGTON,DC 20204, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU US PHARMACOPEIAL CONVENTION PI ROCKVILLE PA 12601 TWINBROOK PKWY, ROCKVILLE, MD 20852 SN 0363-4655 J9 PHARMACOPEIAL FORUM JI Pharmacop. Forum PD JUL-AUG PY 1990 VL 16 IS 4 BP 768 EP 769 PG 2 WC Medicine, Legal; Pharmacology & Pharmacy SC Legal Medicine; Pharmacology & Pharmacy GA DU975 UT WOS:A1990DU97500010 ER PT J AU BATES, HK LABORDE, JB DACRE, JC YOUNG, JF AF BATES, HK LABORDE, JB DACRE, JC YOUNG, JF TI DEVELOPMENTAL TOXICITY OF SOMAN IN RATS AND RABBITS SO TERATOLOGY LA English DT Article C1 PATHOL ASSOCIATES INC,JEFFERSON,AR 72079. NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079. USA,BIOMED BIOENGN RES & DEV LAB,FREDERICK,MD 21701. NR 23 TC 3 Z9 3 U1 0 U2 1 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0040-3709 J9 TERATOLOGY JI Teratology PD JUL PY 1990 VL 42 IS 1 BP 15 EP 23 DI 10.1002/tera.1420420104 PG 9 WC Developmental Biology; Toxicology SC Developmental Biology; Toxicology GA DN384 UT WOS:A1990DN38400003 PM 2392776 ER PT J AU WELSH, JJ RADER, JI COLLINS, TFX BLACK, TN RORIE, JI KOPRAL, CA AF WELSH, JJ RADER, JI COLLINS, TFX BLACK, TN RORIE, JI KOPRAL, CA TI DEVELOPMENTAL EFFECTS AND MINERAL INTERACTIONS IN RATS FED TEXTURED VEGETABLE PROTEIN SO TERATOLOGY LA English DT Article C1 US FDA,DIV TOXICOL,WASHINGTON,DC 20204. US FDA,DIV NUTR,WASHINGTON,DC 20204. US FDA,DIV MATH,WASHINGTON,DC 20204. RP WELSH, JJ (reprint author), US FDA,DIV TOXICOL REVIEW & EVALUAT,HFF 158,200 C ST SW,WASHINGTON,DC 20204, USA. NR 35 TC 0 Z9 0 U1 0 U2 1 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0040-3709 J9 TERATOLOGY JI Teratology PD JUL PY 1990 VL 42 IS 1 BP 67 EP 78 DI 10.1002/tera.1420420109 PG 12 WC Developmental Biology; Toxicology SC Developmental Biology; Toxicology GA DN384 UT WOS:A1990DN38400008 PM 2392780 ER PT J AU PUMFORD, NR HINSON, JA BENSON, RW ROBERTS, DW AF PUMFORD, NR HINSON, JA BENSON, RW ROBERTS, DW TI IMMUNOBLOT ANALYSIS OF PROTEIN CONTAINING 3-(CYSTEIN-S-YL)ACETAMINOPHEN ADDUCTS IN SERUM AND SUBCELLULAR LIVER FRACTIONS FROM ACETAMINOPHEN-TREATED MICE SO TOXICOLOGY AND APPLIED PHARMACOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,HFT 110,NCTR DR,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,DIV INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205. NR 57 TC 76 Z9 77 U1 1 U2 1 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0041-008X J9 TOXICOL APPL PHARM JI Toxicol. Appl. Pharmacol. PD JUL PY 1990 VL 104 IS 3 BP 521 EP 532 DI 10.1016/0041-008X(90)90174-S PG 12 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA EC993 UT WOS:A1990EC99300016 PM 2385841 ER PT J AU JONES, JM YERALAN, O HINES, G MAHER, M ROBERTS, DW BENSON, RW AF JONES, JM YERALAN, O HINES, G MAHER, M ROBERTS, DW BENSON, RW TI EFFECTS OF LITHIUM AND RUBIDIUM ON IMMUNE-RESPONSES OF RATS SO TOXICOLOGY LETTERS LA English DT Article C1 NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,HFT-110,JEFFERSON,AR 72079. UNIV ARKANSAS MED SCI HOSP,DEPT PATHOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,DEPT MICROBIOL IMMUNOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS,DEPT PSYCHOL,LITTLE ROCK,AR 72204. NR 20 TC 13 Z9 13 U1 0 U2 0 PU ELSEVIER SCI IRELAND LTD PI CLARE PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND SN 0378-4274 J9 TOXICOL LETT JI Toxicol. Lett. PD JUL PY 1990 VL 52 IS 2 BP 163 EP 168 DI 10.1016/0378-4274(90)90150-K PG 6 WC Toxicology SC Toxicology GA DQ440 UT WOS:A1990DQ44000007 PM 2378000 ER PT J AU FRATANTONI, JC PRODOUZ, KN HOROWITZ, MS AF FRATANTONI, JC PRODOUZ, KN HOROWITZ, MS TI VIRAL INACTIVATION OF BLOOD PRODUCTS SO TRANSFUSION LA English DT Editorial Material C1 NEW YORK BLOOD CTR,NEW YORK,NY 10021. RP FRATANTONI, JC (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,BETHESDA,MD 20014, USA. NR 14 TC 10 Z9 10 U1 0 U2 0 PU AMER ASSOC BLOOD BANKS PI BETHESDA PA 8101 GLENBROOK RD, BETHESDA, MD 20814-2749 SN 0041-1132 J9 TRANSFUSION JI Transfusion PD JUL-AUG PY 1990 VL 30 IS 6 BP 480 EP 481 DI 10.1046/j.1537-2995.1990.30690333474.x PG 2 WC Hematology SC Hematology GA DR327 UT WOS:A1990DR32700001 PM 2378020 ER PT J AU KIBLERHERZOG, L KELL, B ZON, G SHINOZUKA, K MIZAN, S WILSON, WD AF KIBLERHERZOG, L KELL, B ZON, G SHINOZUKA, K MIZAN, S WILSON, WD TI SEQUENCE DEPENDENT EFFECTS IN METHYLPHOSPHONATE DEOXYRIBONUCLEOTIDE DOUBLE AND TRIPLE HELICAL COMPLEXES SO NUCLEIC ACIDS RESEARCH LA English DT Article C1 GEORGIA STATE UNIV,DEPT CHEM,ATLANTA,GA 30303. GEORGIA STATE UNIV,MICROBIAL & BIOCHEM SCI LAB,ATLANTA,GA 30303. APPL BIOSYST INC,FOSTER CITY,CA 94404. US FDA,MOLEC PHARMACOL LAB,BETHESDA,MD 20892. FU NIAID NIH HHS [AI-27196] NR 96 TC 84 Z9 85 U1 0 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0305-1048 J9 NUCLEIC ACIDS RES JI Nucleic Acids Res. PD JUN 25 PY 1990 VL 18 IS 12 BP 3545 EP 3555 DI 10.1093/nar/18.12.3545 PG 11 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DL815 UT WOS:A1990DL81500016 PM 2362807 ER PT J AU KWEDER, SL SCHNUR, RA COOPER, EC AF KWEDER, SL SCHNUR, RA COOPER, EC TI INOSINE PRANOBEX - IS A SINGLE POSITIVE TRIAL ENOUGH SO NEW ENGLAND JOURNAL OF MEDICINE LA English DT Editorial Material RP KWEDER, SL (reprint author), US FDA,ROCKVILLE,MD 20857, USA. NR 10 TC 13 Z9 13 U1 0 U2 1 PU MASS MEDICAL SOC PI BOSTON PA 10 SHATTUCK, BOSTON, MA 02115 SN 0028-4793 J9 NEW ENGL J MED JI N. Engl. J. Med. PD JUN 21 PY 1990 VL 322 IS 25 BP 1807 EP 1809 DI 10.1056/NEJM199006213222509 PG 3 WC Medicine, General & Internal SC General & Internal Medicine GA DJ232 UT WOS:A1990DJ23200009 PM 1693175 ER PT J AU KLINMAN, DM HOLMES, KL AF KLINMAN, DM HOLMES, KL TI DIFFERENCES IN THE REPERTOIRE EXPRESSED BY PERITONEAL AND SPLENIC LY-1 (CD5)+ B-CELLS SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 NIAID,BIOL RESOURCE BRANCH,FLOW CYTOMETRY SECT,BETHESDA,MD 20892. RP KLINMAN, DM (reprint author), US FDA,CBER,DIV VIROL,BLDG 29A,RM 3D 06,BETHESDA,MD 20892, USA. NR 34 TC 41 Z9 41 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD JUN 15 PY 1990 VL 144 IS 12 BP 4520 EP 4525 PG 6 WC Immunology SC Immunology GA DK406 UT WOS:A1990DK40600005 PM 1693635 ER PT J AU ROSENBERG, AS FINBLOOM, DS MANIERO, TG VANDERMEIDE, PH SINGER, A AF ROSENBERG, AS FINBLOOM, DS MANIERO, TG VANDERMEIDE, PH SINGER, A TI SPECIFIC PROLONGATION OF MHC CLASS-II DISPARATE SKIN ALLOGRAFTS BY INVIVO ADMINISTRATION OF ANTI-IFN-GAMMA MONOCLONAL-ANTIBODY SO JOURNAL OF IMMUNOLOGY LA English DT Article C1 TNO,CTR PRIMATE,RIJSWIJK,NETHERLANDS. NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892. RP ROSENBERG, AS (reprint author), US FDA,DIV CYTOKINE BIOL,BLDG 29A,RM 2B-12,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 13 TC 64 Z9 64 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD JUN 15 PY 1990 VL 144 IS 12 BP 4648 EP 4650 PG 3 WC Immunology SC Immunology GA DK406 UT WOS:A1990DK40600022 PM 2112572 ER PT J AU GERRARD, TL DYER, DR MOSTOWSKI, HS AF GERRARD, TL DYER, DR MOSTOWSKI, HS TI IL-4 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SELECTIVELY INCREASE HLA-DR AND HLA-DP ANTIGENS BUT NOT HLA-DQ ANTIGENS ON HUMAN MONOCYTES SO JOURNAL OF IMMUNOLOGY LA English DT Article RP GERRARD, TL (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BLDG 29A,ROOM 2D-20,HFB-800,BETHESDA,MD 20892, USA. NR 28 TC 52 Z9 52 U1 0 U2 0 PU AMER ASSOC IMMUNOLOGISTS PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0022-1767 J9 J IMMUNOL JI J. Immunol. PD JUN 15 PY 1990 VL 144 IS 12 BP 4670 EP 4674 PG 5 WC Immunology SC Immunology GA DK406 UT WOS:A1990DK40600026 PM 2112573 ER PT J AU FERGUSON, DV ROBERTS, DW HANSHU, H ANDREWS, A BENSON, RW BUCCI, TJ HINSON, JA AF FERGUSON, DV ROBERTS, DW HANSHU, H ANDREWS, A BENSON, RW BUCCI, TJ HINSON, JA TI ACETAMINOPHEN-INDUCED ALTERATIONS IN PANCREATIC BETA-CELLS AND SERUM-INSULIN CONCENTRATIONS IN B6C3F1 MICE SO TOXICOLOGY AND APPLIED PHARMACOLOGY LA English DT Article C1 UNIV ARKANSAS,LITTLE ROCK,AR 72204. RP FERGUSON, DV (reprint author), NATL CTR TOXICOL RES,PATHOL ASSOCIATES INC,JEFFERSON,AR 72079, USA. NR 32 TC 6 Z9 6 U1 0 U2 1 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0041-008X J9 TOXICOL APPL PHARM JI Toxicol. Appl. Pharmacol. PD JUN 15 PY 1990 VL 104 IS 2 BP 225 EP 234 DI 10.1016/0041-008X(90)90297-8 PG 10 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA DL170 UT WOS:A1990DL17000004 PM 2194324 ER PT J AU GERSTMAN, BB AF GERSTMAN, BB TI USE OF THE TERM PHARMACOEPIDEMIOLOGY SO AMERICAN JOURNAL OF EPIDEMIOLOGY LA English DT Letter RP GERSTMAN, BB (reprint author), US FDA,OFF EPIDEMIOL & BIOSTAT,EPIDEMIOL BRANCH,ROCKVILLE,MD 20857, USA. NR 1 TC 0 Z9 0 U1 0 U2 0 PU AMER J EPIDEMIOLOGY PI BALTIMORE PA 624 N BROADWAY RM 225, BALTIMORE, MD 21205 SN 0002-9262 J9 AM J EPIDEMIOL JI Am. J. Epidemiol. PD JUN PY 1990 VL 131 IS 6 BP 1101 EP 1101 PG 1 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA DG762 UT WOS:A1990DG76200025 PM 2343867 ER PT J AU JOHNSON, JM AF JOHNSON, JM TI CONTRIBUTING TO DRUG SAFETY SO AMERICAN JOURNAL OF HOSPITAL PHARMACY LA English DT Editorial Material RP JOHNSON, JM (reprint author), US FDA,ROCKVILLE,MD 20857, USA. NR 0 TC 2 Z9 2 U1 0 U2 0 PU AMER SOC HEALTH-SYSTEM PHARMACISTS PI BETHESDA PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 SN 0002-9289 J9 AM J HOSP PHARM JI Am. J. Hosp. Pharm. PD JUN PY 1990 VL 47 IS 6 BP 1280 EP 1280 PG 1 WC Pharmacology & Pharmacy SC Pharmacology & Pharmacy GA DF883 UT WOS:A1990DF88300018 PM 2368721 ER PT J AU LAMPEL, KA JAGOW, JA TRUCKSESS, M HILL, WE AF LAMPEL, KA JAGOW, JA TRUCKSESS, M HILL, WE TI POLYMERASE CHAIN-REACTION FOR DETECTION OF INVASIVE SHIGELLA-FLEXNERI IN FOOD SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 US FDA,CTR FOOD SAFETY & APPL NUTR,DIV CONTAMINANTS CHEM,WASHINGTON,DC 20204. RP LAMPEL, KA (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 30 TC 82 Z9 82 U1 0 U2 1 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0099-2240 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD JUN PY 1990 VL 56 IS 6 BP 1536 EP 1540 PG 5 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA DG922 UT WOS:A1990DG92200006 PM 2200336 ER PT J AU COLE, EC RUTALA, WA NESSEN, L WANNAMAKER, NS WEBER, DJ AF COLE, EC RUTALA, WA NESSEN, L WANNAMAKER, NS WEBER, DJ TI EFFECT OF METHODOLOGY, DILUTION, AND EXPOSURE TIME ON THE TUBERCULOCIDAL ACTIVITY OF GLUTARALDEHYDE-BASED DISINFECTANTS SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY LA English DT Article C1 UNIV N CAROLINA, DEPT MED, DIV INFECT DIS, CHAPEL HILL, NC 27599 USA. UNIV N CAROLINA HOSP, DEPT HOSP EPIDEMIOL, CHAPEL HILL, NC 27514 USA. US FDA, ROCKVILLE, MD 20850 USA. NR 28 TC 41 Z9 43 U1 0 U2 2 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA SN 0099-2240 EI 1098-5336 J9 APPL ENVIRON MICROB JI Appl. Environ. Microbiol. PD JUN PY 1990 VL 56 IS 6 BP 1813 EP 1817 PG 5 WC Biotechnology & Applied Microbiology; Microbiology SC Biotechnology & Applied Microbiology; Microbiology GA DG922 UT WOS:A1990DG92200049 PM 2116760 ER PT J AU SHAPIRANAHOR, O GOLDING, H VUJCIC, LK RESTORUIZ, S FIELDS, RL ROBEY, FA AF SHAPIRANAHOR, O GOLDING, H VUJCIC, LK RESTORUIZ, S FIELDS, RL ROBEY, FA TI CD4-DERIVED SYNTHETIC PEPTIDE BLOCKS THE BINDING OF HIV-1 GP120 TO CD4-BEARING CELLS AND PREVENTS HIV-1 INFECTION SO CELLULAR IMMUNOLOGY LA English DT Article C1 US FDA,CBER,DIV VIROL,BETHESDA,MD 20892. NIDR,IMMUNOL LAB,BETHESDA,MD 20892. RP SHAPIRANAHOR, O (reprint author), NIDR,CELLULAR DEV & ONCOL LAB,PEPTIDE & IMMUNOCHEM UNIT,BETHESDA,MD 20892, USA. NR 37 TC 25 Z9 25 U1 0 U2 0 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0008-8749 J9 CELL IMMUNOL JI Cell. Immunol. PD JUN PY 1990 VL 128 IS 1 BP 101 EP 117 DI 10.1016/0008-8749(90)90010-O PG 17 WC Cell Biology; Immunology SC Cell Biology; Immunology GA DG044 UT WOS:A1990DG04400010 PM 1971526 ER PT J AU BULL, TE AF BULL, TE TI FOKKER-PLANCK-LANGEVIN AND EXTENDED DIFFUSION-MODELS OF INTERNAL-ROTATION IN MOLECULES .2. QUANTUM-MECHANICAL ANALOGS SO CHEMICAL PHYSICS LA English DT Article RP BULL, TE (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BIOCHEM & BIOPHYS,BIOPHYS LAB,BETHESDA,MD 20892, USA. NR 38 TC 8 Z9 8 U1 0 U2 0 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0301-0104 J9 CHEM PHYS JI Chem. Phys. PD JUN 1 PY 1990 VL 143 IS 3 BP 381 EP 394 DI 10.1016/0301-0104(90)87018-7 PG 14 WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical SC Chemistry; Physics GA DH260 UT WOS:A1990DH26000005 ER PT J AU ZIMMERMAN, ML AF ZIMMERMAN, ML TI COLEOPTERA FOUND IN IMPORTED STORED-FOOD PRODUCTS ENTERING SOUTHERN CALIFORNIA AND ARIZONA BETWEEN DECEMBER 1984 THROUGH DECEMBER 1987 SO COLEOPTERISTS BULLETIN LA English DT Article RP ZIMMERMAN, ML (reprint author), US FDA,900 MADISON AVE,BALTIMORE,MD 21201, USA. NR 0 TC 5 Z9 6 U1 0 U2 1 PU COLEOPTERISTS SOC PI NATCHEZ PA P.O. BOX 767, NATCHEZ, MS 39121 SN 0010-065X J9 COLEOPTS BULL JI Coleopt. Bull. PD JUN PY 1990 VL 44 IS 2 BP 235 EP 240 PG 6 WC Entomology SC Entomology GA DG221 UT WOS:A1990DG22100010 ER PT J AU HEIMBACH, JT LEVY, AS SCHUCKER, RE AF HEIMBACH, JT LEVY, AS SCHUCKER, RE TI DECLARED SERVING SIZES OF PACKAGED FOODS, 1977-86 SO FOOD TECHNOLOGY LA English DT Article C1 US FDA,DIV CONSUMER STUDIES,CONSUMER RES STAFF,WASHINGTON,DC 20204. USDA,HUMAN NUTR INFORMAT SCI,WASHINGTON,DC 20250. NR 8 TC 4 Z9 4 U1 0 U2 0 PU INST FOOD TECHNOLOGISTS PI CHICAGO PA SUITE 300 221 N LASALLE ST, CHICAGO, IL 60601-1291 SN 0015-6639 J9 FOOD TECHNOL-CHICAGO JI Food Technol. PD JUN PY 1990 VL 44 IS 6 BP 82 EP & PG 0 WC Food Science & Technology SC Food Science & Technology GA DJ598 UT WOS:A1990DJ59800007 ER PT J AU WILLIAMS, KM RAYBOURNE, RB AF WILLIAMS, KM RAYBOURNE, RB TI DEMONSTRATION OF CROSS-REACTIVITY BETWEEN BACTERIAL-ANTIGENS AND CLASS-I HUMAN-LEUKOCYTE ANTIGENS BY USING MONOCLONAL-ANTIBODIES TO SHIGELLA-FLEXNERI SO INFECTION AND IMMUNITY LA English DT Article RP WILLIAMS, KM (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 41 TC 20 Z9 20 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0019-9567 J9 INFECT IMMUN JI Infect. Immun. PD JUN PY 1990 VL 58 IS 6 BP 1774 EP 1781 PG 8 WC Immunology; Infectious Diseases SC Immunology; Infectious Diseases GA DF208 UT WOS:A1990DF20800044 PM 2187807 ER PT J AU HILBERT, SL BARRICK, MK FERRANS, VJ AF HILBERT, SL BARRICK, MK FERRANS, VJ TI PORCINE AORTIC-VALVE BIOPROSTHESES - A MORPHOLOGIC COMPARISON OF THE EFFECTS OF FIXATION PRESSURE SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH LA English DT Article C1 NHLBI,PATHOL BRANCH,BETHESDA,MD 20205. RP HILBERT, SL (reprint author), US FDA,CTR DEVICES & RADIOL HLTH,DMMS,12200 WILKINS AVE,ROCKVILLE,MD 20852, USA. NR 10 TC 34 Z9 34 U1 0 U2 0 PU JOHN WILEY & SONS INC PI NEW YORK PA 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0021-9304 J9 J BIOMED MATER RES JI J. Biomed. Mater. Res. PD JUN PY 1990 VL 24 IS 6 BP 773 EP 787 DI 10.1002/jbm.820240611 PG 15 WC Engineering, Biomedical; Materials Science, Biomaterials SC Engineering; Materials Science GA DE176 UT WOS:A1990DE17600010 PM 2113925 ER PT J AU GILL, RW AF GILL, RW TI ECONOMIC-IMPLICATIONS OF A SAFE FOOD-SUPPLY SO JOURNAL OF DAIRY SCIENCE LA English DT Article RP GILL, RW (reprint author), US PHS,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204, USA. NR 3 TC 1 Z9 1 U1 0 U2 1 PU AMER DAIRY SCIENCE ASSN PI CHAMPAIGN PA 309 W CLARK ST, CHAMPAIGN, IL 61820 SN 0022-0302 J9 J DAIRY SCI JI J. Dairy Sci. PD JUN PY 1990 VL 73 IS 6 BP 1662 EP 1664 PG 3 WC Agriculture, Dairy & Animal Science; Food Science & Technology SC Agriculture; Food Science & Technology GA DQ342 UT WOS:A1990DQ34200037 PM 2200815 ER PT J AU HITCHINS, AD TRAN, T AF HITCHINS, AD TRAN, T TI INITIAL CELL CONCENTRATION AND SELECTIVE MEDIA EFFECTS ON THE ISOLATION OF LISTERIA-MONOCYTOGENES FROM ENRICHMENT CULTURES OF INOCULATED FOODS SO JOURNAL OF FOOD PROTECTION LA English DT Note RP HITCHINS, AD (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 8 TC 19 Z9 19 U1 0 U2 0 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JUN PY 1990 VL 53 IS 6 BP 502 EP 504 PG 3 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA DJ779 UT WOS:A1990DJ77900009 ER PT J AU GECAN, JS BANDLER, R AF GECAN, JS BANDLER, R TI MICROANALYTICAL QUALITY OF CANNED COLLARD, CREECY, KALE, MUSTARD, AND TURNIP GREENS SO JOURNAL OF FOOD PROTECTION LA English DT Note RP GECAN, JS (reprint author), US FDA,DIV MICROBIOL,WASHINGTON,DC 20204, USA. NR 3 TC 2 Z9 2 U1 1 U2 4 PU INT ASSOC MILK FOOD ENVIRONMENTAL SANITARIANS, INC PI DES MOINES PA 6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2838 SN 0362-028X J9 J FOOD PROTECT JI J. Food Prot. PD JUN PY 1990 VL 53 IS 6 BP 511 EP & PG 0 WC Biotechnology & Applied Microbiology; Food Science & Technology SC Biotechnology & Applied Microbiology; Food Science & Technology GA DJ779 UT WOS:A1990DJ77900012 ER PT J AU CLARK, DP KASERMAN, DL MAYO, JW AF CLARK, DP KASERMAN, DL MAYO, JW TI BARRIERS TO TRADE AND THE IMPORT VULNERABILITY OF UNITED-STATES MANUFACTURING-INDUSTRIES SO JOURNAL OF INDUSTRIAL ECONOMICS LA English DT Article C1 UNIV TENNESSEE,CBER,KNOXVILLE,TN 37996. AUBURN UNIV,DEPT ECON,AUBURN,AL 36849. RP CLARK, DP (reprint author), UNIV TENNESSEE,DEPT ECON,KNOXVILLE,TN 37996, USA. NR 27 TC 14 Z9 14 U1 0 U2 0 PU BLACKWELL PUBL LTD PI OXFORD PA 108 COWLEY RD, OXFORD, OXON, ENGLAND OX4 1JF SN 0022-1821 J9 J IND ECON JI J. Indust. Econ. PD JUN PY 1990 VL 38 IS 4 BP 433 EP 447 DI 10.2307/2098349 PG 15 WC Business, Finance; Economics SC Business & Economics GA DL305 UT WOS:A1990DL30500005 ER PT J AU LABORDA, J DOUILLARD, JY BURG, C LIZZIO, EF RIDGE, J LEVENBOOK, I HOFFMAN, T AF LABORDA, J DOUILLARD, JY BURG, C LIZZIO, EF RIDGE, J LEVENBOOK, I HOFFMAN, T TI PHARMACOKINETIC STUDIES OF MOUSE MONOCLONAL-ANTIBODIES TO A RAT COLON-CARCINOMA .1. COMPARISON OF BIODISTRIBUTION IN NORMAL RATS, SYNGENEIC TUMOR-BEARING RATS, OR TUMOR-BEARING NUDE-MICE SO JOURNAL OF NUCLEAR MEDICINE LA English DT Article C1 US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,CELL BIOL LAB,8800 ROCKVILLE PIKE,BETHESDA,MD 20892. US FDA,CTR BIOL EVALUAT & RES,DIV PROD QUAL CONTROL,BETHESDA,MD 20014. RI Laborda, Jorge/L-5726-2014 OI Laborda, Jorge/0000-0002-9210-838X NR 18 TC 8 Z9 8 U1 0 U2 3 PU SOC NUCLEAR MEDICINE INC PI RESTON PA 1850 SAMUEL MORSE DR, RESTON, VA 22090-5316 SN 0161-5505 J9 J NUCL MED JI J. Nucl. Med. PD JUN PY 1990 VL 31 IS 6 BP 1028 EP 1034 PG 7 WC Radiology, Nuclear Medicine & Medical Imaging SC Radiology, Nuclear Medicine & Medical Imaging GA DJ247 UT WOS:A1990DJ24700012 PM 2348232 ER PT J AU TOSATO, G TANNER, J JONES, KD REVEL, M PIKE, SE AF TOSATO, G TANNER, J JONES, KD REVEL, M PIKE, SE TI IDENTIFICATION OF INTERLEUKIN-6 AS AN AUTOCRINE GROWTH-FACTOR FOR EPSTEIN-BARR VIRUS-IMMORTALIZED B-CELLS SO JOURNAL OF VIROLOGY LA English DT Article C1 WEIZMANN INST SCI,DEPT VIROL,IL-76100 REHOVOT,ISRAEL. RP TOSATO, G (reprint author), US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892, USA. NR 37 TC 175 Z9 177 U1 0 U2 0 PU AMER SOC MICROBIOLOGY PI WASHINGTON PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 SN 0022-538X J9 J VIROL JI J. Virol. PD JUN PY 1990 VL 64 IS 6 BP 3033 EP 3041 PG 9 WC Virology SC Virology GA DD735 UT WOS:A1990DD73500069 PM 2159561 ER PT J AU BUSH, M MONTALI, RJ PHILLIPS, LG HOLOBAUGH, PA AF BUSH, M MONTALI, RJ PHILLIPS, LG HOLOBAUGH, PA TI BOVINE TUBERCULOSIS IN A BACTRIAN CAMEL HERD - CLINICAL, THERAPEUTIC, AND PATHOLOGICAL FINDINGS SO JOURNAL OF ZOO AND WILDLIFE MEDICINE LA English DT Article C1 SMITHSONIAN INST,NATL ZOOL PK,DEPT PATHOL,WASHINGTON,DC 20008. US FDA,OFF BIOL,BETHESDA,MD 20814. RP BUSH, M (reprint author), SMITHSONIAN INST,NATL ZOOL PK,DEPT ANIM HLTH,WASHINGTON,DC 20008, USA. NR 33 TC 20 Z9 20 U1 0 U2 2 PU AMER ASSOC Z00 VETERINARIANS PI MEDIA PA 6 NORTH PENNELL ROAD, MEDIA, PA 19063 SN 1042-7260 J9 J ZOO WILDLIFE MED JI J. Zoo Wildl. Med. PD JUN PY 1990 VL 21 IS 2 BP 171 EP 179 PG 9 WC Veterinary Sciences SC Veterinary Sciences GA DU108 UT WOS:A1990DU10800005 ER PT J AU HART, RW AF HART, RW TI THE IMPORTANCE OF RISK ASSESSMENT TO THE NATIONS HEALTH AND ECONOMY SO NEUROTOXICOLOGY LA English DT Article; Proceedings Paper CT 7TH INTERNATIONAL NEUROTOXICOLOGY CONF : NEUROTOXICOLOGY AND RISK ASSESSMENT CY SEP 18-21, 1989 CL LITTLE ROCK, AR SP CTR DIS CONTROL, AGCY TOX SUBST & DIS CONTROL, US EPA, HLTH EFFECTS RES LAB, US FDA, NATL CTR TOXICOL RES, NIEHS, US EPA, OFF HLTH & ENVIRONM ASSESSMENT, US EPA, OFF SOLID WASTE, UNIV ARKANSAS MED SCI, ARKANSAS CHILDRENS HOSP, ARKANSAS DEPT HLTH, CIBA GEIGY, DIV PHARM RP HART, RW (reprint author), US FDA,NATL CTR TOXICOL RES,HFT-1,NCTR DR,JEFFERSON,AR 72079, USA. NR 4 TC 3 Z9 3 U1 0 U2 0 PU INTOX PRESS INC PI LITTLE ROCK PA PO BOX 24865, LITTLE ROCK, AR 72221 SN 0161-813X J9 NEUROTOXICOLOGY JI Neurotoxicology PD SUM PY 1990 VL 11 IS 2 BP 181 EP 188 PG 8 WC Neurosciences; Pharmacology & Pharmacy; Toxicology SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology GA DU928 UT WOS:A1990DU92800002 PM 2234539 ER PT J AU GAYLOR, DW SLIKKER, W AF GAYLOR, DW SLIKKER, W TI RISK ASSESSMENT FOR NEUROTOXIC EFFECTS SO NEUROTOXICOLOGY LA English DT Article; Proceedings Paper CT 7TH INTERNATIONAL NEUROTOXICOLOGY CONF : NEUROTOXICOLOGY AND RISK ASSESSMENT CY SEP 18-21, 1989 CL LITTLE ROCK, AR SP CTR DIS CONTROL, AGCY TOX SUBST & DIS CONTROL, US EPA, HLTH EFFECTS RES LAB, US FDA, NATL CTR TOXICOL RES, NIEHS, US EPA, OFF HLTH & ENVIRONM ASSESSMENT, US EPA, OFF SOLID WASTE, UNIV ARKANSAS MED SCI, ARKANSAS CHILDRENS HOSP, ARKANSAS DEPT HLTH, CIBA GEIGY, DIV PHARM RP GAYLOR, DW (reprint author), NATL CTR TOXICOL RES,HFT-20,JEFFERSON,AR 72079, USA. NR 8 TC 95 Z9 97 U1 0 U2 6 PU INTOX PRESS INC PI LITTLE ROCK PA PO BOX 24865, LITTLE ROCK, AR 72221 SN 0161-813X J9 NEUROTOXICOLOGY JI Neurotoxicology PD SUM PY 1990 VL 11 IS 2 BP 211 EP 218 PG 8 WC Neurosciences; Pharmacology & Pharmacy; Toxicology SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology GA DU928 UT WOS:A1990DU92800005 PM 1700346 ER PT J AU ALI, SF JAIRAJ, K NEWPORT, GD LIPE, GW SLIKKER, W AF ALI, SF JAIRAJ, K NEWPORT, GD LIPE, GW SLIKKER, W TI THALLIUM INTOXICATION PRODUCES NEUROCHEMICAL ALTERATIONS IN RAT-BRAIN SO NEUROTOXICOLOGY LA English DT Article; Proceedings Paper CT 7TH INTERNATIONAL NEUROTOXICOLOGY CONF : NEUROTOXICOLOGY AND RISK ASSESSMENT CY SEP 18-21, 1989 CL LITTLE ROCK, AR SP CTR DIS CONTROL, AGCY TOX SUBST & DIS CONTROL, US EPA, HLTH EFFECTS RES LAB, US FDA, NATL CTR TOXICOL RES, NIEHS, US EPA, OFF HLTH & ENVIRONM ASSESSMENT, US EPA, OFF SOLID WASTE, UNIV ARKANSAS MED SCI, ARKANSAS CHILDRENS HOSP, ARKANSAS DEPT HLTH, CIBA GEIGY, DIV PHARM C1 UNIV ARKANSAS MED SCI HOSP,DEPT PHARMACOL & TOXICOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM & MOLEC BIOL,LITTLE ROCK,AR 72205. UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,LITTLE ROCK,AR 72205. UNIV ARKANSAS,DEPT HOME ECON,PINE BLUFF,AR 71601. RP ALI, SF (reprint author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079, USA. NR 31 TC 5 Z9 5 U1 0 U2 0 PU INTOX PRESS INC PI LITTLE ROCK PA PO BOX 24865, LITTLE ROCK, AR 72221 SN 0161-813X J9 NEUROTOXICOLOGY JI Neurotoxicology PD SUM PY 1990 VL 11 IS 2 BP 381 EP 390 PG 10 WC Neurosciences; Pharmacology & Pharmacy; Toxicology SC Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology GA DU928 UT WOS:A1990DU92800021 PM 2172876 ER PT J AU PACKARD, BS AF PACKARD, BS TI MITOGENIC STIMULATION OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES BY SECRETED FACTOR(S) FROM HUMAN TUMOR-CELL LINES SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA LA English DT Article RP PACKARD, BS (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 21 TC 20 Z9 20 U1 0 U2 0 PU NATL ACAD SCIENCES PI WASHINGTON PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 SN 0027-8424 J9 P NATL ACAD SCI USA JI Proc. Natl. Acad. Sci. U. S. A. PD JUN PY 1990 VL 87 IS 11 BP 4058 EP 4062 DI 10.1073/pnas.87.11.4058 PG 5 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DG092 UT WOS:A1990DG09200008 PM 2190213 ER PT J AU HORWITZ, W AF HORWITZ, W TI NOMENCLATURE FOR SAMPLING IN ANALYTICAL-CHEMISTRY - (RECOMMENDATIONS 1990) SO PURE AND APPLIED CHEMISTRY LA English DT Article RP HORWITZ, W (reprint author), US FDA,CTR FOOD SAFETY & APPL NUTR,HFF-7,WASHINGTON,DC 20204, USA. NR 0 TC 49 Z9 49 U1 1 U2 5 PU BLACKWELL SCIENCE LTD PI OXFORD PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL SN 0033-4545 J9 PURE APPL CHEM JI Pure Appl. Chem. PD JUN PY 1990 VL 62 IS 6 BP 1193 EP 1208 DI 10.1351/pac199062061193 PG 16 WC Chemistry, Multidisciplinary SC Chemistry GA DG152 UT WOS:A1990DG15200044 ER PT J AU CHEN, JJ GAYLOR, DW KODELL, RL AF CHEN, JJ GAYLOR, DW KODELL, RL TI ESTIMATION OF THE JOINT RISK FROM MULTIPLE-COMPOUND EXPOSURE BASED ON SINGLE-COMPOUND EXPERIMENTS SO RISK ANALYSIS LA English DT Article RP CHEN, JJ (reprint author), US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 14 TC 17 Z9 17 U1 0 U2 0 PU PLENUM PUBL CORP PI NEW YORK PA 233 SPRING ST, NEW YORK, NY 10013 SN 0272-4332 J9 RISK ANAL JI Risk Anal. PD JUN PY 1990 VL 10 IS 2 BP 285 EP 290 DI 10.1111/j.1539-6924.1990.tb01049.x PG 6 WC Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods SC Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences GA DK694 UT WOS:A1990DK69400014 PM 2367712 ER PT J AU SPRINGER, JA BARTON, CN SOBOTKA, TJ AF SPRINGER, JA BARTON, CN SOBOTKA, TJ TI BEHAVIORAL TERATOGENIC EFFECT OF METHYLMERCURY AND D-AMPHETAMINE - METAANALYSIS AND POWER ANALYSIS OF DATA FROM THE COLLABORATIVE BEHAVIORAL TERATOLOGY STUDY OF NATIONAL-CENTER-FOR-TOXICOLOGICAL-RESEARCH - COMMENTS SO TERATOLOGY LA English DT Letter C1 US FDA,DIV TOXICOL STUDIES,WASHINGTON,DC 20204. RP SPRINGER, JA (reprint author), US FDA,DIV MATH,WASHINGTON,DC 20204, USA. NR 2 TC 2 Z9 2 U1 0 U2 0 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0040-3709 J9 TERATOLOGY JI Teratology PD JUN PY 1990 VL 41 IS 6 BP 747 EP 747 DI 10.1002/tera.1420410613 PG 1 WC Developmental Biology; Toxicology SC Developmental Biology; Toxicology GA DJ591 UT WOS:A1990DJ59100012 ER PT J AU GAYLOR, DW AF GAYLOR, DW TI BEHAVIORAL TERATOGENIC EFFECT OF METHYLMERCURY AND D-AMPHETAMINE - METAANALYSIS AND POWER ANALYSIS OF DATA FROM THE COLLABORATIVE BEHAVIORAL TERATOLOGY STUDY OF NATIONAL-CENTER-FOR-TOXICOLOGICAL-RESEARCH - COMMENTS SO TERATOLOGY LA English DT Letter RP GAYLOR, DW (reprint author), NATL CTR TOXICOL RES,JEFFERSON,AR 72079, USA. NR 3 TC 2 Z9 2 U1 0 U2 0 PU WILEY-LISS PI NEW YORK PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012 SN 0040-3709 J9 TERATOLOGY JI Teratology PD JUN PY 1990 VL 41 IS 6 BP 749 EP 750 DI 10.1002/tera.1420410614 PG 2 WC Developmental Biology; Toxicology SC Developmental Biology; Toxicology GA DJ591 UT WOS:A1990DJ59100013 ER PT J AU LEBEL, CP ALI, SF MCKEE, M BONDY, SC AF LEBEL, CP ALI, SF MCKEE, M BONDY, SC TI ORGANOMETAL-INDUCED INCREASES IN OXYGEN REACTIVE SPECIES - THE POTENTIAL OF 2',7'-DICHLOROFLUORESCIN DIACETATE AS AN INDEX OF NEUROTOXIC DAMAGE SO TOXICOLOGY AND APPLIED PHARMACOLOGY LA English DT Article C1 NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,PHARMACODYNAM BRANCH,JEFFERSON,AR 72079. RP LEBEL, CP (reprint author), UNIV CALIF IRVINE,SO OCCUPAT HLTH CTR,DEPT COMMUNITY & ENVIRONM MED,IRVINE,CA 92717, USA. FU NIEHS NIH HHS [ES 07157, ES 04071] NR 45 TC 220 Z9 223 U1 0 U2 6 PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS PI SAN DIEGO PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 SN 0041-008X J9 TOXICOL APPL PHARM JI Toxicol. Appl. Pharmacol. PD JUN 1 PY 1990 VL 104 IS 1 BP 17 EP 24 DI 10.1016/0041-008X(90)90278-3 PG 8 WC Pharmacology & Pharmacy; Toxicology SC Pharmacology & Pharmacy; Toxicology GA DJ597 UT WOS:A1990DJ59700003 PM 2163122 ER PT J AU REES, MA ROSENBERG, AS SINGER, A AF REES, MA ROSENBERG, AS SINGER, A TI T-CELL SUBSETS MEDIATING REJECTION OF ESTABLISHED FETAL PANCREAS GRAFTS AND FAILURE TO OBSERVE GRAFT ADAPTATION SO TRANSPLANTATION LA English DT Article C1 NCI,EXPTL IMMUNOL BRANCH,BLDG 10,ROOM 4B-17,BETHESDA,MD 20892. US FDA,DIV CYTOKINE BIOL,BETHESDA,MD 20892. NR 17 TC 1 Z9 1 U1 0 U2 0 PU WILLIAMS & WILKINS PI BALTIMORE PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436 SN 0041-1337 J9 TRANSPLANTATION JI Transplantation PD JUN PY 1990 VL 49 IS 6 BP 1130 EP 1133 DI 10.1097/00007890-199006000-00020 PG 4 WC Immunology; Surgery; Transplantation SC Immunology; Surgery; Transplantation GA DK963 UT WOS:A1990DK96300020 PM 2113726 ER PT J AU DRAGUNSKY, EM RIVERA, E HOCHSTEIN, HD LEVENBOOK, IS AF DRAGUNSKY, EM RIVERA, E HOCHSTEIN, HD LEVENBOOK, IS TI INVITRO CHARACTERIZATION OF SALMONELLA-TYPHI MUTANT STRAINS FOR LIVE ORAL VACCINES SO VACCINE LA English DT Article RP DRAGUNSKY, EM (reprint author), US FDA,CTR BIOL EVALUAT & RES,OFF BIOL PROD REVIEW,DIV PROD QUAL CONTROL,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA. NR 18 TC 11 Z9 11 U1 0 U2 0 PU BUTTERWORTH-HEINEMANN LTD PI OXFORD PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB SN 0264-410X J9 VACCINE JI Vaccine PD JUN PY 1990 VL 8 IS 3 BP 263 EP 268 DI 10.1016/0264-410X(90)90056-R PG 6 WC Immunology; Medicine, Research & Experimental SC Immunology; Research & Experimental Medicine GA DF639 UT WOS:A1990DF63900016 PM 2363303 ER PT J AU TESKE, RH NEWKIRK, DR AF TESKE, RH NEWKIRK, DR TI PHARMACOKINETICS - REGULATORY ASPECTS - POINT OF VIEW OF FDA SO VETERINARY AND HUMAN TOXICOLOGY LA English DT Editorial Material RP TESKE, RH (reprint author), US FDA,CTR VET MED,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 0 TC 0 Z9 0 U1 0 U2 0 PU COMPARATIVE TOXICOLOGY LAB KANSAS STATE UNIV PI MANHATTAN PA MANHATTAN, KS 66506 SN 0145-6296 J9 VET HUM TOXICOL JI Vet. Human Toxicol. PD JUN PY 1990 VL 32 IS 3 BP 261 EP 262 PG 2 WC Toxicology; Veterinary Sciences SC Toxicology; Veterinary Sciences GA DE333 UT WOS:A1990DE33300016 PM 2353440 ER PT J AU FINLAYSON, JS TANKERSLEY, DL AF FINLAYSON, JS TANKERSLEY, DL TI ANTI-HCV SCREENING AND PLASMA FRACTIONATION - THE CASE AGAINST SO LANCET LA English DT Letter RP FINLAYSON, JS (reprint author), US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,BETHESDA,MD 20892, USA. NR 10 TC 41 Z9 41 U1 0 U2 0 PU LANCET LTD PI LONDON PA 42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL SN 0140-6736 J9 LANCET JI Lancet PD MAY 26 PY 1990 VL 335 IS 8700 BP 1274 EP 1275 DI 10.1016/0140-6736(90)91335-8 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA DF451 UT WOS:A1990DF45100020 PM 1971337 ER PT J AU MORAN, TM USUBA, O SHAPIRO, E RUBINSTEIN, LJ ITO, M BONA, CA AF MORAN, TM USUBA, O SHAPIRO, E RUBINSTEIN, LJ ITO, M BONA, CA TI A NOVEL TECHNIQUE FOR THE PRODUCTION OF HYBRID ANTIBODIES SO JOURNAL OF IMMUNOLOGICAL METHODS LA English DT Article C1 CUNY MT SINAI SCH MED,DEPT MICROBIOL,NEW YORK,NY 10029. YAMAGATA UNIV,SCH MED,YAMAGATA 990,JAPAN. US FDA,CTR BIOL EVALUAT & RES,DIV BACTERIAL PROD,BETHESDA,MD 20892. NR 18 TC 9 Z9 9 U1 0 U2 1 PU ELSEVIER SCIENCE BV PI AMSTERDAM PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS SN 0022-1759 J9 J IMMUNOL METHODS JI J. Immunol. Methods PD MAY 25 PY 1990 VL 129 IS 2 BP 199 EP 205 DI 10.1016/0022-1759(90)90439-3 PG 7 WC Biochemical Research Methods; Immunology SC Biochemistry & Molecular Biology; Immunology GA DG982 UT WOS:A1990DG98200006 PM 2351836 ER PT J AU JARVIS, BB MAZZOCCHI, DB AMMON, HL MAZZOLA, EP FLIPPENANDERSON, JL GILARDI, RD GEORGE, CF AF JARVIS, BB MAZZOCCHI, DB AMMON, HL MAZZOLA, EP FLIPPENANDERSON, JL GILARDI, RD GEORGE, CF TI CONFORMATIONAL EFFECTS IN TRICHOTHECENES - STRUCTURES OF 15-HYDROXY C4 AND C8 KETONES SO JOURNAL OF ORGANIC CHEMISTRY LA English DT Article C1 US FDA,CTR FOOD SAFETY & APPL NUTR,WASHINGTON,DC 20204. USN,RES LAB,STRUCT MATTER LAB,WASHINGTON,DC 20375. RP JARVIS, BB (reprint author), UNIV MARYLAND,DEPT CHEM & BIOCHEM,COLLEGE PK,MD 20742, USA. NR 21 TC 13 Z9 13 U1 0 U2 2 PU AMER CHEMICAL SOC PI WASHINGTON PA 1155 16TH ST, NW, WASHINGTON, DC 20036 SN 0022-3263 J9 J ORG CHEM JI J. Org. Chem. PD MAY 25 PY 1990 VL 55 IS 11 BP 3660 EP 3662 DI 10.1021/jo00298a053 PG 3 WC Chemistry, Organic SC Chemistry GA DF286 UT WOS:A1990DF28600053 ER PT J AU IYER, RP UZNANSKI, B BOAL, J STORM, C EGAN, W MATSUKURA, M BRODER, S ZON, G WILK, A KOZIOLKIEWICZ, M STEC, WJ AF IYER, RP UZNANSKI, B BOAL, J STORM, C EGAN, W MATSUKURA, M BRODER, S ZON, G WILK, A KOZIOLKIEWICZ, M STEC, WJ TI ABASIC OLIGODEOXYRIBONUCLEOSIDE PHOSPHOROTHIOATES - SYNTHESIS AND EVALUATION AS ANTI-HIV-1 AGENTS SO NUCLEIC ACIDS RESEARCH LA English DT Article C1 POLISH ACAD SCI,CTR MOLEC & MACROMOLEC STUDIES,DEPT BIOORGAN CHEM,BOCZNA 5,PL-90362 LODZ,POLAND. US FDA,CTR BIOL EVALUAT & RES,BIOPHYS LAB,BETHESDA,MD 20014. NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892. APPL BIOSYST INC,FOSTER CITY,CA 94404. NR 24 TC 23 Z9 23 U1 0 U2 1 PU OXFORD UNIV PRESS UNITED KINGDOM PI OXFORD PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP SN 0305-1048 J9 NUCLEIC ACIDS RES JI Nucleic Acids Res. PD MAY 25 PY 1990 VL 18 IS 10 BP 2855 EP 2859 DI 10.1093/nar/18.10.2855 PG 5 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DG797 UT WOS:A1990DG79700001 PM 2349087 ER PT J AU HATHCOCK, JN RADER, JI AF HATHCOCK, JN RADER, JI TI MICRONUTRIENT SAFETY SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES LA English DT Article RP HATHCOCK, JN (reprint author), US FDA,DIV NUTR,200 C ST,SW HFF-268,WASHINGTON,DC 20204, USA. NR 52 TC 4 Z9 4 U1 0 U2 0 PU NEW YORK ACAD SCIENCES PI NEW YORK PA 2 E 63RD ST, NEW YORK, NY 10021 SN 0077-8923 J9 ANN NY ACAD SCI JI Ann. N.Y. Acad. Sci. PD MAY 15 PY 1990 VL 587 BP 257 EP 266 PG 10 WC Multidisciplinary Sciences SC Science & Technology - Other Topics GA DX279 UT WOS:A1990DX27900027 PM 2193575 ER PT J AU VINEIS, P CAPORASO, N TANNENBAUM, SR SKIPPER, PL GLOGOWSKI, J BARTSCH, H CODA, M TALASKA, G KADLUBAR, F AF VINEIS, P CAPORASO, N TANNENBAUM, SR SKIPPER, PL GLOGOWSKI, J BARTSCH, H CODA, M TALASKA, G KADLUBAR, F TI ACETYLATION PHENOTYPE, CARCINOGEN-HEMOGLOBIN ADDUCTS, AND CIGARETTE-SMOKING SO CANCER RESEARCH LA English DT Article C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079. NCI,FAMILY STUDIES SECT,BETHESDA,MD 20892. INT AGCY RES CANC,ENVIRONM CARCINOGENS & HOST FACTORS,F-69372 LYONS,FRANCE. MIT,WHITAKER COLL HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139. RP VINEIS, P (reprint author), DIPARTIMENTO SCI BIOMED & ONCOL UMANA,CANC EPIDEMIOL UNIT,I-10126 TURIN,ITALY. FU NIEHS NIH HHS [ES00597] NR 25 TC 123 Z9 123 U1 1 U2 2 PU AMER ASSOC CANCER RESEARCH PI PHILADELPHIA PA PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106 SN 0008-5472 J9 CANCER RES JI Cancer Res. PD MAY 15 PY 1990 VL 50 IS 10 BP 3002 EP 3004 PG 3 WC Oncology SC Oncology GA DC904 UT WOS:A1990DC90400024 PM 2334904 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI TRYPTOPHAN RECALL EXPANDED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 1 TC 2 Z9 2 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD MAY 9 PY 1990 VL 263 IS 18 BP 2421 EP 2421 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DB724 UT WOS:A1990DB72400005 PM 2329622 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI EXPANDED INDICATION FOR ZIDOVUDINE APPROVED SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 2 TC 2 Z9 2 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD MAY 9 PY 1990 VL 263 IS 18 BP 2421 EP 2421 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DB724 UT WOS:A1990DB72400003 PM 2329622 ER PT J AU NIGHTINGALE, SL AF NIGHTINGALE, SL TI TREATMENT IND FOR INTRATHECAL BACLOFEN SOLUTION SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material C1 US FDA,OFF HLTH AFFAIRS,ROCKVILLE,MD 20857. NR 0 TC 2 Z9 2 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD MAY 9 PY 1990 VL 263 IS 18 BP 2421 EP 2421 PG 1 WC Medicine, General & Internal SC General & Internal Medicine GA DB724 UT WOS:A1990DB72400004 PM 2329622 ER PT J AU RHEINSTEIN, PH AF RHEINSTEIN, PH TI REGULATORY STATUS OF PANCREATIC-ENZYME PREPARATIONS SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION LA English DT Editorial Material RP RHEINSTEIN, PH (reprint author), US FDA,CTR DRUG EVALUAT & RES,OFF DRUG STAND HFD200,5600 FISHERS LANE,ROCKVILLE,MD 20857, USA. NR 4 TC 4 Z9 4 U1 0 U2 0 PU AMER MEDICAL ASSOC PI CHICAGO PA 515 N STATE ST, CHICAGO, IL 60610 SN 0098-7484 J9 JAMA-J AM MED ASSOC JI JAMA-J. Am. Med. Assoc. PD MAY 9 PY 1990 VL 263 IS 18 BP 2491 EP 2492 DI 10.1001/jama.263.18.2491 PG 2 WC Medicine, General & Internal SC General & Internal Medicine GA DB724 UT WOS:A1990DB72400039 PM 2329638 ER PT J AU PARK, YMK YETLEY, EA AF PARK, YMK YETLEY, EA TI TREND CHANGES IN USE AND CURRENT INTAKES OF TROPICAL OILS IN THE UNITED-STATES SO AMERICAN JOURNAL OF CLINICAL NUTRITION LA English DT Article RP PARK, YMK (reprint author), US FDA,DIV NUTR,200 C ST SW,WASHINGTON,DC 20204, USA. NR 29 TC 16 Z9 16 U1 0 U2 0 PU AMER SOC CLIN NUTRITION INC PI BETHESDA PA 9650 ROCKVILLE PIKE SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998 SN 0002-9165 J9 AM J CLIN NUTR JI Am. J. Clin. Nutr. PD MAY PY 1990 VL 51 IS 5 BP 738 EP 748 PG 11 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DC624 UT WOS:A1990DC62400003 PM 2185622 ER PT J AU GREENLAND, S FAIRWEATHER, WR AF GREENLAND, S FAIRWEATHER, WR TI COMPARING PROPORTION EXPOSED IN CASE-CONTROL STUDIES USING SEVERAL CONTROL-GROUPS SO AMERICAN JOURNAL OF EPIDEMIOLOGY LA English DT Letter C1 US FDA,STAT APPLICAT & RES BRANCH,ROCKVILLE,MD 20857. RP GREENLAND, S (reprint author), UNIV CALIF LOS ANGELES,SCH PUBL HLTH,DEPT EPIDEMIOL,LOS ANGELES,CA 90024, USA. NR 5 TC 0 Z9 0 U1 0 U2 0 PU AMER J EPIDEMIOLOGY PI BALTIMORE PA 624 N BROADWAY RM 225, BALTIMORE, MD 21205 SN 0002-9262 J9 AM J EPIDEMIOL JI Am. J. Epidemiol. PD MAY PY 1990 VL 131 IS 5 BP 944 EP 944 PG 1 WC Public, Environmental & Occupational Health SC Public, Environmental & Occupational Health GA CY886 UT WOS:A1990CY88600028 PM 2321638 ER PT J AU KACHADORIAN, WA SPRING, KR SHINOWARA, NL MULLER, J PALAIA, TA DISCALA, VA AF KACHADORIAN, WA SPRING, KR SHINOWARA, NL MULLER, J PALAIA, TA DISCALA, VA TI EFFECTS OF SEROSAL HYPERTONICITY ON WATER PERMEABILITY IN TOAD URINARY-BLADDER SO AMERICAN JOURNAL OF PHYSIOLOGY LA English DT Article C1 NIA,GERONTOL RES CTR,BALTIMORE,MD 21224. US FDA,CTR BIOL EVALUAT & RES,DIV VIROL,BETHESDA,MD 20892. WINTHROP UNIV HOSP,DEPT MED,DIV NEPHROL,MINEOLA,NY 11501. RP KACHADORIAN, WA (reprint author), NHLBI,KIDNEY & ELECTROLYTE METAB LAB,BLDG 31,ROOM 5C12,BETHESDA,MD 20892, USA. NR 42 TC 7 Z9 7 U1 0 U2 1 PU AMER PHYSIOLOGICAL SOC PI BETHESDA PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 SN 0002-9513 J9 AM J PHYSIOL JI Am. J. Physiol. PD MAY PY 1990 VL 258 IS 5 BP C871 EP C878 PN 1 PG 8 WC Physiology SC Physiology GA DE097 UT WOS:A1990DE09700013 PM 2110422 ER PT J AU SHEPPARD, BS CARUSO, JA WOLNIK, KA FRICKE, FL AF SHEPPARD, BS CARUSO, JA WOLNIK, KA FRICKE, FL TI CHARACTERIZATION OF A HELIUM-ARGON MIXED-GAS PLASMA FOR THE DETECTION OF IODINE BY INDUCTIVELY COUPLED PLASMA OPTICAL-EMISSION SPECTROSCOPY SO APPLIED SPECTROSCOPY LA English DT Article C1 UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221. US FDA,CTR ELEMENTAL ANAL RES,CINCINNATI,OH 45202. NR 13 TC 15 Z9 15 U1 2 U2 3 PU SOC APPLIED SPECTROSCOPY PI FREDERICK PA PO BOX 1438, FREDERICK, MD 21701 SN 0003-7028 J9 APPL SPECTROSC JI Appl. Spectrosc. PD MAY PY 1990 VL 44 IS 4 BP 712 EP 715 DI 10.1366/0003702904087299 PG 4 WC Instruments & Instrumentation; Spectroscopy SC Instruments & Instrumentation; Spectroscopy GA DD240 UT WOS:A1990DD24000030 ER PT J AU OLSON, LK CARUSO, JA CREED, JT WOLNIK, KA FRICKE, FL AF OLSON, LK CARUSO, JA CREED, JT WOLNIK, KA FRICKE, FL TI EVALUATION OF A COOLED RECIRCULATING NEBULIZER FOR INDUCTIVELY COUPLED PLASMA SPECTROMETRY SO APPLIED SPECTROSCOPY LA English DT Article C1 UNIV CINCINNATI,DEPT CHEM,CINCINNATI,OH 45221. US FDA,CINCINNATI,OH 45201. US EPA,CINCINNATI,OH 45268. RI Creed, John/A-9187-2009 NR 12 TC 4 Z9 4 U1 0 U2 0 PU SOC APPLIED SPECTROSCOPY PI FREDERICK PA PO BOX 1438, FREDERICK, MD 21701 SN 0003-7028 J9 APPL SPECTROSC JI Appl. Spectrosc. PD MAY PY 1990 VL 44 IS 4 BP 716 EP 721 DI 10.1366/0003702904087406 PG 6 WC Instruments & Instrumentation; Spectroscopy SC Instruments & Instrumentation; Spectroscopy GA DD240 UT WOS:A1990DD24000031 ER PT J AU SIEGRIST, S LAPERCHE, Y CHOBERT, MN BULLE, F NAKHASI, HL GUELLAEN, G AF SIEGRIST, S LAPERCHE, Y CHOBERT, MN BULLE, F NAKHASI, HL GUELLAEN, G TI REGULATION OF MOUSE MAMMARY-GLAND GAMMA-GLUTAMYL-TRANSPEPTIDASE MESSENGER RNA DURING PREGNANCY, LACTATION AND WEANING SO BIOCHEMICAL JOURNAL LA English DT Article C1 HOP HENRI MONDOR,INSERM,U99,F-94010 CRETEIL,FRANCE. US FDA,DIV BIOCHEM & BIOPHYS,BETHESDA,MD 20892. NR 30 TC 19 Z9 19 U1 0 U2 0 PU PORTLAND PRESS PI LONDON PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ SN 0264-6021 J9 BIOCHEM J JI Biochem. J. PD MAY 1 PY 1990 VL 267 IS 3 BP 621 EP 624 PG 4 WC Biochemistry & Molecular Biology SC Biochemistry & Molecular Biology GA DC206 UT WOS:A1990DC20600009 PM 1971168 ER PT J AU WHITTAKER, P VANDERVEEN, JE AF WHITTAKER, P VANDERVEEN, JE TI EFFECT OF EDTA ON THE BIOAVAILABILITY TO RATS OF FORTIFICATION IRON USED IN EGYPTIAN BALADY BREAD SO BRITISH JOURNAL OF NUTRITION LA English DT Article RP WHITTAKER, P (reprint author), US FDA,DIV NUTR,200 C ST,SW HFF268,WASHINGTON,DC 20204, USA. NR 23 TC 17 Z9 18 U1 0 U2 1 PU CAMBRIDGE UNIV PRESS PI NEW YORK PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211 SN 0007-1145 J9 BRIT J NUTR JI Br. J. Nutr. PD MAY PY 1990 VL 63 IS 3 BP 587 EP 595 DI 10.1079/BJN19900145 PG 9 WC Nutrition & Dietetics SC Nutrition & Dietetics GA DK770 UT WOS:A1990DK77000017 PM 2116895 ER PT J AU BIER, JW SAWYER, TK AF BIER, JW SAWYER, TK TI AMEBAS ISOLATED FROM LABORATORY EYEWASH STATIONS SO CURRENT MICROBIOLOGY LA English DT Article C1 RESCON INC,ROYAL OAK,MD. RP BIER, JW (reprint author), US FDA,DIV MICROBIOL HFF-234,200 C ST SW,WASHINGTON,DC 20204, USA. NR 7 TC 6 Z9 6 U1 0 U2 0 PU SPRINGER VERLAG PI NEW YORK PA 175 FIFTH AVE, NEW YORK, NY 10010 SN 0343-8651 J9 CURR MICROBIOL JI Curr. Microbiol. PD MAY PY 1990 VL 20 IS 5 BP 349 EP 350 DI 10.1007/BF02091918 PG 2 WC Microbiology SC Microbiology GA CZ546 UT WOS:A1990CZ54600013 ER PT J AU BEGLEY, TH HOLLIFIELD, HC AF BEGLEY, TH HOLLIFIELD, HC TI EVALUATION OF POLYETHYLENE TEREPHTHALATE CYCLIC TRIMER MIGRATION FROM MICROWAVE FOOD-PACKAGING USING TEMPERATURE TIME PROFILES SO FOOD ADDITIVES AND CONTAMINANTS LA English DT Article RP BEGLEY, TH (reprint author), US FDA,DIV FOOD CHEM & TECHNOL,WASHINGTON,DC 20204, USA. NR 0 TC 21 Z9 23 U1 2 U2 12 PU TAYLOR & FRANCIS LTD PI LONDON PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE SN 0265-203X J9 FOOD ADDIT CONTAM JI Food Addit. Contam. PD MAY-JUN PY 1990 VL 7 IS 3 BP 339 EP 346 PG 8 WC Chemistry, Applied; Food Science & Technology; Toxicology SC Chemistry; Food Science & Technology; Toxicology GA DG899 UT WOS:A1990DG89900004 PM 2379651 ER EF